CELLULAR DOMAINS
ffirs01.indd i
5/6/2011 6:11:55 PM
CELLULAR DOMAINS
Edited by IVAN R. NABI
A JOHN WILEY & SONS, ...
95 downloads
2020 Views
144MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
CELLULAR DOMAINS
ffirs01.indd i
5/6/2011 6:11:55 PM
CELLULAR DOMAINS
Edited by IVAN R. NABI
A JOHN WILEY & SONS, INC. PUBLICATION
ffirs02.indd iii
5/6/2011 6:11:56 PM
Copyright © 2011 by Wiley-Blackwell. All rights reserved Published by John Wiley & Sons, Inc., Hoboken, New Jersey Published simultaneously in Canada No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without either the prior written permission of the Publisher, or authorization through payment of the appropriate per-copy fee to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400, fax (978) 750-4470, or on the web at www.copyright.com. Requests to the Publisher for permission should be addressed to the Permissions Department, John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, (201) 748-6011, fax (201) 748-6008, or online at http://www.wiley.com/go/permissions. Limit of Liability/Disclaimer of Warranty: While the publisher and author have used their best efforts in preparing this book, they make no representations or warranties with respect to the accuracy or completeness of the contents of this book and specifically disclaim any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives or written sales materials. The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Neither the publisher nor author shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages. For general information on our other products and services or for technical support, please contact our Customer Care Department within the United States at (800) 762-2974, outside the United States at (317) 572-3993 or fax (317) 572-4002. Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic formats. For more information about Wiley products, visit our web site at www.wiley.com. Library of Congress Cataloging-in-Publication Data: Cellular domains / edited by Ivan R. Nabi. p. ; cm. Includes bibliographical references and index. ISBN 978-0-470-59544-2 (cloth) 1. Cell membranes. I. Nabi, Ivan R. [DNLM: 1. Cell Membrane Structures. 2. Cell Physiological Phenomena. QH601.C435 2011 571.6'4–dc22
3. Cytoplasmic Structures.
QU 350]
2010042298 Printed in Singapore oBook ISBN: 9781118015759 ePDF ISBN: 9781118015735 ePub ISBN: 9781118013742 10
ffirs03.indd iv
9
8
7
6
5
4
3
2
1
5/17/2011 6:19:52 PM
.
This book is dedicated to my wife Hakima and children Nessim and Zachary as well as to my parents Ruth and Jim who have supported me throughout my career. It is first of all the work of the contributors, whom I thank enormously for their efforts. It is also the result of my own personal scientific journey that was shaped by my mentors, Avraham Raz and Enrique Rodriguez-Boulan, as well as by all the stimulating interactions I have enjoyed over the years with colleagues, collaborators, students and post-docs.
ffirs04.indd v
5/6/2011 6:11:57 PM
.
CO NTENTS
PREFACE
ix
CHAPTER 9
ENDOSOMES
147
Thierry Galvez and Marino Zerial CONTRIBUTORS PART I
xi CHAPTER 10 LYSOSOMES AND PHAGOSOMES
MEMBRANE DOMAINS
165
Guillaume Goyette and Michel Desjardins CHAPTER 1 CYTOSKELETON-INDUCED MESOSCALE DOMAINS
3
Ziya Kalay, Takahiro K. Fujiwara, and Akihiro Kusumi CHAPTER 2
CLATHRIN-COATED PITS
CHAPTER 11 ENDOPLASMIC RETICULUM JUNCTIONS
177
Jesse T. Chao and Christopher J.R. Loewen
23
PART III
CYTOSKELETAL DOMAINS
James R. Thieman and Linton M. Traub CHAPTER 3
CAVEOLAE
39
Dan Tse and Radu V. Stan CHAPTER 4
LIPID RAFTS
61
Leonard J. Foster CHAPTER 5
MODELING MEMBRANE
DOMAINS
71
Daniel Coombs, Raibatak Das, and Jennifer S. Morrison PART II
CHAPTER 12
CHAPTER 13
CHAPTER 14
87
113
Jody Groenendyk and Marek Michalak CHAPTER 8
THE GOLGI APPARATUS
James W. Dennis and Ivan R. Nabi
213
MICROTUBULES
229
CILIA
245
Laura K. Hilton and Lynne M. Quarmby
Michael Zick and Andreas S. Reichert CHAPTER 7 THE ENDOPLASMIC RETICULUM
MICROVILLI
Geoffrey O. Wasteneys and Bettina Lechner CHAPTER 15
ORGANELLAR DOMAINS MITOCHONDRIA
197
Florent Ubelmann, Sylvie Robine, and Daniel Louvard
CHAPTER 16 CHAPTER 6
THE ACTIN CYTOSKELETON
Jonathan A. Kelber and Richard L. Klemke
133
INTERMEDIATE FILAMENTS
267
Normand Marceau, Anne Loranger, Stéphane Gilbert, and François Bordeleau
PART IV ADHESIVE AND COMMUNICATING DOMAINS CHAPTER 17
FOCAL ADHESIONS
285
Caitlin Tolbert and Keith Burridge
vii
ftoc.indd vii
5/6/2011 6:11:59 PM
viii
CONTENTS
CHAPTER 18
THE ADHERENS JUNCTION
303
Christopher P. Toret and W. James Nelson
CHAPTER 22
NEURONAL DOMAINS
371
Jennifer S. Goldman and Timothy E. Kennedy
CHAPTER 19 SPECIALIZED INTERCELLULAR JUNCTIONS IN EPITHELIAL CELLS: THE TIGHT JUNCTION AND DESMOSOME 321
PART VI DOMAINS REGULATING GENE EXPRESSION
Keli Kolegraff, Porfirio Nava, and Asma Nusrat CHAPTER 23 CHAPTER 20
GAP JUNCTIONS
339
Jared M. Churko and Dale W. Laird
CHAPTER 24
POLARIZED CELLULAR DOMAINS PART V
CHAPTER 21
EPITHELIAL DOMAINS
393
THE NUCLEAR PORE
415
Richard W. Wozniak, Christopher Ptak, and John D. Aitchison 351
Nancy Philp, Liora Shoshani, Marcelino Cereijido, and Enrique Rodriguez-Boulan
CHAPTER 25
CYTOPLASMIC RNA DOMAINS
429
Henry Parker and Tom C. Hobman INDEX
ftoc.indd viii
NUCLEAR DOMAINS
Dale Corkery, Kendra L. Cann, and Graham Dellaire
445
5/6/2011 6:11:59 PM
PREFACE Cellular compartmentalization into and within organelles segregates biochemical reactions and increases local molecular concentrations, thereby promoting efficiency of cellular processes. Within membranes, subdomains generate lateral heterogeneity that organizes the spatial distribution of glycoprotein receptors and membrane proximal effectors. Morphologically identifiable plasma membrane domains include not only clathrin-coated pits and caveolae but also lipid rafts that form a class of membrane domains that are poorly defined morphologically. Cellular organelles, such as mitochondria, the endoplasmic reticulum, the Golgi apparatus, endosomes, and lysosomes, also define morphologically distinct domains whose functionality depends, in large part, on the establishment of “domains within domains.” Cellular organization is determined by cytoskeletal elements, including the actin and microtubule cytoskeletons, that generate cell surface microvilli and cilia, respectively, as well as intermediate filaments. Adhesive and communicating domains regulate interaction of the cell with the substrate through focal adhesions, as well as with other cells via adherens junctions, tight junctions, desmosomes, and gap junctions. The latter are particularly expressed in epithelial cells whose apical–basolateral polarization is critical to their transport function. Essentially, all cells are polarized, and the neuron represents a prime example of how cellular polarization results in the formation of functional domains. Nuclear domains control genetic regulation and transcription, and nuclear– cytoplasmic exchange and transport is mediated by the nuclear pore that delivers RNA to cytoplasmic domains that regulate RNA translation and degradation. Molecular determinants of cellular domains therefore include essentially all molecular components of the cell, including DNA, RNA, proteins, lipid, and glycans. Defining domains and understanding the molecular basis of their formation is central to understanding cellular function. Ivan R. Nabi
ix
fpref.indd ix
5/6/2011 6:11:58 PM
.
CONTRIBUTORS John D. Aitchison, PhD, Institute for Systems Biology, Seattle, WA 98103-8904 François Bordeleau, Centre de recherche en cancérologie de l’Université Laval and Centre de Recherche du Centre Hospitalier de Québec (CRCHUQ), Quebec City, Quebec, Canada Keith Burridge, PhD, Department of Cell and Developmental Biology and Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC 27599 Kendra L. Cann, Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada Marcelino Cereijido, MD, PhD, Center for Research and Advanced Studies, Department of Physiology, Biophysics and Neurosciences, Mexico City, Mexico Jesse T. Chao, Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada Jared M. Churko, Department of Anatomy and Cell Biology, Dental Science Building, University of Western Ontario, London, Ontario, Canada Daniel Coombs, PhD, Department of Mathematics and Institute of Applied Mathematics, University of British Columbia, Vancouver, British Columbia, Canada Dale Corkery, Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada Raibatak Das, PhD, Department of Mathematics and Institute of Applied Mathematics, University of British Columbia, Vancouver, British Columbia, Canada Graham Dellaire, PhD, Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada James W. Dennis, PhD, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada Michel Desjardins, PhD, Département de pathologie et biologie cellulaire, Université de Montréal, Montreal, Quebec, Canada Leonard J. Foster, PhD, Centre for High-Throughput Biology and Department of Biochemistry & Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada Takahiro K. Fujiwara, PhD, Center for Meso-Bio Single-Molecule Imaging (CeMI) and Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto, Japan Thierry Galvez, PhD, Max Planck Institute for Molecular Cell Biology and Genetics MPI-CBG, Dresden, Germany Stéphane Gilbert, PhD, Centre de Recherche en Cancérologie de l’Université Laval and Centre de Recherche du Centre Hospitalier de Québec (CRCHUQ), Quebec City, Quebec, Canada Jennifer S. Goldman, Center for Neuronal Survival, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada xi
flast.indd xi
5/6/2011 6:15:34 PM
xii
CONTRIBUTORS
Guillaume Goyette, PhD, Département de pathologie et biologie cellulaire, Université de Montréal, Montreal, Quebec, Canada Jody Groenendyk, PhD, Department of Biochemistry, School of Molecular and Systems Medicine, University of Alberta, Edmonton, Alberta, Canada Laura K. Hilton, Department of Molecular Biology & Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada Tom C. Hobman, PhD, Department of Cell Biology, University of Alberta, Edmonton, Alberta, Canada Ziya Kalay, PhD, Center for Meso-Bio Single-Molecule Imaging (CeMI), Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto, Japan Jonathan A. Kelber, PhD, UCSD School of Medicine, Department of Pathology and Moores Cancer Center, La Jolla, CA 92093-0612 Timothy E. Kennedy, PhD, Center for Neuronal Survival, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada Richard L. Klemke, PhD, UCSD School of Medicine, Department of Pathology and Moores Cancer Center, La Jolla, CA 92093-0612 Keli Kolegraff, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322 Akihiro Kusumi, PhD, Center for Meso-Bio Single-Molecule Imaging (CeMI), Institute for Integrated Cell-Material Sciences (iCeMS) and Research Center for Nano Medical Engineering, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan Dale W. Laird, PhD, Department of Anatomy and Cell Biology, Dental Science Building, University of Western Ontario, London, Ontario, Canada Bettina Lechner, PhD, Department of Botany, University of British Columbia, Vancouver, British Columbia, Canada Christopher J.R. Loewen, PhD, Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada Anne Loranger, PhD, Centre de recherche en cancérologie de l’Université Laval and Centre de Recherche du Centre Hospitalier de Québec (CRCHUQ), Quebec City, Quebec, Canada Daniel Louvard, PhD, CNRS, Institut Curie, Paris, France Normand Marceau, PhD, Centre de recherche en cancérologie de l’Université Laval and Centre de Recherche du Centre Hospitalier de Québec (CRCHUQ), Quebec City, Quebec, Canada Marek Michalak, PhD, Department of Biochemistry, School of Molecular and Systems Medicine, University of Alberta, Edmonton, Alberta, Canada Jennifer S. Morrison, Department of Mathematics and Institute of Applied Mathematics, University of British Columbia, Vancouver, British Columbia, Canada Ivan R. Nabi, PhD, Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, British Columbia, Canada Porfirio Nava, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322
flast.indd xii
5/6/2011 6:15:34 PM
CONTRIBUTORS
xiii
W. James Nelson, PhD, Department of Biology, Stanford University, Stanford, CA 94305 Asma Nusrat, PhD, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322 Henry Parker, PhD, Department of Cell Biology, University of Alberta, Edmonton, Alberta, Canada Nancy Philp, PhD, Department of Pathology, Anatomy and Cell Biology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107 Christopher Ptak, PhD, Department of Cell Biology, University of Alberta, Edmonton, Alberta, Canada Lynne M. Quarmby, PhD, Department of Molecular Biology & Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada Andreas S. Reichert, PhD, CEF Makromolekulare Komplexe, Mitochondriale Biologie, Fachbereich Medizin, Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany Sylvie Robine, PhD, CNRS, Institut Curie, Paris, France Enrique Rodriguez-Boulan, MD, Dyson Vision Research Institute, Departments of Ophthalmology and Cell Biology, Weill Medical College of Cornell University, New York, NY 10065 Liora Shoshani, PhD, Center for Research and Advanced Studies, Department of Physiology, Biophysics and Neurosciences, Mexico City, Mexico Radu V. Stan, MD, Department of Pathology, Dartmouth Medical School, One Medical Center Drive, Lebanon, NH 03756 James R. Thieman, Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261 Caitlin Tolbert, Department of Cell and Developmental Biology, University of North Carolina, Chapel Hill, NC 27599 Christopher P. Toret, PhD, Department of Biology, Stanford University, Stanford, CA 94305 Linton M. Traub, PhD, Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261 Dan Tse, MD, Department of Pathology, Dartmouth Medical School, One Medical Center Drive, Lebanon, NH 03756 Florent Ubelmann, PhD, CNRS, Institut Curie, Paris, France Geoffrey O. Wasteneys, PhD, Department of Botany, University of British Columbia, Vancouver, British Columbia, Canada Richard W. Wozniak, PhD, Department of Cell Biology, University of Alberta, Edmonton, Alberta, Canada Marino Zerial, PhD, Max Planck Institute for Molecular Cell Biology and Genetics MPI-CBG, Dresden, Germany Michael Zick, Adolf-Butenandt-Institut für Physiologische Chemie, Ludwig-MaximiliansUniversität München, München, Germany
flast.indd xiii
5/6/2011 6:15:34 PM
PART
I
MEMBRANE DOMAINS M
E MBR ANE BI L AYE R S form hydrophobic dividers within the aqueous environment that exists both within and without the cell. The plasma membrane surrounds the cell, segregating the intracellular milieu from the outside environment. Domain organization of the plasma membrane is based not only on lipidand protein-based interactions but also on the organization of the underlying actin cytoskeleton that impacts on molecular dynamics and function in the membrane (Chapter 1). Plasma membrane domains include not only clathrin-coated pits (Chapter 2), caveolae (Chapter 3), and less well-characterized lipid rafts (Chapters 4 and 5) but also cell-substrate adhesions (Chapter 17), cell–cell junctions (Chapters 18–20), and specialized polarized cellular domains (Chapters 13, 15, 21, and 22). Molecular transport across the plasma membrane and exchange with the extracellular milieu is the key to cellular functionality. It is mediated in large part by endocytosis via clathrin-coated pits (Chapter 2) and also, as described in later sections, by Golgi secretion (Chapter 8), exosomes (Chapter 9), transporters (Chapter 21), and gap junctions (Chapter 20). How lipids organize domains is a subject of intense investigation that has focused primarily on the role of lipid rafts (Chapters 1, 4, and 5). The underlying cytoskeleton controls and contributes to molecular dynamics in the plane of the membrane and to downstream signaling (Chapter 1; also Chapter 12), and the tools available to study and model membrane domain organization in living cells (Chapters 1 and 5) represent key elements of future research. Importantly, membrane domain organization is relevant not only to the plasma membrane but also to membranes of intracellular organelles (Chapters 6–11).
Cellular Domains, First Edition. Edited by Ivan R. Nabi. © 2011 John Wiley & Sons, Inc. Published 2011 by John Wiley & Sons, Inc.
1
p01.indd 1
5/6/2011 6:11:59 PM
.
CH A P T E R
1
CYTOSKELETON-INDUCED MESOSCALE DOMAINS Ziya Kalay Takahiro K. Fujiwara Akihiro Kusumi
DEFINITION The cell is much more than just a bag of protein juice. Indeed, many mechanisms exist in a living cell to keep its contents well organized. One of the most important apparatuses that the cell utilizes to organize the cytoplasm is the cytoskeleton. Therefore, the influence of the cytoskeleton on the two-dimensional fluid of the plasma membrane is an interesting subject. In this chapter, we will focus on this issue, and review the literature about the membrane domains delimited by the part of the actin-based cytoskeleton that is closely opposed to the cytoplasmic surface of the plasma membrane. This part of the cytoskeleton is referred to as the membrane skeleton. Due to its close association with the cytoplasmic surface of the plasma membrane, the membrane-skeleton meshwork directly influences the functions of the plasma membrane. As a consequence of the membrane-skeleton meshwork, the plasma membrane is effectively partitioned into mesoscale domains, or compartments, with sizes varying between 30 and 250 nm (with the exception of the larger 750-nm domain in the doubly nested compartments in normal rat kidney [NRK] cells; Fujiwara et al. 2002). We emphasize the characteristic size of these compartments, one to several hundred nanometers, that falls in the mesoscale, where collective dynamics of molecules play critical roles. At this size scale, the number of molecules in the system is insufficient for thermodynamics to hold, but is still too big to be tractable for quantum mechanics. In the plasma membrane, there are three types of major mesoscale domains (mesodomains): (1) membrane compartments delineated by the actin-based membrane skeleton; (2) raft domains, where specific proteins, glycosphingolipids, and cholesterol are concentrated; and (3) the protein oligomer domains. In this chapter, we will concentrate on the membraneskeleton-induced membrane compartments. Membrane lipids and proteins are both temporarily trapped in these membrane compartments with residency times between 1 ms and 1 second (Kusumi et al. 2005). Namely, the two key functional elements of the membrane are both influenced by the membrane skeleton, and a growing number of findings support the involvement of the membrane skeleton in many membrane processes (Gaidarov et al. 1999; Nakada et al. 2003; O’Connell et al. 2006; Lajoie et al. 2007; Chung et al. 2010; Treanor et al. 2010). In this respect, one of our main goals in this chapter is to provide an account of the various functions of these membrane-skeleton-based mesodomains. Cellular Domains, First Edition. Edited by Ivan R. Nabi. © 2011 John Wiley & Sons, Inc. Published 2011 by John Wiley & Sons, Inc.
3
c01.indd 3
5/6/2011 6:09:59 PM
4
CHAPTER 1
CYTOSKELETON-INDUCED MESOSCALE DOMAINS
HISTORICAL PERSPECTIVE One of the most important characteristics of the plasma membrane is that it is a twodimensional liquid. The fluid mosaic model proposed by Singer and Nicolson (1972) successfully accounted for many properties of the plasma membrane. In fact, this model is still widely believed to represent the basic structure of the plasma membrane (and intracellular membranes) of all living cells on earth. However, it fails to answer two basic questions, which have puzzled scientists for the past three decades: 1. Why do the membrane proteins and lipids diffuse faster in artificial membranes than in the cellular plasma membrane by a factor of ∼20 (ranging from 5 to 50)? (Murase et al. 2004) 2. How do molecular complexes become immobilized on the cell surface or diffuse at surprisingly lower rates, as compared with single molecules? (Kusumi et al. 2005)
Early Fluorescence Recovery After Photobleaching (FRAP) Observations Early measurements of diffusion coefficients using FRAP revealed significantly slower diffusion in the plasma membrane, as compared with that in artificially reconstituted membranes, by a factor of ∼20 (ranging from 5 to 50) (summarized by Murase et al. 2004). Some of these findings suggested that the discrepancy might be due to interactions between the cytoskeleton and the plasma membrane. In 1980, Sheetz et al. found that the diffusion coefficient of band 3 proteins in mouse erythrocyte mutants lacking the spectrin network is an order of magnitude higher than that in normal cells. In these cells, the membrane skeleton is formed by the spectrin network, and therefore, the results obtained with these mutant cells suggested that the membrane skeleton directly interferes with the diffusion of membrane proteins. For some other early examples of FRAP measurements that detected significantly reduced diffusivity in the plasma membrane (but not rotational diffusion; Tsuji et al. 1988), see the following references: Axelrod et al. (1976), Golan and Veatch (1980), Chang et al. (1981), Tsuji and Ohnishi (1986), and Tsuji et al. (1988).
Early Single-Molecule Observations: Membrane-Skeleton Fence Model for Transmembrane Proteins The advent of single-molecule imaging methods, such as single-particle tracking (SPT) and single fluorescent-molecule tracking (SFMT), allowed researchers to image and track single molecules in the plasma membrane of living cells. In 1994, by using SPT techniques, Sako and Kusumi observed that transferrin receptor and α2-macroglobulin receptor undergo a peculiar kind of motion, which is characterized by temporary confinement of the molecule in a bounded region of the membrane, with an average area of 0.25 μm2, interrupted by rare hops into adjacent, yet still temporarily confining, regions. This behavior was termed hop diffusion, as the membrane molecules seemed to be hopping between adjacent membrane compartments and diffusing freely within a compartment. Subsequent experiments showed that all of the transmembrane proteins in every cell type observed displayed hop diffusion as well. As the single-molecule imaging technique became more popular, a wealth of data started to accumulate that needed to be properly analyzed. The single-particle trajectories that exhibit hop diffusion have been analyzed by fitting appropriate models to them (see also Chapter 5 for further discussion of modeling single-particle trajectories). An early
c01.indd 4
5/6/2011 6:09:59 PM
HISTORICAL PERSPECTIVE
5
theoretical treatment by Powles et al. (1992) considered the diffusion of a particle trapped between partially permeable barriers arranged periodically in space. Here, exact mathematical expressions for some transport quantities in the system were obtained. In more recent treatments by Kenkre et al. (2008) and Kalay et al. (2008), exact formulas for the time-dependent mean square displacement and diffusion coefficient for a particle moving in a similar compartmentalized space were acquired, and the effects of disordered fence strengths and compartment sizes were predicted. The results of these works have successfully been used to deduce compartment sizes from single-particle trajectories recorded in the plasma membrane. Based on these findings, the membrane-skeleton fence model was proposed (Sako and Kusumi 1994; Kusumi and Sako 1996), in which the plasma membrane is effectively partitioned into mesoscale compartments. In this model, the membrane skeleton forms a meshwork near the cytoplasmic part of the plasma membrane with which the cytoplasmic domains of transmembrane proteins can interact. As a result of this interaction, transmembrane proteins are temporarily confined in membrane compartments induced by the membrane-skeleton meshwork. Transmembrane proteins can hop between adjacent compartments if the distance between the meshwork and the membrane becomes large enough, or if the meshwork temporarily and locally dissociates. See Figure 1.1 (top) for an illustration of these ideas. This new, compartmentalized view of the plasma membrane was further supported by an atomic force microscopy study of its cytoplasmic surface (Takeuchi et al. 1998), which produced similar estimates for the spectrin membrane-skeleton mesh size to those obtained by SPT of band 3 proteins in human erythrocyte ghosts (Tomishige et al. 1998).
Super-Speed Single-Molecule Imaging: Hop Diffusion of Phospholipids as well as Transmembrane Proteins and Anchored-Protein Picket Model Another striking discovery was made in 2002. Fujiwara et al. (2002) demonstrated that even phospholipids, which are the most basic molecular species for membrane formation, undergo hop diffusion between compartments with sizes similar to those detected by protein hop diffusion. In previous single-molecule observations, images were obtained at video (30 frames/s) or slower rates. However, the characteristic time for lipid residency within a compartment is generally much shorter than the time between two consecutive image frames employed in those observations. Therefore, the detection of membrane compartments for lipids had to wait for the development of ultrafast methods for performing SPT. Fujiwara et al. (2002) performed their measurements at a rate of 40,000 frames/s, the fastest single-molecule imaging ever made, and have increased the rate even further to 160,000 frames/s. The discovery of lipid molecules undergoing membrane-skeleton-dependent hop diffusion in the outer leaflet of the plasma membrane was very surprising, since they only reach halfway through the membrane and lack the cytoplasmic domains of transmembrane proteins. To explain the hop diffusion of phospholipids in the outer leaflet, the anchoredprotein picket model was proposed (Fujiwara et al. 2002; Kusumi et al. 2005), where lipids are envisaged to interact with the membrane skeleton indirectly through picket proteins that are attached to the membrane skeleton, as shown in Figure 1.1 (middle). Several different mechanisms for the interaction between lipids and protein pickets were proposed. First, the picket can block the passage of a lipid molecule due to volume exclusion, causing steric hindrance. Second, the lipid molecules can be packed more in the immediate vicinity of the picket than the bulk membrane, and thus the free area available for a lipid molecule
c01.indd 5
5/6/2011 6:09:59 PM
6
CHAPTER 1
CYTOSKELETON-INDUCED MESOSCALE DOMAINS
Membrane-skeleton fence model Transmembrane protein
START Actin filament (membrane skeleton)
Anchored-protein picket model START
Phospholipid
Anchored-protein pickets
Actin filament (membrane skeleton)
Picket-induced slowdown effect Anchored-protein picket Phospholipid
Actin filament
Low diffusivity domain
Figure 1.1. Schematic illustrations of the membrane-skeleton fence and anchored-protein picket models, and the picket-induced slowdown effect. According to the membrane-skeleton fence model (top), transmembrane proteins with protrusions in the cytoplasm are temporarily confined in membrane-skeleton-based compartments formed by a dynamic meshwork of actin filaments. Consequently, these proteins undergo hop diffusion, as illustrated by the color-coded trajectory. Lipids in the upper leaflet of the plasma membrane can also undergo hop diffusion even though they lack cytoplasmic domains. In the anchored-protein picket model (middle), the presence of pickets, proteins that are anchored to the boundaries of membrane-skeleton-based compartments, restricts the motion of all membrane molecules including lipids. As explained in the text, the presence of an immobile protein may locally reduce the diffusivity of lipids. This so-called picket-induced slowdown effect is illustrated in the bottom figure. Here, a lipid molecule in the close proximity of a picket, which we refer to as the low diffusivity domain, diffuses at a slower rate as compared with those far from the picket, as indicated by the smaller step size in the particle’s trajectory.
c01.indd 6
5/6/2011 6:09:59 PM
ELECTRON TOMOGRAPHY OF THE THREE-DIMENSIONAL STRUCTURE
7
to move into decreases, leading to diminishing mobility around the picket (Sperotto and Mouritsen 1991; Almeida et al. 1992). Third, lipid molecules can experience hydrodynamic slowing near an immobilized picket molecule, similar to a fluid particle that moves close to the boundary of a container (Bussell et al. 1994, 1995; Dodd et al. 1995). Therefore, lipid diffusivity can be reduced in the vicinity of a picket protein for different reasons, a phenomenon we call the picket-induced slowdown effect. A schematic illustration of the low diffusivity domain due to this effect is shown in Figure 1.1 (bottom). When many such immobilized picket proteins are aligned along the membrane-skeleton fence, the membrane molecules cannot easily pass through the compartment boundaries, and thus become temporarily confined within a compartment. Namely, in the anchored-protein picket model, the entire plasma membrane is partitioned into compartments by transmembrane protein pickets, lining the membrane-skeleton fence. By performing Monte Carlo simulations that account for the reduction in free area, the picket density along the compartment boundary necessary for reproducing the observed hop diffusion of lipids was estimated to be 20–30% (Fujiwara et al. 2002). Namely, the compartment boundaries do not have to be closed off by concentrating the transmembrane protein pickets there, but when only 1/5–1/3 of the boundary is occupied by picket proteins, it would be sufficient to induce temporary trapping of lipids within a compartment. It is important to note that the effect of anchored-protein pickets is not limited to that of mere protein crowding. Several studies have indicated that if the obstacles are mobile, then they do not lead to a significant decrease in the diffusion coefficient of the rest of the mobile particles. Monte Carlo studies by Saxton (1987, 1990), which did not consider hydrodynamic effects, demonstrated that mobile obstacles do not reduce the diffusivity as much as their immobile counterparts. Later on, Bussell et al. (1994, 1995) and Dodd et al. (1995) showed that the inclusion of hydrodynamic effects did not change this conclusion, provided that the lipids can be assumed to form a continuum. This assumption would not hold in cases where the protein diameter is comparable with the diameter of lipids (we will address this point later in this chapter), and one might consider the possibility that the details of collective protein–lipid dynamics on the mesoscale may determine the properties of the system. However, since the diffusion coefficients of proteins and lipids within a compartment are similar to those measured in liposomes, reconstituted membranes, and membrane blebs (see figs. 1 and 2 in Fujiwara et al. 2002 and figure 8 in Murase et al. 2004), the immobilization of obstacles (pickets) seems to be a key factor in the picket-induced slowdown effect. In addition, the proteins do need not be continually anchored in order to function as effective pickets. If the proteins are immobilized for more than ∼10 μs at a time, then this may suffice to produce the observed hindrance of lipid diffusion.
ELECTRON TOMOGRAPHY OF THE THREE-DIMENSIONAL STRUCTURE OF THE CYTOPLASMIC SURFACE OF THE PLASMA MEMBRANE Perhaps the most direct evidence for the membrane-skeleton-based partitioning of the plasma membrane was obtained in 2006 by Morone et al., who imaged the three-dimensional structure of the cytoplasmic surface of the plasma membrane by electron tomography. Here, electron tomography was first applied to platinum-replicated samples: the threedimensional structure of the cytoplasmic surface of the plasma membrane was reconstituted from the platinum-coated membrane specimen, prepared with minimal intrusion, by using the freeze-etching technique. These images clearly demonstrated that the membrane
c01.indd 7
5/6/2011 6:10:00 PM
8
CHAPTER 1
CYTOSKELETON-INDUCED MESOSCALE DOMAINS
NRK
Electron Tomography SPT
FRSK Finish
Start Finish Start
1 µm NRK cell Phospholipid (DOPE)
Figure 1.2. Electron microscopic images of the membrane skeleton of NRK (upper left) and fetal rat skin keratinocytes (FRSKs) (lower left) cells, where the scale bars in the main figures correspond to 100 nm. The inset in the lower left image highlights the 5.5-nm periodic striped pattern characteristic of actin filaments, showing that the membrane skeleton is primarily composed of actin filaments (scale bar 50 nm). Note that both of these images also contain clathrin-coated pits, which are distinguished by their lattice structure (from Morone et al. 2006). In the lower right corner, the trajectory of a gold-tagged phospholipid (DOPE) in an NRK cell, obtained by SPT at 40,000 frames/s, is displayed. The trajectory was color coded after performing a quantitative analysis that detects jumps between adjacent domains. The histograms in the upper right corner show that the size distribution of the membrane-skeleton meshes directly contacting the cytoplasmic surface of the plasma membrane, as determined by electron tomography, is very close to that of the compartments determined from the DOPE diffusion data in either NRK or FRSK cells, whereas the distributions for these two cell types are entirely different (in part from Fujiwara et al. 2002).
skeleton entirely covers the cytoplasmic surface of the plasma membrane, except for certain membrane domains, such as clathrin-coated pits (CCPs) (Chapter 2), caveolae (Chapter 3), and focal adhesions (Chapter 17), that the membrane-skeleton meshwork is primarily composed of actin filaments since almost every filament exhibited a distinct striped pattern with a 5.5-nm periodicity (see Fig. 1.2 for typical electron micrographs, although they are normal two-dimensional images), and that some of the meshwork is located as close as within a nanometer of the plasma membrane. Based on these images, the size distribution of the actin skeleton mesh on the cytoplasmic surface of the plasma membrane was obtained and found to agree well with the compartment sizes found by analyzing phospholipid hop diffusion as revealed by SPT. This result strongly supports the partitioning of the plasma membrane by membraneskeleton fences and transmembrane protein pickets lining the fence.
c01.indd 8
5/6/2011 6:10:00 PM
ANSWERS TO THE TWO THREE-DECADE-OLD ENIGMAS
9
ANSWERS TO THE TWO THREE-DECADE-OLD ENIGMAS The fence–picket model gives straightforward answers to the two three-decade-old questions raised in the beginning of this section. 1. Why do membrane proteins and lipids diffuse faster in artificial membranes than in the cellular plasma membrane by a factor of ∼20 (ranging from 5 to 50)? As stated in the previous paragraph, the diffusion coefficient within a compartment is not small, as compared with that in artificial membranes. However, if the diffusion coefficient is measured on much greater scales, for example, a FRAP spot size of ∼500 nm, or at slower observation rates, for example, single-molecule tracking observed at a rate of 30 frames/s or slower, then the diffusion appeared to be slow because what was observed is the apparent diffusion coefficient, which is affected by the presence of compartment boundaries. It takes time to hop from one compartment to an adjacent one, which makes the macroscopic diffusion of lipids and proteins in the plasma membrane very slow. 2. How do molecular complexes become immobilized on the cell surface or diffuse at surprisingly lower rates, as compared with single molecules? This can be explained by the “oligomerization-induced trapping” effect of the fences and pickets. Monomers of membrane molecules may hop across the intercompartment boundaries with relative ease, but upon forming oligomers or molecular complexes, the entire complex, rather than single molecules, has to hop across the picket–fence all at once, and therefore, these complexes are expected to hop across the boundaries at much slower rates. In addition, due to the avidity effect, molecular complexes are more likely to be bound to the membrane skeleton, perhaps temporarily, which also induces (temporary) immobilization or trapping of oligomers and molecular complexes. Such enhanced confinement and binding effects induced by oligomerization or molecular complex formation are collectively termed oligomerization-induced trapping (Kusumi and Sako 1996; Iino et al. 2001; Kusumi et al. 2005). One might argue that even in the absence of membrane-skeleton fences and anchored pickets lining the fences, the oligomerization of membrane proteins could greatly reduce the diffusion coefficient. However, experimental and theoretical studies clearly showed that this does not occur with transmembrane proteins that contain approximately three or more membrane-spanning α-helices (Saffman and Delbrück 1975; Peters and Cherry 1982; Vaz et al. 1982; Liu et al. 1997; Gambin et al. 2006). Based on these studies, we predict that tetramer formation from monomers (a twofold increase in radius) will only decrease the diffusion coefficient by a factor of 1.1, and even 100mers (a 10-fold increase in radius) will have a diffusion rate reduced by only a factor of less than 2 from that of monomers. Therefore, the large reductions of the diffusion coefficient, upon oligomerization or molecular complex formation, clearly indicate that the plasma membrane cannot be considered as a two-dimensional fluid continuum, and that the fence–picket model is consistent with the experimental observations and theoretical predictions. In artificial membranes without the membrane skeleton, Liu et al. (1997) and Gambin et al. (2006) reported decreases of the diffusion coefficient by a factor of ∼2 when the probe hydrodynamic diameter (in the cross section of the transmembrane domain parallel to the membrane surface) was increased by a factor of ∼2 from the original diameter of ∼0.5 nm. In this spatial scale, the probe (solute) size is comparable with the solvent
c01.indd 9
5/6/2011 6:10:00 PM
10
CHAPTER 1
CYTOSKELETON-INDUCED MESOSCALE DOMAINS
molecular size, and the continuum fluid model is no longer correct. Therefore, the translational diffusion coefficient of the test particle strongly depends on its diameter on this particular spatial scale. However, this should not be confused with the reduction in the diffusion coefficient when single-pass transmembrane proteins, such as many receptor molecules, form oligomers in the plasma membrane. The size-dependent decrease of the diffusion coefficient observed in artificial membranes (Liu et al. 1997; Gambin et al. 2006) occurs only for test particles of ∼0.5 nm in diameter undergoing virtually simple diffusion, which exhibits a monomer diffusion coefficient of ∼10 μm2/s. In the plasma membrane, the effective diffusion coefficients of single-pass transmembrane protein monomers are generally ∼0.2 μm2/s, which are already slower by a factor of 50 than those found in artificial membranes. Oligomerization of such a single-pass transmembrane protein tends to decrease the diffusion coefficient by a factor of ∼2, but the weak resemblance of these reduction factors is merely incidental. The oligomerization-induced reduction of the diffusion coefficient in the plasma membrane was not due to changes in protein interaction with membrane lipids, as was found in artificial membranes, but rather to the compartment boundaries. Evidence for this statement comes from high-speed single-molecule tracking data. Single-pass transmembrane proteins generally exhibit hop diffusion between compartments, with a microscopic diffusion coefficient within a compartment of 5–10 μm2/s and a residency time of 20–100 ms, and oligomerization lengthened the residency time without affecting the compartment size and the microscopic diffusion coefficient within a compartment (Murase et al. 2004; Kusumi et al. 2005). This clearly indicates the necessity for being careful in interpreting long-range, slow-speed diffusion measurements, for carrying out high-speed single-molecule tracking, and for careful attention to loosely applying the results of Liu et al. (1997) and Gambin et al. (2006) to the observations made in the plasma membrane. In addition to the corralling effect of the membrane skeleton and associated transmembrane protein pickets, three major factors are frequently discussed in the literature to account for the slower diffusion of membrane molecules in the cellular plasma membrane, observed by methods with low spatiotemporal resolutions: the crowding effect of transmembrane proteins, the trapping or exclusion effect of raft domains, and the ordering effect of cholesterol. All three of these factors can lead to a decrease in molecular mobility in the plasma membrane, but even if all of these three factors are combined, a decrease in the diffusion coefficient by a factor of 20 cannot be explained (perhaps, a factor of 2 could be explained). Some of the phenomena including the immobilization of receptor complexes can only be explained by considering the effects of the membrane skeleton.
MEMBRANE-SKELETON-BASED MESODOMAINS ARE NOT DETECTED IN EVERY STUDY A number of studies failed to detect the effect of the membrane skeleton on the diffusivity of membrane molecules. Two FRAP studies (Schmidt and Nichols 2004; Frick et al. 2007) found that disruption of the cortical actin did not lead to significant changes in the diffusivity of some membrane proteins and a lipid analog. However, experiments involving drug-induced actin (de)polymerization revealed various effects, depending on the drug concentration, the treatment duration, and the cell type, and thus comparisons of the results are difficult (Vrljic et al. 2005; Umemura et al. 2008). For the intricate cell reactions to such treatments, see Suzuki et al. (2005). Furthermore, Fujiwara et al. (2002) and Murase
c01.indd 10
5/6/2011 6:10:00 PM
MEMBRANE-SKELETON-BASED MESODOMAINS ARE NOT DETECTED IN EVERY STUDY
11
et al. (2004) found that without directly observing the compartment size and the residency time within a compartment, detecting drug-induced changes will be difficult. In studies using fluorescence correlation spectroscopy (FCS) (Wawrezinieck et al. 2005; Lenne et al. 2006) and stimulated emission depletion–FCS (STED-FCS) (Eggeling et al. 2009), phospholipid analogs were observed to diffuse freely. To detect hop diffusion in FCS experiments, the focal area of the laser should be less than the characteristic compartment size. In STED-FCS (Eggeling et al. 2009), the diameter of the laser beam can be as small as 30 nm, which is comparable with the smallest compartment sizes reported in the literature (Murase et al. 2004). Therefore, a further decrease in the diameter of the laser beam seems to be necessary for determining the true nature of molecular diffusion by FCS techniques. In addition to these results obtained by measuring the signal from many molecules simultaneously, several single-molecule/particle studies also did not find hop diffusion. For instance, Wieser et al. (2007, 2008) found simple Brownian diffusion of lipids and a glycosylphosphatidylinositol (GPI)-anchored protein CD59, and Crane and Verkman (2008) reported the observation of freely diffusing aquaporin-1 water channels. In these studies, the rate at which the images were acquired was 2000 Hz or less, resulting in determination of the positions of single molecules at relatively sparse time points such that it would simply be impossible to detect fast hop diffusion among mesoscale compartments. In fact, careful attention must always be paid to the camera frame rates relative to the molecular hop frequency in each cell type when interpreting the single-molecule tracking results, since this is a key factor in the ability to detect confinement. The residency time of a molecule in a compartment may vary between one to hundreds of milliseconds, and will be shorter for lipids (Fujiwara et al. 2002; Murase et al. 2004) and longer for proteins (Tomishige et al. 1998; Tomishige and Kusumi 1999). Especially for lipids, to obtain statistically significant results, single-molecule/particle tracking must be performed at very high speeds. At a camera speed of 40,000 Hz, which was used by Fujiwara et al. to detect the hop diffusion of lipids, the time between two consecutive frames is 25 μs, thus allowing one to obtain 40 data points even for short residency times such as 1 ms (Fujiwara et al. 2002; Murase et al. 2004). Readers are referred to Murase et al. (2004) for the residency times of an unsaturated phospholipid, 1,2-dioleoyl-sn-glycero-3phosphoethanolamine (DOPE), in a number of different cells. The residency time divided by 40 essentially provides a good estimate of the inverse frame rate that is necessary to detect hop diffusion. For example, Sahl et al. (2010) reported that they failed to detect the hop diffusion of a fluorescent phospholipid analog, but instead found alternating temporary entrapment within a domain (30% of the observed duration) and simple Brownian diffusion (70%) in the plasma membrane of PtK2 cell, using an SFMT method with a time resolution of 0.5 ms. Using the same cell line, the average residency time of a phospholipid within a compartment was found to be ∼1 ms (Fujiwara and Kusumi, unpublished observations). This result indicates that, to detect the hop diffusion of phospholipids, the time resolution of the instrument must be better than 0.025 ms, suggesting that the results obtained by Sahl et al. (2010) are due to the lack of time resolution (on average, they made only two coordinate determinations during the average residency time of 1 ms): when a molecule stays in a compartment much longer than average, even the 0.5-ms observation rate would be sufficient to detect confinement, but when the molecule stays in compartments for shorter periods, a 0.5-ms resolution would be insufficient to detect confinement, thus reporting simple Brownian diffusion.
c01.indd 11
5/6/2011 6:10:00 PM
12
CHAPTER 1
CYTOSKELETON-INDUCED MESOSCALE DOMAINS
MOLECULAR COMPOSITION OF THE MEMBRANE SKELETON As shown previously (Heuser and Kirschner 1980; Hirokawa and Heuser 1981; Hirokawa et al. 1982; Morone et al. 2006; Hanson et al. 2008), the membrane skeleton mainly consists of actin filaments (see also Chapter 12). Actin filaments grow at their fast growing ends, which interact with the membrane (Small et al. 1978; Wang 1985). Therefore, the membrane compartments should depend on the proteins involved in actin polymerization, including the Arp2/3 complex, Wiskott–Aldrich syndrome protein (WASP), suppressor of cyclic AMP receptor (SCAR)/WASP family verprolin-homologous protein (WAVE), cortactin, and the formin family of proteins (Pollard 2007; Campellone and Welch 2010), as well as those involved in actin depolymerization such as the cofilin family of proteins (Bernstein and Bamburg 2010). Actin filaments and the plasma membrane are also linked by proteins that can laterally bind to actin, including ponticulin; the ezrin/radixin/moesin family of proteins; the villin–gelsolin superfamily proteins; the epithelial protein lost in neoplasm, filamin, dystrophin and utrophin, and tropomyosin; and the myosin family of proteins (Morone et al. 2008). Furthermore, actin filaments bind to various other membrane-associated proteins and lipids with low affinities, to facilitate dynamic associations with the membrane. This easy binding to and dissociation from the membrane would be needed for the dynamic regulation of the diffusivities of various molecules in the plasma membrane. Despite such low affinities, the binding sites would be numerous, making the dynamic binding very effective, although rendering their binding undetectable in general pull-down assays. As indicated in a previous section, transmembrane proteins transiently bound to the membrane skeleton would serve well as a diffusion barrier, if the anchored durations are greater than ∼10 μs. In normal erythrocytes, the organization of the membrane skeleton has been studied extensively and is known to be different from those of other cell types. The erythrocyte membrane-skeleton mesh is composed of a network of spectrin tetramers, acting as fences, which are cross-linked by protein complexes formed by short actin filaments, adducin, band 4.1, and the transmembrane protein glycophorin C, anchoring the entire network to the plasma membrane (Goodman et al. 1988; Bennett 1990; Anong et al. 2009). Spectrin tetramers form by the tail-to-tail linkage of spectrin dimers, and the dimers and the tetramers exist in a very dynamic equilibrium. For the passage of transmembrane proteins across the spectrin fences, a spectrin tetramer dissociation gate model (SPEQ gate model) was proposed. In the model, the dissociation of a spectrin tetramer into dimers entails transient gate opening, allowing transmembrane molecules to pass through the compartment boundaries (Tomishige et al. 1998). Malfunctions of the human erythrocyte membrane skeleton often lead to serious types of anemia, indicating the important roles played by the membrane skeleton in the functions, stability, and flexibility of the plasma membrane (Bennett and Healy 2008; Kodippili et al. 2009).
FUNCTIONS OF MEMBRANE-SKELETON-INDUCED MESODOMAINS Effects of the Membrane Skeleton on Signaling B-Cell Receptor (BCR) Signal Transduction: The Membrane Skeleton May Be Involved in the Formation of Receptor Oligomers and/or Engaged-ReceptorBased Lipid Rafts Several different mechanisms for the relationship between the actin cytoskeleton and BCR signaling have been proposed. In the oligomeric BCR complex model (Reth et al. 2000;
c01.indd 12
5/6/2011 6:10:00 PM
FUNCTIONS OF MEMBRANE-SKELETON-INDUCED MESODOMAINS
13
Schamel and Reth 2000), disruption of BCR oligomers was considered to be required for signaling, and the role of the membrane skeleton in regulating the formation and maintenance of oligomers was discussed. In another approach, the effect of lipid rafts was emphasized (see also Chapters 4 and 5). In this model, BCR is considered to enter rafts only upon antigen binding, which is accompanied by the coalescence of smaller rafts. This in turn enables BCR to react with raft-associated kinases to start signaling (Tolar et al. 2005; Gupta et al. 2006; Gupta and DeFranco 2007; Sohn et al. 2008). The membrane skeleton can participate in the regulation of signaling as it restricts the growth and coalescence of lipid rafts. Recent observations by Treanor et al. (2010) showed that the treatment of cells with actin-modulating chemicals resulted in up to a 10-fold change in the diffusivity of BCR, suggesting that the membrane skeleton can control the mobility of these molecules. Furthermore, the expression level of ezrin, which is among the proteins that can form a link between the cytoskeleton and membrane proteins, also caused a change in BCR diffusivity by a factor greater than 3. This finding is also consistent with the anchored-protein picket model, since ezrin could act as a link between the protein pickets and the membrane skeleton. Moreover, the crosslinking of BCR and the dynamics of the membrane skeleton were correlated, and BCR signaling upon antigen binding leads to significant cytoskeletal reorganization (Fleire et al. 2006; Arana et al. 2008; Lin et al. 2008). Interestingly, alteration of the actin cytoskeleton also led to B-cell signaling comparable with that elicited by BCR cross-linking. Therefore, a clear link exists between the membrane skeleton and BCR signaling, implying that membrane mesodomains can play a critical role in this process, by controlling the distribution of membrane molecules.
Epidermal Growth Factor (EGF) Receptor (EGFR) and IgE-Fc (FC portion of Immunoglobulin E) Receptor Signal Transduction: The Membrane Skeleton May Increase the Receptor Oligomerization Rate and Promote Receptor Activity Together with the Galectin Lattice Lajoie et al. (2007) raised the question of how the three mechanisms of regulating the dynamics, clustering, distribution, and function of the EGFR are coordinated: (1) Galectin-3 is located on the extracellular surface of the plasma membrane and cross-links β1,6GlcNAc-branched N-glycans on cell-surface glycoproteins, including EGFR, to form a heterogeneous lattice; (2) caveolin-1 (Cav1), a major constituent of caveolae, acts as a negative regulator of growth factor signaling (Parton and Simons 2007), and in addition, Cav1 forms noncaveolar microdomains, which are likely to contain at least 15 Cav1 molecules (Parton et al. 2006); (3) membrane-skeleton fences and pickets suppress the diffusion of EGFR, and particularly that of the signal-capable receptor oligomers. Lajoie et al. (2007) showed that the extracellular galectin-3 lattice interacts with the N-glycans on EGFR and impedes its diffusion, which predominantly protects EGFR from loss to caveolae and Cav1 microdomains where EGFR signaling is suppressed. Disruption of the actin membrane skeleton with latrunculin A increased the mobile fraction of EGFR measured by FRAP, suggesting that the galectin-bound EGFR is further stabilized by the actin membrane skeleton. It is likely that galectin-3 cross-links EGFR to other actinassociated membrane glycoproteins or pickets, thus generating actin-stabilized signaling domains. Using quantum-dot-based SPT techniques, Chung et al. (2010) measured the diffusion coefficient of EGFR as a function of time. Assuming a relationship between diffusivity and molecular size, the authors inferred that EGFRs form transient oligomers, even in the absence of ligand, with lifetimes ranging from a few to a few tens of seconds. Interestingly, the probability of finding receptor dimers was reportedly higher at the
c01.indd 13
5/6/2011 6:10:00 PM
14
CHAPTER 1
CYTOSKELETON-INDUCED MESOSCALE DOMAINS
periphery of EGFR-overexpressing A431 and BT20 cells, in an actin-dependent manner. The abundance of dimers along the cell periphery might be a consequence of the increased collision frequency of receptors confined in the mesodomains delimited by the membrane skeleton. Previous observations provided evidence for the increased density of actin filaments near the leading edge of migrating cells (Borisy and Svitkina 2000; Pollard et al. 2000). In this respect, another function of the membrane-skeleton-induced compartments could be promoting the formation of receptor complexes, and enabling the polarized response after ligand binding that is necessary in certain cellular processes such as chemotaxis. The involvement of raft domains induced by receptor engagement in signaling, by enhancing the recruitment of Lyn kinase and reducing the collisions with phosphatases, was shown in the case of the IgE-Fc receptor, FcεRI (Field et al., 1997; Wu et al. 2004; Young et al. 2005). In addition, the involvement of membrane-skeleton-delimited compartments was found by simultaneous observations of the quantum-dot-labeled FcεRI and green fluorescent protein (GFP)-tagged actin (Andrews et al. 2008). The diffusion rate of cross-linked receptor in cells with a disrupted actin cytoskeleton was significantly higher than that in intact cells, in accordance with oligomerization-induced trapping. Immobilization of cross-linked receptors at the onset of signaling (Menon et al. 1986) also enables the cell to remember the position of the stimulus for short periods (on the order of 10 seconds) and to perform localized responses. This is essential in certain processes, such as chemotaxis. Therefore, the actin meshwork is also involved in reliably responding to local changes in the environment (Kusumi and Sako 1996; Kusumi et al. 2005). In fact, receptor redistribution and clustering are key steps in many signal transduction pathways (Petrini et al. 2004; Minguet et al. 2007; Briegel et al. 2009; Nikolaev et al. 2010). Several reports have indicated the active roles played by the cytoskeleton in inhibiting (Wang et al. 2001; Boggs and Wang 2004) or enabling (Gomez-Mouton et al. 2001; Rodgers and Zavzavadjian 2001; Baumgartner et al. 2003) the redistribution/ clustering of membrane molecules. In oligodendrocytes, stimulation of the cells induced actin depolymerization that was followed by coclustering of membrane molecules, including myelin basic protein and galactosylceramide (Boggs and Wang 2004). However, when the actin filaments were artificially stabilized, coclustering was not observed. This observation is consistent with the presence of membrane-skeleton-based mesodomains, since lateral diffusion, which is necessary for coclustering, is hindered by the presence of actinbased membrane-skeleton fences and pickets. Kv2.1 Potassium Channels: The Membrane Skeleton Is Involved in Cluster Maintenance and Distribution FRAP and quantum-dot-based imaging revealed that Kv2.1 potassium channels form dynamic clusters with sizes and spatial distributions that are influenced by the actin-based membrane skeleton (O’Connell et al. 2006). Interestingly, the individual channels diffused freely within a cluster, suggesting that the clusters might actually be channels corralled by the membrane skeleton. This proposal was further supported by the results obtained upon disruption of the membrane skeleton by latrunculin A treatment, which resulted in a 10-fold increase in the average cluster area and a decrease in the number of clusters, indicating that the smaller clusters merged during the treatment. Furthermore, the spatial distribution of Kv2.1 channels in hippocampal neurons was also affected by the disruption of the membrane skeleton (O’Connell et al. 2006). In cells with an intact cytoskeleton, the channels were restricted to the cell body. However, after the latrunculin A treatment, the channels were found in the neurites as well as in the cell body. These observations suggest that the Kv2.1 clusters are maintained in membrane-
c01.indd 14
5/6/2011 6:10:00 PM
FUNCTIONS OF MEMBRANE-SKELETON-INDUCED MESODOMAINS
15
skeleton-based mesodomains and that an actin-based mechanism is involved in determining the spatial distribution of Kv2.1 channels.
Micron-to-Cell-Sized Diffusion Barriers Generated by the Membrane-Skeleton Fences and Associated Pickets Numerous experiments have indicated that diffusion barriers, with sizes between a micron to several tens of microns, thus producing macroscopic plasma membrane domains, might be generated by the actin-based membrane-skeleton fences and the transmembrane picket proteins lining the fence. In the following, we will discuss a few such cases. A study on fish keratocytes revealed the presence of an F-actin-dependent lipid diffusion barrier, located at the leading edge of migrating cells (Weisswange et al. 2005). In boar sperm cells, observations indicated the presence of a diffusion barrier between the equatorial segment and the postacrosome, which prevents the passage of large molecular complexes. Based on the diffusivity measurements and the topographical properties of the cell surface revealed by atomic force microscopy, the authors suggested that a high concentration of anchored transmembrane proteins in the region could be involved in forming the barriers (James et al. 2004). The plasma membrane of the neuron consists of two distinct domains: the somatodendritic and axonal domains (Kobayashi et al. 1992; Winckler et al. 1999). Single-molecule imaging of a phospholipid revealed the developmental formation, by day 10 after birth in cultured hippocampal neurons (see also Chapter 22 on neuronal domains), of a diffusion barrier that blocks the diffusion of even phospholipids in the plasma membrane, in the boundary region between the two domains, called the initial segment (Nakada et al. 2003). Moreover, the barrier was formed by highly concentrating various transmembrane proteins and membrane skeletal proteins, including actin filaments and ankyrin, which bound to each other to create very dense rows of anchored pickets. This would effectively block diffusion, even that of phospholipids, in accordance with the anchored-protein picket model. More recently, Renner et al. (2009) made a surprising discovery concerning lipid diffusion, not necessarily involving diffusion barriers, in the synaptic membranes of mature hippocampal neurons. The authors showed that the lipids ganglioside GM1 and DOPE, and the artificial fluorescent lipid probe DiIC18, undergo confined diffusion in submicron-sized regions whose extent is proportional to molecular size, being the smallest for DOPE (∼110 nm). For a review on how singlemolecule techniques have played an important role in the advancement of synaptic biology, the readers are referred to Triller and Choquet (2008).
The Role of the Membrane Skeleton in CCP Formation during Endocytosis CCP-mediated endocytosis constitutes the major route for the uptake of nutrients and signaling ligands, as well as for the entry of viruses and toxins (see also Chapter 2 on CCPs). CCPs are very closely associated with or bound by the actin filaments in the membrane skeleton, as seen in the electron microscopic images in Figure 1.2. Consistent with this observation, the mobility of CCPs visualized by GFP-tagged clathrin light chain was found to be highly restricted to submicron regions (0.5–0.8 μm in diameter) in the plasma membrane, and the disruption of actin filaments by latrunculin B led to the increased mobility of CCPs (Gaidarov et al. 1999). In a different study (Ehrlich et al. 2004), the analysis of the experimental data suggested that the CCPs are preferentially formed in the so-called active domains of ∼400 nm in diameter, which are similar in size to the membrane-skeleton-based domains. Total internal reflection fluorescence
c01.indd 15
5/6/2011 6:10:00 PM
16
CHAPTER 1
CYTOSKELETON-INDUCED MESOSCALE DOMAINS
microscopic studies (Merrifield et al. 2002; Yarar et al. 2005) have revealed that actin polymerization is required when CCPs are undergoing invagination and scission. These results suggest the involvement of the dynamic actin meshwork in CCP formation. However, others have shown that this is not always true, depending on the cell type (Fujimoto et al. 2000) and the choice of locations on the cell surface (Saffarian et al. 2009; upper surface vs. lower surface in contact with the coverslip). Thus, CCP researchers are still vigorously discussing the possible roles of both actin polymerization (to generate force for membrane deformation) and depolymerization (to remove the dense actin meshwork that would otherwise form a steric barrier) in the regulation of CCP formation.
Regulation of Lipid Rafts by the Membrane-Skeleton-Based Compartments Lipid domains/rafts are important, and difficult to detect, constituents of the plasma membrane (see also Chapters 4 and 5 on lipid rafts). They are considered to participate in many membrane processes, including the formation of platforms for signaling molecules. In resting cells, rafts could be highly dynamic entities with a wide range of diameters. In the literature, the estimated diameters of raft-associated molecule clusters have been reported to be 5–15, 20, 50–80, 120, and 700 nm. Many different structures and processes have been proposed to describe the generation and maintenance of rafts (Kusumi et al. 2004, 2010). Among these, membrane-skeleton-induced compartmentalization can be a major regulator of raft dynamics. Most transmembrane proteins are known to exclude cholesterol from their boundary regions. Therefore, an array of anchored-protein pickets would prevent the motion and growth of rafts in their vicinity. As a result, one would expect the raft size to be limited by the typical membrane-skeleton-delimited compartment size of 30–250 nm, which is quite consistent with experimental findings.
Reaction Kinetics: Increased Collision Rate due to the Presence of Membrane-Skeleton-Based Compartments When reactants are confined to a region with a characteristic size that is comparable with their mean free path, the frequency of collisions between them will increase (see, for instance, Saxton 2002 for a discussion). However, the overall efficiency of the reaction can increase or decrease depending on the details of the compartmentalization and the properties of the reactants (Melo et al. 1992). The collision frequency of molecules in the plasma membrane has not been directly measured. Nevertheless, as mentioned earlier in this section, at least one experiment in the live-cell plasma membrane suggested a modification in the oligomerization rate of EGFR by the increased density of the actin-based membrane skeleton (Chung et al. 2010). The presence of membrane-skeleton-based compartments has two competing effects on reaction kinetics. One of them is to increase the time required for the reactants to collide for the first time (if initially they are not in the same compartment), since the long-term diffusivity is reduced by compartmentalization. The other is a substantial decrease in the first recollision time, along with a significant increase in the collision frequency, when the reactants are within the same compartment. Together, these effects can selectively control the kinetics of reactions in the membrane. For instance, at low concentrations, chemically limited reactions that require many collisions would be promoted, whereas diffusion-limited reactions would be suppressed. A detailed analysis of the modifications of reaction kinetics due to membrane-skeleton-based compartments is in progress in our laboratories.
c01.indd 16
5/6/2011 6:10:00 PM
FUTURE PERSPECTIVES
17
Artificial Regulation of Membrane Molecular Dynamics Using Fabricated Mesostructures Recently, membrane-skeleton-induced mesodomains or compartments have inspired new lines of research. Using nanofabricated materials, structures similar to membrane mesodomains have been conducted. Several recent examples of such studies can be found in Mossman et al. (2005), Tsai et al. (2008), Kam (2009), Takimoto et al. (2009), and Salaita et al. (2010). Tsai et al. (2008) constructed supported lipid bilayers on a glass substrate patterned with 50-nm-wide chromium or titanium stripes, separated by 125–250 nm. The stripes were tall enough to act as perfect barriers to lipid diffusion, but they contained periodically placed gaps that allowed the lipids to pass. Using FRAP, the authors demonstrated that the characteristics of lipid diffusion on large and small spatial/temporal scales are very different, with the short-range/time diffusivity being much higher. Although this artificial system is quite different from the cellular plasma membrane, it is a good example of a controllable nano–meso structure that can mimic biological systems. In addition, Mossman et al. (2005) used artificial structures to manipulate the geometry of immunological synapses, the interfaces between T cells and their target cells (Grakoui et al. 1999; Yokosuka and Saito 2010), which provided valuable insight into the functions of membrane compartmentalization. Mossman et al. (2005) placed T cells on a supported antigen-containing lipid membrane that was partitioned into micron-sized compartments by either an artificial meshwork or more elaborate structures. As a result, the mobility of T-cell receptors was significantly modified. When the artificial structure was a meshwork, a strong correlation between the receptor activity and position was found, such that receptors at the periphery of the interface showed prolonged signaling activity, as compared with the others. For another recent study using similar techniques, see Salaita et al. (2010), who reported the correlations between the activation of a signaling pathway related to breast cancer and the mechanical forces that act on the receptors. In the future, these artificial systems will be invaluable for studying the mechanisms of protein immobilization and the effects of pickets on other molecules, which both require further clarification.
FUTURE PERSPECTIVES Membrane-skeleton-based compartmentalization has been observed in all of the cultured mammalian cells examined thus far and in many other cell types, suggesting that it is a common feature rather than a rare occurrence (Murase et al. 2004). We should stress that although this type of plasma membrane compartmentalization might be ubiquitous, it is probably just part of a hierarchy of domain structures that organize the membrane in a coordinated fashion. As we discussed in the previous section, these compartments may contain even smaller, and possibly highly dynamic, membrane domains with various diameters, such as lipid rafts, and these compartments also coexist with CCPs (Chapter 2), caveolae (Chapter 3), cell-adhesion structures (Chapter 17), and immunological/ neuronal synaptic junctions. Similarly, these compartments reside in larger domain structures, such as the apical/basolateral domains in epithelial cells (Chapter 21) and the somatodendritic/axonal domains in neurons (Chapter 22). The actin cytoskeleton (Chapter 12) and the membrane skeleton are likely to play important roles in organizing and orchestrating all of these structures. As we highlight in this chapter, a variety of cell functions are affected by the disruption of the membrane skeleton. Among the plethora of factors that determine membrane
c01.indd 17
5/6/2011 6:10:00 PM
18
CHAPTER 1
CYTOSKELETON-INDUCED MESOSCALE DOMAINS
function, the reduction of membrane homogeneity may play a particularly special role. This point of view encourages us to think about the evolutionary reasons behind domain formation. For instance, if plasma membrane molecules were well mixed, then various cell functions, such as the regulation of the activity of receptors that is dependent on oligomerization and the localization of receptors, could become extremely inefficient. This suggests that many structures or mesoscale domains that increase membrane heterogeneity, including the membrane-skeleton-induced compartments, might have been selected and preserved during the long course of evolution. In a reductionist point of view, the actin fences and anchored-protein pickets provide a basis for molecular interactions in the plasma membrane. When many molecules are involved, these basic interactions can lead to rich collective dynamics. The presence of membrane-skeleton-based compartments may facilitate the persistence of molecular complexes, required for many cellular functions, that otherwise would be disrupted by thermal fluctuations. The membrane compartments and partitioning thus play crucially important roles in various plasma membrane functions, ranging from signaling to endocytosis, and future research will lead to a better understanding of their role in multiple cellular processes.
ABBREVIATIONS BCR Cav1 CCP DOPE EGF EGFR FCS FRAP FRSKs
B-cell receptor caveolin-1 clathrin-coated pit 1,2-dioleoyl-sn-glycero3-phosphoethanolamine epidermal growth factor epidermal growth factor receptor fluorescence correlation spectroscopy fluorescence recovery after photobleaching fetal rat skin keratinocytes (cell line)
GFP GPI NRK SCAR SFMT SPT STED-FCS WASP WAVE
green fluorescent protein glycosylphosphatidylinositol normal rat kidney (cell line) suppressor of cyclic AMP receptor single fluorescent-molecule tracking single-particle tracking stimulated emission depletion–FCS Wiskott–Aldrich syndrome protein WASP family verprolin-homologous protein
REFERENCES Almeida PFF, Vaz WLC, Thompson TE. 1992. Lateral diffusion and percolation in 2-phase, 2-component lipid bilayers—topology of the solid-phase domains inplane and across the lipid bilayer. Biochemistry 31:7198–210. Andrews NL, Lidke KA, Pfeiffer JR, Burns AR, Wilson BS, Oliver JM, Lidke DS. 2008. Actin restricts FcepsilonRI diffusion and facilitates antigen-induced receptor immobilization. Nat Cell Biol 10:955–63. Anong WA, Franco T, Chu H, Weis TL, Devlin EE, Bodine DM, An X, Mohandas N, Low PS. 2009. Adducin forms a bridge between the erythrocyte membrane and its cytoskeleton and regulates membrane cohesion. Blood 114:1904–12. Arana E, Vehlow A, Harwood NE, Vigorito E, Henderson R, Turner M, Tybulewicz VL, Batista FD. 2008. Activation of the small GTPase Rac2 via the B cell receptor regulates B cell adhesion and immunological-synapse formation. Immunity 28:88–99.
c01.indd 18
Axelrod D, Ravdin P, Koppel DE, Schlessinger J, Webb WW, Elson EL, Podleski TR. 1976. Lateral motion of fluorescently labeled acetylcholine receptors in membranes of developing muscle fibers. Proc Natl Acad Sci U S A 73:4594–8. Baumgartner W, Schutz GJ, Wiegand J, Golenhofen N, Drenckhahn D. 2003. Cadherin function probed by laser tweezer and single molecule fluorescence in vascular endothelial cells. J Cell Sci 116:1001–11. Bennett V. 1990. Spectrin-based membrane skeleton: a multipotential adaptor between plasma membrane and cytoplasm. Physiol Rev 70:1029–65. Bennett V, Healy J. 2008. Organizing the fluid membrane bilayer: diseases linked to spectrin and ankyrin. Trends Mol Med 14:28–36. Bernstein BW, Bamburg JR. 2010. ADF/cofilin: a functional node in cell biology. Trends Cell Biol 20: 187–95.
5/6/2011 6:10:00 PM
REFERENCES
Boggs JM, Wang H. 2004. Co-clustering of galactosylceramide and membrane proteins in oligodendrocyte membranes on interaction with polyvalent carbohydrate and prevention by an intact cytoskeleton. J Neurosci Res 76:342–55. Borisy GG, Svitkina TM. 2000. Actin machinery: pushing the envelope. Curr Opin Cell Biol 12:104–12. Briegel A, Ortega DR, Tocheva EI, Wuichet K, Li Z, Chen S, Muller A, Iancu CV, Murphy GE, Dobro MJ, Zhulin IB, Jensen GJ. 2009. Universal architecture of bacterial chemoreceptor arrays. Proc Natl Acad Sci U S A 106:17181–6. Bussell SJ, Hammer DA, Koch DL. 1994. The effect of hydrodynamic interactions on the tracer and gradient diffusion of integral membrane-proteins in lipid bilayers. J Fluid Mech 258:167–90. Bussell SJ, Koch DL, Hammer DA. 1995. Effect of hydrodynamic interactions on the diffusion of integral membrane-proteins—tracer diffusion in organelle and reconstituted membranes. Biophys J 68:1828–35. Campellone KG, Welch MD. 2010. A nucleator arms race: cellular control of actin assembly. Nat Rev Mol Cell Biol 11:237–51. Chang CH, Takeuchi H, Ito T, Machida K, Ohnishi S. 1981. Lateral mobility of erythrocyte-membrane proteins studied by the fluorescence photobleaching recovery technique. J Biochem 90:997–1004. Chung I, Akita R, Vandlen R, Toomre D, Schlessinger J, Mellman I. 2010. Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 464:783–7. Crane JM, Verkman AS. 2008. Long-range nonanomalous diffusion of quantum dot-labeled aquaporin-1 water channels in the cell plasma membrane. Biophys J 94:702–13. Dodd TL, Hammer DA, Sangani AS, Koch DL. 1995. Numerical simulations of the effect of hydrodynamic interactions on diffusivities of integral membrane proteins. J Fluid Mech 293:147–80. Eggeling C, Ringemann C, Medda R, Schwarzmann G, Sandhoff K, Polyakova S, Belov VN, Hein B, von Middendorff C, Schonle A, Hell SW. 2009. Direct observation of the nanoscale dynamics of membrane lipids in a living cell. Nature 457:1159–62. Ehrlich M, Boll W, Van Oijen A, Hariharan R, Chandran K, Nibert ML, Kirchhausen T. 2004. Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell 118:591–605. Field KA, Holowka D, Baird B. 1997. Compartmentalized activation of the high affinity immunoglobulin E receptor within membrane domains. J Biol Chem 272:4276–80. Fleire SJ, Goldman JP, Carrasco YR, Weber M, Bray D, Batista FD. 2006. B cell ligand discrimination through a spreading and contraction response. Science 312:738–41. Frick M, Schmidt K, Nichols BJ. 2007. Modulation of lateral diffusion in the plasma membrane by protein density. Curr Biol 17:462–7.
c01.indd 19
19
Fujimoto LM, Roth R, Heuser JE, Schmid SL. 2000. Actin assembly plays a variable, but not obligatory role in receptor-mediated endocytosis in mammalian cells. Traffic 1:161–71. Fujiwara T, Ritchie K, Murakoshi H, Jacobson K, Kusumi A. 2002. Phospholipids undergo hop diffusion in compartmentalized cell membrane. J Cell Biol 157: 1071–81. Gaidarov I, Santini F, Warren RA, Keen JH. 1999. Spatial control of coated-pit dynamics in living cells. Nat Cell Biol 1:1–7. Gambin Y, Lopez-Esparza R, Reffay M, Sierecki E, Gov NS, Genest M, Hodges RS, Urbach W. 2006. Lateral mobility of proteins in liquid membranes revisited. Proc Natl Acad Sci U S A 103:2098–102. Golan DE, Veatch W. 1980. Lateral mobility of band 3 in the human erythrocyte membrane studied by fluorescence photobleaching recovery: evidence for control by cytoskeletal interactions. Proc Natl Acad Sci U S A 77: 2537–41. Gomez-Mouton C, Abad JL, Mira E, Lacalle RA, Gallardo E, Jimenez-Baranda S, Illa I, Bernad A, Manes S, Martinez AC. 2001. Segregation of leadingedge and uropod components into specific lipid rafts during T cell polarization. Proc Natl Acad Sci U S A 98: 9642–7. Goodman SR, Krebs KE, Whitfield CF, Riederer BM, Zagon IS. 1988. Spectrin and related molecules. CRC Crit Rev Biochem 23:171–234. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285:221–7. Gupta N, DeFranco AL. 2007. Lipid rafts and B cell signaling. Semin Cell Dev Biol 18:616–26. Gupta N, Wollscheid B, Watts JD, Scheer B, Aebersold R, DeFranco AL. 2006. Quantitative proteomic analysis of B cell lipid rafts reveals that ezrin regulates antigen receptor-mediated lipid raft dynamics. Nat Immunol 7:625–33. Hanson PI, Roth R, Lin Y, Heuser JE. 2008. Plasma membrane deformation by circular arrays of ESCRT-III protein filaments. J Cell Biol 180:389–402. Heuser JE, Kirschner MW. 1980. Filament organization revealed in platinum replicas of freeze-dried cytoskeletons. J Cell Biol 86:212–34. Hirokawa N, Heuser JE. 1981. Quick-freeze, deep-etch visualization of the cytoskeleton beneath surface differentiations of intestinal epithelial cells. J Cell Biol 91:399–409. Hirokawa N, Tilney LG, Fujiwara K, Heuser JE. 1982. Organization of actin, myosin, and intermediate filaments in the brush border of intestinal epithelial cells. J Cell Biol 94:425–43. Iino R, Koyama I, Kusumi A. 2001. Single molecule imaging of green fluorescent proteins in living cells: E-cadherin forms oligomers on the free cell surface. Biophys J 80:2667–77.
5/6/2011 6:10:00 PM
20
CHAPTER 1
CYTOSKELETON-INDUCED MESOSCALE DOMAINS
James PS, Hennessy C, Berge T, Jones R. 2004. Compartmentalisation of the sperm plasma membrane: a FRAP, FLIP and SPFI analysis of putative diffusion barriers on the sperm head. J Cell Sci 117:6485–95. Kalay Z, Parris PE, Kenkre VM. 2008. Effects of disorder in location and size of fence barriers on molecular motion in cell membranes. J Phys Condens Matter 20: 245105. Kam LC. 2009. Capturing the nanoscale complexity of cellular membranes in supported lipid bilayers. J Struct Biol 168:3–10. Kenkre VM, Giuggioli L, Kalay Z. 2008. Molecular motion in cell membranes: analytic study of fencehindered random walks. Phys Rev E 77:051907. Kobayashi T, Storrie B, Simons K, Dotti CG. 1992. A functional barrier to movement of lipids in polarized neurons. Nature 359:647–50. Kodippili GC, Spector J, Sullivan C, Kuypers FA, Labotka R, Gallagher PG, Ritchie K, Low PS. 2009. Imaging of the diffusion of single band 3 molecules on normal and mutant erythrocytes. Blood 113: 6237–45. Kusumi A, Sako Y. 1996. Cell surface organization by the membrane skeleton. Curr Opin Cell Biol 8:566–74. Kusumi A, Koyama-Honda I, Suzuki, KGN. 2004. Molecular dynamics and interactions for creation of stimulation-induced stabilized rafts from small unstable steady-state rafts. Traffic 5:213–30. Kusumi A, Nakada C, Ritchie K, Murase K, Suzuki K, Murakoshi H, Kasai RS, Kondo J, Fujiwara T. 2005. Paradigm shift of the plasma membrane concept from the two-dimensional continuum fluid to the partitioned fluid: high-speed single-molecule tracking of membrane molecules. Annu Rev Biophys Biomol Struct 34: 351–78. Kusumi A, Shirai YM, Koyama-Honda I, Suzuki KG, Fujiwara TK. 2010. Hierarchical organization of the plasma membrane: investigations by single-molecule tracking versus fluorescence correlation spectroscopy. FEBS Lett 584:1814–23. Lajoie P, Partridge EA, Guay G, Goetz JG, Pawling J, Lagana A, Joshi B, Dennis JW, Nabi IR. 2007. Plasma membrane domain organization regulates EGFR signaling in tumor cells. J Cell Biol 179:341–56. Lenne PF, Wawrezinieck L, Conchonaud F, Wurtz O, Boned A, Guo XJ, Rigneault H, He HT, Marguet D. 2006. Dynamic molecular confinement in the plasma membrane by microdomains and the cytoskeleton meshwork. EMBO J 25:3245–56. Lin KB, Freeman SA, Zabetian S, Brugger H, Weber M, Lei V, Dang-Lawson M, Tse KW, Santamaria R, Batista FD, Gold MR. 2008. The rap GTPases regulate B cell morphology, immune-synapse formation, and signaling by particulate B cell receptor ligands. Immunity 28:75–87. Liu C, Paprica A, Petersen NO. 1997. Effects of size of macrocyclic polyamides on their rate of diffusion in model membranes. Biophys J 73:2580–7. Melo EC, Lourtie IM, Sankaram MB, Thompson TE, Vaz WL. 1992. Effects of domain connection and discon-
c01.indd 20
nection on the yields of in-plane bimolecular reactions in membranes. Biophys J 63:1506–12. Menon AK, Holowka D, Webb WW, Baird B. 1986. Cross-linking of receptor-bound IgE to aggregates larger than dimers leads to rapid immobilization. J Cell Biol 102:541–50. Merrifield CJ, Feldman ME, Wan L, Almers W. 2002. Imaging actin and dynamin recruitment during invagination of single clathrin-coated pits. Nat Cell Biol 4:691–8. Minguet S, Swamy M, Alarcon B, Luescher IF, Schamel WW. 2007. Full activation of the T cell receptor requires both clustering and conformational changes at CD3. Immunity 26:43–54. Morone N, Fujiwara T, Murase K, Kasai RS, Ike H, Yuasa S, Usukura J, Kusumi A. 2006. Threedimensional reconstruction of the membrane skeleton at the plasma membrane interface by electron tomography. J Cell Biol 174:851–62. Morone N, Nakada C, Umemura Y, Usukura J, Kusumi A. 2008. Three-dimensional molecular architecture of the plasma-membrane-associated cytoskeleton as reconstructed by freeze-etch electron tomography. Methods Cell Biol 88:207–36. Mossman KD, Campi G, Groves JT, Dustin ML. 2005. Altered TCR signaling from geometrically repatterned immunological synapses. Science 310:1191–3. Murase K, Fujiwara T, Umemura Y, Suzuki K, Iino R, Yamashita H, Saito M, Murakoshi H, Ritchie K, Kusumi A. 2004. Ultrafine membrane compartments for molecular diffusion as revealed by single molecule techniques. Biophys J 86:4075–93. Nakada C, Ritchie K, Oba Y, Nakamura M, Hotta Y, Iino R, Kasai RS, Yamaguchi K, Fujiwara T, Kusumi A. 2003. Accumulation of anchored proteins forms membrane diffusion barriers during neuronal polarization. Nat Cell Biol 5:626–32. Nikolaev VO, Moshkov A, Lyon AR, Miragoli M, Novak P, Paur H, Lohse MJ, Korchev YE, Harding SE, Gorelik J. 2010. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 327:1653–7. O’Connell KM, Rolig AS, Whitesell JD, Tamkun MM. 2006. Kv2.1 potassium channels are retained within dynamic cell surface microdomains that are defined by a perimeter fence. J Neurosci 26:9609–18. Parton RG, Simons K. 2007. The multiple faces of caveolae. Nat Rev Mol Cell Biol 8:185–94. Parton RG, Hanzal-Bayer M, Hancock JF. 2006. Biogenesis of caveolae: a structural model for caveolininduced domain formation. J Cell Sci 119:787–96. Peters R, Cherry RJ. 1982. Lateral and rotational diffusion of bacteriorhodopsin in lipid bilayers: experimental test of the Saffman-Delbruck equations. Proc Natl Acad Sci U S A 79:4317–21. Petrini EM, Marchionni I, Zacchi P, Sieghart W, Cherubini E. 2004. Clustering of extrasynaptic GABA(A) receptors modulates tonic inhibition in cultured hippocampal neurons. J Biol Chem 279: 45833–43.
5/6/2011 6:10:00 PM
REFERENCES
Pollard TD. 2007. Regulation of actin filament assembly by Arp2/3 complex and formins. Annu Rev Biophys Biomol Struct 36:451–77. Pollard TD, Blanchoin L, Mullins RD. 2000. Molecular mechanisms controlling actin filament dynamics in nonmuscle cells. Annu Rev Biophys Biomol Struct 29: 545–76. Powles JG, Mallett MJD, Rickayzen G, Evans WAB. 1992. Exact analytic solutions for diffusion impeded by an infinite array of partially permeable barriers. Proc R Soc Lond A Math Phys Sci 436:391–403. Renner ML, Cognet L, Lounis B, Triller A, Choquet D. 2009. The excitatory postsynaptic density is a size exclusion diffusion environment. Neuropharmacology 56:30–6. Reth M, Wienands J, Schamel WW. 2000. An unsolved problem of the clonal selection theory and the model of an oligomeric B-cell antigen receptor. Immunol Rev 176:10–8. Rodgers W, Zavzavadjian J. 2001. Glycolipid-enriched membrane domains are assembled into membrane patches by associating with the actin cytoskeleton. Exp Cell Res 267:173–83. Saffarian S, Cocucci E, Kirchhausen T. 2009. Distinct dynamics of endocytic clathrin-coated pits and coated plaques. PLoS Biol 7:e1000191. Saffman PG, Delbrück M. 1975. Brownian motion in biological membranes. Proc Natl Acad Sci U S A 72: 3111–3. Sahl SJ, Leutenegger M, Hilbert M, Hell SW, Eggeling C. 2010. Fast molecular tracking maps nanoscale dynamics of plasma membrane lipids. Proc Natl Acad Sci U S A 107:6829–34. Sako Y, Kusumi A. 1994. Compartmentalized structure of the plasma membrane for receptor movements as revealed by a nanometer-level motion analysis. J Cell Biol 125: 1251–64. Salaita K, Nair PM, Petit RS, Neve RM, Das D, Gray JW, Groves JT. 2010. Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Science 327:1380–5. Saxton MJ. 1987. Lateral diffusion in an archipelago. The effect of mobile obstacles. Biophys J 52:989–97. Saxton MJ. 1990. Lateral diffusion in a mixture of mobile and immobile particles. A Monte Carlo study. Biophys J 58:1303–6. Saxton MJ. 2002. Chemically limited reactions on a percolation cluster. J Chem Phys 116:203–8. Schamel WW, Reth M. 2000. Monomeric and oligomeric complexes of the B cell antigen receptor. Immunity 13:5–14. Schmidt K, Nichols BJ. 2004. A barrier to lateral diffusion in the cleavage furrow of dividing mammalian cells. Curr Biol 14:1002–6. Sheetz MP, Schindler M, Koppel DE. 1980. Lateral mobility of integral membrane proteins is increased in spherocytic erythrocytes. Nature 285:510–1. Singer SJ, Nicolson GL. 1972. The fluid mosaic model of the structure of cell membranes. Science 175: 720–31.
c01.indd 21
21
Small JV, Isenberg G, Celis JE. 1978. Polarity of actin at the leading edge of cultured cells. Nature 272: 638–9. Sohn HW, Tolar P, Pierce SK. 2008. Membrane heterogeneities in the formation of B cell receptor-Lyn kinase microclusters and the immune synapse. J Cell Biol 182: 367–79. Sperotto MM, Mouritsen OG. 1991. Monte Carlo simulation studies of lipid order parameter profiles near integral membrane proteins. Biophys J 59:261–70. Suzuki K, Ritchie K, Kajikawa E, Fujiwara T, Kusumi A. 2005. Rapid hop diffusion of a G-protein-coupled receptor in the plasma membrane as revealed by singlemolecule techniques. Biophys J 88:3659–80. Takeuchi M, Miyamoto H, Sako Y, Komizu H, Kusumi A. 1998. Structure of the erythrocyte membrane skeleton as observed by atomic force microscopy. Biophys J 74:2171–83. Takimoto B, Nabika H, Murakoshi K. 2009. Single molecular observation of hop diffusion in a lipid bilayer at metallic nanogates. J Phys Chem C 113: 3127–32. Tolar P, Sohn HW, Pierce SK. 2005. The initiation of antigen-induced B cell antigen receptor signaling viewed in living cells by fluorescence resonance energy transfer. Nat Immunol 6:1168–76. Tomishige M, Kusumi A. 1999. Compartmentalization of the erythrocyte membrane by the membrane skeleton: intercompartmental hop diffusion of band 3. Mol Biol Cell 10:2475–9. Tomishige M, Sako Y, Kusumi A. 1998. Regulation mechanism of the lateral diffusion of band 3 in erythrocyte membranes by the membrane skeleton. J Cell Biol 142:989–1000. Treanor B, Depoil D, Gonzalez-Granja A, Barral P, Weber M, Dushek O, Bruckbauer A, Batista FD. 2010. The membrane skeleton controls diffusion dynamics and signaling through the B cell receptor. Immunity 32:187–99. Triller A, Choquet D. 2008. New concepts in synaptic biology derived from single-molecule imaging. Neuron 59:359–74. Tsai J, Sun E, Gao Y, Hone JC, Kam LC. 2008. NonBrownian diffusion of membrane molecules in nanopatterned supported lipid bilayers. Nano Lett 8: 425–30. Tsuji A, Ohnishi S. 1986. Restriction of the lateral motion of band 3 in the erythrocyte membrane by the cytoskeletal network: dependence on spectrin association state. Biochemistry 25:6133–9. Tsuji A, Kawasaki K, Ohnishi S, Merkle H, Kusumi A. 1988. Regulation of band 3 mobilities in erythrocyte ghost membranes by protein association and cytoskeletal meshwork. Biochemistry 27:7447–52. Umemura YM, Vrljic M, Nishimura SY, Fujiwara TK, Suzuki KGN, Kusumi A. 2008. Both MHC class II and its GPI-anchored form undergo hop diffusion as observed by single-molecule tracking. Biophys J 95:435–50. Vaz WL, Criado M, Madeira VM, Schoellmann G, Jovin TM. 1982. Size dependence of the translational dif-
5/6/2011 6:10:00 PM
22
CHAPTER 1
CYTOSKELETON-INDUCED MESOSCALE DOMAINS
fusion of large integral membrane proteins in liquidcrystalline phase lipid bilayers. A study using fluorescence recovery after photobleaching. Biochemistry 21:5608–12. Vrljic M, Nishimura SY, Moerner WE, McConnell HM. 2005. Cholesterol depletion suppresses the translational diffusion of class II major histocompatibility complex proteins in the plasma membrane. Biophys J 88:334–47. Wang YL. 1985. Exchange of actin subunits at the leading edge of living fibroblasts: possible role of treadmilling. J Cell Biol 101:597–602. Wang J, Chen H, Brown EJ. 2001. L-plastin peptide activation of alpha(v)beta(3)-mediated adhesion requires integrin conformational change and actin filament disassembly. J Biol Chem 276:14474–81. Wawrezinieck L, Rigneault H, Marguet D, Lenne PF. 2005. Fluorescence correlation spectroscopy diffusion laws to probe the submicron cell membrane organization. Biophys J 89:4029–42. Weisswange I, Bretschneider T, Anderson KI. 2005. The leading edge is a lipid diffusion barrier. J Cell Sci 118:4375–80. Wieser S, Moertelmaier M, Fuertbauer E, Stockinger H, Schutz GJ. 2007. (Un)confined diffusion of CD59
c01.indd 22
in the plasma membrane determined by high-resolution single molecule microscopy. Biophys J 92:3719–28. Wieser S, Axmann M, Schutz GJ. 2008. Versatile analysis of single-molecule tracking data by comprehensive testing against Monte Carlo simulations. Biophys J 95:5988–6001. Winckler B, Forscher P, Mellman I. 1999. A diffusion barrier maintains distribution of membrane proteins in polarized neurons. Nature 397:698–701. Wu M, Holowka D, Craighead HG, Baird B. 2004. Visualization of plasma membrane compartmentalization with patterned lipid bilayers. Proc Natl Acad Sci U S A 101:13798–803. Yarar D, Waterman-Storer CM, Schmid SL. 2005. A dynamic actin cytoskeleton functions at multiple stages of clathrin-mediated endocytosis. Mol Biol Cell 16: 964–75. Yokosuka T, Saito T. 2010. The immunological synapse, TCR microclusters, and T cell activation. Curr Top Microbiol Immunol 340:81–107. Young RM, Zheng X, Holowka D, Baird B. 2005. Reconstitution of regulated phosphorylation of FcepsilonRI by a lipid raft-excluded protein-tyrosine phosphatase. J Biol Chem 280:1230–5.
5/6/2011 6:10:00 PM
CH A P T E R
2
CLATHRIN-COATED PITS James R. Thieman Linton M. Traub
DEFINITION Eukaryotic cells contain abundant surface molecules that must be maintained at appropriate concentrations for normal operation and cellular homeostasis. This can be accomplished by regulating the itinerary and delivery of outward-bound molecules (termed exocytosis) as well as by the inward-bound removal of macromolecules and transmembrane proteins from the surface (endocytosis) as necessary. Clathrin-coated pits are morphologically discernible invaginations of small regions (∼200 nm) of the plasma membrane that function as endocytic cellular domains. Composed of a clathrin protein scaffold, numerous adaptors, and phosphoinositide lipids, these pits serve a variety of functions in cell metabolism and organism homeostasis including neurotransmission, nutrient uptake, signaling termination, regulation of immune surveillance, cell motility, and pathogen entry. Clathrin-coated pits are a morphologically and temporally defined intermediate of this endocytic process, which proceeds from initial adaptor and clathrin placement at sites on the plasma membrane, through simultaneous cargo capture and membrane invagination, membrane scission, vesicle uncoating, and, finally, recycling of adaptors and clathrin for further rounds of endocytosis. The resulting uncoated vesicle can then fuse with early endosomes for further intracellular sorting of membrane components. While only occupying 1–2% of the cell surface (Anderson et al. 1978), it is estimated that in fibroblasts, clathrin-coated pits can turnover nearly the equivalent of the entire plasma membrane in 1 hour (Bretscher 1982). A heterogeneous population of transmembrane proteins, termed cargo, is recognized by clathrin-coated pits. Through capture of nutrient receptors, for example, the pits can efficiently concentrate ligands orders of magnitude over freely diffusing molecules in the extracellular milieu for packaging into vesicles. Indeed, while other endocytic pathways coexist at the plasma membrane, including pinocytosis, phagocytosis, caveolae-mediated endocytosis, and other less well-defined clathrin-independent endocytic routes, the hallmark of clathrin-mediated endocytosis remains selectivity. Central to this selectivity are phylogenetically conserved peptide-based endocytic sorting signals present within receptor cargo or appended protein folds that can be read by clathrin adaptors for packaging into these trafficking vesicles.
HISTORICAL PERSPECTIVE The first ultrastructural observations of clathrin-coated pits as discrete plasma membrane specializations were by Thomas Roth and Keith Porter in 1964 (Roth and Porter 1964). Cellular Domains, First Edition. Edited by Ivan R. Nabi. © 2011 John Wiley & Sons, Inc. Published 2011 by John Wiley & Sons, Inc.
23
c02.indd 23
5/6/2011 6:10:01 PM
24
CHAPTER 2
CLATHRIN-COATED PITS
They were interested in how circulating proteins within female mosquito hemolymph were deposited as yolk inside developing oocytes. They noticed that shortly following a blood meal, a proliferation of “bristle-coated pits and vesicles” on the cytoplasmic surface of the mosquito oocyte plasma membrane occurs. These pits and vesicles contained three distinguishable layers by electron microscopy: an inner, extracellular/luminal layer corresponding to massed yolk protein; a middle layer of ∼75-Å corresponding to the bilayer membrane; and an outer layer ∼200 Å thick that resembled a coat of fibrous bristles in the thin sections (Fig. 2.1A). Most remarkably, they correctly predicted from static images that these coated pit domains likely operated as a shuttle: They concentrated the yolk and then budded from the surface, uncoated and fused to form the large mature yolk bodies seen in mosquito oocytes––central tenets of modern coated vesicle biogenesis models. Subsequent studies revealed that these coats are arranged into cages composed of pentagonal and hexagonal facets closely apposed around the central vesicle. Similar appearing coated vesicles are also found in a variety of vertebrate tissues. In 1975, Barbara Pearse was the first to biochemically purify and characterize the coat complex as a single protein that she named “clathrin” (Pearse 1976). A ∼190-kDa molecule, the clathrin heavy chain, is organized into three-legged trimers named triskelions with three noncovalently associated clathrin light chains of ∼25 kDa (Ungewickell and Branton 1981). Somewhat surprising was that clathrin has no inherent affinity for membranes. Less abundant “associated proteins” or “assembly polypeptides” (APs) form a layer between assembled clathrin and the plasma membrane to assist in adhering clathrin to assembling pits and vesicles. Around this time it was appreciated that extracellular nutrients and hormones had specific receptors on the cell surface for their binding. Landmark work by Joseph Goldstein and Michael Brown with the low-density lipoprotein (LDL) receptor, a surface receptor for the plasma LDL particles that transport cholesterol and esterified lipids, showed that it could cluster in the plasma membrane above clathrin-coated pits and use these zones as portals of entry into the cell. Furthermore, fibroblasts from patients suffering from familial hypercholesterolemia, a hereditary condition in which patients have elevated plasma cholesterol contributing to cardiovascular disease, were shown to have defects in the clustering of LDL receptor into clathrin-coated pits as a result of a mutation in the receptor. On pinpointing disease-causing inherited mutations within the cytosolic domain of the LDL receptor, Goldstein and Brown proposed that this receptor could be concentrated and internalized by clathrin-coated pits through interactions between its cytosolic portion and the coat components (Goldstein et al. 1979). These observations laid the groundwork for the characterization of a whole collection of endocytic sorting signals that are the basis for the selectivity of clathrin-coated pits for its cargo. When two or more different receptors were found to be present within individual coated pits, it became apparent that these structures were common entry points for diverse cell-surface proteins (Maxfield et al. 1978). Throughout the early 1980s, researchers began to characterize the assembly polypeptides. Originally described as potential contaminating proteins in coated vesicle preparations, these APs of approximately 100 and 50 kDa copurify with coated vesicles and are found sandwiched between the vesicle and the clathrin coat (Vigers et al. 1986). APs promote the polymerization of clathrin into more uniform-sized cages in vitro than clathrin alone (Zaremba and Keen 1983). Later, it was determined that these polypeptides correspond to the tetrameric adaptor complexes AP-1 and AP-2, involved in clathrin-coated vesicle formation at the trans-Golgi network (TGN) and endosomes or at the plasma membrane, respectively (see also Chapters 8 and 9 on the Golgi and endosomes, respectively). From brain-derived coated vesicles, a separate fraction of ∼100-kDa proteins would turn out to be other monomeric endocytic adaptors that bind to clathrin, and the
c02.indd 24
5/6/2011 6:10:01 PM
HISTORICAL PERSPECTIVE
25
Figure 2.1. Microscopic observation of clathrin-coated pits. (A) Thin-section electron micrograph of synaptosome membranes generated from synaptic terminals. The plasma membrane is visible as two dense parallel lines contiguous with the inner layer of the deeply invaginated clathrin-coated pits. The bristle-like clathrin coat is visible around the forming vesicles. (B) Freeze-etch electron micrograph of clathrin-coated pits on the adherent plasma membrane of cultured cells. The clathrin coat has been pseudocolored blue, and the position of an individual clathrin triskelion has been colored red. Notice the array of pentagons and hexagons of the clathrin lattice in both flat and invaginating pits. (C, D) HeLa cervical carcinoma cells in culture visualized by transmitted light (C) or fluorescence microscopy for exogenously expressed clathrin light chain (D). (E, F) BS-C-1 kidney cells under the same conditions as in C and D. Notice the uniform diffraction-limited clathrin structures of BS-C-1 cells in F compared with the diffractionlimited and large clathrin structures of HeLa cells in D. Scale bars represent (A) 50 nm, (B) 100 nm, and (C–F) 10 μm.
c02.indd 25
5/6/2011 6:10:01 PM
26
CHAPTER 2
CLATHRIN-COATED PITS
APs and can also polymerize clathrin in vitro (Ahle and Ungewickell 1986). Then in the early 1990s, two structurally unrelated classes of tyrosine-based sorting signals and one leucine-based sorting signal were discovered within the cytosolic domains of various cellsurface receptors. Because they are autonomous and transplantable, these conserved amino acid stretches specify a receptor ’s fate for endocytosis. The 50-kDa subunit of AP-2 was shown to recognize one class of tyrosine-based sorting signal, describing a molecular mechanism for adaptor sorting during clathrin-mediated endocytosis. It was clearly evident at this time that clathrin-coated vesicles were well-ordered protein assemblies––a defined cellular domain. The cloning of cDNAs for clathrin and adaptors, starting in 1987 (Kirchhausen et al. 1987; Robinson 1989), opened up the field for mutagenesis studies and the creation of fluorescent protein fusions. This permitted the identification of additional regions of the adaptors that recognize receptor cargo and clathrin as well as the ability to perform studies of clathrin and adaptor dynamics in living cells. Concurrently, structural studies by X-ray crystallography, nuclear magnetic resonance, and cryo-electron microscopy were revealing the architecture of clathrin and adaptors and providing an exciting picture of how these proteins engage one another (Owen 2004). The past decade has seen a rapid expansion of research using sophisticated, timeresolved imaging techniques to study endocytosis. In the process, many of the original tenets of endocytosis proposed earlier were confirmed and extended (Roth 2006). Recent results suggest that the adaptors and clathrin are recruited to regions of the plasma membrane undergoing endocytosis in a regulated manner both in space and time.
MOLECULAR COMPONENTS OF CLATHRIN-COATED PITS AND VESICLES Clathrin-coated structures are discernable as flat to deeply invaginated regions of the plasma membrane that range from ∼50 to >500 nm (Heuser 1980). By thin-section electron microscopy, they appear to have a cytosol-oriented, electron-dense, fuzzy coat in longitudinal sections (Fig. 2.1A), while by freeze-etch electron microscopy, the coat displays a honeycomb-like polyhedral appearance (Fig. 2.1B) (Heuser 1980). Although clathrincoated pits only occupy a small percentage of the surface area at steady state (Fig. 2.1C–F), this dedicated domain is also visible from the extracellular surface of the plasma membrane. In freeze-etch electron micrographs, spherical ∼25-nm LDL particles are seen clustered at dimpled specializations (Heuser and Anderson 1989), and immunofluorescence analysis shows transferrin, LDL, and epidermal growth factor (EGF), as well as other extracellular ligands, clustered in discrete puncta, which are coated on the intracellular surface with clathrin. The clear concentration of cargo away from the freely diffusing molecules in the plasma membrane and the defined appearance of the assembled clathrin lattice make this sorting device a discrete membrane domain physically and functionally distinguishable from the surrounding membrane. Because the clathrin-coated membrane domain typically progresses to clathrincoated vesicles that physically detach from the plasma membrane, the protein composition of biochemically isolated coated vesicles was the starting point for molecular characterization of the chief coated pit constituents. But a diverse array of proteins are now known to accumulate at clathrin-coated pits, either transiently or throughout the entire life of these structures, as determined by methods such as biochemical purification, proteomics, light microscopy, and electron microscopy. The arrangement and complexity of the clathrincoated pit domain reflects its role as the first sorting station that surface receptors encounter on their way through the retrograde endomembrane system.
c02.indd 26
5/6/2011 6:10:04 PM
MOLECULAR COMPONENTS OF CLATHRIN-COATED PITS AND VESICLES
27
Clathrin Clathrin, the principal protein of coated pits and vesicles, is a 1675 residue, ∼190-kDa heavy chain with one associated 25- to 29-kDa light chain. Three heavy chains combine to form a trimer known as a clathrin triskelion (Fig. 2.2A). Triskelions have a threefold rotational symmetry about their trimerization domain. The leg is made up of an extended α-helical solenoid fold with kinks at regular intervals, giving the legs an overall arched appearance. Either under acidic pH or at physiological conditions with the assistance of adaptor proteins, the triskelions engage one another in an antiparallel manner to form a spherical, polygonal array called a clathrin coat. At the free end of each clathrin triskelion leg, and projecting down into the inner layer of the clathrin-coated pit or vesicle, is the so-called clathrin terminal domain. This corresponds to the N-terminal section and performs the vital function of attaching clathrin to the membrane. Unlike the adaptor proteins that have dedicated domains for engaging lipids or receptor cargo at the plasma membrane, clathrin does not bind membranes directly. Instead, the terminal domains, composed of a seven-bladed β-propeller fold, provide binding pockets for unstructured and conserved motifs within the adaptors. The ability of the clathrin terminal domain to recognize multiple adaptor-type proteins, the presence of three terminal domains in each triskelion, and the tight packing of triskelions together (Fig. 2.1B) create a very stable scaffold that assists in bending and stabilizing as well as organizing the plasma membrane beneath the coat (Edeling et al. 2006).
The Adaptor Complexes AP-2 The APs were discovered as proteins copurifying with clathrin-coated vesicles and apparently positioned between the vesicle and the outer clathrin coat. Their established role in sorting cargo in addition to coat assembly has led them to more commonly be dubbed “adaptor protein” complexes. Four structurally analogous AP complexes are ubiquitously expressed: AP-1, AP-2, AP-3, and AP-4. Clathrin-coated vesicle formation is a general cellular phenomenon for producing transport vesicles and occurs not only during endocytosis at the plasma membrane but also at the TGN and on endosomes along the biosynthetic and degradative pathways. While AP-1, AP-3, and AP-4 can be found at the TGN and endosomes, AP-2 is exclusively found on the plasma membrane and chiefly coordinates clathrin-mediated endocytosis (Nakatsu and Ohno 2003). While clathrin-coated structures on the TGN and endosomes may morphologically resemble clathrin-coated pit domains at the surface, they are biochemically distinct, are regulated differently, and, in some cases, sort distinct cargo. AP-2 (like the other APs) is a heterotetramer composed of two large subunits, α and β2; one medium, μ2; and one small subunit, σ2 (Fig. 2.2B). The subunits combine to form a brick-like core composed largely of solenoid-folded α-helices (the α- and β2-subunit trunks), while the μ2 is mostly β-sheet with its N-terminus contributing to core structural stability and its C-terminus tucked against the core. The σ2-subunit is structurally analogous to the N-terminus portion of μ2 (Collins et al. 2002). The large subunits also contain unstructured hinge domains near their C-termini that extend from the core and end in independently folded appendage domains. This overall arrangement has implications for clathrin-coated pit and vesicle formation. The AP-2 core orients upon the plasma membrane by recognizing the negatively charged phosphate groups on the lipid phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) through the α- and μ2-subunits while positioning the appendages toward the cytosol. Attached to intrinsically unfolded linkers,
c02.indd 27
5/6/2011 6:10:04 PM
28
c02.indd 28
5/6/2011 6:10:04 PM
SIDE
TOP
heavy chain
GPCR
β -arrestin EGF receptor
epsin
light chain
CD4
AP-2
90o
terminal domain
AP-2 transferrin receptor
LDL receptor
Dab2
clathrin binding
(B)
β2
PtdIns(4,5)P2
μ2
ARH
σ2
LDL receptor
hinge
α
core
clathrin coat
cargo
membrane
adaptors
appendages
Figure 2.2. Clathrin-coated pit assembly. (A) Schematic of a clathrin triskelion. Three clathrin heavy chains trimerize at the vertex of the triskelion, while three light chains bind noncovalently to the triskelion legs. The legs are curved in appearance. (B) Adaptor protein 2 (AP-2) is a heterotetramer. Large subunits α and β2 are in blue and green, respectively. Medium subunit μ2 is in magenta. The μ2 N-terminus is circular and C-terminus is elliptical. The small subunit σ2 is in orange. The large subunit C-termini appendages are shown connected to the core by flexible hinge domains. Regions dedicated to clathrin binding are indicated by yellow circles. (C) Initial placement of adaptors and clathrin on the plasma membrane prior to membrane invagination. AP-2 molecules are transiently recruited by binding PtdIns(4,5)P2 through the α-subunit (far left) and are stabilized by μ2 rearrangement (far right). This promotes receptor binding (center). Clustering of AP-2 and adaptors promotes clathrin binding through AP-2 appendages and clathrin box motifs in the AP-2 hinge and monomeric adaptors. This flat clathrin assembly will proceed to a spherical coat such as those seen in Figure 2.1A, B.
(C)
(A)
MOLECULAR COMPONENTS OF CLATHRIN-COATED PITS AND VESICLES
29
the motional freedom of the appendages allows sampling of the nearby cytosol, increasing the frequency of appendage collision with, and binding to, one of their many interaction partners (Fig. 2.2C). Importantly, the β2-subunit appendage and a defined region of the adjacent unstructured hinge can bind bivalently to clathrin, at the leg and terminal domain, respectively (Fig. 2.2B). This multivalent interaction allows AP-2, in part, to act as a glue holding clathrin to the plasma membrane (Edeling et al. 2006). AP-2 acts not only to hold clathrin to the plasma membrane but also to recognize and retain select cargo within forming clathrin-coated vesicles. Two classes of sorting signals within the cytoplasmic portion of transmembrane proteins are recognized by AP-2: (1) YXXØ (where Y is tyrosine, X is any amino acid, and Ø represents a bulky hydrophobic residue) and (2) [DE]XXXL[LIM] (where the first position can be aspartic acid or glutamic acid and the last position can be leucine, isoleucine, or methionine). These short linear signals are recognized by the μ2 C-terminus for YXXØ or the α/σ2-subunit hemicomplex for dileucine signals (Ohno et al. 1995; Kelly et al. 2008). The YXXØ signal is found in numerous receptors, including the prototypical clathrin-coated vesicle cargo, the transferrin receptor, while the dileucine signal is often found in immunological receptors such as CD4. Functionally, this means that AP-2 can simultaneously sort at least two different kinds of receptors. This reduces competition at the plasma membrane for receptor entry (Traub 2009b). For example, a clathrin-coated pit could perform the task of iron uptake through transferrin receptor capture by AP-2 but not compromise its ability to also regulate surface expression of the CD4 receptor. Monomeric Adaptors While the tetrameric AP-2 complex is the quintessential adaptor coordinating interactions between clathrin, the plasma membrane, cargo, and numerous other endocytic proteins, many other monomeric adaptors are present within the cell. The general architecture of these proteins typically reveals a folded, modular domain at one terminus flanked by an unstructured segment typically containing short peptide-based interaction motifs, often tandemly arranged. Some of these motifs facilitate binding to the clathrin terminal domain such as the “clathrin box” (consensus sequence LØ[DEN]Ø[DEN]), while other motifs specifically engage the AP-2 appendages. The function of these monomeric adaptors is one or both of the following: (1) to bind clathrin and assist in tethering it to the membrane, and (2) to act as alternate adaptors by recognizing additional sorting signals within the cargo not decoded directly by AP-2 and connecting it to the nascent endocytic machinery. Because these coat components play an important role in cargo selection, they have been designated clathrin-associated sorting proteins (CLASPs) (Traub 2009b). β-Arrestins β-Arrestins 1 and 2 were the first proteins recognized to act as alternate adaptors by increasing the sorting potential of clathrin-coated pits beyond cargo recognized by AP-2 (Goodman et al. 1996). Following stimulation of G-protein-coupled receptors (GPCRs) with an appropriate ligand and subsequent phosphorylation of the GPCR by kinases, β-arrestins recognize the phosphorylated serine/threonine residues within the cytosolic loops of these seven-pass transmembrane receptors. β-Arrestin is usually soluble in the basal state as the largely unstructured C-terminus is bound back on the major β-arrestin fold as an inhibitory clamp. Upon receptor engagement, electrostatic associations with the receptor-attached phosphates discharge the C-terminus, revealing AP-2 appendage and clathrin box binding motifs. This interaction rapidly desensitizes signal propagation by uncoupling G proteins from the receptor. In addition, the revealed clathrin coat interaction motifs target β-arrestin and the associated desensitized receptor to preexisting clathrin-coated pits for endocytosis (Fig. 2.2C) and downregulation where
c02.indd 29
5/6/2011 6:10:04 PM
30
CHAPTER 2
CLATHRIN-COATED PITS
they will either recycle or be degraded (Luttrell and Lefkowitz 2002). Hence, clathrinmediated endocytosis is important in the establishment of a refractory period in the cell in many GPCR signaling pathways. Autosomal Recessive Hypercholesterolemia (ARH) and Disabled-2 (Dab2) The ARH protein and Dab2 CLASPs cooperate in recognizing cargo containing FXNPXY sorting signals such as those commonly found in lipoprotein receptors and integrins. Mutations in this sorting signal discovered by Goldstein and Brown prevent the LDL receptor from clustering in pits (Anderson et al. 1977). ARH and Dab2 contain N-terminal phosphotyrosine-binding domains that, despite the name, bind selectively to unphosphorylated FXNPXY signals and PtdIns(4,5)P2 simultaneously. Again through unstructured AP-2 appendage and clathrin-binding motifs in ARH and Dab2, these adaptors target cargo such as the LDL receptor to clathrin-coated pits for internalization (Traub 2009b). In the case of ARH, the unstructured AP-2 motif becomes structured as it engages the AP-2 β2-appendage. Interestingly, mutations in ARH that prevent its recognition of the LDL receptor result in failure to clear LDL receptor from the surface and hypercholesterolemia with a different inheritance pattern than that studied by Goldstein and Brown (Garcia et al. 2001). ARH and/or Dab2 may also be important for integrin internalization during cell migration for redistribution to the leading edge (Teckchandani et al. 2009). AP180 AP180 was the second AP to be discovered following the heterotetrameric AP-1 and AP-2 complexes. This adaptor binds to PtdIns(4,5)P2 via the AP180 N-terminal homology (ANTH) domain. The unstructured C-terminus harbors several motifs for AP-2 appendage and clathrin binding as well, so AP180 contributes to the structural integrity of clathrin-coated pits. AP180 expression is restricted to neurons, but a ubiquitously expressed isoform CALM performs similar functions in other tissues. There is some evidence that AP180/CALM might be involved in targeting soluble N-ethylmaleimidesensititive fusion protein (NSF) attachment receptors (SNAREs), which promote the ethylmaleimide-sensititive fusion protein (NSF) attachment receptors (SNAREs), which promote the subsequent membrane fusion of uncoated transport vesicles with the appropriate acceptor compartment (Harel et al. 2008). Epsin and Eps15 Epsin and Eps15 are monomeric adaptors found at clathrincoated pits at the cell surface. Through either an epsin N-terminal homology (ENTH) domain structurally related to the ANTH domain or an Eps15 homology (EH) domain, these two proteins are able to bind PtdIns(4,5)P2, while their unstructured C-termini can engage the AP-2 appendages. Epsin also binds to clathrin and therefore stabilizes the assembly, but Eps15 does not. Both proteins contain ubiquitin-interacting motifs (UIMs) that allow them to bind receptors that have been ubiquitinated. In this respect, they are able to target cargo that becomes ubiquitinated following activation, such as the EGF receptor, to clathrin-coated pits for internalization (Traub 2009b). This increases the diversity of cargo that can be endocytosed in a clathrin-dependent fashion beyond that recognized by the AP-2 adaptor.
Regulatory Proteins and Lipids PtdIns(4,5)P2 Lipid Clathrin-coated pits are not only protein assemblies but also “lipid assemblies” as they are constructed on the plasma membrane and depend on the lipid PtdIns(4,5)P2. Phosphatidylinositol is a phospholipid with two acyl chains, a glycerol backbone, and a phosphate group connecting a six-carbon inositol ring. Variable phosphorylation of three of the other five carbons generates a total of eight phosphoinositide species, a subset
c02.indd 30
5/6/2011 6:10:04 PM
MOLECULAR COMPONENTS OF CLATHRIN-COATED PITS AND VESICLES
31
of which has defined distributions throughout the endosomal system (Roth 2004). Phosphorylation of carbons 4 and 5 hydroxyl group yields PtdIns(4,5)P2, which is found highly concentrated on the inner leaflet of the plasma membrane. PtdIns(4,5)P2 is a vital component for assembly and progression of clathrin-coated pits and AP-2, and many monomeric adaptors bind this lipid (Haucke 2005). This bioactive lipid may be transiently enriched at sites of coat assembly; however, this may not be obvious due to the rudimentary methods currently used to visualize this lipid in cells (i.e., fluorescently labeled lipidtargeting protein domains that uniformly label the plasma membrane). Strong evidence for an actuating role of PtdIns(4,5)P2 in clathrin-coated pit assembly comes from the synaptic phenotypes in PtdIns(4,5)P2-generating PIPKIγ (Di Paolo et al. 2004) and PtdIns(4,5)P2-hydrolyzing synaptojanin (Cremona et al. 1999) gene-specific knockout animal models, and cellular perturbation of PtdIns(4,5)P2 metabolism in cultured cells (Zoncu et al. 2007). Dynamin Successful production of a clathrin-coated vesicle requires the scission of the coated pit from the plasma membrane. The GTPase dynamin can oligomerize into a ring-like collar at the base of deeply invaginated clathrin-coated pits such as those in Figure 2.1A. At this late stage of clathrin-coated pit assembly, in which only a tubular bilayer stalk connects the bud to the plasma membrane, very little further incorporation or escape of sorted cargo is expected to occur due to the reduced surface area for cargo transfer. Through conformational changes induced by GTP binding/hydrolysis and likely coincident tensile force from actin-based propulsion of the vesicle, dynamin promotes cleavage of the membrane. There is also evidence for dynamin regulating assembly of clathrin-coated pits (Mettlen et al. 2009). The precise mode of lipid destabilization and reorganization that facilitates bilayer fusion is not yet clear, but dynamin may exit the bud before final fission has occurred. Synaptojanin, Auxilin/G-Cyclin-Associated Kinase (GAK), and Hsc70 Through numerous protein–protein interactions, many of high avidity, a relatively stable assembly surrounding the bud and nascent vesicle is constructed. In order to recycle clathrin triskelions and adaptors for future rounds of clathrin-coated pit assembly and for the vesicle to sterically recognize and fuse with a target membrane, the overlying cytosolic components must be stripped from the vesicle. To accomplish this, the molecular chaperone ATPase Hsc70 is recruited to late-stage clathrin-coated pits or fully formed vesicles by the co-chaperone auxilin (expressed in neurons) or GAK (expressed ubiquitously). Through ATP hydrolysis, Hsc70 promotes the dissociation of clathrin triskelions, destabilizing the underlying adaptors and promoting uncoating (Eisenberg and Greene 2007). Hydrolysis of PtdIns(4,5)P2 by synaptojanin also plays a role in clathrin/adaptor uncoating, and AP-2 removal from vesicles requires dephosphorylation of the μ2-subunit (see below), which may require competitive removal of the μ2 targeting adaptor-associated kinase (AAK1) from AP-2 (Semerdjieva et al. 2008).
Structural Proteins Bin/Amphiphysin/Rvs161/167 (BAR)-Domain-Containing Proteins Proteins containing BAR domains are involved in membrane curvature in the endocytic/ endosomal membrane system. BAR domains are crescent-shaped protein dimers lined with positively charged residues along their concave surfaces that recognize negatively charged phospholipids. Their ability to tubulate membrane in vitro and their structure suggest they may generate or stabilize bending of target membranes (Brett and Traub 2006). Amphiphysin, endophilin, and sorting nexin 9 are BAR domain proteins that target to
c02.indd 31
5/6/2011 6:10:04 PM
32
CHAPTER 2
CLATHRIN-COATED PITS
clathrin-coated pits by binding to the AP-2 appendages. These proteins are thought to assist in later stages of invagination at the neck of clathrin-coated pits where membrane curvature is highest. Many BAR proteins have Src homology-3 (SH3) domains that can directly engage the large GTPase dynamin and might recruit this late regulator to the neck of coated-pits. Filamentous Actin and Its Adaptor One striking feature of clathrin-coated pits by deep-etch cryo-electron microscopy is their frequent positioning adjacent to the cortical actin cytoskeleton. In fact, while controversy remains over the absolute requirement for actin polymerization in scission and propulsion of nascent clathrin-coated vesicles away from the plasma membrane, it is likely that filamentous actin at a minimum plays a role in the regulation of vesicle formation. Clathrin adaptors HIP1/Hip1R bind to the plasma membrane via an ANTH domain, form homoand heterodimers and bind clathrin light chain through a central coiled-coil domain, and bind to filamentous actin via an ILWEQ/THATCH domain. These proteins, conserved from yeast to human, support a role for actin attachment to clathrin-coated pits during clathrincoated pit progression (Brett and Traub 2006).
FUNCTIONAL IMPLICATIONS OF CLATHRIN-COATED PIT ORGANIZATION Constructing Clathrin-Coated Pits For years, it was presumed that either receptors destined for endocytic uptake or an unidentified, compartment-specific nucleating membrane protein were responsible for recruiting the AP-2 adaptor to regions of the plasma membrane to begin assembly of clathrin-coated pits. However, AP-2 is not recruited to endosomal membranes containing highly concentrated receptors, so it is clear that regulation of AP-2 placement involves additional factors. Instead, it is now known that AP-2 and monomeric adaptors initially bind to PtdIns(4,5) P2 through their dedicated lipid-binding modular domains. In nerve terminals, PtdIns(4,5) P2 for clathrin-mediated endocytosis is generated from phosphatidylinositol 4-phosphate (PtdIns(4)P) by type Iγ phosphatidylinositol 4-phosphate (PIP) kinase (Wenk et al. 2001). For AP-2, a patch of basic residues in the α-subunit recognize the negatively charged phosphate groups of PtdIns(4,5)P2. However, this interaction is weak, and further contacts are needed to stabilize AP-2 at the membrane. Phosphorylation of the μ2-subunit of AP-2 by AAK1 causes AP-2 to undergo a conformational change. The μ2-subunit is displaced, positioning itself parallel with the plasma membrane. Thereby, a second PtdIns(4,5)P2 recognizing patch of residues on μ2 is realigned to bind this lipid, increasing the affinity of AP-2 for the plasma membrane by roughly 100 times (Maldonado-Baez and Wendland 2006). A second consequence of this open AP-2 conformation is its receptiveness to binding YXXØ sorting signal-containing cargo binding by μ2-subunit. This could further stabilize AP-2 on the membrane. Following the initial binding of a few molecules of AP-2 to the plasma membrane, additional AP-2 and monomeric adaptors are concentrated at these sites through a mechanism termed coincidence detection (Carlton and Cullen 2005). In this scenario, the placement of a protein within the cell is determined by the close proximity of not one but two or more binding partners for simultaneous engagement. As AP-2-recognized cargo becomes concentrated in regions of the membrane along with PtdIns(4,5)P2, the likelihood of AP-2 becoming deposited is increased. Similarly for monomeric adaptors, locally increased
c02.indd 32
5/6/2011 6:10:04 PM
FUNCTIONAL IMPLICATIONS OF CLATHRIN-COATED PIT ORGANIZATION
33
concentrations of PtdIns(4,5)P2 can potentially be recognized by ENTH, ANTH, and EH domains, while the AP-2 appendage domains can be recognized by motifs presented by the CLASPs. This helps ensure that AP-2 and CLASPs/adaptors are recruited selectively to the plasma membrane relative to other organellar membranes within the cell that may contain recycling or degrading cargo or PtdIns(4,5)P2. While clathrin does not recognize membrane lipids directly, it binds AP-2 and CLASPs with high avidity. Each of the three clathrin terminal domains can engage at least one AP-2 or CLASP through short linear clathrin box motifs (Edeling et al. 2006). Thus, once an appreciable number of adaptors become concentrated on the plasma membrane, they could in theory begin to recruit clathrin triskelions. Adjacent positioning of clathrin triskelions on a planar surface would promote their self-association into a flat, hexagonal lattice (Fig. 2.1B). The appearance of additional clathrin molecules would provide positive feedback for AP-2 and monomeric adaptor recruitment and help drive assembly.
Generating Membrane Curvature Clathrin-coated pit domains must transition from an initial two-dimensional membrane assembly through high levels of curvature to a spherical end product in the course of vesicle generation. It is known that clathrin is required for inducing curvature, stabilizing membrane bending in the nascent bud, or both, as cells depleted of clathrin form discernable adaptor protein assemblies on the membrane that are entirely flat (Ungewickell and Hinrichsen 2007). The transition from a flat clathrin lattice formed mostly of hexagons to an invaginated coat (Fig. 2.1B) also requires the introduction of new pentagonal facets, but whether this provides a driving force for membrane curvature is unknown. Another possibility is that the adaptor epsin assists in curvature generation by the insertion of an amphipathic helix into the plasma membrane inner leaflet, changing relative bilayer spacing. The local expansion of the inner leaflet to the outer leaflet could promote bending toward the cytosol. Finally, BAR domain proteins with different intrinsic radii of curvature may assist at different stages of membrane bending either by generating curvature or stabilizing the existing membrane surface conformation (Ungewickell and Hinrichsen 2007).
Incorporating Cargo Beginning as early as the deposition of a cluster of adaptors on the plasma membrane and possibly occurring up until the neck of the late-stage pit becomes occluded or sealed off by dynamin, clathrin-coated pits perform their principal function of cargo capture. As the plasma membrane is roughly 50% protein by weight (Cooper 2000) and many of these proteins can diffuse within the membrane, clathrin-coated pits are confronted with the challenge of recognizing specific receptor cargo for entry into the cell within a vast sea of heterogeneous protein. It can be envisioned that clathrin-coated pits act as filters on the plasma membrane, capturing cargo that has specific sorting signals within its exposed cytosolic domain as it diffuses through and allowing nonspecific proteins to diffuse out. Endocytic adaptors are arranged in a way such that cargo recognition takes place near the plasma membrane and deep within the clathrin coat. Monomeric adaptors typically contain their modular PtdIns(4,5)P2-binding domain at their N-termini. For βarrestins, Dab2, and ARH, cargo recognition also occurs through this domain. For epsin, a region just to the C-terminus of its lipid-binding ENTH domain is responsible for recognizing ubiquitinated cargo. Similarly for AP-2, the membrane adjacent μ2-subunit can bind to YXXØ sorting signals. A binding pocket for [DE]XXXL[LIM] dileucine sorting
c02.indd 33
5/6/2011 6:10:04 PM
34
CHAPTER 2
CLATHRIN-COATED PITS
signals is created by a space between the AP-2 α- and σ2-subunits. However, this site appears to be blocked by the large β2-subunit and might need a conformational change in order to recognize dileucine sorting signals. Altogether, these adaptors recognize sorting signals a short distance from the membrane (Traub 2009b). In contrast, interactions that are structural in nature and act to connect monomeric adaptors to AP-2 and adaptors to the clathrin scaffold occur at a greater distance from the membrane. These interactions converge around the AP-2 appendage domains. The appendage domains have the potential to bind numerous partners. They recognize short, linear, and, in some cases, α-helical motifs within monomeric adaptors and accessory endocytic proteins (Traub 2009b). Often, these motifs are at the C-termini of these proteins distal to membrane association domains. The unstructured segments of monomeric adaptors also often contain short, linear clathrin boxes (Maldonado-Baez and Wendland 2006). Together, these monomeric adaptors and the β2-subunit of AP-2 bind and recruit soluble clathrin triskelions to the plasma membrane for lattice assembly and invagination.
Clathrin-Coated Plaques and De Novo Forming Clathrin-Coated Pits Thus far, clathrin-coated pit assembly has been described as a process that gives rise to one clathrin-coated vesicle and in doing so removes this temporary domain from the plasma membrane. For some cells in culture, these de novo forming structures are the primary clathrin-coated pits decorating the plasma membrane in the cell and are diffraction limited (<200 nm) by light microscopy (Fig. 2.1E, F). However, in other cultured and primary cells, large (>500 nm), static and mostly flat clathrin-coated structures can also be observed on the adherent plasma membrane (Fig. 2.1C, D) (Traub 2009a). These so-called clathrin-coated plaques sequester cargo, yet the regulation and functional consequences of plaque formation versus de novo pit formation are unknown. Static freeze-etch electron microscope images suggest that clathrin-coated vesicles can bud from the periphery of these structures (Fig. 2.1C), but it has also been suggested that the entire “plaque” may internalize (Saffarian et al. 2009). How a “plaque” is kept in a flat conformation and what triggers clathrin rearrangements will be topics for future research.
Cargo-Dedicated Clathrin-Coated Pits From what we now know of how AP-2 and CLASPs recognize their cargo for incorporation into clathrin-coated pits, and the diversity of receptors containing various sorting signals encoded in their cytosolic domains, it would be expected that an individual clathrin-coated pit would contain numerous different cargo molecules. Interestingly, there is evidence for some GPCR cargos utilizing only a subset of clathrin-coated pits. In one study, exogenously expressed and ligand-bound delta opioid receptor occupied only ∼40% of clathrin-coated pits (Puthenveedu and von Zastrow 2006), while in another study, exogenously expressed purinergic receptors P2Y1 and P2Y12 localized to distinct coated pits upon ligand stimulation (Mundell et al. 2006). Typically, CLASPs have a wide distribution and colocalize with nearly all clathrin-coated pits (Keyel et al. 2006) including a mutant form of β-arrestin capable of localizing to clathrin-coated pits in the absence of activated GPCRs (Burtey et al. 2007). Thus, how certain cargo manages to be selectively incorporated into a subset of pits, if these pits are morphologically and biochemically different, and whether they are targeted to distinct endosomal compartments remains to be determined.
c02.indd 34
5/6/2011 6:10:04 PM
ABBREVIATIONS
35
Future Perspectives Great strides have been made in the past two decades in uncovering novel endocytic proteins that contribute to clathrin-coated pit domain construction and deciphering how these proteins interact with one another. In addition, various structural studies have uncovered how endocytic protein architecture dictates unique modes of regulation of this process. While we have some understanding of the individual pieces of the puzzle, exactly how and when these proteins assemble remain a major focus in the field. It may be possible to imagine clathrin-coated pit assembly is analogous to an energy landscape model of protein folding (Onuchic and Wolynes 2004). In these models, an unfolded protein can assume many different conformations of high entropy, but as it folds, it moves down the sides of its folding funnel to its native conformation of lowest free energy and lowest entropy. There are many different pathways (or sides of the funnel) to reach the same final protein fold. Clathrin-coated pits and vesicles may form in a similar fashion in which different components could have the ability to contribute at different times. Different cell types may also use slightly different endocytic components and adaptors, yet as adaptors and clathrin triskelion begin to assemble, they limit the possible subsequent conformations of the forming coated pit and drive the process forward vectorially. Implied by this model is that a series of ordered protein–lipid and protein–protein interactions could guide the formation of a clathrin-coated pit. It has been proposed that interactions of lower affinity are progressively replaced by interactions of higher affinity thereby giving directionality to the assembly process (Mishra et al. 2004; Praefcke et al. 2004). As other fields have moved toward a systems biology holistic approach to understanding complex biological reactions, future studies into clathrin-coated pits and vesicles may also follow this trend. In order to fully understand how clathrin-coated pits assemble a comprehensive characterization of endocytic protein motifs, sorting signals, interaction dissociation constants, and endocytic protein cellular concentrations would provide valuable data that could be used to build computation-based assembly models––an approach that can now be fully realized thanks to greatly improved computing capabilities. This information could be used to validate current hypotheses on clathrin-coated pit assembly. Other exciting avenues include determining how clathrin-coated plaques form, if they are capable of budding from the plasma membrane en masse, and if they perform specialized sorting functions in comparison with de novo forming clathrin-coated pits. Also, whether cargo-specific clathrin-coated pits exist, how they would exclude specific cargo, and what benefit this early sorting has for the downstream endosomal system are now being explored.
ABBREVIATIONS APs ANTH ARH BAR CLASP Dab2 EGF EH
c02.indd 35
associated proteins or assembly polypeptides AP180 N-terminal homology autosomal recessive hypercholesterolemia bin/amphiphysin/Rvs161/167 clathrin-associated sorting protein disabled-2 epidermal growth factor Eps15 homology
ENTH GPCR LDL NSF PtdIns(4)P PtdIns(4,5)P2 SH3 SNARE TGN
epsin/Eps15 N-terminal homology G-protein-coupled receptor low-density lipoprotein N-ethylmaleimide sensitive fusion protein phosphatidylinositol 4-phosphate phosphatidylinositol 4,5-bisphosphate Src homology-3 soluble NSF attachment receptor trans-Golgi network
5/6/2011 6:10:04 PM
36
CHAPTER 2
CLATHRIN-COATED PITS
REFERENCES Ahle S, Ungewickell E. 1986. Purification and properties of a new clathrin assembly protein. EMBO J 5:3143–9. Anderson RG, Goldstein JL, Brown MS. 1977. A mutation that impairs the ability of lipoprotein receptors to localise in coated pits on the cell surface of human fibroblasts. Nature 270:695–9. Anderson RG, Vasile E, Mello RJ, Brown MS, Goldstein JL. 1978. Immunocytochemical visualization of coated pits and vesicles in human fibroblasts: relation to low density lipoprotein receptor distribution. Cell 15: 919–33. Bretscher MS. 1982. Surface uptake by fibroblasts and its consequences. Cold Spring Harb Symp Quant Biol 46(Pt 2):707–12. Brett TJ, Traub LM. 2006. Molecular structures of coat and coat-associated proteins: function follows form. Curr Opin Cell Biol 18:395–406. Burtey A, Schmid EM, Ford MG, Rappoport JZ, Scott MG, Marullo S, Simon SM, McMahon HT, Benmerah A. 2007. The conserved isoleucine-valine-phenylalanine motif couples activation state and endocytic functions of beta-arrestins. Traffic 8:914–31. Carlton JG, Cullen PJ. 2005. Coincidence detection in phosphoinositide signaling. Trends Cell Biol 15:540–7. Collins BM, McCoy AJ, Kent HM, Evans PR, Owen DJ. 2002. Molecular architecture and functional model of the endocytic AP2 complex. Cell 109:523–35. Cooper GM. 2000. The cell: a molecular approach. Washington, DC; Sunderland, MA: ASM Press; Sinauer Associates. Cremona O, Di Paolo G, Wenk MR, Luthi A, Kim WT, Takei K, Daniell L, Nemoto Y, Shears SB, Flavell RA, McCormick DA, De Camilli P. 1999. Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell 99:179–88. Di Paolo G, Moskowitz HS, Gipson K, Wenk MR, Voronov S, Obayashi M, Flavell R, Fitzsimonds RM, Ryan TA, De Camilli P. 2004. Impaired PtdIns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking. Nature 431:415–22. Edeling MA, Smith C, Owen D. 2006. Life of a clathrin coat: insights from clathrin and AP structures. Nat Rev 7:32–44. Eisenberg E, Greene LE. 2007. Multiple roles of auxilin and hsc70 in clathrin-mediated endocytosis. Traffic 8: 640–6. Garcia CK, Wilund K, Arca M, Zuliani G, Fellin R, Maioli M, Calandra S, Bertolini S, Cossu F, Grishin N, Barnes R, Cohen JC, Hobbs HH. 2001. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 292: 1394–8. Goldstein JL, Anderson RG, Brown MS. 1979. Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 279:679–85. Goodman OB, Jr., Krupnick JG, Santini F, Gurevich VV, Penn RB, Gagnon AW, Keen JH, Benovic JL.
c02.indd 36
1996. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 383: 447–50. Harel A, Wu F, Mattson MP, Morris CM, Yao PJ. 2008. Evidence for CALM in directing VAMP2 trafficking. Traffic 9:417–29. Haucke V. 2005. Phosphoinositide regulation of clathrinmediated endocytosis. Biochem Soc Trans 33:1285–9. Heuser J. 1980. Three-dimensional visualization of coated vesicle formation in fibroblasts. J Cell Biol 84:560–83. Heuser JE, Anderson RG. 1989. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrincoated pit formation. J Cell Biol 108:389–400. Kelly BT, McCoy AJ, Spate K, Miller SE, Evans PR, Honing S, Owen DJ. 2008. A structural explanation for the binding of endocytic dileucine motifs by the AP2 complex. Nature 456:976–79. Keyel PA, Mishra SK, Roth R, Heuser JE, Watkins SC, Traub LM. 2006. A single common portal for clathrinmediated endocytosis of distinct cargo governed by cargo-selective adaptors. Mol Biol Cell 17:4300–17. Kirchhausen T, Harrison SC, Chow EP, Mattaliano RJ, Ramachandran KL, Smart J, Brosius J. 1987. Clathrin heavy chain: molecular cloning and complete primary structure. Proc Natl Acad Sci U S A 84:8805–9. Luttrell LM, Lefkowitz RJ. 2002. The role of betaarrestins in the termination and transduction of G-proteincoupled receptor signals. J Cell Sci 115:455–65. Maldonado-Baez L, Wendland B. 2006. Endocytic adaptors: recruiters, coordinators and regulators. Trends Cell Biol 16:505–13. Maxfield FR, Schlessinger J, Shechter Y, Pastan I, Willingham MC. 1978. Collection of insulin, EGF and alpha2-macroglobulin in the same patches on the surface of cultured fibroblasts and common internalization. Cell 14:805–10. Mettlen M, Pucadyil T, Ramachandran R, Schmid SL. 2009. Dissecting dynamin’s role in clathrin-mediated endocytosis. Biochem Soc Trans 37:1022–6. Mishra SK, Hawryluk MJ, Brett TJ, Keyel PA, Dupin AL, Jha A, Heuser JE, Fremont DH, Traub LM. 2004. Dual engagement regulation of protein interactions with the AP-2 adaptor alpha appendage. J Biol Chem 279: 46191–203. Mundell SJ, Luo J, Benovic JL, Conley PB, Poole AW. 2006. Distinct clathrin-coated pits sort different G proteincoupled receptor cargo. Traffic 7:1420–31. Nakatsu F, Ohno H. 2003. Adaptor protein complexes as the key regulators of protein sorting in the post-Golgi network. Cell Struct Funct 28:419–29. Ohno H, Stewart J, Fournier MC, Bosshart H, Rhee I, Miyatake S, Saito T, Gallusser A, Kirchhausen T, Bonifacino JS. 1995. Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science 269:1872–5. Onuchic JN, Wolynes PG. 2004. Theory of protein folding. Curr Opin Struct Biol 14:70–5.
5/6/2011 6:10:04 PM
REFERENCES
Owen DJ. 2004. Linking endocytic cargo to clathrin: structural and functional insights into coated vesicle formation. Biochem Soc Trans 32:1–14. Pearse BM. 1976. Clathrin: a unique protein associated with intracellular transfer of membrane by coated vesicles. Proc Natl Acad Sci U S A 73:1255–9. Praefcke GJ, Ford MG, Schmid EM, Olesen LE, Gallop JL, Peak-Chew SY, Vallis Y, Babu MM, Mills IG, McMahon HT. 2004. Evolving nature of the AP2 alphaappendage hub during clathrin-coated vesicle endocytosis. EMBO J 23:4371–83. Puthenveedu MA, von Zastrow M. 2006. Cargo regulates clathrin-coated pit dynamics. Cell 127:113–24. Robinson MS. 1989. Cloning of cDNAs encoding two related 100-kD coated vesicle proteins (alpha-adaptins). J Cell Biol 108:833–42. Roth MG. 2004. Phosphoinositides in constitutive membrane traffic. Physiol Rev 84:699–730. Roth MG. 2006. Clathrin-mediated endocytosis before fluorescent proteins. Nat Rev 7:63–8. Roth TF, Porter KR. 1964. Yolk protein uptake in the oocyte of the mosquito Aedes aegypti L. J Cell Biol 20: 313–32. Saffarian S, Cocucci E, Kirchhausen T. 2009. Distinct dynamics of endocytic clathrin-coated pits and coated plaques. PLoS Biol 7:e1000191. Semerdjieva S, Shortt B, Maxwell E, Singh S, Fonarev P, Hansen J, Schiavo G, Grant BD, Smythe E. 2008. Coordinated regulation of AP2 uncoating from clathrin-coated vesicles by rab5 and hRME-6. J Cell Biol 183:499–511.
c02.indd 37
37
Teckchandani A, Toida N, Goodchild J, Henderson C, Watts J, Wollscheid B, Cooper JA. 2009. Quantitative proteomics identifies a Dab2/integrin module regulating cell migration. J Cell Biol 186:99–111. Traub LM. 2009a. Clathrin couture: fashioning distinctive membrane coats at the cell surface. PLoS Biol 7: e1000192. Traub LM. 2009b. Tickets to ride: selecting cargo for clathrin-regulated internalization. Nat Rev 10:583–96. Ungewickell E, Branton D. 1981. Assembly units of clathrin coats. Nature 289:420–2. Ungewickell EJ, Hinrichsen L. 2007. Endocytosis: clathrin-mediated membrane budding. Curr Opin Cell Biol 19:417–25. Vigers GP, Crowther RA, Pearse BM. 1986. Location of the 100 kd-50 kd accessory proteins in clathrin coats. EMBO J 5:2079–85. Wenk MR, Pellegrini L, Klenchin VA, Di Paolo G, Chang S, Daniell L, Arioka M, Martin TF, De Camilli P. 2001. PIP kinase Igamma is the major PI(4,5) P(2) synthesizing enzyme at the synapse. Neuron 32: 79–88. Zaremba S, Keen JH. 1983. Assembly polypeptides from coated vesicles mediate reassembly of unique clathrin coats. J Cell Biol 97:1339–47. Zoncu R, Perera RM, Sebastian R, Nakatsu F, Chen H, Balla T, Ayala G, Toomre D, De Camilli PV. 2007. Loss of endocytic clathrin-coated pits upon acute depletion of phosphatidylinositol 4,5-bisphosphate. Proc Natl Acad Sci U S A 104:3793–8.
5/6/2011 6:10:04 PM
.
CH A P T E R
3
CAVEOLAE Dan Tse Radu V. Stan
DEFINITION Caveolae constitute a plasma membrane microdomain abundant in vertebrate cells, with few exceptions. They are defined as spherical invaginations of the plasma membrane with a strikingly constant diameter in the range of 60–70 nm. The invaginations can exist singly or in grapelike clusters with noncaveolar plasma membrane between the invaginations. Caveolae neck (or stoma, or introit) is defined as the transition region where the membrane of the invagination continues the membrane of the plasmalemma proper. In endothelial cells, the neck contains a protein structure called a stomatal diaphragm (SD). Select members of the caveolin (Cav) and cavin families of proteins are critical for the formation of the caveolar invaginations. The Cav family comprises Cav1–3 and one invertebrate member. Cav1 and Cav3 are critical for the formation of caveolae in cells where they are expressed. Cavin family of proteins is less well described. It contains four isoforms such as cavin-1/Pol I and transcript release factor (PTRF), cavin-2/serum deprivation protein response (SDPR), cavin-3/sdr-related gene product that binds to c-kinase (SRBC), and the muscle-cell-specific cavin-4/muscle-restricted coiled-coil (MURC4). Of these, cavin-1 and cavin-4 were shown to be critical for caveolae formation. Caveolae formation also requires a certain set of lipids such as cholesterol and sphingolipids, representing a subdomain of lipid rafts (see also Chapters 4 and 5 on lipid rafts) as well as phosphatidylserine (PS), which are enriched in the caveolae membrane but present in all membranes. Although both classes of preoteins are required for caveolae formation, at this point in time, caveolins seem to define the best caveolae not each individual member of the cavin family being present in every caveola. However, caveolins can also exist on flat plasma membrane, even in cells lacking morphologically distinct caveolae; thereby, their mere presence in the absence of invaginations does not define caveolae. Thus, at this point in time, defining caveolae should rely on a double criterion of morphological invagination and imunocytochemical demonstration of Cav1 on these invaginations, achieved only by electron microscopy (EM).
HISTORICAL PERSPECTIVE The introduction of the electron microscope to the study of biological materials in the second half of the last century has dramatically expanded our understanding of the inner workings of cells. It enabled a first glimpse of the cellular architecture leading to the discovery and study of subcellular organelles and microdomains. Cellular Domains, First Edition. Edited by Ivan R. Nabi. © 2011 John Wiley & Sons, Inc. Published 2011 by John Wiley & Sons, Inc.
39
c03.indd 39
5/6/2011 6:10:06 PM
40
CHAPTER 3
CAVEOLAE
Uncoated membrane invaginations in the size range of caveolae were first described in 1953 in the continuous endothelium of the heart by G.E. Palade (Palade 1953) who called them plasmalemmal vesicles. Two years later, E. Yamada described similar structures in the gall bladder epithelium, naming them caveolae intracellulares (Yamada 1955) due to their resemblance to “little caves.” Since their discovery, the presence of caveolaelike invaginations has been documented by electron microscopists in most cell types (reviewed in Parton 2003; Stan 2005b). These studies revealed the structural features of caveolae (Peters et al. 1985) as well as some of their protein (Fujimoto et al. 1992; Fujimoto 1993) and lipid residents. Functional postulates were also formulated such as transcytosis of physiologically relevant cargo across endothelial cells (Palade 1960; Simionescu 1981) or uptake of lipid—binding cholera and tetanus toxins (Montesano et al. 1982) by noncoated vesicles. In muscle cells, caveolae were associated with the developing T tubules (Ishikawa 1968) and were proposed to be involved in excitation–contraction coupling (Popescu 1974; Fry et al. 1977; Severs 1988). Caveolae were also postulated to act as stretch sensors and/or as reservoirs of membrane during cycles of contraction and relaxation (Severs 1988). These studies banked on a purely morphological definition of caveolae. In the absence of molecular markers, terms such as caveolae or plasmalemmal vesicles were used to describe morphological entities that do not always correspond to the operational definitions in use today. Moreover, several uncoated membrane invaginations in the size range of caveolae but devoid of Cav1 are found in cells (Mayor and Pagano 2007; Hansen and Nichols 2009, 2010; Howes et al. 2010; Kumari et al. 2010); therefore, care should be exercised when interpreting these early data. With the discovery of Cav1 (Glenney 1992; Glenney and Soppet 1992; Kurzchalia et al. 1992) as the first molecular marker of caveolae (Rothberg et al. 1992; Dupree et al. 1993) in the early 1990s, the study of caveolae was ushered into the molecular era. After this date, ensuing biochemical and cell biological approaches have revealed numerous features of caveolae and served as basis for hypotheses involving caveolae in a plethora of cellular functions such as vesicular trafficking, signal transduction, lipid homeostasis, and cell growth and division as well as adhesion and motility. Many excellent reviews discuss these findings (Cohen et al. 2004; Parton and Simons 2007; Hansen and Nichols 2009, 2010; Lajoie et al. 2009a). Genetic models in which critical components of caveolae such as caveolins (Drab et al. 2001; Galbiati et al. 2001; Razani et al. 2001, 2002; Park et al. 2002; Zhao et al. 2002; Cao et al. 2003; Bauer et al. 2005) and cavins (Hill et al. 2008; Liu et al. 2008; Bastiani et al. 2009; Hansen et al. 2009) were depleted have tremendously helped in defining the biogenesis, function, and regulation of caveolae. Lastly and most excitingly, caveolae and their residents have been demonstrated to play important roles in disease, such as atherosclerosis, cancer, inflammation, calcium phosphate balance, kidney stone disease, and muscular dystrophy, and to be involved in host–pathogen interactions.
DISTRIBUTION AND MORPHOLOGY Caveolae occur at different surface densities in different cell types with endothelial cells, adipocytes, and muscle cells being the richest. In adipocytes, ∼20% of the plasma membrane was estimated to be caveolar membrane (Sheldon et al. 1962; Williamson 1964). There is marked variation in caveolar surface density within a given cellular type, which is best exemplified in the case of the different types of endothelium (Simionescu et al. 1974) or mesothelia (von Ruhland et al. 2004). Variations in numbers of surface-connected
c03.indd 40
5/6/2011 6:10:06 PM
DISTRIBUTION AND MORPHOLOGY
41
Figure 3.1. (A) Endothelium of continuous type as seen by freeze fracture. The P face of the abluminal membrane of a heart EC shows the numerous caveolae. These are organized in linear arrays, better seen in the higher magnification images (insets). Reproduced from Simionescu et al. (1974) with permission. (B–E) Caveolae with (D–E) and without (B–C) SDs as seen by TEM (C, E) or in deep-etch specimens (B, D). (B, D) Reproduced from Bearer and Orci (1985) with permission.
caveolae are caused by differentiation status (Williamson 1964; Novikoff et al. 1980), oncogenic transformation (Koleske et al. 1995; Lee et al. 1998), shear stress (Rizzo et al. 2003), and cell adhesion (del Pozo et al. 2004). Please see Parton (2003), Stan (2005b), and Parton et al. (2006) for a more detailed analysis of the morphological aspects of caveolae. Caveolae occur in ordered, linear arrays over the entire cell body (Fig. 3.1A), suggesting a link with the underlying cytoskeleton (Simionescu et al. 1974; Tani et al. 1977; Gabella 1978; Sawada et al. 1978; Frank et al. 1980; Severs 1981; Peters et al. 1985; Izumi et al. 1988; Parton et al. 1994; Fujimoto et al. 2000). In migrating cells, caveolins and caveolae seem to preferentially distribute to the retracting edge of the cell (Isshiki et al. 1998, 2002; Parat et al. 2003; Beardsley et al. 2005). In many cell types, caveolae occur single or in chains or grapelike clusters. In the endothelium, these are attached to either front of the cell (Bruns and Palade 1968a, b; Palade and Bruns 1968; Bundgaard et al. 1979, 1983; Frokjaer-Jensen 1980, 1984, 1991; Frokjaer-Jensen et al. 1988). In other epithelia, caveolae are preferentially attached to the basolateral surface such as in Madin-Darby canine kidney (MDCK) cells and in CaCo2 cells upon de novo expression of Cav1 (Vogel et al. 1998). In muscle cells (Ishikawa 1968; Parton et al. 1997) or in freshly isolated adipocytes (Thorn et al. 2003), caveolae occur mostly as single entities rather than clusters. In adipocytes (Williamson 1964; Novikoff et al. 1980; Kanzaki and Pessin 2002; Parton et al. 2002), endothelia (Simionescu et al. 1974; Uehara and Miyoshi 1999), or epithelial cells (Parton 1994), caveolae could be attached to large, fingerlike invaginations of the plasma membrane surrounded by cortical actin, called “cav-actin” (Kanzaki and Pessin 2002), “caves” (Parton et al. 2002), or “caveolae rosettes” (Fig. 3.2B) (Novikoff et al. 1980). Rosette numbers seem to be increased in endothelial cells upon overexpression of intersectin, a protein involved in caveolae endocytosis (Predescu et al. 2003) or astrocytes under the influence of okadaic acid, a phosphatase inhibitor (Bento-Abreu et al. 2009).
c03.indd 41
5/6/2011 6:10:06 PM
(C)
(A)
(D)
(B)
(E)
(F)
(G) (H)
(I)
Figure 3.2. Caveolar coat. Striations have been demonstrated by TEM in smooth muscle (A) and fibroblasts (F). They are readily apparent by either SEM on chromium-coated replicas of endothelial cells (B) or in platinum-carbon replicas of deeply etched specimens in fibroblasts (C, E–F). The ridges are best seen when caveolae are flattened by treatment with cholesterolbinding drugs (nystatin) (E–F). (F) Immunolocalization of Cav1 to the caveolar coat ridges. Reprints from (A) Somlyo et al. (1971), (B) Peters et al. (1985), and (C–F) Rothberg et al. (1992) with permission. B is courtesy of Rob Parton.
c03.indd 42
5/6/2011 6:10:07 PM
MOLECULAR COMPONENTS
43
In frozen, unfixed specimens caveolae surface density is reduced, suggesting that fixation might induce the formation of the invaginations (McGuire and Twietmeyer 1983; Wood et al. 1986; Noguchi et al. 1987). Moreover, there are differences between the typical morphology of caveolae in aldehyde-fixed tissues and caveolae in unfixed frozen tissues. In the latter, caveolae are slightly larger, have the aspect of cups rather than omega-shaped invaginations, and can be found with different degrees of membrane curvature (Richter et al. 2008). On their cytoplasmic face, caveolar invaginations feature a filamentous coat formed by Cav polymerization (Fernandez et al. 2002; Parton et al. 2006). The existence of the coat was first suggested by transmission electron microscopy (TEM) in smooth muscle caveolae (Somlyo et al. 1971) (Fig. 3.2A) and later confirmed by high-resolution scanning electron microscopy (SEM) in endothelial cells (Peters et al. 1985) and by rapid-freeze deep-etch techniques in endothelial cells (ECs) and fibroblasts in both unfixed and glutaraldehyde-fixed cells (Izumi et al. 1988, 1989, 1991). The coat ridges are enhanced by phalloidin and could be decorated with myosin fragments (Izumi et al. 1989). Carbonplatinum deep-etch replicas of fibroblast plasma membrane sheets showed that the coat contains Cav1-positive “spiral patterns” resistant to high-salt and high-pH extraction (Fig. 3.2E, G–I) (Rothberg et al. 1992). Cholesterol-binding drugs (i.e., nystatin) flatten caveolae and disassemble the coat (Rothberg et al. 1992) (Fig. 3.2G); the fragmentation of the coat resulted in what appeared to be ∼10-nm-diameter uniform units (Fernandez et al. 2002). TEM tomography combined with manual annotation (Richter et al. 2008) or powerful computer-assisted template matching (Lebbink et al. 2010) have recently demonstrated a spiral coat on caveolae in unfixed high-pressure freeze-substituted cells or tissues.
MOLECULAR COMPONENTS Cav Family of Proteins An important milestone in the field was achieved with the demonstration by immunocytochemistry that Cav1 is a specific component of the ridges that make the caveolar coat (Rothberg et al. 1992) (Fig. 3.2H–I). This advanced the operational definition of caveolae to plasma membrane invaginations that contain caveolins. The Cav family of proteins encompassing Cav1 (Glenney and Soppet 1992), Cav2 (Scherer et al. 1996), and Cav3 (Way and Parton 1995) is part of a gene family well conserved in amniotes (Kirkham et al. 2008). Cav1 and Cav2 have similar tissue distribution being expressed in most cell types (Kurzchalia et al. 1994; Parton et al. 1994; Scherer et al. 1997; Scheiffele et al. 1998), while Cav3 occurs primarily in striated muscle cells (Way and Parton 1995). Cav1 and Cav3 seem to coexist in different subdomains in some smooth muscle cells. Cav1 was identified as a v-Src phosphorylation substrate in Rous sarcoma virustransformed fibroblasts (Glenney 1992; Glenney and Soppet 1992) and independently cloned as VIP21, a component of the trans-Golgi-derived vesicles (Kurzchalia et al. 1992, 1994). Cav1 has two isoforms: Cav1α contains residues 1–178 and Cav1β contains residues 32–178. Cav1β is translated from a different mRNA than Cav1α (Kogo and Fujimoto 2000; Kogo et al. 2004). Cav1 is phosphorylated on serine/threonine sites by protein kinase Cα (PKCα) (Smart et al. 1995; Mineo et al. 1998; Isshiki and Anderson 1999) and on tyrosines (Tyr14 being the most important) by c-Src and possibly other nonreceptor tyrosine kinases (Glenney and Soppet 1992; Li et al. 1996a; Tiruppathi et al. 1997; Aoki et al. 1999; Nomura and Fujimoto 1999; Caselli et al. 2001; Volonte et al. 2001; Cao et al. 2002; Kim et al. 2002; Kimura et al. 2002; Labrecque et al. 2004; Nohe et al. 2005).
c03.indd 43
5/6/2011 6:10:09 PM
44
CHAPTER 3
CAVEOLAE
Tyrosine phosphorylation seems to occur mainly on Cav1α. The two Cav1 isoforms have a different subcellular distribution (Fujimoto et al. 2000) and can be expressed in a celltype-specific manner (Kogo et al. 2004). Cav1 and Cav3 (but not Cav2) are palmitoylated on three cysteines in the C-terminal region, but the palmitoylation is not necessary for Cav targeting to caveolae (Dietzen et al. 1995). In ECs, the palmitoylation occurs posttranslationally and is irreversible, which is an important difference from other acylated proteins where palmitoylation is reversible and regulatable (Dunphy and Linder 1998; Parat and Fox 2001; Resh 2004). Based on these last data and the demonstration that palmitoylation stabilizes the Cav oligomers (Monier et al. 1996), the palmitoylation of Cav has been proposed to have a role in increasing its membrane association mediated by the hydrophobic domain (Parat and Fox 2001). Another feature of the Cav molecule is the “scaffolding domain,” a region adjacent to the hydrophobic domain used by Cavs to interact with signal transduction molecules (Sargiacomo et al. 1995; Schlegel et al. 2001). Unconventional membrane attachment domains responsible for targeting the molecule to caveolae (Schlegel et al. 2001) and Golgi (Luetterforst et al. 1999) (see also Chapter 8 on the Golgi apparatus) have been proposed to exist in the Cav molecule. However, a recent paper (Ren et al. 2004) questioned the existence of a specific targeting domain, suggesting that the disruption of the overall conformation of Cav molecule would impair caveolae targeting, raft association, and Golgi exit. Cav2 has three known isoforms (α, β, γ) that were discovered in adipocytes (Scherer et al. 1996). Cav2α is the full-length isoform, whereas 2β is an alternatively spliced isoform that has a different subcellular distribution than Cav2α (Kogo et al. 2002). The phosphorylation of Cav2 on serines 23 and 36 modulates Cav1-dependent caveolae formation (Sowa et al. 2003). Cav2 is also phosphorylated on tyrosine 19 or 27. Phospho-Cav2 (pY19) and phospho-Cav2 (pY27) display different cellular localization patterns (Wang et al. 2004). Finally, mice lacking Cav2 show severe pulmonary dysfunction but without disruption of caveolar invaginations (Razani et al. 2002). Cav3 (Way and Parton 1996) is expressed in the skeletal muscle and myocardium where it is essential for the formation of caveolae (Hagiwara et al. 2000; Galbiati et al. 2001). It was also shown to be expressed in smooth muscle cells (Song et al. 1996), astrocytes (Ikezu et al. 1998), and sinus endothelial cells (Uehara and Miyoshi 2002). Loss of Cav3 results in muscle degeneration (Hagiwara et al. 2000), cardiomyopathy (Woodman et al. 2002), and increased adipose tissue deposition (Park et al. 2002). Increased Cav3 levels are associated with muscle dystrophy, cardiomyopathy, and cardiac hypertrophy inhibition (Repetto et al. 1999; Galbiati et al. 2000; Aravamudan et al. 2003). For more detailed reviews on Cavs, see Gratton et al. (2004) and Williams and Lisanti (2004b).
Cav1 and Cav3, but Not Cav2, Are Essential for the Formation of Caveolar Invaginations Several lines of evidence demonstrate the essential role of Cav proteins in the structure of caveolae. Cav1 and Cav3 expression in cells lacking both caveolae and Cav expression induces caveolae formation (Fra et al. 1995b) and reconstitutes the caveolar coat (Chung et al. 1996). Both Cav1α and Cav1β isoforms are able to induce the formation of caveolae de novo, Cav1β being less efficient (Fujimoto et al. 2000). Expression of Cav2 alone does not lead to caveolae formation; in fact, Cav2 alone does not traffic further than Golgi, needing expression of Cav1 in order to reach plasma membrane caveolae (Scheiffele et al. 1998; Mora et al. 1999; Parolini et al. 1999).
c03.indd 44
5/6/2011 6:10:09 PM
MOLECULAR COMPONENTS
45
The most compelling evidence for the structural role of Cav1 and Cav3 in the formation of caveolae came from genetic mouse models lacking one or both of these proteins (Drab et al. 2001; Razani et al. 2001; Park et al. 2002; Zhao et al. 2002). It has been shown that upon Cav3 gene disruption, muscle cells do not have any caveolae while they are still present in other cell types (Hagiwara et al. 2000; Galbiati et al. 2001). Conversely, Cav1−/− mice lack caveolae in all cells except in muscle cells (Drab et al. 2001; Zhao et al. 2002). Loss of Cav2 does not disrupt caveolae (Razani et al. 2002), Cav2−/− mice having unaltered number of caveolae. Taken together, these data show that Cav1 and Cav3 are essential for caveolae formation, whereas Cav2 is not. However, larger (100–150 nm) invaginations of the plasma membrane and vesicle clusters are present in the endothelium of the venules in the heart and lungs of Cav1−/− mice (Drab et al. 2001; Zhao et al. 2002). Recently, these structures were shown to be vesiculovacuolar organelles (VVOs) (Chang et al. 2009). This provides genetic evidence that other smooth invaginations could exist in absence of Cav1, and by our operational definition, these invaginations are not caveolae.
Cavins Recently, it became apparent that a new family of proteins, now known as cavins, is intimately involved in caveolae biogenesis. These are cavin-1/PTRF (Hill et al. 2008; Liu and Pilch 2008; Liu et al. 2008), cavin-2/SDPR (Gustincich et al. 1999; Hansen et al. 2009), cavin-3/SRBC (McMahon et al. 2009), and the muscle-specific cavin-4/MURC (Bastiani et al. 2009). Their role in caveolae biogenesis will be discussed below (reviewed in Briand et al. 2010, Chidlow and Sessa 2010, and Hansen and Nichols 2010). In terms of common features, all cavins bind PS, which is important in their targeting to the plasma membrane. They contain consensus sites and domains such as phosphorylation motifs (phosphorylated upon insulin stimulation), leucine zipper-like domains through which they interact with other proteins, and PEST (proline, glutamic acid, serine, and threonine) domains involved in protein turnover (Rahman and Sward 2009). Cavin-1 or PTRF was cloned as a transcript release factor (Jansa et al. 1998, 2001; Jansa and Grummt 1999). It was later shown to be a major caveolar protein mainly in adipocytes (Vinten et al. 2001, 2005; Aboulaich et al. 2004) and other tissues (Voldstedlund et al. 2001, 2003). It localizes to caveolae, and its total cellular levels correlate with those of Cav1 and the number of caveolae (Voldstedlund et al. 2001, 2003; Aboulaich et al. 2004; Liu and Pilch 2008). Cavin-1 was subsequently shown to be essential for caveola formation in mammalian cells (Hill et al. 2008; Liu et al. 2008; Liu and Pilch 2008), zebra fish (Hill et al. 2008), and mice (Liu et al. 2008). Cavin-2 or SDPR (or SDR) was isolated as a PS-binding protein from platelets (Burgener et al. 1990; Gustincich et al. 1999). It was shown in vitro to bind to and be a substrate for protein kinase C (PKC) isoforms in caveolae (Izumi et al. 1997; Mineo et al. 1998). Cavin-2 levels are increased by serum deprivation but not by contact inhibition (Gustincich et al. 1999). The presence of cavin-2 in caveolae was demonstrated by immunocytochemistry (Mineo et al. 1998). Cavin-2 has a role in the formation of caveolae, as demonstrated in cells in culture (Hansen et al. 2009; McMahon et al. 2009). Cavin-2 binds directly to cavin-1 and recruits it to caveolar membranes. Overexpression of cavin-2, unlike cavin-1, induces deformation of caveolae and extensive tubulation of the plasma membrane. Cavin-2 colocalizes extensively with both B-subunit of Shiga toxin (STB) and Cav1 on the similar membrane tubes induced by STB, which is lost when caveolae are absent (Hansen et al. 2009). Cavin-3 or SRBC (Gustincich et al. 1999) or protein kinase C delta-binding protein (PRKCDBP) (Burgener et al. 1990) was shown to co-immunoprecipitate with Cav1 and
c03.indd 45
5/6/2011 6:10:09 PM
46
CHAPTER 3
CAVEOLAE
Cav2 (Bastiani et al. 2009; McMahon et al. 2009) and to remain colocalized with Cav1 when caveolae bud off (McMahon et al. 2009). Its downregulation impairs intracellular trafficking of Cav1-containing “cavicles” but does not change the number of caveolae (McMahon et al. 2009). Cavin-4 (Bastiani et al. 2009) or MURC4 (Ogata et al. 2008; Tagawa et al. 2008) is a muscle-specific, coiled-coil-containing protein involved in muscle biogenesis. It forms complexes with other cavins and has a role in caveolae biogenesis (Bastiani et al. 2009).
CAVEOLAR LIPIDS Indications of a specific lipid composition of the caveolar membranes came from EM experiments in different cell types employing cholesterol-binding probes and showed an enrichment of cholesterol in caveolae (Simionescu et al. 1983; Fujimoto 1996; Fujimoto et al. 1997). Subsequent studies have demonstrated that Cav1 binds tightly to free cholesterol and to bind to artificial phospholipid liposomes only upon cholesterol incorporation (Murata et al. 1995; Tillmann et al. 1995; Li et al. 1996b). Moreover, cholesterol is necessary to stabilize Cav oligomers, both sterol and protein being necessary to generate and maintain caveolar structure (Monier et al. 1996). These data and the sensitivity of caveolae architecture to cholesterol depletion (Rothberg et al. 1992) and oxidation (Smart et al. 1994) have established caveolae as cholesterol-enriched membrane microdomains. Caveolae are also enriched in sphingolipids (such as sphingomyelin, ceramide, and gangliosides) that occur mostly in the exoplasmic leaflet of the membrane bilayer (Parton 1994; Smart et al. 1994; Liu and Anderson 1995; Schnitzer et al. 1995a; Fujimoto 1996; Fujimoto et al. 1997). Cav1 also binds glycosphingolipids (such as GM1 ganglioside) (Fra et al. 1995a) and fatty acids (Trigatti et al. 1999). The lipid composition of caveolae (i.e., cholesterol, sphingomyelin, glycosphingolipids, and saturated fatty acids) is similar to that of “lipid rafts,” membrane microdomains that occur in all cell types (Brown and London 2000; Simons and Toomre 2000; Shogomori and Brown 2003; Simons and Vaz 2004). Comprehensive comparison of the lipid composition of the caveolae/lipid raftenriched fractions from cells that express or not Cav1 (and caveolae), also show that both lipid rafts and caveolae are enriched in cholesterol, sphingomyelin, arachidonic acid containing ethanolamine plasmalogens, and PS with decreases in phosphatidylinositol and phosphatidylcholine (Pike et al. 2002). Interestingly, only cholesterol and not sphingomyelin was enriched in raft fractions of cells expressing Cav1 over cells that do not express it. Because Cav1 could not directly bind all the excess cholesterol present in the caveolae/ lipid raft fraction, it was postulated that it might direct the organization of a structure that facilitates cholesterol enrichment (Pike et al. 2002). It was also concluded that the extra cholesterol must either be sequestered in some fashion or restricted to the inner leaflet of the plasma membrane so that it does not alter the balance of cholesterol and sphingomyelin at the cell surface. The observation that lipid rafts and caveolae were highly enriched in PS in the cytoplasmic leaflet of the membrane (Pike et al. 2002) nicely dovetails with recent findings that all cavin proteins that are required for caveola biogenesis bind PS (Hill et al. 2008; Liu and Pilch 2008; Liu et al. 2008; Bastiani et al. 2009; Hansen et al. 2009). Lipid analysis of immunoisolated adipocyte caveolae (Ortegren et al. 2004) found the same cholesterol, sphingomyelin, and glycerophospholipid makeup. In addition, glycosphingolipid GD3 was highly enriched in caveolae, whereas GM3, GM1, and GD1a were present inside as well as outside the caveolae membrane. GD1b, GT1b, GM2, GQ1b, sulfatide, and lactosylceramide sulfate were not detected in adipocyte caveolae (Ortegren et al. 2004).
c03.indd 46
5/6/2011 6:10:09 PM
CAVEOLAE BIOGENESIS
47
CAVEOLAR NECKS: TRANSITION ZONE BETWEEN CAVEOLAR MEMBRANE AND PLASMALEMMA PROPER The neck of caveolae is the region where the membrane of the caveolar invagination is in continuity with that of plasmalemma proper. In aldehyde-fixed tissues, this region forms an inverted bend, which, in some cases, appears rounded, whereas in others, it appears as a sharp angle. Electron opaque material fills the cytoplasmatic aspect of the neck. The sharp angle is mostly present in endothelial cells where caveolae are provided with an SD (see below). However, electron microscopic examination of unfixed frozen tissues or highpressure freeze-substituted samples revealed differences with the fixed material. In the former conditions, caveolae have a cuplike appearance with a much larger introit and no electron opaque material around the neck (Westermann et al. 2005; Richter et al. 2008; Schlormann et al. 2010). The same is encountered in endothelial caveolae featuring SDs (Richter et al. 2008). The neck region seems to have a different composition than the rest of the caveolar body. In endothelial cells (Moldovan et al. 1995; Schnitzer et al. 1995b; Stan et al. 1999a) and adipocytes (Foti et al. 2007), the neck is readily soluble in anionic detergents. Insulin receptors seem to be concentrated at the neck of adipocyte caveolae (Foti et al. 2007). In endothelial cells, the neck contains a specialized SD (Bruns and Palade 1968a, b; Clementi and Palade 1969a, b; Stan et al. 1999a, b; Stan 2004; Stan et al. 2004) (reviewed in Stan 2005b, 2007) (Figs. 3.1D–E and 3.3). The existence of caveolae with or without SDs has been clearly demonstrated by rapid-freeze deep-etch techniques (Bearer and Orci 1985; Noguchi et al. 1987; Fig. 3.1B–E) as well as unfixed high-pressure freezesubstituted samples (Richter et al. 2008). The SD is a thin (∼5–6 nm) protein (Simionescu et al. 1981, 1982) barrier of unknown function that occurs in the caveolar neck (introit, mouth, or stoma—hence the name) or at the stomata (or communication) between fused caveolae. Similar diaphragms occur in normal endothelium on transendothelial channels (TECs), fenestrae (Clementi and Palade 1969a, b; Stan et al. 2004), or VVOs in the vascular endothelium in tumors and the endothelium of normal venules (Dvorak and Feng 2001). Recently, the SDs were postulated to be formed by the Plvap/PV1 (Fig. 3.3), type II membrane glycoprotein found in vertebrates (Stan et al. 1999a, b, 2001, 2004; Stan 2004). PV1 is a key structural component of both the SDs and fenestrated diaphragms (FDs), necessary and sufficient for diaphragm formation (Stan et al. 2004). This is based on several lines of evidence: (1) Several PV1 homodimers reside in close proximity within the same diaphragm as shown by cross-linking experiments of PV1 carried out in situ in rat lungs and kidneys (Stan 2004). (2) De novo formation of FDs and SDs correlates with PV1 expression. As expected, PV1 was found in the newly formed FDs and SDs. (3) PV1 mRNA silencing by siRNA prevented the formation of both FDs and SDs. (4) Expression of tagged PV1 in either endothelial cells or nonendothelial cells (e.g., fibroblasts, COS7, HeLa, HEK293), which lack PV1 expression and diaphragms, led to the formation of caveolar SDs (Stan et al. 2004). A model of PV1 integration in the diaphragms was recently proposed (Stan 2005b, 2007).
CAVEOLAE BIOGENESIS Immediately after synthesis in the endoplasmic reticulum (ER; see also Chapter 7), Cav1 assembles into 8S complexes that concentrated in ER exit sites, due to a DXE sequence in the N-terminal domain (Hayer et al. 2010). The coat protein II (COPII) machinery
c03.indd 47
5/6/2011 6:10:09 PM
48
CHAPTER 3
CAVEOLAE
Caveolae
TEC
Fenestrae
(A)
Stomatal diaphragms
(B)
Fenestral diaphragms
(C)
Rim (plasma membrane) (D)
N-glycosylation Central knob
PV1 dimer
Scaffold proteins Diaphragm filbrils
Stan, figure
Rim
Figure 3.3. Working model for PV1 integration in the structure of the diaphragms. (A) Perpendicular TEM sections of a caveola provided with SD (left), TEC (middle), and fenestra (right) from specimens labeled with anti-PV1 antibodies, demonstrating the presence of PV1 in these structures. (B) En face views of SDs (left) and FDs (right), as shown by deep-etch rapidfreeze techniques, demonstrating the fibrils in the FDs and the hints of fibrils in their SD counterparts. Reprinted from Bearer and Orci (1985) with permission. (C) Schematic of the membrane insertion and features of the PV1 monomer. (D) Model of PV1 integration in the endothelial diaphragms. Left panel: PV1 dimers participate in the formation of the fibrils inserted in the rim (via PV1 N-terminus) and interweaving in the central mesh (via PV1 C-terminus). The glycan antennae (accounting for ∼15% of PV1 mass) are situated near the membrane, which would keep the protein “afloat” by preventing collapse on the plasma membrane. The sharp angle formed by the plasma membrane at the level of the rim is maintained by “scaffold proteins” that can be either transmembrane or associated with the cytosolic face of the membrane. Right panels: PV1 dimer seen from the top (up) and in a section perpendicular on the diaphragm plane (bottom).
c03.indd 48
5/6/2011 6:10:09 PM
CELLULAR FUNCTIONS OF CAVEOLAE
49
allows rapid transport to the Golgi complex where the Cavs lose their diffusional mobility, undergo conformational changes (Ren et al. 2004), and assemble into 70S complexes by association with cholesterol (Hayer et al. 2010). Together with green fluorescent protein– glycosylphosphatidylinositol (GFP-GPI), the newly assembled Cav complexes undergo transport to the plasma membrane in vesicular carriers distinct from those containing vesicular stomatitis virus (VSV) G protein (Hayer et al. 2010). After the arrival at the plasma membrane, PTRF/cavin-1 is recruited to the caveolar domains over a period of 25 minutes or longer (Hayer et al. 2010). PTRF/cavin-1 is present in 60S complexes that form in the absence of Cav1 (Hayer et al. 2010) possibly by interactions with other cavins (Hansen et al. 2009). Cavin-1 was postulated to act as a stabilizer of caveolae (Hill et al. 2008). Its lack results in loss of caveolae and a higher lateral mobility of Cav1, which forms a uniform smooth pattern into the membrane and is targeted for degradation via endocytosis (Hill et al. 2008). In cancer cells that lack both Cav1 and cavin-1, reintroduction of Cav1 results in membrane tubules that contain Rab8 and EHD (dynamin-like C-terminal Eps15 homology domain) proteins (Verma et al. 2010). Actomyosin-induced tension causes the tubules to disperse into small vesicles (Verma et al. 2010). Similar tubules are formed when cavin2/SDPR is overexpressed (Hansen et al. 2009). Coexpression of cavin-1 and Cav1 in these cells results in the inhibition of membrane tubulation induced by Cav1 (Verma et al. 2010). At this point in time, the essential role of Cavs in the formation of the invaginations is pretty well established. The evidence for a coat on the cytoplasmic face of caveolae is very strong and the list of the structural proteins required for caveolae formation is growing. What is unclear is the precise role of the coat in caveolae structure and the precise spatial arrangement of its molecular makeup.
CELLULAR FUNCTIONS OF CAVEOLAE Although they were implicated in many cellular functions, the precise roles of caveolae are still debated (for a review, see Parton and Simons 2007). As better, more discriminative tools became available, some caveolar roles begin to crystallize.
Endocytosis of Caveolae Early data demonstrated noncoated invaginations to participate in transcytosis across endothelial cells (Palade 1960) and endocytosis (Montesano et al. 1982). The capacity of caveolae to internalize ligands was further reinforced during the years and much was learned about the process (Parton and Simons 2007; Howes et al. 2010; Kumari et al. 2010). At the cell surface, caveolae have low lateral mobility as shown by fluorescence recovery after photobleaching (FRAP) experiments (Thomsen et al. 2002) and by cell fusion experiments (Tagawa et al. 2005). They describe kiss-and-run movements (Pelkmans and Zerial 2005) and internalize quite slowly (Thomsen et al. 2002; Pelkmans et al. 2004; Kirkham et al. 2005) in actin cytoskeleton, tyrosine kinase, and dynamin-2-dependent manner (Oh et al. 1998; Pelkmans et al. 2001, 2002, 2004; Tagawa et al. 2005). Caveolae endocytosis is triggered by cell detachment from the extracellular cell matrix (del Pozo et al. 2004, 2005), by cargo molecules such as serum albumin (Tiruppathi et al. 1997) or SV40 virus (Pelkmans et al. 2001; Tagawa et al. 2005), or treatments with phosphatase inhibitors (Parton et al. 1994; Vepa et al. 1997). Cell loading with either cholesterol or glycosphingolipids (Sharma et al. 2003; Singh et al. 2003), or removal of sialic acid
c03.indd 49
5/6/2011 6:10:09 PM
50
CHAPTER 3
CAVEOLAE
moieties from glycoproteins and gangliosides (Singh et al. 2010), was also reported to increase caveolae internalization. After internalization caveolae carriers fuse with either the caveosomes or the Rab5positive early endosomes (see also Chapter 9) from where they can be recycled to the plasma membrane (Pelkmans et al. 2004). Very interestingly, caveolae seem to remain as a stable structure upon fusing with these compartments exchanging soluble cargo but not membrane (Pelkmans et al. 2004). It is not very clear how fission and fusion occur in the light of the apparent stability of the caveolae containers. A possibility would be a small subdomain of more fluid membrane (possibly derived from the caveolar neck) that can support these processes. The field is at an impasse with respect to specific markers to be used for internalization studies. Those thought to be the most specific include serum albumin, SV40 virus, cholera toxin B subunit as a ligand for GM1 ganglioside, lactosyl ceramide, and GPIanchored proteins. Recently, it has become clear that all these markers can be internalized via other pathways (Nichols 2003; Lajoie and Nabi 2007; Parton and Simons 2007; Howes et al. 2010; Kumari et al. 2010). GPI-anchored proteins are primarily internalized via a cdc42-regulated clathrin and Cav-independent pathway (Sabharanjak et al. 2002). Only 1 in 10 SV40 particles may enter cells via caveolae, the virus being able to induce invaginations de novo (Damm et al. 2005; Ewers et al. 2010). Cholera toxin enters cells via multiple pathways (Kirkham et al. 2005; Lajoie et al. 2009b). In endothelial cells, serum albumin is supposedly internalized in caveolae via albondin/gp60, its low affinity receptor (Schnitzer and Oh 1994; Tiruppathi et al. 1997; Minshall et al. 2000). However, it has been clear for a long time that albumin can enter cells via other pathways chiefly as fluid phase (SiflingerBirnboim et al. 1991). Lastly, fluorescent lipid analogs such as lactosylceramide can be used for identification of the carriers with limited application for studies at the cell surface. Caveolae were proposed to mediate the exchange of macromolecules across the endothelial barrier by the process of transcytosis (reviewed in Stan 2002, 2005a), and recent in situ data seem to bolster the idea (Oh et al. 2007). However, with exception of a mild hypertriglyceridemia, the blood homeostasis in Cav1−/− mice is unperturbed, especially with respect to protein levels (Drab et al. 2001). Loss of caveolae in Cav1−/− (Schubert et al. 2002) or siRNA-mediated downregulation of Cav1 (Miyawaki-Shimizu et al. 2006) resulted in an increase in albumin clearance and accumulation into the tissues (except for aorta; Schubert et al. 2001). The increased vascular permeability to albumin might be the result of the opening of endothelial intercellular junctions. These studies are contradicted by another (Rosengren et al. 2004) showing no difference in transport in the Cav1-null and wild-type mice in a peritoneal dialysis model, arguing against a significant role for caveolar transcytosis in transport across the endothelium. These Cav1 deletion models seem to raise more questions than provide answers. It is not clear whether these findings are due to a lack of significant role of caveolae in transcytosis or to compensatory mechanisms such as increased permeability due to disregulation of endothelial nitric oxide (NO) synthase and NO production (Bauer et al. 2005; Lin et al. 2007; Murata et al. 2007) or the already documented dependence of albumin endocytosis on multiple pathways that may take over in Cav1−/− mice. If the opening of junctions compensates for the lack of caveolae, it is not clear how maintenance of the blood homeostasis is achieved.
Transducing Mechanical Stimuli Endothelial caveolae numbers are increased after exposure to chronic shear stress, and caveolae are required for the ensuing signaling (Rizzo et al. 1998, 2003). These early observations were bolstered by experiments in an arterial injury model in Cav1−/− mice,
c03.indd 50
5/6/2011 6:10:09 PM
ABBREVIATIONS
51
which showed defects in chronic flow-dependent remodeling, and in acute flow-dependent dilation (Yu et al. 2006). Expression of Cav1 in endothelium rescues these defects (Yu et al. 2006). Cav1 and caveolae were involved in cyclic strain proliferative signaling in smooth muscle cells (Sedding et al. 2005). Caveolae were hypothesized that could play a role as tension regulators by flattening out in the membrane (Sens and Turner 2004).
INVOLVEMENT OF CAVEOLAE IN DISEASE There is good evidence for a role of caveolae in the pathogenesis of human disease (Williams and Lisanti 2004a). Endothelial Cav1 was shown to be involved in the progression of atherosclerosis (Frank et al. 2004; Fernandez-Hernando et al. 2009). There is a large body of data supporting a role for Cav1 in cancer (reviewed in Goetz et al. 2008). Cav1−/− cells show increased proliferation, (Koleske et al. 1995; Lee et al. 1998). Based on data from mouse models, Cav1 promotes tumorigenesis (Williams et al. 2005) although overexpression of Cav1 can inhibit tumor progression by decreasing tumor vessel permeability (Gratton et al. 2003). Cav can have different roles in different tumors (Sunaga et al. 2004). Additionally, Cav1 was involved in kidney stone disease (Cao et al. 2003), inflammatory diseases (Chidlow et al. 2009), and infections (Shin and Abraham 2001; Harris et al. 2002; Marsh and Helenius 2006; Mercer et al. 2010). The muscle-specific Cav isoform Cav3 is linked to a number of human muscle disorders including limb girdle muscular dystrophy and rippling muscle disease (Woodman et al. 2004).
FUTURE PERSPECTIVES Caveolae are membrane invaginations containing Cavs, cavins, gycosphingolipids, and cholesterol. Their biogenesis, trafficking, and maintenance are now beginning to be understood. Their physiological roles are just emerging with certain support for mechanosensing, maintenance of cell lipid balance, cell migration and adhesion, and endocytosis. However, their physiological roles are far from being understood. They are important as informed by their participation in panoply of human diseases such as atherosclerosis and cancer, to name a few. Questions remain as to the structure of caveolae. What is the mechanism of invagination formation and precise mechanism of budding? Proteomic approaches (Souto et al. 2003; Oh et al. 2007; Massey and Schnitzer 2009) have revealed a list of proteins that reside in caveolae. With more pieces of the puzzle known, it will be easier to assemble the final picture.
ACKNOWLEDGMENTS RVS was supported by the NIH grants HL65418, HL083249, and HL092085.
ABBREVIATIONS Cav EM
c03.indd 51
caveolin electron microscopy
ER FD
endoplasmic reticulum fenestrated diaphragm
5/6/2011 6:10:09 PM
52
CHAPTER 3
GFP GPI MURC4 NO PEST PKC PRKCDBP PTRF
CAVEOLAE
green fluorescent protein glycosylphosphatidylinositol muscle-restricted coiled-coil nitric oxide proline, glutamic acid, serine, and threonine protein kinase C protein kinase C delta-binding protein Pol I and transcript release factor (also cavin-1)
SD stomatal diaphragm SDR or SDPR serum deprivation protein response (also cavin-2) SEM scanning electron microscopy SRBC sdr-related gene product that binds to c-kinase (also cavin-3) TEC transendothelial channel TEM transmission electron microscopy VSV vesicular stomatitis virus VVO vesiculo-vacuolar organelle
REFERENCES Aboulaich N, Vainonen JP, Stralfors P, Vener AV. 2004. Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytes. Biochem J 383:237–48. Aoki T, Nomura R, Fujimoto T. 1999. Tyrosine phosphorylation of caveolin-1 in the endothelium. Exp Cell Res 253:629–36. Aravamudan B, Volonte D, Ramani R, Gursoy E, Lisanti MP, London B, Galbiati F. 2003. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype. Hum Mol Genet 12:2777–88. Bastiani M, Liu L, Hill MM, Jedrychowski MP, Nixon SJ, Lo HP, Abankwa D, Luetterforst R, FernandezRojo M, Breen MR, Gygi SP, Vinten J, Walser PJ, North KN, Hancock JF, Pilch PF, Parton RG. 2009. MURC/cavin-4 and cavin family members form tissuespecific caveolar complexes. J Cell Biol 185:1259–73. Bauer PM, Yu J, Chen Y, Hickey R, Bernatchez PN, Looft-Wilson R, Huang Y, Giordano F, Stan RV, Sessa WC. 2005. Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc Natl Acad Sci U S A 102:204–9. Beardsley A, Fang K, Mertz H, Castranova V, Friend S, Liu J. 2005. Loss of caveolin-1 polarity impedes endothelial cell polarization and directional movement. J Biol Chem 280:3541–7. Bearer EL, Orci L. 1985. Endothelial fenestral diaphragms: a quick-freeze, deep-etch study. J Cell Biol 100:418–28. Bento-Abreu A, Velasco A, Polo-Hernandez E, Lillo C, Kozyraki R, Tabernero A, Medina JM. 2009. Albumin endocytosis via megalin in astrocytes is caveolaand Dab-1 dependent and is required for the synthesis of the neurotrophic factor oleic acid. J Neurochem 111: 49–60. Briand N, Dugail I, Le Lay S. 2010. Cavin proteins: new players in the caveolae field. Biochimie 93:71–7. Brown DA, London E. 2000. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275:17221–4. Bruns RR, Palade GE. 1968a. Studies on blood capillaries. I. General organization of blood capillaries in muscle. J Cell Biol 37:244–76. Bruns RR, Palade GE. 1968b. Studies on blood capillaries. II. Transport of ferritin molecules across the wall of muscle capillaries. J Cell Biol 37:277–99.
c03.indd 52
Bundgaard M, Frokjaer-Jensen J, Crone C. 1979. Endothelial plasmalemmal vesicles as elements in a system of branching invaginations from the cell surface. Proc Natl Acad Sci U S A 76:6439–42. Bundgaard M, Hagman P, Crone C. 1983. The threedimensional organization of plasmalemmal vesicular profiles in the endothelium of rat heart capillaries. Microvasc Res 25:358–68. Burgener R, Wolf M, Ganz T, Baggiolini M. 1990. Purification and characterization of a major phosphatidylserine-binding phosphoprotein from human platelets. Biochem J 269:729–34. Cao H, Courchesne WE, Mastick CC. 2002. A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase. J Biol Chem 277:8771–4. Cao G, Yang G, Timme TL, Saika T, Truong LD, Satoh T, Goltsov A, Park SH, Men T, Kusaka N, Tian W, Ren C, Wang H, Kadmon D, Cai WW, Chinault AC, Boone TB, Bradley A, Thompson TC. 2003. Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis. Am J Pathol 162:1241–8. Caselli A, Taddei ML, Manao G, Camici G, Ramponi G. 2001. Tyrosine-phosphorylated caveolin is a physiological substrate of the low M(r) protein-tyrosine phosphatase. J Biol Chem 276:18849–54. Chang SH, Feng D, Nagy JA, Sciuto TE, Dvorak AM, Dvorak HF. 2009. Vascular permeability and pathological angiogenesis in caveolin-1-null mice. Am J Pathol 175:1768–76. Chidlow JH, Jr., Sessa WC. 2010. Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res 86:219–25. Chidlow JH, Jr., Greer JJ, Anthoni C, Bernatchez P, Fernandez-Hernando C, Bruce M, Abdelbaqi M, Shukla D, Granger DN, Sessa WC, Kevil CG. 2009. Endothelial caveolin-1 regulates pathologic angiogenesis in a mouse model of colitis. Gastroenterology 136:575– 84; e2. Chung KN, Elwood PC, Heuser JE. 1996. Caveolin is necessary and sufficient for caveolae formation. Mol Biol Cell 7:276a. Clementi F, Palade GE. 1969a. Intestinal capillaries. I. Permeability to peroxidase and ferritin. J Cell Biol 41:33–58.
5/6/2011 6:10:09 PM
REFERENCES
Clementi F, Palade GE. 1969b. Intestinal capillaries. II. Structural effects of EDTA and histamine. J Cell Biol 42:706–14. Cohen AW, Hnasko R, Schubert W, Lisanti MP. 2004. Role of caveolae and caveolins in health and disease. Physiol Rev 84:1341–79. Damm EM, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T, Helenius A. 2005. Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol 168: 477–88. del Pozo MA, Alderson NB, Kiosses WB, Chiang HH, Anderson RG, Schwartz MA. 2004. Integrins regulate Rac targeting by internalization of membrane domains. Science 303:839–42. del Pozo MA, Balasubramanian N, Alderson NB, Kiosses WB, Grande-Garcia A, Anderson RG, Schwartz MA. 2005. Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization. Nat Cell Biol 7:901–8. Dietzen DJ, Hastings WR, Lublin DM. 1995. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae. J Biol Chem 270:6838–42. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV. 2001. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449–52. Dunphy JT, Linder ME. 1998. Signalling functions of protein palmitoylation. Biochim Biophys Acta 1436: 245–61. Dupree P, Parton RG, Raposo G, Kurzchalia TV, Simons K. 1993. Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J 12:1597–605. Dvorak AM, Feng D. 2001. The vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelle. J Histochem Cytochem 49:419–32. Ewers H, Romer W, Smith AE, Bacia K, Dmitrieff S, Chai W, Mancini R, Kartenbeck J, Chambon V, Berland L, Oppenheim A, Schwarzmann G, Feizi T, Schwille P, Sens P, Helenius A, Johannes L. 2010. GM1 structure determines SV40-induced membrane invagination and infection. Nat Cell Biol 12:11–8; Suppl., pp. 1–12. Fernandez I, Ying Y, Albanesi J, Anderson RG. 2002. Mechanism of caveolin filament assembly. Proc Natl Acad Sci U S A 99:11193–8. Fernandez-Hernando C, Yu J, Suarez Y, Rahner C, Davalos A, Lasuncion MA, Sessa WC. 2009. Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis. Cell Metab 10:48–54. Foti M, Porcheron G, Fournier M, Maeder C, Carpentier JL. 2007. The neck of caveolae is a distinct plasma membrane subdomain that concentrates insulin receptors in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A 104:1242–7. Fra AM, Masserini M, Palestini P, Sonnino S, Simons K. 1995a. A photo-reactive derivative of ganglioside
c03.indd 53
53
GM1 specifically cross-links VIP21-caveolin on the cell surface. FEBS Lett 375:11–4. Fra AM, Williamson E, Simons K, Parton RG. 1995b. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci U S A 92: 8655–9. Frank JS, Beydler S, Kreman M, Rau EE. 1980. Structure of the freeze-fractured sarcolemma in the normal and anoxic rabbit myocardium. Circ Res 47: 131–43. Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, Lisanti MP. 2004. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vasc Biol 24:98–105. Frokjaer-Jensen J. 1980. Three-dimensional organization of plasmalemmal vesicles in endothelial cells. An analysis by serial sectioning of frog mesenteric capillaries. J Ultrastruct Res 73:9–20. Frokjaer-Jensen J. 1984. The plasmalemmal vesicular system in striated muscle capillaries and in pericytes. Tissue Cell 16:31–42. Frokjaer-Jensen J. 1991. The endothelial vesicle system in cryofixed frog mesenteric capillaries analysed by ultrathin serial sectioning. J Electron Microsc Tech 19: 291–304. Frokjaer-Jensen J, Wagner RC, Andrews SB, Hagman P, Reese TS. 1988. Three-dimensional organization of the plasmalemmal vesicular system in directly frozen capillaries of the rete mirabile in the swim bladder of the eel. Cell Tissue Res 254:17–24. Fry GN, Devine CE, Burnstock G. 1977. Freeze-fracture studies of nexuses between smooth muscle cells. Close relationship to sarcoplasmic reticulum. J Cell Biol 72: 26–34. Fujimoto T. 1993. Calcium pump of the plasma membrane is localized in caveolae. J Cell Biol 120:1147–57. Fujimoto T. 1996. GPI-anchored proteins, glycosphingolipids, and sphingomyelin are sequestered to caveolae only after crosslinking. J Histochem Cytochem 44:929–41. Fujimoto T, Nakade S, Miyawaki A, Mikoshiba K, Ogawa K. 1992. Localization of inositol 1,4,5trisphosphate receptor-like protein in plasmalemmal caveolae. J Cell Biol 119:1507–13. Fujimoto T, Hayashi M, Iwamoto M, Ohno-Iwashita Y. 1997. Crosslinked plasmalemmal cholesterol is sequestered to caveolae: analysis with a new cytochemical probe. J Histochem Cytochem 45:1197–205. Fujimoto T, Kogo H, Nomura R, Une T. 2000. Isoforms of caveolin-1 and caveolar structure. J Cell Sci 113(Pt 19):3509–17. Gabella G. 1978. Inpocketings of the cell membrane (caveolae) in the rat myocardium. J Ultrastruct Res 65: 135–47. Galbiati F, Volonte D, Chu JB, Li M, Fine SW, Fu M, Bermudez J, Pedemonte M, Weidenheim KM, Pestell RG, Minetti C, Lisanti MP. 2000. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc Natl Acad Sci U S A 97:9689–94. Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, Hou H, Jr., Kneitz B, Edelmann W,
5/6/2011 6:10:09 PM
54
CHAPTER 3
CAVEOLAE
Lisanti MP. 2001. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J Biol Chem 276:21425–33. Glenney JR, Jr. 1992. The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles. FEBS Lett 314:45–8. Glenney JR, Jr., Soppet D. 1992. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci U S A 89:10517–21. Goetz JG, Lajoie P, Wiseman SM, Nabi IR. 2008. Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev 27:715–35. Gratton JP, Lin MI, Yu J, Weiss ED, Jiang ZL, Fairchild TA, Iwakiri Y, Groszmann R, Claffey KP, Cheng YC, Sessa WC. 2003. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell 4:31–9. Gratton JP, Bernatchez P, Sessa WC. 2004. Caveolae and caveolins in the cardiovascular system. Circ Res 94:1408–17. Gustincich S, Vatta P, Goruppi S, Wolf M, Saccone S, Della Valle G, Baggiolini M, Schneider C. 1999. The human serum deprivation response gene (SDPR) maps to 2q32-q33 and codes for a phosphatidylserinebinding protein. Genomics 57:120–9. Hagiwara Y, Sasaoka T, Araishi K, Imamura M, Yorifuji H, Nonaka I, Ozawa E, Kikuchi T. 2000. Caveolin-3 deficiency causes muscle degeneration in mice. Hum Mol Genet 9:3047–54. Hansen CG, Nichols BJ. 2009. Molecular mechanisms of clathrin-independent endocytosis. J Cell Sci 122: 1713–21. Hansen CG, Nichols BJ. 2010. Exploring the caves: cavins, caveolins and caveolae. Trends Cell Biol 20: 177–86. Hansen CG, Bright NA, Howard G, Nichols BJ. 2009. SDPR induces membrane curvature and functions in the formation of caveolae. Nat Cell Biol 11:807–14. Harris J, Werling D, Hope JC, Taylor G, Howard CJ. 2002. Caveolae and caveolin in immune cells: distribution and functions. Trends Immunol 23:158–64. Hayer A, Stoeber M, Bissig C, Helenius A. 2010. Biogenesis of caveolae: stepwise assembly of large caveolin and cavin complexes. Traffic 11:361–82. Hill MM, Bastiani M, Luetterforst R, Kirkham M, Kirkham A, Nixon SJ, Walser P, Abankwa D, Oorschot VM, Martin S, Hancock JF, Parton RG. 2008. PTRF-cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 132: 113–24. Howes MT, Mayor S, Parton RG. 2010. Molecules, mechanisms, and cellular roles of clathrin-independent endocytosis. Curr Opin Cell Biol 22:519–27. Ikezu T, Ueda H, Trapp BD, Nishiyama K, Sha JF, Volonte D, Galbiati F, Byrd AL, Bassell G, Serizawa H, Lane WS, Lisanti MP, Okamoto T. 1998. Affinity-purification and characterization of caveolins
c03.indd 54
from the brain: differential expression of caveolin-1, -2, and -3 in brain endothelial and astroglial cell types. Brain Res 804:177–92. Ishikawa H. 1968. Formation of elaborate networks of T-system tubules in cultured skeletal muscle with special reference to the T-system formation. J Cell Biol 38:51. Isshiki M, Anderson RG. 1999. Calcium signal transduction from caveolae. Cell Calcium 26:201–8. Isshiki M, Ando J, Korenaga R, Kogo H, Fujimoto T, Fujita T, Kamiya A. 1998. Endothelial Ca2+ waves preferentially originate at specific loci in caveolin-rich cell edges. Proc Natl Acad Sci U S A 95:5009–14. Isshiki M, Ando J, Yamamoto K, Fujita T, Ying Y, Anderson RG. 2002. Sites of Ca(2+) wave initiation move with caveolae to the trailing edge of migrating cells. J Cell Sci 115:475–84. Izumi T, Shibata Y, Yamamoto T. 1988. Striped structures on the cytoplasmic surface membranes of the endothelial vesicles of the rat aorta revealed by quick-freeze, deepetching replicas. Anat Rec 220:225–32. Izumi T, Shibata Y, Yamamoto T. 1989. The cytoplasmic surface structures of uncoated vesicles in various tissues of rat as revealed by quick-freeze, deep-etching replicas. J Electron Microsc (Tokyo) 38:47–53. Izumi T, Shibata Y, Yamamoto T. 1991. Quick-freeze, deep-etch studies of endothelial components, with special reference to cytoskeletons and vesicle structures. J Electron Microsc Tech 19:316–26. Izumi Y, Hirai S, Tamai Y, Fujise-Matsuoka A, Nishimura Y, Ohno S. 1997. A protein kinase Cdeltabinding protein SRBC whose expression is induced by serum starvation. J Biol Chem 272:7381–9. Jansa P, Grummt I. 1999. Mechanism of transcription termination: PTRF interacts with the largest subunit of RNA polymerase I and dissociates paused transcription complexes from yeast and mouse. Mol Gen Genet 262: 508–14. Jansa P, Mason SW, Hoffmann-Rohrer U, Grummt I. 1998. Cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes. EMBO J 17:2855–64. Jansa P, Burek C, Sander EE, Grummt I. 2001. The transcript release factor PTRF augments ribosomal gene transcription by facilitating reinitiation of RNA polymerase I. Nucleic Acids Res 29:423–9. Kanzaki M, Pessin JE. 2002. Caveolin-associated filamentous actin (Cav-actin) defines a novel F-actin structure in adipocytes. J Biol Chem 277:25867–9. Kim YN, Dam P, Bertics PJ. 2002. Caveolin-1 phosphorylation in human squamous and epidermoid carcinoma cells: dependence on ErbB1 expression and Src activation. Exp Cell Res 280:134–47. Kimura A, Mora S, Shigematsu S, Pessin JE, Saltiel AR. 2002. The insulin receptor catalyzes the tyrosine phosphorylation of caveolin-1. J Biol Chem 277: 30153–8. Kirkham M, Fujita A, Chadda R, Nixon SJ, Kurzchalia TV, Sharma DK, Pagano RE, Hancock JF, Mayor S, Parton RG. 2005. Ultrastructural identification of
5/6/2011 6:10:10 PM
REFERENCES
uncoated caveolin-independent early endocytic vehicles. J Cell Biol 168:465–76. Kirkham M, Nixon SJ, Howes MT, Abi-Rached L, Wakeham DE, Hanzal-Bayer M, Ferguson C, Hill MM, Fernandez-Rojo M, Brown DA, Hancock JF, Brodsky FM, Parton RG. 2008. Evolutionary analysis and molecular dissection of caveola biogenesis. J Cell Sci 121:2075–86. Kogo H, Fujimoto T. 2000. Caveolin-1 isoforms are encoded by distinct mRNAs. Identification of mouse caveolin-1 mRNA variants caused by alternative transcription initiation and splicing. FEBS Lett 465:119–23. Kogo H, Ishiguro K, Kuwaki S, Fujimoto T. 2002. Identification of a splice variant of mouse caveolin-2 mRNA encoding an isoform lacking the C-terminal domain. Arch Biochem Biophys 401:108–14. Kogo H, Aiba T, Fujimoto T. 2004. Cell type-specific occurrence of caveolin-1alpha and -1beta in the lung caused by expression of distinct mRNAs. J Biol Chem 279:25574–81. Koleske AJ, Baltimore D, Lisanti MP. 1995. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci U S A 92:1381–5. Kumari S, Mg S, Mayor S. 2010. Endocytosis unplugged: multiple ways to enter the cell. Cell Res 20:256–75. Kurzchalia TV, Dupree P, Parton RG, Kellner R, Virta H, Lehnert M, Simons K. 1992. VIP21, a 21-kD membrane protein is an integral component of transGolgi-network-derived transport vesicles. J Cell Biol 118:1003–14. Kurzchalia TV, Dupree P, Monier S. 1994. VIP21caveolin, a protein of the trans-Golgi network and caveolae. FEBS Lett 346:88–91. Labrecque L, Nyalendo C, Langlois S, Durocher Y, Roghi C, Murphy G, Gingras D, Beliveau R. 2004. Src-mediated tyrosine phosphorylation of caveolin-1 induces its association with membrane type 1 matrix metalloproteinase. J Biol Chem 279:52132–40. Lajoie P, Nabi IR. 2007. Regulation of raft-dependent endocytosis. J Cell Mol Med 11:644–53. Lajoie P, Goetz JG, Dennis JW, Nabi IR. 2009a. Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane. J Cell Biol 185:381–5. Lajoie P, Kojic LD, Nim S, Li L, Dennis JW, Nabi IR. 2009b. Caveolin-1 regulation of dynamin-dependent, raft-mediated endocytosis of cholera toxin-B sub-unit occurs independently of caveolae. J Cell Mol Med 13: 3218–25. Lebbink MN, Jimenez N, Vocking K, Hekking LH, Verkleij AJ, Post JA. 2010. Spiral coating of the endothelial caveolar membranes as revealed by electron tomography and template matching. Traffic 11:138–50. Lee SW, Reimer CL, Oh P, Campbell DB, Schnitzer JE. 1998. Tumor cell growth inhibition by caveolin reexpression in human breast cancer cells. Oncogene 16: 1391–7. Li S, Seitz R, Lisanti MP. 1996a. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J Biol Chem 271:3863–8.
c03.indd 55
55
Li S, Song KS, Lisanti MP. 1996b. Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes. J Biol Chem 271: 568–73. Lin MI, Yu J, Murata T, Sessa WC. 2007. Caveolin-1deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res 67: 2849–56. Liu P, Anderson RG. 1995. Compartmentalized production of ceramide at the cell surface. J Biol Chem 270: 27179–85. Liu L, Pilch PF. 2008. A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization. J Biol Chem 283:4314–22. Liu L, Brown D, McKee M, Lebrasseur NK, Yang D, Albrecht KH, Ravid K, Pilch PF. 2008. Deletion of cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metab 8:310–7. Luetterforst R, Stang E, Zorzi N, Carozzi A, Way M, Parton RG. 1999. Molecular characterization of caveolin association with the Golgi complex: identification of a cis-Golgi targeting domain in the caveolin molecule. J Cell Biol 145:1443–59. Marsh M, Helenius A. 2006. Virus entry: open sesame. Cell 124:729–40. Massey KA, Schnitzer JE. 2009. Targeting and imaging signature caveolar molecules in lungs. Proc Am Thorac Soc 6:419–30. Mayor S, Pagano RE. 2007. Pathways of clathrinindependent endocytosis. Nat Rev Mol Cell Biol 8: 603–12. McGuire PG, Twietmeyer TA. 1983. Morphology of rapidly frozen aortic endothelial cells. Glutaraldehyde fixation increases the number of caveolae. Circ Res 53:424–9. McMahon KA, Zajicek H, Li WP, Peyton MJ, Minna JD, Hernandez VJ, Luby-Phelps K, Anderson RG. 2009. SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function. EMBO J 28:1001–15. Mercer J, Schelhaas M, Helenius A. 2010. Virus entry by endocytosis. Annu Rev Biochem 79:803–33. Mineo C, Ying YS, Chapline C, Jaken S, Anderson RG. 1998. Targeting of protein kinase Calpha to caveolae. J Cell Biol 141:601–10. Minshall RD, Tiruppathi C, Vogel SM, Niles WD, Gilchrist A, Hamm HE, Malik AB. 2000. Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway. J Cell Biol 150:1057–70. Miyawaki-Shimizu K, Predescu D, Shimizu J, Broman M, Predescu S, Malik AB. 2006. siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway. Am J Physiol Lung Cell Mol Physiol 290:L405–13. Moldovan NI, Heltianu C, Simionescu N, Simionescu M. 1995. Ultrastructural evidence of differential solubility in Triton X-100 of endothelial vesicles and plasma membrane. Exp Cell Res 219:309–13. Monier S, Dietzen DJ, Hastings WR, Lublin DM, Kurzchalia TV. 1996. Oligomerization of VIP21
5/6/2011 6:10:10 PM
56
CHAPTER 3
CAVEOLAE
-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol. FEBS Lett 388:143–9. Montesano R, Roth J, Robert A, Orci L. 1982. Noncoated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature 296:651–3. Mora R, Bonilha VL, Marmorstein A, Scherer PE, Brown D, Lisanti MP, Rodriguez-Boulan E. 1999. Caveolin-2 localizes to the golgi complex but redistributes to plasma membrane, caveolae, and rafts when coexpressed with caveolin-1. J Biol Chem 274:25708–17. Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV, Simons K. 1995. VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci U S A 92:10339–43. Murata T, Lin MI, Huang Y, Yu J, Bauer PM, Giordano FJ, Sessa WC. 2007. Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J Exp Med 204:2373–82. Nichols B. 2003. Caveosomes and endocytosis of lipid rafts. J Cell Sci 116:4707–14. Noguchi Y, Shibata Y, Yamamoto T. 1987. Endothelial vesicular system in rapid-frozen muscle capillaries revealed by serial sectioning and deep etching. Anat Rec 217:355–60. Nohe A, Keating E, Underhill TM, Knaus P, Petersen NO. 2005. Dynamics and interaction of caveolin-1 isoforms with BMP-receptors. J Cell Sci 118:643–50. Nomura R, Fujimoto T. 1999. Tyrosine-phosphorylated caveolin-1: immunolocalization and molecular characterization. Mol Biol Cell 10:975–86. Novikoff AB, Novikoff PM, Rosen OM, Rubin CS. 1980. Organelle relationships in cultured 3T3-L1 preadipocytes. J Cell Biol 87:180–96. Ogata T, Ueyama T, Isodono K, Tagawa M, Takehara N, Kawashima T, Harada K, Takahashi T, Shioi T, Matsubara H, Oh H. 2008. MURC, a muscle-restricted coiled-coil protein that modulates the Rho/ROCK pathway, induces cardiac dysfunction and conduction disturbance. Mol Cell Biol 28:3424–36. Oh P, Borgstrom P, Witkiewicz H, Li Y, Borgstrom BJ, Chrastina A, Iwata K, Zinn KR, Baldwin R, Testa JE, Schnitzer JE. 2007. Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol 25:327–37. Oh P, McIntosh DP, Schnitzer JE. 1998. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J Cell Biol 141:101–14. Oh P, Borgstrom P, Witkiewicz H, Li Y, Borgstrom BJ, Chrastina A, Iwata K, Zinn KR, Baldwin R, Testa JE, Schnitzer JE. 2007. Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol 25: 327–37. Ortegren U, Karlsson M, Blazic N, Blomqvist M, Nystrom FH, Gustavsson J, Fredman P, Stralfors P. 2004. Lipids and glycosphingolipids in caveolae and surrounding plasma membrane of primary rat adipocytes. Eur J Biochem 271:2028–36.
c03.indd 56
Palade GE. 1953. Fine structure of blood capillaries. J Appl Phys 24:1424. Palade GE. 1960. Transport in quanta across endothelium in blood capillaries. Anat Rec 136:254. Palade GE, Bruns RR. 1968. Structural modulations of plasmalemmal vesicles. J Cell Biol 37:633–49. Parat MO, Fox PL. 2001. Palmitoylation of caveolin-1 in endothelial cells is post-translational but irreversible. J Biol Chem 276:15776–82. Parat MO, Anand-Apte B, Fox PL. 2003. Differential caveolin-1 polarization in endothelial cells during migration in two and three dimensions. Mol Biol Cell 14:3156–68. Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, Chandra M, Shirani J, Razani B, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP. 2002. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol 160: 2207–17. Parolini I, Sargiacomo M, Galbiati F, Rizzo G, Grignani F, Engelman JA, Okamoto T, Ikezu T, Scherer PE, Mora R, Rodriguez-Boulan E, Peschle C, Lisanti MP. 1999. Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the golgi complex. J Biol Chem 274:25718–25. Parton RG. 1994. Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J Histochem Cytochem 42:155–66. Parton RG. 2003. Caveolae––from ultrastructure to molecular mechanisms. Nat Rev Mol Cell Biol 4:162–7. Parton RG, Simons K. 2007. The multiple faces of caveolae. Nat Rev Mol Cell Biol 8:185–94. Parton RG, Joggerst B, Simons K. 1994. Regulated internalization of caveolae. J Cell Biol 127:1199–215. Parton RG, Way M, Zorzi N, Stang E. 1997. Caveolin-3 associates with developing T-tubules during muscle differentiation. J Cell Biol 136:137–54. Parton RG, Molero JC, Floetenmeyer M, Green KM, James DE. 2002. Characterization of a distinct plasma membrane macrodomain in differentiated adipocytes. J Biol Chem 277:46769–78. Parton RG, Hanzal-Bayer M, Hancock JF. 2006. Biogenesis of caveolae: a structural model for caveolininduced domain formation. J Cell Sci 119:787–96. Pelkmans L, Zerial M. 2005. Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae. Nature 436:128–33. Pelkmans L, Kartenbeck J, Helenius A. 2001. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 3: 473–83. Pelkmans L, Puntener D, Helenius A. 2002. Local actin polymerization and dynamin recruitment in SV40 -induced internalization of caveolae. Science 296: 535–9. Pelkmans L, Burli T, Zerial M, Helenius A. 2004. Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 118:767–80.
5/6/2011 6:10:10 PM
REFERENCES
Peters KR, Carley WW, Palade GE. 1985. Endothelial plasmalemmal vesicles have a characteristic striped bipolar surface structure. J Cell Biol 101:2233–8. Pike LJ, Han X, Chung KN, Gross RW. 2002. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 41:2075–88. Popescu LM. 1974. Conceptual model of excitationcontraction coupling in smooth-muscle—possible role of surface microvesicles. Studia Biophysica 44:141–53. Predescu SA, Predescu DN, Timblin BK, Stan RV, Malik AB. 2003. Intersectin regulates fission and internalization of caveolae in endothelial cells. Mol Biol Cell 14:4997–5010. Rahman A, Sward K. 2009. The role of caveolin-1 in cardiovascular regulation. Acta Physiol (Oxf) 195: 231–45. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H, Jr., Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP. 2001. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276:38121–38. Razani B, Wang XB, Engelman JA, Battista M, Lagaud G, Zhang XL, Kneitz B, Hou H, Jr., Christ GJ, Edelmann W, Lisanti MP. 2002. Caveolin-2deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol 22:2329–44. Ren X, Ostermeyer AG, Ramcharan LT, Zeng Y, Lublin DM, Brown DA. 2004. Conformational defects slow Golgi exit, block oligomerization, and reduce raft affinity of caveolin-1 mutant proteins. Mol Biol Cell 15: 4556–67. Repetto S, Bado M, Broda P, Lucania G, Masetti E, Sotgia F, Carbone I, Pavan A, Bonilla E, Cordone G, Lisanti MP, Minetti C. 1999. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Biochem Biophys Res Commun 261:547–50. Resh MD. 2004. Membrane targeting of lipid modified signal transduction proteins. Subcell Biochem 37: 217–32. Richter T, Floetenmeyer M, Ferguson C, Galea J, Goh J, Lindsay MR, Morgan GP, Marsh BJ, Parton RG. 2008. High-resolution 3D quantitative analysis of caveolar ultrastructure and caveola-cytoskeleton interactions. Traffic 9:893–909. Rizzo V, Sung A, Oh P, Schnitzer JE. 1998. Rapid mechanotransduction in situ at the luminal cell surface of vascular endothelium and its caveolae. J Biol Chem 273: 26323–9. Rizzo V, Morton C, DePaola N, Schnitzer JE, Davies PF. 2003. Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro. Am J Physiol Heart Circ Physiol 285:H1720–9. Rosengren BI, Carlsson O, Venturoli D, al Rayyes O, Rippe B. 2004. Transvascular passage of macromolecules
c03.indd 57
57
into the peritoneal cavity of normo- and hypothermic rats in vivo: active or passive transport? J Vasc Res 41: 123–30. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG. 1992. Caveolin, a protein component of caveolae membrane coats. Cell 68:673–82. Sabharanjak S, Sharma P, Parton RG, Mayor S. 2002. GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev Cell 2:411–23. Sargiacomo M, Scherer PE, Tang Z, Kubler E, Song KS, Sanders MC, Lisanti MP. 1995. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci U S A 92:9407–11. Sawada H, Ishikawa H, Yamada E. 1978. High resolution scanning electron microscopy of frog sartorius muscle. Tissue Cell 10:179–90. Scheiffele P, Verkade P, Fra AM, Virta H, Simons K, Ikonen E. 1998. Caveolin-1 and -2 in the exocytic pathway of MDCK cells. J Cell Biol 140:795–806. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP. 1996. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci U S A 93:131–5. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, Lisanti MP. 1997. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 272:29337–46. Schlegel A, Arvan P, Lisanti MP. 2001. Caveolin-1 binding to endoplasmic reticulum membranes and entry into the regulated secretory pathway are regulated by serine phosphorylation. Protein sorting at the level of the endoplasmic reticulum. J Biol Chem 276:4398–408. Schlormann W, Steiniger F, Richter W, Kaufmann R, Hause G, Lemke C, Westermann M. 2010. The shape of caveolae is omega-like after glutaraldehyde fixation and cup-like after cryofixation. Histochem Cell Biol 133:223–8. Schnitzer JE, Oh P. 1994. Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins. J Biol Chem 269:6072–82. Schnitzer JE, Allard J, Oh P. 1995a. NEM inhibits transcytosis, endocytosis, and capillary permeability: implication of caveolae fusion in endothelia. Am J Physiol 268: H48–55. Schnitzer JE, Oh P, Jacobson BS, Dvorak AM. 1995b. Caveolae from luminal plasmalemma of rat lung endothelium: microdomains enriched in caveolin, Ca(2+)-ATPase, and inositol trisphosphate receptor. Proc Natl Acad Sci U S A 92:1759–63. Schubert W, Frank PG, Razani B, Park DS, Chow CW, Lisanti MP. 2001. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J Biol Chem 276:48619–22. Schubert W, Frank PG, Woodman SE, Hyogo H, Cohen DE, Chow CW, Lisanti MP. 2002. Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment
5/6/2011 6:10:10 PM
58
CHAPTER 3
CAVEOLAE
with a specific nitric-oxide synthase inhibitor, L-name, restores normal microvascular permeability in Cav-1 null mice. J Biol Chem 277:40091–8. Sedding DG, Hermsen J, Seay U, Eickelberg O, Kummer W, Schwencke C, Strasser RH, Tillmanns H, BraunDullaeus RC. 2005. Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Circ Res 96:635–42. Sens P, Turner MS. 2004. Theoretical model for the formation of caveolae and similar membrane invaginations. Biophys J 86:2049–57. Severs NJ. 1981. Plasma membrane cholesterol in myocardial muscle and capillary endothelial cells. Distribution of filipin-induced deformations in freeze-fracture. Eur J Cell Biol 25:289–99. Severs NJ. 1988. Caveolae: static inpocketings of the plasma membrane, dynamic vesicles or plain artifact? J Cell Sci 90:341–8. Sharma DK, Choudhury A, Singh RD, Wheatley CL, Marks DL, Pagano RE. 2003. Glycosphingolipids internalized via caveolar-related endocytosis rapidly merge with the clathrin pathway in early endosomes and form microdomains for recycling. J Biol Chem 278:7564–72. Sheldon H, Hollenberg CH, Winegrad AI. 1962. Observations on the morphology of adipose tissue. I. The fine structure of cells from fasted and diabetic rats. Diabetes 11:378–87. Shin JS, Abraham SN. 2001. Caveolae as portals of entry for microbes. Microbes Infect 3:755–61. Shogomori H, Brown DA. 2003. Use of detergents to study membrane rafts: the good, the bad, and the ugly. Biol Chem 384:1259–63. Siflinger-Birnboim A, Schnitzer J, Lum H, Blumenstock FA, Shen CP, Del Vecchio PJ, Malik AB. 1991. Lectin binding to gp60 decreases specific albumin binding and transport in pulmonary artery endothelial monolayers. J Cell Physiol 149:575–84. Simionescu N. 1981. Transcytosis and traffic of membranes in endothelial cells. In: Schweiger HG, editor. International cell biology. Berlin, Germany: Springer-Verlag, pp. 657–72. Simionescu M, Simionescu N, Palade GE. 1974. Morphometric data on the endothelium of blood capillaries. J Cell Biol 60:128–52. Simionescu M, Simionescu N, Silbert JE, Palade GE. 1981. Differentiated microdomains on the luminal surface of the capillary endothelium. II. Partial characterization of their anionic sites. J Cell Biol 90:614–21. Simionescu M, Simionescu N, Palade GE. 1982. Differentiated microdomains on the luminal surface of capillary endothelium: distribution of lectin receptors. J Cell Biol 94:406–13. Simionescu N, Lupu F, Simionescu M. 1983. Rings of membrane sterols surround the openings of vesicles and fenestrae, in capillary endothelium. J Cell Biol 97: 1592–600. Simons K, Toomre D. 2000. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31–9. Simons K, Vaz WL. 2004. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 33: 269–95.
c03.indd 58
Singh RD, Puri V, Valiyaveettil JT, Marks DL, Bittman R, Pagano RE. 2003. Selective caveolin-1dependent endocytosis of glycosphingolipids. Mol Biol Cell 14:3254–65. Singh RD, Marks DL, Holicky EL, Wheatley CL, Kaptzan T, Sato SB, Kobayashi T, Ling K, Pagano RE. 2010. Gangliosides and beta1-integrin are required for caveolae and membrane domains. Traffic 11: 348–60. Smart EJ, Ying YS, Conrad PA, Anderson RG. 1994. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J Cell Biol 127: 1185–97. Smart EJ, Ying YS, Anderson RG. 1995. Hormonal regulation of caveolae internalization. J Cell Biol 131:929–38. Somlyo AP, Devine CE, Somlyo AV, North SR. 1971. Sarcoplasmic reticulum and the temperature-dependent contraction of smooth muscle in calcium-free solutions. J Cell Biol 51:722–41. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP. 1996. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and cofractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271:15160–5. Souto RP, Vallega G, Wharton J, Vinten J, TranumJensen J, Pilch PF. 2003. Immunopurification and characterization of rat adipocyte caveolae suggest their dissociation from insulin signaling. J Biol Chem 278:18321–9. Sowa G, Pypaert M, Fulton D, Sessa WC. 2003. The phosphorylation of caveolin-2 on serines 23 and 36 modulates caveolin-1-dependent caveolae formation. Proc Natl Acad Sci U S A 100:6511–6. Stan RV. 2002. Structure and function of endothelial caveolae. Microsc Res Tech 57:350–64. Stan RV. 2004. Multiple PV1 dimers reside in the same stomatal or fenestral diaphragm. Am J Physiol Heart Circ Physiol 286:H1347–53. Stan RV. 2005a. Channels across endothelial cells. In: Baluska F, Volkmann D, Barlowe PW, editors. Cell-Cell channels. Georgetown, TX: Landes Biosciences pp. 271–8. Stan RV. 2005b. Structure of caveolae. Biochim Biophys Acta 1746:334–48. Stan RV. 2007. Endothelial stomatal and fenestral diaphragms in normal vessels and angiogenesis. J Cell Mol Med 11:621–43. Stan RV, Ghitescu L, Jacobson BS, Palade GE. 1999a. Isolation, cloning, and localization of rat PV-1, a novel endothelial caveolar protein. J Cell Biol 145:1189–98. Stan RV, Kubitza M, Palade GE. 1999b. PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia. Proc Natl Acad Sci U S A 96:13203–7. Stan RV, Arden KC, Palade GE. 2001. cDNA and protein sequence, genomic organization, and analysis of cis regulatory elements of mouse and human PLVAP genes. Genomics 72:304–13. Stan RV, Tkachenko E, Niesman IR. 2004. PV1 is a key structural component for the formation of the stomatal and fenestral diaphragms. Mol Biol Cell 15:3615–30.
5/6/2011 6:10:10 PM
REFERENCES
Sunaga N, Miyajima K, Suzuki M, Sato M, White MA, Ramirez RD, Shay JW, Gazdar AF, Minna JD. 2004. Different roles for caveolin-1 in the development of nonsmall cell lung cancer versus small cell lung cancer. Cancer Res 64:4277–85. Tagawa A, Mezzacasa A, Hayer A, Longatti A, Pelkmans L, Helenius A. 2005. Assembly and trafficking of caveolar domains in the cell: caveolae as stable, cargo-triggered, vesicular transporters. J Cell Biol 170: 769–79. Tagawa M, Ueyama T, Ogata T, Takehara N, Nakajima N, Isodono K, Asada S, Takahashi T, Matsubara H, Oh H. 2008. MURC, a muscle-restricted coiled-coil protein, is involved in the regulation of skeletal myogenesis. Am J Physiol Cell Physiol 295:C490–8. Tani E, Yamagata S, Ito Y. 1977. Cell membrane structure of vascular smooth muscle of circle of Willis. Cell Tissue Res 179:131–42. Thomsen P, Roepstorff K, Stahlhut M, van Deurs B. 2002. Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol Biol Cell 13:238–50. Thorn H, Stenkula KG, Karlsson M, Ortegren U, Nystrom FH, Gustavsson J, Stralfors P. 2003. Cell surface orifices of caveolae and localization of caveolin to the necks of caveolae in adipocytes. Mol Biol Cell 14:3967–76. Tillmann B, Rudert H, Schunke M, Werner JA. 1995. Morphological studies on the pathogenesis of Reinke’s edema. Eur Arch Otorhinolaryngol 252:469–74. Tiruppathi C, Song W, Bergenfeldt M, Sass P, Malik AB. 1997. Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J Biol Chem 272:25968–75. Trigatti BL, Anderson RG, Gerber GE. 1999. Identification of caveolin-1 as a fatty acid binding protein. Biochem Biophys Res Commun 255:34–9. Uehara K, Miyoshi M. 1999. Tubular invaginations with caveolae and coated pits in the sinus endothelial cells of the rat spleen. Histochem Cell Biol 112:351–8. Uehara K, Miyoshi M. 2002. Localization of caveolin-3 in the sinus endothelial cells of the rat spleen. Cell Tissue Res 307:329–36. Vepa S, Scribner WM, Natarajan V. 1997. Activation of protein phosphorylation by oxidants in vascular endothelial cells: identification of tyrosine phosphorylation of caveolin. Free Radic Biol Med 22:25–35. Verma P, Ostermeyer-Fay AG, Brown DA. 2010. Caveolin-1 induces formation of membrane tubules that sense actomyosin tension and are inhibited by PTRF/ cavin-1. Mol Biol Cell 21:2226–40. Vinten J, Voldstedlund M, Clausen H, Christiansen K, Carlsen J, Tranum-Jensen J. 2001. A 60-kDa protein abundant in adipocyte caveolae. Cell Tissue Res 305:99–106. Vinten J, Johnsen AH, Roepstorff P, Harpoth J, Tranum-Jensen J. 2005. Identification of a major protein on the cytosolic face of caveolae. Biochim Biophys Acta 1717:34–40. Vogel U, Sandvig K, van Deurs B. 1998. Expression of caveolin-1 and polarized formation of invaginated caveo-
c03.indd 59
59
lae in Caco-2 and MDCK II cells. J Cell Sci 111(Pt 6):825–32. Voldstedlund M, Vinten J, Tranum-Jensen J. 2001. cav-p60 expression in rat muscle tissues. Distribution of caveolar proteins. Cell Tissue Res 306:265–76. Voldstedlund M, Thuneberg L, Tranum-Jensen J, Vinten J, Christensen EI. 2003. Caveolae, caveolin and cav-p60 in smooth muscle and renin-producing cells in the rat kidney. Acta Physiol Scand 179:179–88. Volonte D, Galbiati F, Pestell RG, Lisanti MP. 2001. Cellular stress induces the tyrosine phosphorylation of caveolin-1 (Tyr[14]) via activation of p38 mitogenactivated protein kinase and c-Src kinase. Evidence for caveolae, the actin cytoskeleton, and focal adhesions as mechanical sensors of osmotic stress. J Biol Chem 276: 8094–103. von Ruhland CJ, Campbell L, Gumbleton M, Jasani B, Newman GR. 2004. Immunolocalization of caveolin-1 in rat and human mesothelium. J Histochem Cytochem 52:1415–25. Wang XB, Lee H, Capozza F, Marmon S, Sotgia F, Brooks JW, Campos-Gonzalez R, Lisanti MP. 2004. Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phosphoCav-2 (pY19 and pY27). Biochemistry 43:13694–706. Way M, Parton RG. 1995. M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett 376:108–12 [corrected and republished in FEBS Lett 1996 Jan 2;378(1): 108–12]. Way M, Parton RG. 1996. M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett 378:108–12. Westermann M, Steiniger F, Richter W. 2005. Belt-like localisation of caveolin in deep caveolae and its redistribution after cholesterol depletion. Histochem Cell Biol 123:613–20. Williams TM, Lisanti MP. 2004a. The caveolin genes: from cell biology to medicine. Ann Med 36:584–95. Williams TM, Lisanti MP. 2004b. The caveolin proteins. Genome Biol 5:214. Williams TM, Hassan GS, Li J, Cohen AW, Medina F, Frank PG, Pestell RG, Di Vizio D, Loda M, Lisanti MP. 2005. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. J Biol Chem 280:25134–45. Williamson JR. 1964. Adipose tissue. Morphological changes associated with lipid mobilization. J Cell Biol 20:57–74. Wood MR, Wagner RC, Andrews SB, Greener DA, Williams SK. 1986. Rapidly-frozen, cultured, human endothelial cells: an ultrastructural and morphometric comparison between freshly-frozen and glutaraldehyde prefixed cells. Microcirc Endothelium Lymphatics 3:323–58. Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J, Tang B, Jelicks LA, Kitsis RN, Christ GJ, Factor SM, Tanowitz HB, Lisanti MP. 2002. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 277:38988–97. Woodman SE, Sotgia F, Galbiati F, Minetti C, Lisanti MP. 2004. Caveolinopathies: mutations in caveolin-3
5/6/2011 6:10:10 PM
60
CHAPTER 3
CAVEOLAE
cause four distinct autosomal dominant muscle diseases. Neurology 62:538–43. Yamada E. 1955. The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol 1:445–57. Yu J, Bergaya S, Murata T, Alp IF, Bauer MP, Lin MI, Drab M, Kurzchalia TV, Stan RV, Sessa WC. 2006. Direct evidence for the role of caveolin-1 and caveolae in
c03.indd 60
mechanotransduction and remodeling of blood vessels. J Clin Invest 116:1284–91. Zhao YY, Liu Y, Stan RV, Fan L, Gu Y, Dalton N, Chu PH, Peterson K, Ross J, Jr., Chien KR. 2002. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci U S A 99:11375–80.
5/6/2011 6:10:10 PM
CH A P T E R
4
LIPID RAFTS Leonard J. Foster
DEFINITION Lipid rafts are small (∼100 nm) cholesterol- and sphingomyelin-rich subdomains of the plasma membrane that function in numerous cellular processes. Simons and Ikonen (1997) proposed the concept, envisioning the ordered lipids like a raft in the large ocean of the plasma membrane. Rafts have been contentious for many years, starting very early on when the idea was one of the first to challenge the homogenous distribution of proteins and lipids predicted by the Singer and Nicolson (1972) fluid mosaic model of membrane bilayers. Simons et al. originally identified a role for rafts in lipid trafficking between and to the apical and basolateral surfaces in polarized epithelial cells; subsequently rafts have been implicated, to one degree or another, in a wide variety of cellular processes. Membrane lipids in general can be considered a solvent for membrane proteins, and the particular solvent properties of the lipids in rafts create an environment into which a specific set of membrane proteins are thought to partition; it is these proteins that convey many of the functional roles of rafts. They are best known for their role in signal transduction, where rafts seem to act as platforms for coordinating signaling events, but by virtue of their particular biophysical properties are also integral to maintaining nonuniform lipid distribution within cells, as in the case of polarized epithelial cells. Being located on the plasmalemma, rafts mediate interactions between the cell and various external processes: They are the attachment and/or entry point for numerous pathogens and the home for the diverse family of extracellular proteins anchored to the cell via a glycophosphatidylinositol (GPI) moiety.
HISTORICAL PERSPECTIVE The near-liquid crystal state of lipids in rafts makes them stable even in nonionic detergents, and it is this property, together with their relatively low density imparted by their high lipid content, that was initially used as the basis for biochemically enriching rafts (Brown and Rose 1992). In the raft enrichment procedure (Fig. 4.1) most commonly used today, suspension or adherent cells are typically extracted gently (i.e., with no mechanical force used) in a cold solution of 1% Triton X-100. This solution is then diluted 1:1 with 90% sucrose and layered in the bottom of an ultracentrifuge tube, with 35% and 5% sucrose solutions layered on top of that. After centrifugation at 150,000 to 200,000 relative centrifugal force for 18 hours, the rafts float to the interface between 35% and 5% sucrose, where they can be visualized as a faint, light scattering band, and harvested for further analysis (see Foster 2009 for detailed protocols). The fraction extracted from the interface Cellular Domains, First Edition. Edited by Ivan R. Nabi. © 2011 John Wiley & Sons, Inc. Published 2011 by John Wiley & Sons, Inc.
61
c04.indd 61
5/6/2011 6:10:11 PM
62
CHAPTER 4
LIPID RAFTS
Discontinuous
Continuous
5%
5%
35%
45% 45%
Figure 4.1. Conventional and high-resolution enrichment of detergent-resistant membranes (DRMs). DRMs are typically enriched using a discontinuous sucrose and other density gradients. In this way, all detergent-insoluble cellular components with a density of between 5% and 35% sucrose will appear to comigrate. Since different detergent-insoluble components could conceivably have more subtle differences in density, a continuous or pseudo-continuous density gradient can be used to partially or completely resolve some of the components of DRMs.
between 35% and 5% sucrose in this way, however, is more accurately referred to as a detergent-resistant membrane (DRM) fraction since it is most certainly contaminated by nonraft material (see below). Thus, throughout this chapter, we use the term DRM to refer to the biochemical fraction and the term “raft” to refer to the actual liquid-ordered domain in the plasma membrane; to reinforce the point, DRMs are not equivalent to rafts, rather rafts are a subset of all DRMs. Although Brown and Rose (1992) used Triton X-100 initially—and this reagent is by far the most popular for biochemically enriching rafts—rafts are also stable in other nonionic detergents (Chamberlain 2004). The complication, however, is that the composition of DRMs isolated by different detergents can vary widely and that it is far from clear which detergent, if any, extracts “true” rafts (for a review of raft proteomics, see Foster and Chan 2007). Quantitative proteomic analysis of DRMs isolated with Triton X-100 versus Brij-96, the second most popular detergent for these experiments, reveals some striking differences in many classes of proteins (Blonder et al. 2006). Importantly, neither detergent was effective in enriching all accepted markers of rafts, and the nonraft proteins in the DRM preparations were also not consistent. Thus, the choice of detergent can have a significant impact on the results of raft biochemistry experiments. Rafts have faced a barrage of criticism, especially since the initial claims (Brown and Rose 1992) that they could be enriched using detergents. For many biophysicists, the fact that detergents were required to enrich rafts suggested that the rafts were forming in the presence of the detergent and that they did not actually exist prior to the introduction of the detergent. This doubt seems to have been finally put to rest (see “Raft Biophysics”), but the whole argument was always a bit of a Catch-22 for raft biochemistry since it is difficult to fully remove all the nonraft lipids and proteins without using detergents because they are, by definition, insoluble in water. The nonraft lipids could be solubilized in organic solvents; however, such reagents are rarely useful when working with proteins, and so other approaches for enriching rafts were explored. The main detergent-free approach has involved physical disruption of the cells, usually by sonication, followed by flotation on a sucrose or other density gradients similar to that used with detergents (Fig. 4.1; Smart et al. 1995). Besides mechanical disruption, another point of distinction with the conventional method has been the use of high pH (∼11.5) to strip off nonintegral membrane
c04.indd 62
5/6/2011 6:10:11 PM
HISTORICAL PERSPECTIVE
63
proteins (Song et al. 1996). These methods were originally developed to enrich caveolae (discussed elsewhere in this book), but the fractions isolated in this way contain many of the same proteins found in DRMs (Foster et al. 2003), perpetuating the controversies surrounding the distinction between rafts and caveolae. Perhaps most importantly, detergentfree methods for enriching rafts yield a membrane fraction that contains far more known contaminants than those enriched using detergents (Foster et al. 2003). Thus, since rafts have been demonstrated to be not just an artifact of detergent extraction, the use of detergent-free methods seems no longer justified given the levels of contaminants in these preparations.
Protein Composition A great many proteins have been localized to rafts with one technique or another, but a small set of proteins (Table 4.1) is acknowledged as reliable markers of lipid rafts based on a plethora of supporting data. More widely, proteins have been localized to rafts based on microscopic colocalization or equivalent buoyant density with one or more of the markers listed in Table 4.1. Until more recently, when fluorescence resonance energy transfer (FRET) and sub-diffraction imaging methods became more widespread, claims of a protein being localized to lipid rafts based on immunofluorescence colocalization must be considered dubious since rafts are typically well below the conventional resolution of visible light microscopes (see Chapter 5 for discussion of fluorescence analysis of lipid rafts). The other approach, more widely applied, has been to probe the distribution of a candidate protein in the sucrose density gradient described in Figure 4.1 versus the distribution of a known raft protein. If a protein is enriched in the 5/35% interface of the density gradient, then it can at least be claimed to enrich with rafts, although as we and others have shown, this can be misleading (Foster et al. 2003; Kierszniowska et al. 2009; Zheng et al. 2009). The final piece of evidence that is usually required to claim a protein is in rafts is a demonstration that its colocalization and/or buoyant density migration with a raft marker can be disrupted using a pharmacological antagonist of cholesterol, typically methyl β-cyclodextrin (mβCD), or one of the statin family of compounds (Keller and Simons 1998). The physical integrity of rafts has been shown to be completely dependent on cholesterol and so disruption of membrane cholesterol, either via blocking its biosynthesis (e.g., with lovastatin) or via its chelation (e.g., with mβCD), breaks up rafts and allows the other raft lipids and proteins to diffuse away and become soluble in ionic
TABLE 4.1.
Some of the Classical Markers of Lipid Rafts
Protein Flotillina Alkaline phosphatase 5′-nucleotidase Lyn Yes Complement delay accelerating factor T-cell receptor B-cell receptor Lck
Class
Anchor
Structural protein Extracellular enzyme Extracellular enzyme Tyrosine kinase Tyrosine kinase Complement receptor Receptor Receptor Tyrosine kinase
Transmembrane domain GPI GPI Palmitate and myristate Myristate GPI Transmembrane Transmembrane Palmitate and myristate
a
Also a caveolae protein.
c04.indd 63
5/6/2011 6:10:11 PM
64
CHAPTER 4
LIPID RAFTS
detergents. Thus, by microscopy, the raft marker and protein of interest should no longer colocalize after mβCD treatment, and by buoyant density both the raft marker and protein of interest should not migrate up to the 5/35% interface (Fig. 4.1). Using these lines of evidence, studies focusing on one or a few proteins have demonstrated raft localization for an estimated 200 proteins. While these studies would have been skewed toward those proteins that people thought to look for, proteomics, on the other hand, provides an excellent means to probe the composition of lipid rafts in a relatively unbiased manner—only “relatively unbiased” because current proteomic technology does not allow all the proteins in a sample to be identified and so there is a bias toward the more abundant species and those that are more hydrophilic. Nonetheless, proteomics does allow us to query the static composition of rafts and to test how the composition changes in response to stimuli. Comprehensive summaries of lipid raft proteomics literature can be found elsewhere (Foster and Chan 2007), but the major families of raftlocalized proteins are discussed below. Several other categories of proteins have been reported to be found in DRMs and therefore claimed to be in rafts (Bae et al. 2004; Man et al. 2005; McMahon et al. 2006; Kim et al. 2010), but most of these have been debunked as contaminants since their presence in DRMs is not dependent on cholesterol. The following classes of proteins are either in rafts or have been implicated in rafts. GPI-Anchored Proteins This is a functionally diverse family of proteins whose only common feature is the presence of an O- or N-linked GPI moiety that is added in the endoplasmic reticulum. There are 15 such proteins known in yeast and at least 45 in humans, comprising enzymes, receptors, and transport-type proteins, and where there is a human ortholog of a yeast GPI-anchored protein, the human protein is also known to have a GPI anchor. After they are fully processed, GPI-anchored proteins localize primarily to the exoplasmic leaflet of the plasma membrane, where many of them are targeted to rafts. They are, of course, not absolutely exclusive to the plasma membrane as they must pass through biosynthetic organelles, such as the endoplasmic reticulum and Golgi, to get to the plasma membrane. Once on the plasma membrane, GPI-anchored proteins are internalized into the endosomal system through various mechanisms; by and large, however, their primary localization is thought to be the plasma membrane. GPI-anchored proteins can be released from the membrane by phospholipases, and this approach has provided a mechanism for identifying raft-localized GPI-anchored proteins from a variety of species (Sherrier et al. 1999; Fivaz et al. 2000; Borner et al. 2003; Elortza et al. 2003; Elortza et al. 2006). In humans, some of the common raft-associated GPI-anchored proteins include CD59, Thy-1, 5′-nucleotidase, alkaline phosphatase, folate receptor, bone marrow stromal cell antigen, and decay acceleration factor. Signaling Proteins Rafts gained a great degree of popularity in the 1990s in part due to the claims that they were organizing centers for signal transduction at a time when there was an incredibly intense interest in signal transduction in general and phosphorylation cascades in particular. Interestingly, the evidence suggesting that rafts were more involved in signaling than other regions of the plasma membrane were largely anecdotal until proteomics established in an unbiased way that signal transduction proteins were enriched on rafts relative to other membranes (Foster et al. 2003). By comparing the enrichment of signaling proteins moving from a total membrane preparation through to DRMs and then to only those DRM proteins that displayed a sensitivity to MβCD, it was clear that signaling proteins are indeed more abundant on rafts than other membranes (Foster et al. 2003). While there are
c04.indd 64
5/6/2011 6:10:11 PM
HISTORICAL PERSPECTIVE
65
sporadic reports of many signaling pathways acting through rafts (Simons and Toomre 2000), we highlight here some of the best understood: 1. T-cell receptor (TCR) pathway. Ligation and dimerization of T-cell receptors induce raft clustering, activating Lck and Fyn kinases. This in turn leads to recruitment of Zap-70, and then GPI-anchored proteins and other signaling adaptors amplify the signal (many contributing studies—for reviews, see Janes et al. 2000; Langlet et al. 2000). 2. High-affinity immunoglobulin E (IgE) receptor pathway. Aggregation of receptors cause their translocation to lipid rafts, leading to activation of Lyn (Field et al. 1995; Sheets et al. 1999) and similar events to TCR. 3. Glial cell-derived neurotrophic factor (GDNF). Ligation of the GPI-anchored GDNF receptor-α recruits the RET tyrosine kinase to rafts (Tansey et al. 2000). 4. Hedgehog. The Hedgehog protein is posttranslationally modified with a cholesterol moiety on one end (Porter et al. 1996) and a palmitate on the other (Pepinsky et al. 1998), likely helping to localize it to lipid rafts (Rietveld et al. 1999). Binding of Hedgehog to the Patched receptor protein releases the inhibitory effects of Smoothened, leading to a signaling cascade that activates transcription. Acyl-Anchored Proteins Numerous acylated, intracellular proteins are localized to lipid rafts, particularly members of the Src family of protein tyrosine kinases such as those listed in the various signaling pathways above. With few exceptions, these acylations are saturated, unbranched lipids that can easily partition into the highly ordered lipid structure of a raft. Even Ras, perhaps the quintessential signaling protein, is found in rafts in some cases: Palmitoylation of the C-terminal CAAX motif can target it to plasma membrane rafts where it can actively transduce a signal to Raf (Roy et al. 1999). Other small GTPases in the Ras superfamily also seem to localize to rafts, but this does not apply generally to all members (e.g., Rabs 1, 2, 3, and 10 are all in DRMs, but only isoforms 2 and 3 are mβCD sensitive [Foster et al. 2003], although all Rabs are thought to be doubly geranylgeranylated). Thus, acylation per se does not determine that a protein will segregate into lipid rafts; even specific types of acylation do not guarantee lipid raft association, although, in general, saturated, unbranched lipidations will tend to localize to rafts more often than other types. Mitochondrial Proteins Prior to the first proteomic analyses of DRMs (von Haller et al. 2001; Nebl et al. 2002; Bini et al. 2003; Foster et al. 2003; Ledesma et al. 2003; Li et al. 2003; von Haller et al. 2003a, b) there was no indication that mitochondrial proteins might reside in lipid rafts, but in all DRM proteomic studies to date, the voltage-dependent anion selective channels and components of the F1/F0-ATPase have been detected. Since there was no apparent link with the other known functions of lipid rafts, the cell biology community greeted these reports with some skepticism (Magee and Parmryd 2003). As mentioned previously, one of the hallmarks of lipid raft proteins is their sensitivity to cholesterol disruption, but two early quantitative DRM proteomic studies reported conflicting results regarding the sensitivity of mitochondrial proteins in DRMs to mβCD (Bini et al. 2003; Foster et al. 2003). Other than cell type differences and some other minor variations in experimental details, the main distinction between the two studies was the point at which the amounts of protein in the untreated and mβCD-treated samples were normalized, with one study showing protein is normalized before DRM isolation (Foster et al. 2003) and the other study, after
c04.indd 65
5/6/2011 6:10:11 PM
66
CHAPTER 4
LIPID RAFTS
DRM isolation (Bini et al. 2003). Normalizing protein after pharmacological treatment is certainly justified if the agents (i.e., mβCD) are not expected to drastically alter the amount of protein in the biochemical fraction. However, in the case of mβCD, the effect on the DRM fraction is profound: fully 50+% of DRM proteins are partially or fully depleted after mβCD treatment, making it critical to equalize the amounts of protein in each treatment before the DRM enrichment. When protein amounts are normalized prior to treatment, there is no effect of mβCD on mitochondrial proteins (Foster et al. 2003; Zheng et al. 2009). Intriguingly, however, other studies have linked mitochondrial proteins to lipid rafts as well. Kim et al. reported that the F1/F0 ATPase (the mitochondrial complex) can be found on the cell surface and is even reactive to impermeant biotinylation reagents (Kim et al. 2010). More recently, they have also demonstrated that mitochondrial oxidative phosphorylation complexes can be surface exposed and that mβCD can disrupt the production of extracellular reactive oxygen species by these complexes (Kim et al. 2010). The very low resolution of the discontinuous density gradient used for most DRM preparations may also contribute to mislocalization of proteins, particularly mitochondrial proteins. In the normal method, all membranes or other complexes with densities between 35% and 5% sucrose will appear to comigrate with lipid raft proteins. To get around this limitation, we used a quantitative proteomic approach called peptide correlation profiling– stable isotope labeling by amino acids in cell culture (PCP–SILAC) to measure how closely mitochondrial proteins and lipid raft proteins comigrate on a higher resolution, pseudo-continuous sucrose density gradient (Fig. 4.1; Zheng et al. 2009). Under these conditions, we were able to clearly resolve the mitochondrial proteins from the classical lipid raft markers, reinforcing our previous claims that mitochondrial proteins cannot be localized to rafts and must instead be contaminants of the normal DRM preparation.
Lipid Composition As mentioned, cholesterol and sphingomyelin are two of the principal components of lipid rafts. Indeed, together with certain glycosphingolipids and saturated glycerophospholipids, these lipids can form a liquid-ordered state all on their own (Brown and London 1998). Beyond these broad general categories, there have been no detailed lipidomic descriptions of rafts, as of yet, presumably because of the problems involved in obtaining “pure” raft preparations through the conventional approaches (see above). However, using immunoaffinity purification, Zech et al. (2009) were able to generate highly purified membrane domains containing the TCR and then use these to investigate how the TCR-bound domains change in response to stimulation. Not surprisingly, they found that the TCR membrane domains were highly enriched in cholesterol and sphingomyelin, relative to transferrin receptor membrane domains. However, they also noted an overabundance of phosphatidylserine and phosphatidic acid in TCR membrane domains, in contrast to an underrepresentation of phosphatidylcholine and phosphatidylinositol.
RAFT BIOPHYSICS: DO THEY REALLY EXIST? A subset of the published raft studies using biophysical methods has shown that the presence of Triton can force the formation of liquid-ordered domains in synthetic and biological membranes (Heerklotz 2002; Heerklotz et al. 2003; Heffer-Lauc et al. 2005), suggesting that many of the results based on DRM preparations may be artifacts. Countering this, however, is a series of biochemical, biophysical, and cell biological experiments suggest-
c04.indd 66
5/6/2011 6:10:11 PM
FUTURE PERSPECTIVES
67
ing that sphingolipid–cholesterol rafts do exist in biological membranes before the addition of a detergent and that these domains are effectively extracted by detergents (but not that detergent extracts are composed purely of these domains). Studies employing cross-linking (Friedrichson and Kurzchalia 1998), FRET (Varma and Mayor 1998), biophysical studies in model membranes (Ahmed et al. 1997; Garner et al. 2008), and single-particle measurements of diffusion in conventional light microscopy (Pralle et al. 2000) and sub-diffraction imaging using fluorescence photoactivation localization microscopy (Hess et al. 2007) all indicate that rafts exist in biological membranes and that the detergent-based methods for extracting them are extracting the expected structures. The preponderance of evidence now strongly favors the existence of rafts and justifies most of the work that has been carried out on them over the past two or more decades (see also Chapters 1 and 5).
RAFTS IN HOST–PATHOGEN INTERACTIONS A great many parasites, viruses, and bacteria have evolved the ability to invade host cells and co-opt the host machinery to survive, replicate, and cause disease. Most of these pathogens rely on the host machinery to gain entry as well, and it is here that lipid rafts and/or caveolae are frequently engaged. Disruption of rafts through the use of mβCD, filipin, or nystatin is known to disrupt internalization of numerous bacterial pathogens, including Campylobacter jejuni (Wooldridge et al. 1996), Brucella abortus (Watarai et al. 2002), Escherichia coli (Duncan et al. 2004), and Mycobacterium kansasii (Watarai et al. 2002). For other pathogens, rafts seem to mediate signaling pathways that the bacteria interfere with in order to avoid host defenses, as is the case with Pseudomonas aeruginosa (Zhang et al. 2005). Rafts in different guises are involved in classical clathrin-mediated endocytosis (Stoddart et al. 2002; Abrami et al. 2003), providing a mechanism for some pathogens (e.g., viruses, some bacteria) and virulence factors or toxins to enter into host cells. For example, in the case of Bacillus anthracis, the anthrax toxin receptor is located in lipid rafts and is internalized on ligation with the anthrax toxin (Abrami et al. 2003). Although not yet widely recognized, Salmonella bacteria also employ host lipid rafts, if not for entry then at least for the initial adherence step (Lim et al. 2010). Salmonella are among those pathogens that can induce their own internalization via a phagocytosis-like mechanism (Brumell et al. 1999); although the functional link between rafts and the process of phagocytosis is not yet established, there is increasing evidence that rafts are involved in some way as the composition of rafts changes during phagocytosis (personal observations) and the raft components of phagosomes change with phagosome maturation (Dermine et al. 2001; Rogers and Foster 2007; see Chapter 10 for a discussion of raft domains in phagosomes). The examples mentioned above likely only represent those host– pathogen systems where investigators have considered the role of rafts or where the system is a well-established model (Zaas et al. 2005); it is likely that rafts will be found to be critical to the ability of many other pathogens to cause disease as well.
FUTURE PERSPECTIVES Lipid rafts are now assured a place in our model of the cell and of membrane structure. The biophysical arguments that rafts are simply an artifact of detergent usage died out two or three years ago, and there is now widespread agreement that they are a real function of phase separation between different classes of lipids, together with structural assistance provided by proteins. Now that the reality versus artifact discussion has concluded, the
c04.indd 67
5/6/2011 6:10:11 PM
68
CHAPTER 4
LIPID RAFTS
field can finally move on and focus on the role of rafts in cell biology. Clearly, rafts play a fundamental role in many signaling processes, as well as in intracellular trafficking. As domains/organelles go, lipid rafts are an excellent subject for “omic” approaches since their composition is relatively simple; with quantitative lipidomic and/or proteomic approaches that can control well for contaminants or functional relevance, studies of how the protein and lipid composition changes in response to various stimuli will surely open up new avenues for investigation. Partnering these discovery approaches with some of the amazing new imaging methods (Hess et al. 2007) currently available could make rafts the most exciting field in cell biology again.
ABBREVIATIONS DRM FRET GDNF GPI
detergent-resistant membrane fluorescence resonance energy transfer glial cell-derived neurotrophic factor glycophosphatidylinositol
mβCD methyl β-cyclodextrin PCP–SILAC peptide correlation profiling–stable isotope labeling by amino acids in cell culture TCR T-cell receptor
REFERENCES Abrami L, Liu S, Cosson P, Leppla SH, van der Goot FG. 2003. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J Cell Biol 160:321–8. Ahmed SN, Brown DA, London E. 1997. On the origin of sphingolipid/cholesterol-rich detergent-insoluble cell membranes: physiological concentrations of cholesterol and sphingolipid induce formation of a detergentinsoluble, liquid-ordered lipid phase in model membranes. Biochemistry 36:10944–53. Bae TJ, Kim MS, Kim JW, Kim BW, Choo HJ, Lee JW, Kim KB, Lee CS, Kim JH, Chang SY, Kang CY, Lee SW, Ko YG. 2004. Lipid raft proteome reveals ATP synthase complex in the cell surface. Proteomics 4:3536–48. Bini L, Pacini S, Liberatori S, Valensin S, Pellegrini M, Raggiaschi R, Pallini V, Baldari CT. 2003. Extensive temporally regulated reorganization of the lipid raft proteome following T-cell antigen receptor triggering. Biochem J 369:301–9. Blonder J, Yu LR, Radeva G, Chan KC, Lucas DA, Waybright TJ, Issaq HJ, Sharom FJ, Veenstra TD. 2006. Combined chemical and enzymatic stable isotope labeling for quantitative profiling of detergent-insoluble membrane proteins isolated using Triton X-100 and Brij96. J Proteome Res 5:349–60. Borner GH, Lilley KS, Stevens TJ, Dupree P. 2003. Identification of glycosylphosphatidylinositol-anchored proteins in Arabidopsis. A proteomic and genomic analysis. Plant Physiol 132:568–77. Brown DA, London E. 1998. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14: 111–36. Brown DA, Rose JK. 1992. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68: 533–44.
c04.indd 68
Brumell JH, Steele-Mortimer O, Finlay BB. 1999. Bacterial invasion: force feeding by Salmonella. Curr Biol 9:R277–80. Chamberlain LH. 2004. Detergents as tools for the purification and classification of lipid rafts. FEBS Lett 559: 1–5. Dermine JF, Duclos S, Garin J, St-Louis F, Rea S, Parton RG, Desjardins M. 2001. Flotillin-1-enriched lipid raft domains accumulate on maturing phagosomes. J Biol Chem 276:18507–12. Duncan MJ, Li G, Shin JS, Carson JL, Abraham SN. 2004. Bacterial penetration of bladder epithelium through lipid rafts. J Biol Chem 279:18944–51. Elortza F, Nuhse TS, Foster LJ, Stensballe A, Peck SC, Jensen ON. 2003. Proteomic analysis of glycosylphosphatidylinositol-anchored membrane proteins. Mol Cell Proteomics 2:1261–70. Elortza F, Mohammed S, Bunkenborg J, Foster LJ, Nuhse TS, Brodbeck U, Peck SC, Jensen ON. 2006. Modification-specific proteomics of plasma membrane proteins: identification and characterization of glycosylphosphatidylinositol-anchored proteins released upon phospholipase D treatment. J Proteome Res 5: 935–43. Field KA, Holowka D, Baird B. 1995. Fc epsilon RImediated recruitment of p53/56lyn to detergent-resistant membrane domains accompanies cellular signaling. Proc Natl Acad Sci U S A 92:9201–5. Fivaz M, Vilbois F, Pasquali C, van der Goot FG. 2000. Analysis of glycosyl phosphatidylinositol-anchored proteins by two-dimensional gel electrophoresis. Electrophoresis 21:3351–6. Foster LJ. 2009. Moving closer to the lipid raft proteome using quantitative proteomics. Methods Mol Biol 528:189–99. Foster LJ, Chan QWT. 2007. Lipid raft proteomics: more than just detergent resistant membranes. In: Faupel M,
5/6/2011 6:10:11 PM
REFERENCES
Bertrand E, editors. Subcellular Biochemistry: Subcellular fractionation and proteomics. London: Springer-Verlag, pp. 35–47. Foster LJ, de Hoog CL, Mann M. 2003. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci U S A 100: 5813–8. Friedrichson T, Kurzchalia TV. 1998. Microdomains of GPI-anchored proteins in living cells revealed by crosslinking. Nature 394:802–5. Garner AE, Smith DA, Hooper NM. 2008. Visualization of detergent solubilization of membranes: implications for the isolation of rafts. Biophys J 94:1326–40. Heerklotz H. 2002. Triton promotes domain formation in lipid raft mixtures. Biophys J 83:2693–701. Heerklotz H, Szadkowska H, Anderson T, Seelig J. 2003. The sensitivity of lipid domains to small perturbations demonstrated by the effect of Triton. J Mol Biol 329:793–9. Heffer-Lauc M, Lauc G, Nimrichter L, Fromholt SE, Schnaar RL. 2005. Membrane redistribution of gangliosides and glycosylphosphatidylinositol-anchored proteins in brain tissue sections under conditions of lipid raft isolation. Biochim Biophys Acta 1686(3):200–8. Hess ST, Gould TJ, Gudheti MV, Maas SA, Mills KD, Zimmerberg J. 2007. Dynamic clustered distribution of hemagglutinin resolved at 40 nm in living cell membranes discriminates between raft theories. Proc Natl Acad Sci U S A 104:17370–5. Janes PW, Ley SC, Magee AI, Kabouridis PS. 2000. The role of lipid rafts in T cell antigen receptor (TCR) signalling. Semin Immunol 12:23–34. Keller P, Simons K. 1998. Cholesterol is required for surface transport of influenza virus hemagglutinin. J Cell Biol 140:1357–67. Kierszniowska S, Seiwert B, Schulze WX. 2009. Definition of Arabidopsis sterol-rich membrane microdomains by differential treatment with methyl-beta-cyclodextrin and quantitative proteomics. Mol Cell Proteomics 8:612–23. Kim BW, Lee JW, Choo HJ, Lee CS, Jung SY, Yi JS, Ham YM, Lee JH, Hong J, Kang MJ, Chi SG, Hyung SE, Lee SW, Kim HM, Cho BR, Min DS, Yoon G, Ko YG. 2010. Mitochondrial oxidative phosphorylation system is recruited to detergent-resistant lipid rafts during myogenesis. Proteomics 10:2498–515. Langlet C, Bernard AM, Drevot P, He HT. 2000. Membrane rafts and signaling by the multichain immune recognition receptors. Curr Opin Immunol 12:250–5. Ledesma MD, Da Silva JS, Schevchenko A, Wilm M, Dotti CG. 2003. Proteomic characterisation of neuronal sphingolipid-cholesterol microdomains: role in plasminogen activation. Brain Res 987:107–16. Li N, Mak A, Richards DP, Naber C, Keller BO, Li L, Shaw AR. 2003. Monocyte lipid rafts contain proteins implicated in vesicular trafficking and phagosome formation. Proteomics 3:536–48. Lim JS, Choy HE, Park SC, Han JM, Jang IS, Cho KA. 2010. Caveolae-mediated entry of Salmonella typhimurium into senescent nonphagocytotic host cells. Aging Cell 9:243–51.
c04.indd 69
69
Magee AI, Parmryd I. 2003. Detergent-resistant membranes and the protein composition of lipid rafts. Genome Biol 4:234. Man P, Novak P, Cebecauer M, Horvath O, Fiserova A, Havlicek V, Bezouska K. 2005. Mass spectrometric analysis of the glycosphingolipid-enriched microdomains of rat natural killer cells. Proteomics 5:113–22. McMahon KA, Zhu M, Kwon SW, Liu P, Zhao Y, Anderson RG. 2006. Detergent-free caveolae proteome suggests an interaction with ER and mitochondria. Proteomics 6:143–52. Nebl T, Pestonjamasp KN, Leszyk JD, Crowley JL, Oh SW, Luna EJ. 2002. Proteomic analysis of a detergentresistant membrane skeleton from neutrophil plasma membranes. J Biol Chem 277:43399–409. Pepinsky RB, Zeng C, Wen D, Rayhorn P, Baker DP, Williams KP, Bixler SA, Ambrose CM, Garber EA, Miatkowski K, Taylor FR, Wang EA, Galdes A. 1998. Identification of a palmitic acid-modified form of human Sonic hedgehog. J Biol Chem 273:14037–45. Porter JA, Young KE, Beachy PA. 1996. Cholesterol modification of hedgehog signaling proteins in animal development. Science 274:255–9. Pralle A, Keller P, Florin EL, Simons K, Horber JK. 2000. Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J Cell Biol 148:997–1008. Rietveld A, Neutz S, Simons K, Eaton S. 1999. Association of sterol- and glycosylphosphatidylinositollinked proteins with Drosophila raft lipid microdomains. J Biol Chem 274:12049–54. Rogers LD, Foster LJ. 2007. The dynamic phagosome proteome and the contribution of the ER. Proc Natl Acad Sci U S A 104:18520–5. Roy S, Luetterforst R, Harding A, Apolloni A, Etheridge M, Stang E, Rolls B, Hancock JF, Parton RG. 1999. Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nat Cell Biol 1:98–105. Sheets ED, Holowka D, Baird B. 1999. Critical role for cholesterol in Lyn-mediated tyrosine phosphorylation of FcepsilonRI and their association with detergent-resistant membranes. J Cell Biol 145:877–87. Sherrier DJ, Prime TA, Dupree P. 1999. Glycosylphosphatidylinositol-anchored cell-surface proteins from Arabidopsis. Electrophoresis 20:2027–35. Simons K, Ikonen E. 1997. Functional rafts in cell membranes. Nature 387:569–72. Simons K, Toomre D. 2000. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31–9. Singer SJ, Nicolson GL. 1972. The fluid mosaic model of the structure of cell membranes. Science 175:720–31. Smart EJ, Ying YS, Mineo C, Anderson RG. 1995. A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci U S A 92: 10104–8. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. 1996. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 271:9690–7.
5/6/2011 6:10:11 PM
70
CHAPTER 4
LIPID RAFTS
Stoddart A, Dykstra ML, Brown BK, Song W, Pierce SK, Brodsky FM. 2002. Lipid rafts unite signaling cascades with clathrin to regulate BCR internalization. Immunity 17:451–62. Tansey MG, Baloh RH, Milbrandt J, Johnson EM, Jr. 2000. GFRalpha-mediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival. Neuron 25:611–23. Varma R, Mayor S. 1998. GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 394:798–801. von Haller PD, Donohoe S, Goodlett DR, Aebersold R, Watts JD. 2001. Mass spectrometric characterization of proteins extracted from Jurkat T cell detergent-resistant membrane domains. Proteomics 1:1010–21. von Haller PD, Yi E, Donohoe S, Vaughn K, Keller A, Nesvizhskii AI, Eng J, Li XJ, Goodlett DR, Aebersold R, Watts JD. 2003a. The application of new software tools to quantitative protein profiling via ICAT and tandem mass spectrometry: I. Statistically annotated data sets for peptide sequences and proteins identified via the application of ICAT and tandem mass spectrometry to proteins co-purifying with T cell lipid rafts. Mol Cell Proteomics 2:425–27. von Haller PD, Yi E, Donohoe S, Vaughn K, Keller A, Nesvizhskii AI, Eng J, Li XJ, Goodlett DR, Aebersold R, Watts JD. 2003b. The application of new software tools to quantitative protein profiling via ICAT
c04.indd 70
and tandem mass spectrometry: II. Evaluation of tandem mass spectrometry methodologies for large-scale protein analysis and the application of statistical tools for data analysis and interpretation. Mol Cell Proteomics 2:428–42. Watarai M, Makino S, Fujii Y, Okamoto K, Shirahata T. 2002. Modulation of Brucella-induced macropinocytosis by lipid rafts mediates intracellular replication. Cell Microbiol 4:341–55. Wooldridge KG, Williams PH, Ketley JM. 1996. Host signal transduction and endocytosis of Campylobacter jejuni. Microb Pathog 21:299–305. Zaas DW, Duncan M, Rae Wright J, Abraham SN. 2005. The role of lipid rafts in the pathogenesis of bacterial infections. Biochim Biophys Acta 1746: 305–13. Zech T, Ejsing CS, Gaus K, de Wet B, Shevchenko A, Simons K, Harder T. 2009. Accumulation of raft lipids in T-cell plasma membrane domains engaged in TCR signalling. Embo J 28:466–76. Zhang M, Moran M, Round J, Low TA, Patel VP, Tomassian T, Hernandez JD, Miceli MC. 2005. CD45 signals outside of lipid rafts to promote ERK activation, synaptic raft clustering, and IL-2 production. J Immunol 174:1479–90. Zheng YZ, Berg KB, Foster LJ. 2009. Mitochondria do not contain lipid rafts and lipid rafts do not contain mitochondrial proteins. J Lipid Res 50:988–98.
5/6/2011 6:10:11 PM
CH A P T E R
5
MODELING MEMBRANE DOMAINS Daniel Coombs Raibatak Das Jennifer S. Morrison
DEFINITION Cell membranes are known to be heterogeneous structures, featuring distinct domains on the scale of tens to hundreds of nanometers. Membrane domains are characterized by the enrichment or exclusion of membrane constituents and proteins, and are believed to play important roles in modulating cell signaling through surface receptors. Fluorescence microscopic techniques, including fluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), single-particle tracking (SPT), and fluorescence correlation spectroscopy (FCS), have played important roles in shaping our understanding of membrane domains and their dynamics. These techniques have been used to study the membrane domains known as lipid rafts, which were originally defined as detergent-resistant regions that are enriched in glycosphingolipids (see also Chapter 4). We comment on our evolving understanding of these domains and show how careful data analysis and mathematical modeling naturally complement fluorescence microscopy in this context.
HISTORICAL PERSPECTIVE The Singer–Nicolson fluid mosaic model for the membrane of a cell states that the membrane of a cell can be thought of as a two-dimensional fluid, within which membrane components and transmembrane proteins diffuse freely (Singer and Nicolson 1972). However, ongoing work indicates that a better picture of the membrane may be one consisting of dynamically rearranging structures, or domains, on the scale of 50–500 nm in size. Membrane domains can be characterized according to which molecules are enriched in the region (e.g., the canonical lipid raft, enriched in cholesterol and sphingolipids), and they may influence the mobility of membrane components, lipids, and proteins by confining or hindering their motion. It is widely believed that the choreography of intracellular signaling following surface receptor engagement is affected by localization of key signaling proteins. Several well-characterized examples are found in the immunological context: FcεRI receptor signaling on mast cells following cross-linking by immunoglobulin E (IgE) and antigen, B-cell receptor (BCR) signaling following receptor cross-linking by antigen, and T-cell receptor (TCR) signaling following peptide–major histocompatibility complex (MHC) binding at the immunological synapse. Cellular Domains, First Edition. Edited by Ivan R. Nabi. © 2011 John Wiley & Sons, Inc. Published 2011 by John Wiley & Sons, Inc.
71
c05.indd 71
5/6/2011 6:10:16 PM
72
CHAPTER 5
MODELING MEMBRANE DOMAINS
The definition of membrane rafts has evolved considerably in the last decade concurrently with advances in high-resolution imaging that have allowed cellular membranes to be probed with increasing spatiotemporal resolution. Until the early 2000s, rafts were defined primarily on the basis of their biochemical properties (detergent resistance, glycosphingolipid enrichment, and the preferential partitioning of glycosylphosphatidylinositol [GPI]-anchored proteins) (see Chapter 4 for a discussion of detergent-resistant raft domains) and were thought to be a distinct phase in the plasma membrane such as was observed in model membrane systems with well-defined lipid composition (Edidin 2003). With rapid advances in imaging techniques (reviewed in Lagerholm et al. 2005), and the emergence of suboptical resolution microscopy (Betzig et al. 2006), it became obvious that membrane heterogeneities occur at many length scales and have different characteristic persistence times (Hancock 2006; Hess et al. 2007). In this respect, cellular membranes differ substantially from model membranes that exhibit persistent and large-scale phase separation. As a result, a more recent definition of membrane rafts is short-lived spontaneous aggregates of variable size in resting cells, which may coalesce around activated receptors and could aggregate to form larger rafts (Pike 2006). A greater appreciation has also emerged for the role played by the membrane-associated proteins in organizing the lipid environment around them (Jacobson et al. 2007; Lingwood and Simons 2010). The recent discovery of receptor microclusters in T and B cells also supports aspects of this hypothesis, while raising new questions about the formation and function of these entities, and the role played by the actin cytoskeleton in regulating membrane organization (Bunnell 2010). The purpose of this chapter is to outline how fluorescence microscopic techniques can be used to study the dynamics of membrane domain organization, and to highlight how careful mathematical modeling and data fitting can give important insights into membrane dynamics. We will not discuss other important tools such as electron microscopy (EM) and atomic force microscopy (AFM). EM in particular has been used alongside fluorescence microscopic approaches to characterize the distribution of surface receptors and surface-associated signaling molecules with great success (e.g., Lillemeier et al. 2010). However, EM cannot be used to track dynamic reorganization of domains in response to stimuli, since cells must be fixed and the membranes removed from the cells before imaging. For this reason, EM will probably continue to be used in tandem with other techniques for studying dynamics of membrane domains. In contrast, AFM can be used with live cells and has great promise to provide resolution comparable with EM, with reasonable time resolution (Lee et al. 2007). Wider use of AFM in studies of membrane organization and signaling can be expected in the future.
THEORETICAL BASICS Fluorescence microscopic techniques for studying membrane domains are intimately connected with the theory of diffusion of molecules in the membrane. Brownian diffusion is the simplest form of random (thermal) motion and assumes that a molecule moves randomly and without any memory of its previous motion. This means that a purely Brownian particle behaves identically at all times and in all parts of the membrane. For Brownian diffusion, the expected mean square displacement (MSD) of a molecule is a linear function of time: r 2 (t ) = 4 Dt ,
c05.indd 72
5/6/2011 6:10:16 PM
FRAP
73
where D is defined as the diffusion coefficient of the particle, and the angle brackets indicate averaging over many particle trajectories. According to the Einstein–Stokes relationship, D is inversely proportional to the particle size and the effective viscosity of the membrane (Einstein and Fürth 1956). The existence of membrane domains breaks the assumption that the molecular motion is spatiotemporally homogeneous, because (1) the particle mobility may be altered within a domain and/or (2) domains may be defined by fence-like structures that do not permit the particle to pass. As a result, the motion is “subdiffusive” and the expected MSD grows less than linearly over time: r 2 (t ) ~ 4 Dt α , where the exponent α is less than 1. Intuitively, this can be understood by imagining a particle diffusing within a fixed cage. Over short times, the walls of the cage do not significantly affect the motion. However, over longer times, the particle’s overall displacement cannot grow beyond the size of the cage. This means that long-term diffusion is slower than short-term diffusion, or equivalently, the diffusivity of the particle can be thought of as time dependent (Saxton 2001). Similarly, a particle moving in and between cages with partially porous boundaries will show reduced long-term mobility compared with short-term mobility. At the other extreme, particles might be described as “superdiffusive” when the exponent α is greater than 1. This would be the situation for a particle undergoing directed motion (e.g., a surface protein that is actively transported along a filament of the cell cytoskeleton). If a particle moves with velocity v, superimposed on Brownian diffusion, then its MSD is given as r 2 (t ) = 4 Dt + v 2 t 2 . The term involving t2 is the square of the distance traveled due to directed motion. At long times, the MSD is dominated by this term and thus grows faster than linearly. Data from each of the microscopic techniques we describe here can be analyzed based on these basic ideas of diffusion processes. In the case of SPT, statistical comparisons can be made directly between labeled protein tracks and the diffusion model. On the other hand, when fluorescent proteins are labeled en masse (e.g., in FRAP experiments, see below), we have to use a diffusion process averaged over many particles. In the case of Brownian diffusion, this leads to a relatively simple partial differential equation that can be solved analytically or numerically (Crank 1980). For sub- or superdiffusive processes, the averaging process can be much more complex because the motion of the particle depends on its previous history of movements. Mathematical research in this area is ongoing but it is not clear how to confidently fit experimental data (e.g., from fluorescence recovery) to subdiffusive models and thus detect membrane domains.
FRAP FRAP is routinely used to study the mobility of cell-surface proteins. In this method, a fluorescent probe is conjugated to the surface population of the protein of interest. A short period of high laser intensity is used to bleach the probe in a specific region, reducing the fluorescence in that region to background levels. Motion of unbleached proteins into the bleached region causes fluorescence in the bleached region to recover. The level of fluorescence in the bleached region is monitored over time, generating a saturating recovery curve. The shape of the recovery curve is governed by the motion of the labeled protein
c05.indd 73
5/6/2011 6:10:16 PM
74
CHAPTER 5
MODELING MEMBRANE DOMAINS
and the precise details of the experimental protocol. FRAP recovery curves can be fit to mathematical models, yielding estimates of the diffusion coefficient and the fraction of labeled proteins that are mobile on the cell surface. The book chapter by Rabut and Ellenberg provides a detailed description of the technique, taking into account practical considerations for FRAP experiments (Rabut and Ellenberg 2004). The question of how FRAP recovery curves would be affected by subdiffusive particle behavior was addressed in Saxton (2001). In this study, FRAP recovery curves were simulated for three different mathematical models that yield subdiffusive motion. The main result was that, for a single experiment, determining the nature of the molecular dynamics (diffusive, subdiffusive, confined, etc.) is a very difficult task. This is shown in that paper by fitting simulated data with both anomalous and standard diffusion models and obtaining good fits in both cases. More recently, FRAP experiments have been used to study transient binding of a labeled mobile protein to a slow-moving or stationary binding partner (Sprague and McNally 2005). This is achieved by fitting the recovery curves to a reaction–diffusion model (rather than a simple diffusion model) that is parameterized by forward and reverse rate constants for a binding interaction and the diffusion coefficients of the free protein and the bound complex. Qualitatively, transient binding to an immobile partner slows recovery and changes the shape of the recovery curve. We applied this approach to study the mobility of TCRs on the surfaces of live T cells (Dushek et al. 2008). We found that the recovery of fluorescently labeled TCR was best fit by a model of TCR diffusion and transient binding to an immobile partner. The binding hindrance was removed upon treating the cells with cytoskeletal inhibitors, leading us to hypothesize that the cortical actin cytoskeleton of the cell provided (unspecified) transient binding sites. However, in other situations, this method might detect transient confinement zones within the cell membrane. In that situation, the effective on and off rates that are estimated from the data would be interpreted as rates of arriving and leaving the confinement zones. A complete comparison of the characteristic FRAP recovery curves for anomalous motion due to confinement in membrane domains versus transient binding to immobile partners would be informative. If such a study were performed, it might lead to the development of diagnostics as to which models are suitable to interpret deviations from purely diffusive behavior. However, as shown by Saxton, recovering molecular-scale information from a (relatively coarse) FRAP experiment is a near-impossible task. For this reason, we move on to discussion of other techniques that can offer greater precision.
FRET FRET microscopy is a sensitive tool to detect the close proximity between two fluorophores (Selvin 2000; Lakowicz 2006). The two fluorophores may be conjugated to the different parts of the same biomolecule, so that the FRET signal reveals conformational changes in the molecule, or they may be on two different molecules, in which case it reveals close proximity, and thus potential association. In typical FRET experiments, a donor–acceptor pair of fluorophores is chosen in a way that the emission spectrum of the donor overlaps with the excitation spectrum of the acceptor. When the donor is excited by incident light tuned to its excitation wavelength, it can transfer energy to a nearby acceptor molecule, leading to a decrease in the donor emission, while increasing the acceptor emission. The efficiency of this energy transfer process is typically measured as donor quenching in the presence of the acceptor: E = 1 − FDA / FD ,
c05.indd 74
5/6/2011 6:10:16 PM
FRET
75
where FD and FDA are the donor fluorescence intensities in the absence and the presence of an acceptor, respectively. This efficiency can also be calculated by measuring the change in the lifetime of a donor in the presence of the acceptor. FRET efficiency is strongly dependent on the distance between the two fluorophores and their relative orientations, and is given as E = 1 /(1 + ( R / R0 )6 ), where R is the separation between the molecules. When R = R0, the Forster radius, the energy transfer is 50% efficient (Forster 1959). The Forster radii for a number of FRET pairs are tabulated (Lakowicz 2006) and are typically in the range of 20–60 Å. Because of the strong sixth power dependence on fluorophore separation, FRET efficiency drops off precipitously for separations exceeding R0, and in practice, FRET is only useful for measuring separations in the range of 10–100 Å.
What Do We Know about Membrane Organization from FRET Studies? A number of studies have used fluorophore density-dependent FRET measurements of GPI-anchored proteins and glycosphingolipids to examine their organization into microdomains variously called lipid rafts or membrane rafts. The principles underlying these studies are the following: For proteins (or lipids) that are organized into spatial clusters (raft) with fixed densities of component molecules, FRET efficiency is independent of the overall surface density of a raft component. In contrast, for randomly distributed molecules, FRET efficiency increases with increasing surface density, as the molecules are packed more closely. Initial studies (Kenworthy and Edidin 1998; Varma and Mayor 1998) led to conflicting reports and were followed up with a more careful examination of the membrane distributions of different GPI-anchored proteins and glycosphingolipids (Kenworthy et al. 2000; Sharma et al. 2004). The results from these studies are now reconciled within the raft hypothesis, which posits that membrane rafts are small, heterogeneous, and dynamic structures that span tens of nanometers, and that may be stabilized to form larger structures during cell signaling (Lagerholm et al. 2005; Pike 2006). Moreover, only a small fraction (5–20%) of the total amount of putative raft component is presumed to be associated with these dynamic rafts in resting cells. FRET measurements using fluorescent lipid probes also support the existence of nanometer-scale heterogeneities in the plasma membrane of mast cells (Sengupta et al. 2007).
Consequences for Cell Signaling Lipid rafts are postulated to segregate components of signal transduction. The generally accepted mechanism for the role of membrane rafts in B cells and mast cells proposes that, in resting cells, monomeric BCRs or the high-affinity IgE receptors, FcεRI, are largely excluded from lipid rafts, while the Src family kinase Lyn is preferentially distributed in rafts. Membrane phosphatases such as CD45 are also excluded from rafts, and serve to maintain the receptors in a predominantly dephosphorylated state in resting cells. Upon binding to a multivalent antigen, cross-linked receptors redistribute into Lyn-enriched lipid rafts, where they are susceptible to Lyn phosphorylation, while being shielded from phosphatases. Other signaling components such as CD19, Syk, and LAT are also enriched in rafts, either due to transient associations with the phosphorylated receptors or by virtue of their lipid anchors (for LAT), and thus rafts provide a spatial platform for downstream signal propagation (reviewed in Pizzo and Viola 2004). Some of the most detailed direct observations of these events have emerged in a series of FRET microscopy studies from the lab of Susan Pierce (reviewed in Tolar et al.
c05.indd 75
5/6/2011 6:10:16 PM
76
CHAPTER 5
MODELING MEMBRANE DOMAINS
2008). Using an elegant system of reconstituted BCRs in J558L B cells containing different cyan fluorescent protein (CFP)- or yellow fluorescent protein (YFP)-labeled BCR components, Pierce and colleagues established the stoichiometry of the BCR (1 mIg : 1 Igα-Igβ heterodimer) and demonstrated (1) antigen-induced receptor aggregation, (2) Lyndependent conformational change in the cytosolic domains of the BCR, and (3) transient associations between cross-linked receptor and Lyn that peak within 10 seconds of antigenstimulation and dissipate within minutes (Tolar et al. 2005; Sohn et al. 2006). Subsequently, these observations were recapitulated for B-cell activation with a surface-bound antigen, presented through a supported bilayer, replicating a B-cell immunological synapse (Sohn et al. 2008). Notably, high-resolution imaging of the B-cellsupported bilayer interface using total internal reflection fluorescence (TIRF) microscopy revealed the formation and migration of signaling competent BCR microclusters at the immune synapse (Depoil et al. 2008). Receptor microclusters have also been observed during the formation of a T-cell immune synapse at the interface with an antigen-containing bilayer (Bunnell et al. 2002; Campi et al. 2005). These microclusters form spontaneously at the periphery of a synapse within seconds of contact with the antigen, contain phosphorylated Src kinases, and recruit downstream signaling molecules such as Syk/Zap-70 and SLP-76 (Yokosuka et al. 2005). The molecular basis of microcluster formation and their role in immune signal transduction is still poorly understood.
SPT In contrast to FRAP and FRET, techniques that both monitor a population of molecules and thus provide an ensemble measurement, SPT is a powerful single-molecule technique that yields direct observation of molecular motion (see also Chapter 1). The protein of interest is labeled with an immunofluorescent probe or an antibody-coated bead, at a sufficiently low concentration so as to allow the visualization of single molecules or diffractionlimited clusters. Using high-speed video microscopy, the particle’s position is then tracked over time to obtain its trajectory, as the experimental output. Typical SPT experiments have a spatial resolution of tens of nanometers and a time resolution of tens of milliseconds (although experiments with microsecond resolution have been performed; Fujiwara et al. 2002; Murase et al. 2004; Umemura et al. 2008). It is also common to treat cells with pharmacological agents (such as cytochalasin D to disrupt the actin cytoskeleton) and examine changes in particle trajectories. In principle, particle trajectories contain information about the nature of molecular motion, signatures of spatiotemporal heterogeneity, and the presence of multiple subpopulations, though it is a nontrivial task to extract this information in a statistically reliable fashion.
Analysis of Particle Tracks In classical SPT analysis, particle trajectories are classified on the basis of their MSD versus time plot (see Theoretical Basics). The MSD as a function of time is calculated from the individual displacements (Qian et al. 1991; Kusumi et al. 1993), and tracks are then sorted into various modes of motion based on fitting their MSD curve to the equation MSD(t ) = 4 Dt α (see Theoretical Basics; Anderson et al. 1992; Wilson et al. 1996; Saxton and Jacobson 1997). Other MSD-based parameters, such as the relative deviation from Brownian diffusion (Kusumi et al. 1993) and the radius of gyration tensor (Rudnick and Gaspari 1987; Saxton 1993), have also been used to categorize particle trajectories.
c05.indd 76
5/6/2011 6:10:16 PM
SPT
77
A series of theoretical studies by Saxton has examined the origin of anomalous diffusion due to confinement, the presence of obstacles, or binding, and proposed algorithms for detecting these through MSD measurements (Saxton 1993, 1994, 1995, 1996). An analytical treatment also exists for diffusion through an infinite array of impermeable barriers, relating the macroscopic and microscopic diffusion coefficients to the average compartment size and the average residency time within a compartment (Powles et al. 1992). The results from this study were used to test a hop diffusion model for membrane phospholipids and MHC molecules (Fujiwara et al. 2002; Umemura et al. 2008). These MSD-based classifications assume a single mode of motion within each trajectory, and as such, are suitable for identifying the global behavior of all trajectories in an experiment, or classifying trajectories into subpopulations exhibiting different characteristics. A different class of statistical analysis exists for identifying transient confinement (Simson et al. 1995; Meilhac et al. 2006), or transient directed motion (Bouzigues and Dahan 2007; Arcizet et al. 2008) within individual trajectories. Methods used to detect these transient events are typically based on a sliding average technique: MSD is calculated for short windows along the trajectory to identify deviations from Brownian diffusion within segments of an individual track. An issue with these methods is their need for a judicious choice of input parameters such as the length of the sliding window and the assumed size of confinement regions. Changes in these parameter values could alter the results significantly. We have recently developed a novel technique to identify transient changes in diffusivity within single trajectories that does not require any user-supplied parameters. Our method uses a “hidden Markov” model to identify transient periods of reduced mobility in single-particle tracks of the integrin LFA-1 and the phosphatase CD45 on the surface of T cells (Das et al. 2009; Cairo et al. 2010). The term “hidden Markov” refers to a collection of methods that exploit changes in the behavior of an observed variable to make inferences about an unobservable, or “hidden,” variable. In our approach, we use observations of particle motion to break particle trajectories up into rapidly diffusing and slowly diffusing segments. We were able to attribute reduced mobility to a binding interaction between the cell-surface receptor and the cortical actin cytoskeleton. Furthermore, our method gives estimates for the rates of transitions between the two distinct states that can be interpreted as chemical binding rates for the integrin–actin interaction. As an extension, we have also developed an algorithm to identify transient periods of directed motion within individual trajectories (Morrison 2010). As shown in Figure 5.1, our segmentation algorithm robustly detects regions within which particle diffusivity is reduced, and we believe that this type of analysis will allow SPT-based assays to be used to detect and characterize membrane domains on the cell surface. We are currently testing this application. Directed motion on the plasma membrane has been observed in SPT experiments for proteins such as E-cadherin (Kusumi et al. 1993), MHC II (Wilson et al. 1996), and gamma-aminobutyric acid (GABA) receptors on nerve growth cones (Bouzigues and Dahan 2007). Bouzigues and Dahan presented a sliding window statistical analysis that estimates velocity and diffusion coefficients in tracks where a particle switches between directed and pure diffusive modes. They found that drift occurs most often in the central region of the cell rather than in the actin-rich lamellipodia, thus defining two distinct domains for GABA receptor mobility.
Models of Plasma Membrane Domains Studied with SPT The analysis of particle trajectories with anomalous diffusion motivated the study of three main classes of membrane domain models:
c05.indd 77
5/6/2011 6:10:16 PM
78
CHAPTER 5
MODELING MEMBRANE DOMAINS
pure diffusion confined diffusion scale: 0.5 µm Figure 5.1. Detection of regions of reduced mobility in SPT data. We show a simulated diffusive particle track across a landscape where the particle mobility is reduced within diskshaped domains. The particle’s ability to enter the disks is also reduced to simulate picket fences at domain boundaries. The particle track has been segmented into free (black) and reduced mobility (gray) parts using our hidden Markov analysis (Das et al. 2009). Parameters: Dconfined = 0.01 μm2/s, Dfree = 1 μm2/s, pjump = 0.1.
• membrane picket fence model, • lipid rafts, • protein–protein interactions and clustering. The membrane-skeleton fence model was first proposed by Sako and Kusumi after performing SPT on the α2-macroglobulin receptor (Sako and Kusumi 1994). They observed short-term confined diffusion within a submicron-sized compartment and longterm hop diffusion between compartments (see also Chapter 1). Partial destruction of the cytoskeleton decreased the confined diffusion mode and increased the simple diffusion. This model is further evidenced by experiments where the residency times within corrals decrease when the cytoplasmic side of the protein is removed (Sako et al. 1998; Leitner et al. 2000). More recently, an impressive experiment shows that single FcεRI receptors on the surface of mast cells tend not to cross green fluorescent protein (GFP)-labeled cortical actin cytoskeleton barriers (Andrews et al. 2008). Hop diffusion has been observed in the trajectories of many transmembrane proteins such as E-cadherin (Sako et al. 1998), transferrin receptor (Sako and Kusumi 1994), Band-3 (Tomishige et al. 1998; Leitner et al. 2000), and MHC II (Umemura et al. 2008). The model was revised after SPT experiments with the unsaturated phospholipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) were performed by the Kusumi lab. Labeled DOPE was only tracked on the outer leaflet of the plasma membrane and thus had no cytoplasmic domain to directly interact with the cytoskeleton fence. Despite this, hop diffusion was observed in the trajectories (Fujiwara et al. 2002; Murase et al. 2004). This led to the hypothesis that there are transmembrane anchor protein pickets bound to the skeleton fence that block the free diffusion of lipids and proteins via steric
c05.indd 78
5/6/2011 6:10:16 PM
SPT
79
hindrance and hydrodynamic friction effects. Careful biophysical modeling led to the prediction that the skeleton fence must be 20–30% covered by these picket proteins (Fujiwara et al. 2002). There are two major consequences of the picket fence model. First, it explains why diffusion coefficients measured in liposomes are much higher than in live cells. Second, oligomers—formed due to receptor cross-linking, or through other molecular associations—have a much lower probability of crossing fence barriers due to their size, explaining the discrepancy between what is predicted by the Stokes–Einstein relation and what is observed experimentally (Kusumi et al. 2005). Lipid rafts may also play a major role in modulating the mobility of membrane components. It is conjectured that lipid rafts may increase clustering of raft-philic proteins during signaling (Kusumi et al. 2005; Day and Kenworthy 2009). Because lipid rafts are so small (<10–200 nm) (Jacobson et al. 2007), SPT is an effective way to study them due to its high resolution. To investigate the importance of rafts, it is common to deplete cholesterol or sphingolipids to see how this influences the diffusivity of single molecules. Jacobson and colleagues used this protocol in their experiments with the raft-associated transmembrane proteins Thy-1 and GM1. Depletion led to a decrease in the <200-nm confinement zones and confinement times, yet it had no effect on the diffusion of a nonraftassociated protein (Sheets et al. 1997; Dietrich et al. 2002). However, interpretations of these experiments remain controversial since cholesterol depletion affects the distribution of phosphatidylinositol 4, 5-bisphosphate (PIP2) with unknown effects on the cortical actin cytoskeleton. It has also been suggested that the small size and short lifetimes of lipid domains results in inadequate detection by SPT (Destainville et al. 2008). Protein clusters are important for receptor signaling, and it is believed that cluster formation is facilitated by lipid rafts and the cytoskeleton fence. However, specialized protein–protein interactions provide the specificity required for signaling within these microdomains. Destainville and colleagues showed that under pairwise protein interaction, the small-scale individual protein diffusion coefficient (Dmicro) is inversely proportional to the concentration of proteins within a cluster and thus is proportional to the area of the cluster (Dmicro ∼ area). This relationship was observed in single-particle tracks of the μopioid receptor (a G-protein-coupled receptor) on normal rat kidney (NRK) cells (Daumas et al. 2003). After thorough statistical analysis, they concluded that confinement by lipid rafts or the cytoskeleton cannot explain the observed area dependence (Meilhac et al. 2006). Instead, they proposed that the receptors are undergoing “walking confined diffusion” described by short-term confined diffusion within a protein cluster and long-term simple diffusion of the entire cluster. Stable protein aggregates have been observed using SPT on other cell types as well—activated T cells being one example (discussed below) (Cherry et al. 1998; Douglass and Vale 2005). Their existence is also supported by numerical simulations by Destainville (2008). Although the role and biogenesis of many protein clusters remain as an open question, SPT has allowed for rapid advancement of knowledge in this area.
Consequences for T-Cell Signaling SPT has been an invaluable tool in the study of T-cell signaling. During T-cell activation, a coordinated reorganization of the cytoskeleton and signaling molecules forms a highly concentrated signaling region (the immunological synapse) containing clusters of TCRs. Using SPT, cytoskeleton fences, lipid rafts, and protein–protein interactions have all been found to play important roles in this process. A critical step is the recruitment of signaling molecules into the core of the immunological synapse. The recruitment of one particular protein, Lck (an Src family kinase), was observed through SPT—and both lipid rafts
c05.indd 79
5/6/2011 6:10:16 PM
80
CHAPTER 5
MODELING MEMBRANE DOMAINS
and the cytoskeleton fence were required (Ike et al. 2003). It is known that the actin cytoskeleton is thought to be concentrated toward the core of the synapse, leading to slower diffusion and thus longer residency time around TCR clusters. Researchers hypothesize that this effect is enhanced by Lck’s association with lipid rafts (Ike et al. 2003). Once at the center, further single-particle experiments combined with FRAP and fluorescence imaging show that Lck preferentially associates with some proteins (CD2 and LAT) and not with others (CD45). These interactions are independent of the cytoskeleton and lipid rafts (Douglass and Vale 2005). It is hypothesized that these protein–protein interactions concentrate or exclude specific proteins in order to facilitate effective signaling. This is one example of how sophisticated analysis of single-particle trajectories has led to a better understanding of the complex mechanisms governing a protein’s spatiotemporal dynamics.
FCS FCS is a technique that measures fluctuations in the intensity of a freely diffusing fluorophore within a small excitation volume (Lakowicz 2006; Mütze et al. 2009). The autocorrelation function of the fluctuations contains information about the concentration and mobility of the molecule: The higher the concentration, the larger the magnitude of the autocorrelation function at short times, and the greater the mobility, the faster the decay in autocorrelation. The cross correlation between signals from two different fluorophores are a measure of correlated motion and putative associations between them. A typical FCS setup consists of a confocal microscope augmented with sensitive avalanche photodiodes (APDs) to efficiently detect the low fluorescence intensity within the focal volume, and a correlator that can rapidly compute the correlation functions in real time.
What Does FCS Reveal about Membrane Organization? A number of technical challenges limit the application of FCS to the study of membrane organization and dynamics. As discussed in detail in Ries and Schwille (2008), these include difficulty in accurately determining the axial position of the membrane within the focal volume, leading to a systematic error in estimating the detection area, and the necessity of long acquisition times due to slow diffusion in the membrane, resulting in artifacts such as photobleaching and a loss of stability. Consequently, FCS measurements have been primarily limited to identifying differences in translational mobility of raft and nonraft markers on model membranes (Bacia et al. 2004) and have yielded limited insight into membrane organization in live cells. The problem of estimating the detection area has been somewhat circumvented by the development of “calibration-free” FCS techniques such as Z-scan FCS and two-focus FCS (reviewed in Chiantia et al. 2009). Despite these limitations, FCS measurements have revealed important details about the spatial organization of signaling in mast cells and T cells. Cross-correlation measurements between fluorescently labeled FcεRI and Lyn on live mast cells show multiple transient peaks in the association between them within minutes of antigen stimulation, followed by a decline at longer times (Larson et al. 2005). Notably, in this study, the lateral mobility of Lyn was found to decrease throughout the time course of the experiments, suggesting spatial reorganization of the membrane as a consequence of IgE signaling. A similar pattern of association was observed in T cells using FCS measurements between TCR and LAT. The two molecules show little or no association in the absence of antigen stimulation, but an appreciable correlation that persists for tens of minutes in the presence of antigen (Lillemeier et al. 2010).
c05.indd 80
5/6/2011 6:10:16 PM
REFERENCES
81
FUTURE PERSPECTIVES Fluorescence microscopy has become an invaluable tool for studying membrane domains. However, beyond the methods described here, it is likely that new experimentation and improved data analysis/modeling techniques will play important roles in the future. We draw particular attention to the rapid development of super-resolution fluorescence techniques such as stimulated emission depletion (STED) and photo-activated localization microscopy (PALM) (Hess et al. 2006; Hein et al. 2008). In both these techniques, resolutions of tens of nanometers are achieved, which will allow us to probe raft structures at a finer scale than previously. For example, the mobility of labeled membrane components has been studied at the millisecond timescale using STED by holding the (50-nm scale) region of observation fixed and observing single molecules transiting the region (Eggeling et al. 2008). However, studying raft dynamics over larger spatial scales may be challenging since the temporal resolution of STED and PALM over a larger area is currently limited (at most, tens of frames per second have been achieved; Hess et al. 2007). The most likely scenario is that super-resolution techniques will be applied in tandem with other techniques described here. The recent study of Lillemeier et al. is a case in point, combining EM, PALM, and FCS to study protein islands during T-cell activation (Lillemeier et al. 2010). The combination of high- and medium-resolution techniques provides a potent combination for the study of static and dynamic properties of membrane domains and cell signaling.
ACKNOWLEDGMENTS This work was supported by the National Science and Engineering Research Council, the Pacific Institute of Mathematical Sciences, and the Mathematics of Information Technology and
Complex Systems National Centre of Excellence. We thank Christopher Cairo, Omer Dushek, Gerda de Vries, and Vishaal Rajani for useful discussions.
ABBREVIATIONS AFM BCR CFP D EM FCS FD FDA FRAP FRET
atomic force microscopy B-cell receptor cyan fluorescent protein diffusion coefficient of the particle electron microscopy fluorescence correlation spectroscopy donor fluorescence intensities in the absence of an acceptor donor fluorescence intensities in the presence of an acceptor fluorescence recovery after photobleaching fluorescence resonance energy transfer
GABA GFP GPI MHC MSD R R0 SPT TCR TIRF YFP
gamma-aminobutyric acid green fluorescent protein glycosylphosphatidylinositol major histocompatibility complex mean square displacement separation between molecules Forster radius single-particle tracking T-cell receptor total internal reflection fluorescence yellow fluorescent protein
REFERENCES Anderson CM, Georgiou GN, Morrison IE, Stevenson GV, Cherry RJ. 1992. Tracking of cell surface receptors by fluorescence digital imaging microscopy using a
c05.indd 81
charge-coupled device camera. Low-density lipoprotein and influenza virus receptor mobility at 4 degrees C. J Cell Sci 101:415–25.
5/6/2011 6:10:17 PM
82
CHAPTER 5
MODELING MEMBRANE DOMAINS
Andrews NL, Lidke KA, Pfeiffer JR, Burns AR, Wilson BS, Oliver JM, Lidke DS. 2008. Actin restricts FcepsilonRI diffusion and facilitates antigen-induced receptor immobilization. Nat Cell Biol 10:955–63. Arcizet D, Meier B, Sackmann E, Radler JO, Heinrich D. 2008. Temporal analysis of active and passive transport in living cells. Phys Rev Lett 101:248103. Bacia K, Scherfeld D, Kahya N, Schwille P. 2004. Fluorescence correlation spectroscopy relates rafts in model and native membranes. Biophys J 87:1034–43. Betzig E, Patterson GH, Sougrat R, Lindwasser OW, Olenych S, Bonifacino JS, Davidson MW, LippincottSchwartz J, Hess HF. 2006. Imaging intracellular fluorescent proteins at nanometer resolution. Science 313: 1642–5. Bouzigues C, Dahan M. 2007. Transient directed motions of GABA(A) receptors in growth cones detected by a speed correlation index. Biophys J 92:654–60. Bunnell SC. 2010. Multiple microclusters: diverse compartments within the immune synapse. Curr Top Microbiol Immunol 340:123–54. Bunnell SC, Hong DI, Kardon JR, Yamazaki T, McGlade CJ, Barr VA, Samelson LE. 2002. T cell receptor ligation induces the formation of dynamically regulated signaling assemblies. J Cell Biol 158: 1263–75. Cairo CW, Das R, Albohy A, Baca QJ, Pradhan D, Morrow JS, Coombs D, Golan DE. 2010. Dynamic regulation of CD45 lateral mobility by the spectrinankyrin cytoskeleton of T cells. J Biol Chem. 285:11392–11401 Campi G, Varma R, Dustin ML. 2005. Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J Exp Med 202:1031–6. Cherry RJ, Wilson KM, Triantafilou K, O’Toole P, Morrison IE, Smith PR, Fernandez N. 1998. Detection of dimers of dimers of human leukocyte antigen (HLA)DR on the surface of living cells by single-particle fluorescence imaging. J Cell Biol 140:71–9. Chiantia S, Ries J, Schwille P. 2009. Fluorescence correlation spectroscopy in membrane structure elucidation. Biochim Biophys Acta 1788:225–33. Crank J. 1980. The mathematics of diffusion, 2nd ed. Oxford: Oxford University Press. Das R, Cairo CW, Coombs D. 2009. A hidden Markov model for single particle tracks quantifies dynamic interactions between LFA-1 and the actin cytoskeleton. PLoS Comput Biol 5:e1000556. Daumas F, Destainville N, Millot C, Lopez A, Dean D, Salome L. 2003. Confined diffusion without fences of a G-protein-coupled receptor as revealed by single particle tracking. Biophys J 84:356–66. Day CA, Kenworthy AK. 2009. Tracking microdomain dynamics in cell membranes. Biochim Biophys Acta 1788:245–53. Depoil D, Fleire S, Treanor BL, Weber M, Harwood NE, Marchbank KL, Tybulewicz VL, Batista FD. 2008. CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat Immunol 9:63–72.
c05.indd 82
Destainville N. 2008. Cluster phases of membrane proteins. Phys Rev E 77:011905. Destainville N, Dumas F, Salome L. 2008. What do diffusion measurements tell us about membrane compartmentalisation? Emergence of the role of interprotein interactions. J Chem Biol 1:37–48. Dietrich C, Yang B, Fujiwara T, Kusumi A, Jacobson K. 2002. Relationship of lipid rafts to transient confinement zones detected by single particle tracking. Biophys J 82:274–84. Douglass AD, Vale RD. 2005. Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells. Cell 121:937–50. Dushek O, Mueller S, Soubies S, Depoil D, Caramalho I, Coombs D, Valitutti S. 2008. Effects of intracellular calcium and actin cytoskeleton on TCR mobility measured by fluorescence recovery. PLoS One 3:e3913. Edidin M. 2003. The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol Struct 32: 257–83. Eggeling C, Ringemann C, Medda R, Schwarzmann G, Sandhoff K, Polyakova S, Belov VN, Hein B, von Middendorff C, Schonle A, Hell SW. 2008. Direct observation of the nanoscale dynamics of membrane lipids in a living cell. Nature 457:1159–62. Einstein A, Fürth R. 1956. Investigations on the theory of the Brownian movement, 2nd ed. Mineola, NY: Courier Dover Publications. Forster T. 1959. 10th spiers memorial lecture. Transfer mechanisms of electronic excitation. Discuss Faraday Soc 27:7–17. Fujiwara T, Ritchie K, Murakoshi H, Jacobson K, Kusumi A. 2002. Phospholipids undergo hop diffusion in compartmentalized cell membrane. J Cell Biol 157: 1071–81. Hancock JF. 2006. Lipid rafts: contentious only from simplistic standpoints. Nat Rev Mol Cell Biol 7:456–62. Hein B, Willig KI, Hell SW. 2008. Stimulated emission depletion (sted) nanoscopy of a fluorescent proteinlabeled organelle inside a living cell. Proc Natl Acad Sci U S A 105:14271–6. Hess ST, Girirajan TPK, Mason MD. 2006. Ultra-high resolution imaging by fluorescence photoactivation localization microscopy. Biophys J 91:4258–72. Hess ST, Gould TJ, Gudheti MV, Maas SA, Mills KD, Zimmerberg J. 2007. Dynamic clustered distribution of hemagglutinin resolved at 40 nm in living cell membranes discriminates between raft theories. Proc Natl Acad Sci U S A 104:17370–5. Ike H, Kosugi A, Kato A, Iino R, Hirano H, Fujiwara T, Ritchie K, Kusumi A. 2003. Mechanism of Lck recruitment to the T-cell receptor cluster as studied by single-molecule-fluorescence video imaging. Chemphyschem 4:620–6. Jacobson K, Mouritsen OG, Anderson RG. 2007. Lipid rafts: at a crossroad between cell biology and physics. Nat Cell Biol 9:7–14. Kenworthy AK, Edidin M. 1998. Distribution of a glycosylphosphatidylinositol-anchored protein at the
5/6/2011 6:10:17 PM
REFERENCES
apical surface of MDCK cells examined at a resolution of <100 A using imaging fluorescence resonance energy transfer. J Cell Biol 142:69–84. Kenworthy AK, Petranova N, Edidin M. 2000. Highresolution FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell plasma membranes. Mol Biol Cell 11:1645–55. Kusumi A, Sako Y, Yamamoto M. 1993. Confined lateral diffusion of membrane receptors as studied by single particle tracking (nanovid microscopy). Effects of calciuminduced differentiation in cultured epithelial cells. Biophys J 65:2021–40. Kusumi A, Ike H, Nakada C, Murase K, Fujiwara T. 2005. Single-molecule tracking of membrane molecules: plasma membrane compartmentalization and dynamic assembly of raft-philic signaling molecules. Semin Immunol 17:3–21. Lagerholm BC, Weinreb GE, Jacobson K, Thompson NL. 2005. Detecting microdomains in intact cell membranes. Annu Rev Phys Chem 56:309–36. Lakowicz JR. 2006. Principles of fluorescence spectroscopy, 3rd ed. New York: Springer. Larson DR, Gosse JA, Holowka DA, Baird BA, Webb WW. 2005. Temporally resolved interactions between antigen-stimulated IgE receptors and Lyn kinase on living cells. J Cell Biol 171:527–36. Lee S, Mandic J, Van Vliet KJ. 2007. Chemomechanical mapping of ligand-receptor binding kinetics on cells. Proc Natl Acad Sci U S A 104:9609–14. Leitner DM, Brown FL, Wilson KR. 2000. Regulation of protein mobility in cell membranes: a dynamic corral model. Biophys J 78:125–35. Lillemeier BF, Mortelmaier MA, Forstner MB, Huppa JB, Groves JT, Davis MM. 2010. TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation. Nat Immunol 11:90–6. Lingwood D, Simons K. 2010. Lipid rafts as a membraneorganizing principle. Science 327:46–50. Meilhac N, Le Guyader L, Salome L, Destainville N. 2006. Detection of confinement and jumps in singlemolecule membrane trajectories. Phys Rev E 73:011915. Morrison JS. 2010. Deciphering multi-state mobility within single particle trajectories of proteins on the plasma membrane. MSc. Thesis, University of British Columbia. Murase K, Fujiwara T, Umemura Y, Suzuki K, Iino R, Yamashita H, Saito M, Murakoshi H, Ritchie K, Kusumi A. 2004. Ultrafine membrane compartments for molecular diffusion as revealed by single molecule techniques. Biophys J 86:4075–93. Mütze J, Ohrt T, Schwille P. 2009. Fluorescence correlation spectroscopy in vivo. Laser Photon Rev 5:52–67. Pike LJ. 2006. Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res 47:1597–8. Pizzo P, Viola A. 2004. Lipid rafts in lymphocyte activation. Microbes Infect 6:686–92. Powles J, Mallett M, Rickayzen G, Evans W. 1992. Exact analytic solutions for diffusion impeded by an infi-
c05.indd 83
83
nite array of partially permeable barriers. Proceedings: mathematical and physical. Sciences 436:391–403. Qian H, Sheetz MP, Elson EL. 1991. Single particle tracking. Analysis of diffusion and flow in twodimensional systems. Biophys J 60:910–21. Rabut G, Ellenberg J. 2004. Photobleaching techniques to study mobility and molecular dynamics of proteins in live cells: FRAP, iFRAP and FLIP. In: Goldman RD, Spector DL, editors. Live cell imaging: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, pp. 101–27. Ries J, Schwille P. 2008. New concepts for fluorescence correlation spectroscopy on membranes. Phys Chem Chem Phys 10:3487–97. Rudnick J, Gaspari G. 1987. The shapes of random walks. Science 237:384–9. Sako Y, Kusumi A. 1994. Compartmentalized structure of the plasma membrane for receptor movements as revealed by a nanometer-level motion analysis. J Cell Biol 125: 1251–64. Sako Y, Nagafuchi A, Tsukita S, Takeichi M, Kusumi A. 1998. Cytoplasmic regulation of the movement of E-cadherin on the free cell surface as studied by optical tweezers and single particle tracking: corralling and tethering by the membrane skeleton. J Cell Biol 140: 1227–40. Saxton MJ. 1993. Lateral diffusion in an archipelago. Single-particle diffusion. Biophys J 64:1766–80. Saxton MJ. 1994. Anomalous diffusion due to obstacles: a Monte Carlo study. Biophys J 66:394–401. Saxton MJ. 1995. Single-particle tracking: effects of corrals. Biophys J 69:389–98. Saxton MJ. 1996. Anomalous diffusion due to binding: a Monte Carlo study. Biophys J 70:1250–62. Saxton MJ. 2001. Anomalous subdiffusion in fluorescence photobleaching recovery: a Monte Carlo study. Biophys J 81:2226–40. Saxton M, Jacobson K. 1997. Single-particle tracking: applications to membrane dynamics. Annu Rev Biophys Biomol Struct 26:373–99. Selvin PR. 2000. The renaissance of fluorescence resonance energy transfer. Nat Struct Biol 7:730–4. Sengupta P, Holowka D, Baird B. 2007. Fluorescence resonance energy transfer between lipid probes detects nanoscopic heterogeneity in the plasma membrane of live cells. Biophys J 92:3564–74. Sharma P, Varma R, Sarasij RC, Ira, Gousset K, Krishnamoorthy G, Rao M, Mayor S. 2004. Nanoscale organization of multiple GPI-anchored proteins in living cell membranes. Cell 116:577–89. Sheets ED, Lee GM, Simson R, Jacobson K. 1997. Transient confinement of a glycosylphosphatidylinositolanchored protein in the plasma membrane. Biochemistry 36:12449–58. Simson R, Sheets ED, Jacobson K. 1995. Detection of temporary lateral confinement of membrane proteins using single-particle tracking analysis. Biophys J 69:989–93. Singer S, Nicolson G. 1972. The fluid mosaic model of the structure of cell membranes. Science 175:720–31.
5/6/2011 6:10:17 PM
84
CHAPTER 5
MODELING MEMBRANE DOMAINS
Sohn HW, Tolar P, Jin T, Pierce SK. 2006. Fluorescence resonance energy transfer in living cells reveals dynamic membrane changes in the initiation of B cell signaling. Proc Natl Acad Sci U S A 103:8143–8. Sohn HW, Tolar P, Pierce SK. 2008. Membrane heterogeneities in the formation of B cell receptor-Lyn kinase microclusters and the immune synapse. J Cell Biol 182: 367–79. Sprague BL, McNally JG. 2005. FRAP analysis of binding: proper and fitting. Trends Cell Biol 15:84–91. Tolar P, Sohn HW, Pierce SK. 2005. The initiation of antigen-induced B cell antigen receptor signaling viewed in living cells by fluorescence resonance energy transfer. Nat Immunol 6:1168–76. Tolar P, Sohn HW, Pierce SK. 2008. Viewing the antigeninduced initiation of B-cell activation in living cells. Immunol Rev 221:64–76. Tomishige M, Sako Y, Kusumi A. 1998. Regulation mechanism of the lateral diffusion of band 3 in erythrocyte
c05.indd 84
membranes by the membrane skeleton. J Cell Biol 142: 989–1000. Umemura YM, Vrljic M, Nishimura SY, Fujiwara TK, Suzuki KG, Kusumi A. 2008. Both MHC class II and its GPI-anchored form undergo hop diffusion as observed by single-molecule tracking. Biophys J 95:435–50. Varma R, Mayor S. 1998. GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 394:798–801. Wilson KM, Morrison IE, Smith PR, Fernandez N, Cherry RJ. 1996. Single particle tracking of cell-surface HLA-DR molecules using R-phycoerythrin labeled monoclonal antibodies and fluorescence digital imaging. J Cell Sci 109:2101–9. Yokosuka T, Sakata-Sogawa K, Kobayashi W, Hiroshima M, Hashimoto-Tane A, Tokunaga M, Dustin ML, Saito T. 2005. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat Immunol 6:1253–62.
5/6/2011 6:10:17 PM
PART
II
ORGANELLAR DOMAINS ME MBR ANE - BO UND cellular organelles represent fundamental cellular domains that are characterized by their distinctive morphology. Mitochondria, organized as an intracellular network and encircled by a dual-membrane system, fulfill various, often pivotal functions, being most well known for their role as the cellular powerhouse (Chapter 6). The endoplasmic reticulum (Chapter 7) and Golgi apparatus (Chapter 8) are key components of the secretory pathway that controls protein and lipid biosynthesis and targeting for secretion or delivery to intracellular sites (see also Chapters 18, 21, and 22). Endosomes (Chapter 9) are downstream of endocytic plasma membrane domains, such as clathrin-coated pits (Chapter 2), and function to sort internalized material for recycling or targeting to lysosomes (Chapter 10) for degradation. Lysosomal compartments also receive material for degradation via phagocytosis of large particles and autophagy of cellular material (Chapter 10). Importantly, domain organization of membrane organelles (domains within domains) is key to their function. This can be observed both at the ultrastructural level (i.e., rough vs. smooth endoplasmic reticulum and Golgi cisternae) and at the level of lipid- and protein-based domain organization, suggesting that mechanisms that regulate domain organization at the plasma membrane (Chapters 1–5) may also apply to intracellular membrane organelles. Intriguingly, it is increasingly clear that interactions between organelles, in particular endoplasmic reticulum junctions (Chapter 11), regulate organellar crosstalk and function.
Cellular Domains, First Edition. Edited by Ivan R. Nabi. © 2011 John Wiley & Sons, Inc. Published 2011 by John Wiley & Sons, Inc.
85
p02.indd 85
5/6/2011 6:12:00 PM
.
CH A P T E R
6
MITOCHONDRIA Michael Zick Andreas S. Reichert
DEFINITION On an average day the human body consumes a quantity of adenosine-5′-triphosphate (ATP) that almost equals its own weight. The vast majority, to satisfy this tremendous demand, is supplied by mitochondria, which are cytosolic organelles of endosymbiotic origin. Mitochondria harbor a sophisticated enzymatic machinery that employs molecular oxygen to complete the oxidation of fats, proteins, and sugars to carbon dioxide and water, finally transforming the released energy into ATP. As they function in an integrated network that is subjected to constant remodeling by fusion and fission events, one can consider mitochondria as the “power grid” of eukaryotic cells. Furthermore, they play pivotal roles in a diverse set of functions such as the metabolism of lipids and amino acids, the biosynthesis of iron–sulfur clusters, heme, and further prosthetic groups, ion homeostasis, cell signaling, and the regulation of apoptosis. To be able to fulfill these various functions, the mitochondrion is organized into different compartments (Fig. 6.1). This is achieved by the two membranes, inner (IM) and outer (OM) mitochondrial membranes, that surround the organelle. The IM encloses the mitochondrial matrix and is further subdivided into two distinct regions: (1) the inner boundary membrane (IBM), which is adjacent to the OM, and together with it delineates the intermembrane space (IMS); (2) the crista membrane (CM), which represents invaginations of the IM that protrude into the matrix space, thus surrounding the intracristal space (ICS). This compartmentalization appears to be dynamic, and loss of its integrity marks a key step during the course of programmed cell death.
HISTORICAL PERSPECTIVE Discovery of Mitochondria The first time that the organelles which now refer to as mitochondria were observed dates back more than one and a half centuries. Already in 1841, J. Henle reported characteristic granules within myocytes (Henle 1841). In the year 1856, the Swiss anatomist A. Kölliker performed a first careful study of the sarcoplasmic components and described an arrangement of “blasse Körnchen” (pale grains) between the myofibrils; he even suggested a correlation of these granules with the metabolism of muscle fibers (Kölliker 1856). Due to the development of improved staining techniques, in particular the introduction of Crystal Violet (Benda 1901) and Janus Green (Michaelis 1900), these organelles had been
Cellular Domains, First Edition. Edited by Ivan R. Nabi. © 2011 John Wiley & Sons, Inc. Published 2011 by John Wiley & Sons, Inc.
87
c06.indd 87
5/6/2011 6:40:06 PM
88
CHAPTER 6
MITOCHONDRIA
-40
Outer Membrane (OM)
nm
30 -2 00 nm
12
Crista Junction (CJ)
InterMembrane Space (IMS)
- TCA Cycle - Amino Acid & Lipid Metabolism - Heme Biosynthesis - etc.
Fusion / Fission
Oxidative Phosphorylation
Apoptosis Cristae
Matrix
Inner Membrane (IM) Inner Boundary Membrane (IBM) + Crista Membrane (CM) Intracristal Space (ICS)
Fe/S Cluster Biosynthesis
Protein Synthesis
Protein Import
M
IM
IMS
OM
CS
Figure 6.1. Scheme of a mitochondrion. The architecture of a mitochondrion is determined by its two membranes, which partition the organelle into several discrete compartments that host a multitude of functions crucial for eukaryotic life. M, matrix; IM, inner membrane; IMS, intermembrane space; OM, outer membrane; CS, cytosol.
observed in basically every type of eukaryotic cell until the early twentieth century. They have been referred to with a multitude of various terms, such as chondriosomes, bioblasts, and plastochondria, until F. Cavers noticed in 1914 that these structures were essentially all the same (Cavers 1914). What has become the common name originates from C. Benda, who called these organelles “mitochondria” due to their appearance as threads (Greek mitos or “μιτoσ”) and grains (Greek chondros or “χóνδρoσ”) (Benda 1898).
Origin of Mitochondria The Endosymbiotic Theory The idea that eukaryotic organelles could be derivatives of bacteria was already put forward in the late nineteenth century, however, mainly for chloroplasts (Schimper 1883; Mereschkowsky 1905). While Altmann (1894) recognized an apparent resemblance between mitochondria and bacteria, Wallin (1923) was the first to extend the idea of an endosymbiotic origin to mitochondria in 1923. Nevertheless, it took about half a century until the endosymbiotic hypothesis gained considerable attention due to the popular work of L. Margulis (Margulis, 1981; Sagan 1967). The hypothesis received substantial support by the discovery of mitochondrial DNA (mtDNA) (Nass and Nass 1963a, b), and it was generally accepted that mitochondria were the direct descendants of a bacterial endosymbiont (Gray 1992). Comparative genomic approaches imply that mitochondria are monophyletic in origin, and the closest relatives to the protomitochondrial ancestor are considered to be found within the rickettsial subdivision of the α-proteobacteria (Emelyanov 2001). It is, however, a matter of discussion whether the endosymbiotic evolution of eukaryotic cells was indeed a serial event or mitochondria originated at essentially the same time as the nuclear compartment (Gray et al. 1999; Emelyanov 2003).
c06.indd 88
5/6/2011 6:40:06 PM
THE BUILDING BLOCKS OF MITOCHONDRIA
89
Mitochondria-Related Organelles: Anaerobic Mitochondria, Hydrogenosomes, and Mitosomes Mitochondria evolved over a period of at least 1500 million years under an enormous range of environmental conditions (van der Giezen and Tovar 2005). Thus, a diverse set of related organelles emerged, supposedly from one single ancestor, ranging from archetypal aerobic mitochondria, via various anaerobic versions and hydrogenosomes, to the most distantly evolved forms, mitosomes (Tielens et al. 2002; Hackstein et al. 2006; van der Giezen 2009). Anaerobic mitochondria, which can be found in several protists, flatworms, parasitic nematodes, invertebrates, and algae, possess a respiratory chain, as classical aerobic mitochondria do, but they do not use oxygen as a final electron acceptor. Rather they harbor alternative terminal oxidases that are capable of using either an environmental (e.g., NO3−) or an endogenously produced (e.g., fumarate) substrate as a final electron acceptor (Tielens et al. 2002). Hydrogenosomes, which can be found in a wide spectrum of anaerobic protists, represent another type of anaerobic ATP-producing relative of mitochondria. They do not possess a membrane-associated electron transport chain but employ substrate-level phosphorylation and use protons as terminal electron acceptor, thus producing hydrogen, to generate ATP (Hackstein et al. 2006; van der Giezen 2009). Another type of double-membrane enclosed organelles, which are considered the result of reductive evolution of mitochondria, are mitosomes (van der Giezen 2009). They have been identified in a range of anaerobic/microaerophilic parasitic protozoa in recent years (Tovar et al. 1999; Williams et al. 2002; Tovar et al. 2003; Goldberg et al. 2008). Mitosomes have lost the capability of producing ATP, and so far it remains largely elusive whether they have a relevance to cell physiology beyond their role in iron–sulfur cluster biogenesis (Tovar et al. 2003; Aguilera et al. 2008; Maralikova et al. 2009). Further research on the organellar descendants of mitochondria will substantially contribute to our global understanding of the evolution and cell biology of eukaryotes.
Mitochondrial Research throughout the Last Century Over its long history, mitochondrial research has revealed a large number of essential findings, primarily concerning cellular metabolism and energy conversion as the driving force of life (Fig. 6.2). Along the way, it has sustainably influenced many scientific disciplines, for example, biochemistry and cell biology. Due to their enormous breadth, the tremendous advancements leading to our current knowledge on mitochondria are beyond the scope of this contribution. However, the progress of mitochondrial research has been well documented by a series of excellent reviews throughout the years, to which the reader can refer as sources of additional information (Wallin 1923; Cowdry 1953; Crane 1961; Ernster and Schatz 1981; Rasmussen 1995; Scheffler 2001; Bechtel and Abrahamsen 2007).
THE BUILDING BLOCKS OF MITOCHONDRIA The Mitochondrial Genome Reminiscent of their origin, mitochondria of all species contain their own set of DNA. However, the size of these genomes, their architecture, as well as the number and nature of the encoded proteins (Burger et al. 2003), and even the mitochondrial genetic code itself (Knight et al. 2001), vary greatly among different organisms. The human mitochondrial
c06.indd 89
5/6/2011 6:40:07 PM
90
CHAPTER 6
MITOCHONDRIA
Apoptosis Dynamics Mitochondrial Disease Metabolism Bioenergetics
Cytology 1900
1925
1950
Molecular Evolution Protein Import 1975
2000
Figure 6.2. A century of mitochondrial research. During the twentieth century mitochondrial research has experienced many highly productive periods that have significantly advanced our understanding of many aspects of mitochondria in particular, and cell biology in general. Thus, it is not surprising that a considerable number of researchers that have dedicated their interest to mitochondria have been rewarded with a Nobel Prize in Physiology or Medicine, or in Chemistry (indicated by encircled N below the timeline; http://nobelprize.org). Some key discoveries of mitochondrial biology are also specified with their corresponding references: 1Michaelis (1900); 2 Warburg (1913); 3Keilin (1925); 4Krebs and Henseleit (1932a,b, c); 5Krebs and Johnson (1937); 6 Hogeboom et al. (1947, 1948); 7Palade (1952) and Sjostrand (1953); 8Mitchell (1961); 9Nass and Nass (1963a, b) and Schatz et al. (1964); 10Sagan (1967); 11Anderson et al. (1981); 12Wallace et al. (1988a, b); and 13Liu et al. (1996).
genome, for instance, encodes 37 genes on a compact, circular DNA molecule of about 16.6 kbp in size (Fig. 6.3). The multiple copies are organized in numerous protein–DNA complexes, commonly referred to as nucleoids, which are likely to play important roles in protection, inheritance, replication, and transcription of the mitochondrial genome (Chen and Butow 2005; Malka et al. 2006; Falkenberg et al. 2007; Spelbrink 2009). Analysis of mtDNA provides highly useful information in different scientific fields. (1) Alterations of mtDNA play a crucial role in numerous human disorders (Taylor and Turnbull 2005; Brandon et al. 2006; Copeland 2008; DiMauro and Schon 2008) and in the aging process (Trifunovic et al. 2004; Trifunovic et al. 2005; Kujoth et al. 2007; Edgar et al. 2009; Greaves and Turnbull 2009; Khrapko and Vijg 2009). (2) Since the mitochondrial genome of almost 2000 distinct organisms is completely sequenced (O’Brien et al. 2009), and approximately 7000 human mtDNA sequences are available (Ingman and Gyllensten 2006; Ruiz-Pesini et al. 2007), mtDNA represents a versatile tool for evolutionary analyses and studies in population biology (Ballard and Rand 2005; Pakendorf and Stoneking 2005; Underhill and Kivisild 2007). (3) Analysis of mtDNA even plays an expanding role in the forensic sciences (Budowle et al. 2003).
c06.indd 90
5/6/2011 6:40:07 PM
THE BUILDING BLOCKS OF MITOCHONDRIA
12
OH T
D Loop
SNHL DEAF
P
PL
MM E N DM LS LHON Dystonia
rR S
16
MELAS MMC DMDF LHON Dystonia
MELAS
Human mtDNA
MELAS Q ADPD
I M ND2
W
16,569 bp
MERRF LS LHON
LS A O L N C Y SNHL CO I
LS NARP PEM MILS AMDF MERRF FBSN UCN S COII
K
ATP6
I CO
II
ND 3 R 4L D N G
ATP8
D
LS
LCUN AGY S H
ND 4
ND1
UUR
ND 5
L
Cy tb
D6
NA
V
PH1 PH2 F A RN Sr
91
Figure 6.3. The human mitochondrial genome. In humans, the mitochondrial DNA encodes 37 gene products; 2 ribosomal RNAs (12S and 16S), 22 tRNAs (indicated by the cognate amino acids in one-letter code), and 13 protein subunits of the respiratory chain: NADH dehydrogenase (ND1-4, -4L, -5, and -6); cytochrome b (Cytb); cytochrome c oxidase (COI-III); ATP synthase (ATP6 and ATP8). The origins of light- and heavy-strand replication (OL and OH), the promotor of the light strand (PL), as well as the two transcription initiation sites of the heavy strand (PH1 and PH2) are depicted. The D Loop region is a non-coding, regulatory region involved in mtDNA replication. A growing number of primarily neurological disorders have been linked to mutations within the mtDNA. In fact, with a prevalence of about 10 in 100,000 they have to be considered one of the most common inherited neuromuscular disorders (Schaefer et al. 2008). Some of the disease entities are indicated next to the correspondingly affected gene product. Abbreviations: ADPD, Alzeimer ’s disease and Parkinson’s disease; AMDF, ataxia, myoclonus and deafness; DEAF, maternally inherited deafness; DM, diabetes mellitus; DMDF, diabetes mellitus and deafness; FBSN, familial bilateral striatal necrosis; LHON, Leber hereditary optic neuropathy; LS, Leigh syndrome; MELAS, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes; MERRF, myoclonic epilepsy and ragged red muscle fibers; MILS, maternally inherited Leigh syndrome; MM, mitochondrial myopathy; MMC, maternal myopathy and cardiomyopathy; NARP, neurogenic muscle weakness, ataxia, and retinitis pigmentosa; PEM, progressive encephalomyopathy; SNHL, sensorineural hearing loss.
c06.indd 91
5/6/2011 6:40:07 PM
92
CHAPTER 6
MITOCHONDRIA
Mitochondrial Biogenesis Mitochondrial energy supply and metabolic activity require a vivid modulation in order to meet constantly changing physiological demands. Therefore, mitochondrial biogenesis is dynamically regulated, primarily via the transcriptional control of both nuclear and mitochondrial genomes (Hock and Kralli 2009). As mitochondria are nonautonomous organelles, the vast majority of its constituents need to be imported. Best characterized is the translocation of proteins across the two mitochondrial membranes; a basic overview is shown in Figure 6.4. Considerably less well explored is the delivery of phospholipids to the mitochondrial compartment (Daum and Vance 1997). The zones of close contact between mitochondria and the endoplasmic reticulum (ER; see also Chapter 11 for further discussion of ER– mitochondria interactions), also called mitochondria-associated membranes (MAM), seem to play a crucial role in the synthesis and nonvesicular trafficking of phospholipids (Gaigg et al. 1995; Hayashi et al. 2009; Wieckowski et al. 2009). The import of one further class of molecules, tRNAs, and its physiological relevance to mitochondrial translation is only just beginning to be understood (Tarassov et al. 2007; Alfonzo and Soll 2009; Duchene et al. 2009).
The Proteome of Mitochondria Mitochondria represent an extremely protein-rich compartment exhibiting a highly concentrated mixture of hundreds of enzymes in the matrix (26–56% weight/volume; Hackenbrock 1968) as well as a high protein : phospholipid ratio in the IM (>3:1 by weight; OM membrane, ∼1:1 by weight; Sperka-Gottlieb et al. 1988). Thus, in order to gain a deeper understanding of the multiple functions of this complex organelle, a tremendous effort has been made in defining the mitochondrial proteome (Da Cruz et al. 2005; Meisinger et al. 2008). Around 1500–2000 distinct proteins are estimated to be localized to the mitochondrial subcompartments: matrix (∼45%), IM (∼40%), IMS (∼5%), and OM (∼10%). Multiple databases on the protein composition of mitochondria in diverse organisms are available; a representative list can be found in Table 6.1. The problem of false positive or negative attribution of mitochondrial localization is aggravated by the fact that at least one-tenth of the mitochondrial proteins may exhibit a dual cellular localization (Sickmann et al. 2003; Regev-Rudzki and Pines 2007; Pagliarini et al. 2008). A next and crucial step will be to link the many newly discovered members of the mitochondrial inventory with their functions. Analysis of the dynamic alterations of the mitochondrial proteome under various, including pathological, conditions will hopefully expedite this endeavor. In particular, the integration of all the newly obtained information into a comprehensive mitochondrial interactome has the potential to uncover further details about the roles that mitochondria play in cellular processes and the pathogenesis of disease (Shutt and Shadel 2007; Reja et al. 2009). More specialized studies, surveying the mitochondrial phosphoproteome, provided good evidence that protein phosphorylation serves as a regulatory mechanism across a broad range of important processes in mitochondria (Lee et al. 2007; Reinders et al. 2007; Ito et al. 2009). In addition, acetylation has recently emerged as a posttranslational modification that regulates mitochondrial proteins (Huang et al. 2010); it gained enormous interest, as the main mitochondrial deacetylase (SIRT3; Lombard et al. 2007) has been implicated in modulation of mitochondrial bioenergetics (Ahn et al. 2008) and control of longevity (Bellizzi et al. 2005). A further posttranslational modification that needs to be explored is tyrosine nitration (Liu et al. 2009). Comprehensive quantitative analyses of
c06.indd 92
5/6/2011 6:40:07 PM
THE BUILDING BLOCKS OF MITOCHONDRIA
Precursor with internal targeting signal
Precursor with MTS presequence
CS
++ ++
OM Proteins
93
β-Barrel Proteins ?
TOM small Tims
IM Proteins (Stop-Transfer)
Oxa1 IM Proteins (conservatively sorted or mtDNA mtRibosome encoded)
OM
TOB
Oxidized IMS Proteins S S IMS S S
MIA TIM23
IM
TIM22 Carrier Proteins
Hsp70
M
Hsp70
MPP
Matrix Proteins
Figure 6.4. Mitochondrial protein import. The major portion of mitochondrial proteins is encoded in the nuclear DNA. They are synthesized by cytosolic ribosomes and consecutively transported to their respective destination within mitochondria. Thereby they are directed by mitochondrial targeting signals. The necessary information is present either in the matrix-targeting sequence (MTS), a presequence of 10–80 amino acids that forms an amphipathic helix with one hydrophobic and one positively charged face or within an internal targeting signal instead. Several major complexes are involved in the translocation of proteins across the mitochondrial membranes (for a more detailed view see Neupert and Herrmann 2007; Chacinska et al. 2009). TOM complex: Effectively all proteins that are imported into mitochondria are translocated across the outer mitochondrial membrane via the TOM complex. Besides its function as an entry gate, the TOM complex also mediates the insertion of certain outer membrane proteins (Walther and Rapaport 2009). TOB complex (topogenesis of β-barrel proteins; also termed SAM complex): Precursors of β-barrel proteins pass through the TOM channel, form a temporary complex with small Tim proteins in the IMS, and are thereby guided to the TOB complex, which then facilitates membrane insertion and assembly of the new β-barrel protein (Paschen et al. 2005). TIM23 complex: In concerted action with the TOM complex, it translocates all matrix proteins, the majority of inner membrane proteins, and many proteins of the intermembrane space (not depicted; Popov-Celeketic et al. 2008). The TIM23 translocase is thereby driven by the electrochemical potential (Δψ) across the inner membrane. Subsequently, the matrix localized import motor, which is driven by ATP hydrolysis, takes over. One of its core components is the chaperone Hsp70, which mediates the vectorial protein movement supposedly via a Brownian ratchet mechanism (Yamano et al. 2008). Inner membrane proteins can either be arrested at the level of TIM23 while being translocated and thereupon laterally sorted (Stop-Transfer pathway); alternatively, the preprotein is initially completely translocated into the matrix and successively inserted into the inner membrane in an exportresembling manner (Conservative sorting pathway). A third class is assembled into the inner membrane via the TIM22 complex: The family of solute carrier proteins and hydrophobic TIM subunits are complexed in the IMS by small Tim proteins that guide the precursors to the TIM22 translocase into the inner membrane in a Δψ-dependent reaction (Rehling et al. 2004). Oxa1 complex: Several of the conservatively sorted inner membrane proteins are inserted by the Oxa1 complex. Additionally, this complex mediates the insertion and assists the assembly of the mtDNA-encoded subunits of the respiratory chain—at least in part cotranslationally (Ott and Herrmann 2009). MIA complex: A subset of IMS proteins contains disulfide bonds. Their import is mediated by the Mia40/Erv1 disulfide relay system. This pathway is coupled to oxidative folding of the proteins that are thereby trapped in the IMS (Deponte and Hell 2009).
c06.indd 93
5/6/2011 6:40:07 PM
94
CHAPTER 6
TABLE 6.1.
MITOCHONDRIA
List of Mitochondrial Proteome Databases
Database MitoP2 MitoMiner MitoCarta MitoRes
Species
Methods
Hs, Mm, Nc, Sc, At Hs, Mm, Rn, Dm, Ce, Sc, Bt, Pf Hs, Mm
MS, FT, DA MS, FT, DA MS, FT, DA DA
http://www.mitop.de: 8080/mitop2/ http://mitominer.mrcmbu.cam.ac.uk/ http://www.broadinstitute. org/pubs/MitoCarta/ http://mitores.ba.itb.cnr.it/
Elstner et al. 2008; Elstner et al. 2009 Smith and Robinson 2009 Pagliarini et al. 2008
MS, DA
http://www.mitoproteome.org/ http://bioinfo.nist.gov/ http://141.61.102.16/ormd/ http://www.biochem.oulu.fi/ proteomics/ymp.html http://www-deletion.stanford. edu/YDPM/ http://www.plantenergy.uwa. edu.au/ampdb/
Cotter et al. 2004; Guda et al. 2007 — Foster et al. 2006 Ohlmeier et al. 2004
MitoProteome
Hs, Mm, Rn, Dm, Ce, Bt, Dr, m* Hs
HMPDb ORMD YMP
Hs Mm Sc
DA MS, FT MS
YDPM
Sc
MS
AMPDb
At
MS, DA
TrypsProteome
Tb
MS
URL
http://www.trypsproteome.org/
Reference
Catalano et al. 2006
Steinmetz et al. 2002; Prokisch et al. 2004 Heazlewood et al. 2004; Heazlewood and Millar 2005 Panigrahi et al. 2009
Several databases exist that integrate the growing body of proteomic data on the composition of mitochondria in diverse organisms. Species: At, Arabidopsis thaliana; Bs, Bos taurus; Ce, Caenorhabditis elegans; Dm, Drosophila melanogaster; Dr, Danio rerio; Hs, Homo sapiens; m*, metazoa listed in UniProt Knowledgebase; Mm, Mus musculus; Nc, Neurospora crassa; Pf, Plasmodium falciparum; Rn, Ratus norvegicus; Sc, Saccharomyces cerevisiae; Tb, Trypanosoma brucei. Methods: MS, mass spectrometry of purified mitochondria; FT, subcellular localization of fluorescently tagged proteins; DA, analysis of public databases.
the posttranslational modifications of mitochondrial proteins (Distler et al. 2008) will sustain these concepts in the future (Allison et al. 2009), and help to understand their role in signaling pathways within mitochondria (Pagliarini and Dixon 2006).
Mitochondrial Membrane Lipids The role of mitochondrial membrane lipids (Table 6.2; Daum 1985), in contrast, has been rather neglected. Recent lipidomic studies, however, imply that the phospholipid composition of mitochondria has a considerable impact on their function (Kiebish et al. 2008a, b, c). Future analyses focusing on the dynamic changes in phospholipid composition of mitochondrial membranes will potentially reveal highly interesting novel insights. The characteristic mitochondrial phospholipid, diphosphatidylglycerol, better known as cardiolipin, has, nevertheless, gained considerable attention throughout the years (Schlame et al. 2000; Chicco and Sparagna 2007; Houtkooper and Vaz 2008). Preferentially localized to the mitochondrial IM, it affects energy metabolism by stabilizing respective enzyme complexes (Bogdanov et al. 2008; Claypool 2009; Klingenberg 2009; Wittig and Schagger 2009). Furthermore, it plays an important role in the structural organization of mitochondrial membranes (Schlame 2008; Lewis and McElhaney 2009; Schlame and Ren 2009) and regulates different steps of the mitochondrial apoptotic pathway (Orrenius et al. 2007; Ott et al. 2007; Kagan et al. 2009; Schug and Gottlieb 2009). Impairment of
c06.indd 94
5/6/2011 6:40:07 PM
RECENT AND PROSPECTIVE DEVELOPMENTS IN MITOCHONDRIAL RESEARCH
TABLE 6.2.
Phospholipid Composition of Mitochondria
Mammals
PC PE CL PI PS PA
95
Plants
Fungi
IM
OM
IM
OM
IM
OM
40 34 18 5 3 —
54 29 <1 13 2 —
42 38 15 5 — —
47 27 3 23 — —
38 30 20 8 2 2
45 23 6 21 3 2
Adapted from Daum and Vance (1997) with permission from Elsevier. Data taken from Daum (1985), Hovius et al. (1990), Zinser et al. (1991), de Kroon et al. (1997), and Wriessnegger et al. (2009). In contrast to phospholipids, sterols comprise only a minor fraction of mitochondrial membranes (∼1:30; Bottema and Parks 1980). The approximate levels of each individual phospholipid are indicated as percentage of the total phospholipid content. PC, phosphatidylcholine; PE, phosphatidylethanolamine; CL, cardiolipin = diphosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; PA, phosphatidic acid; IM, inner mitochondrial membrane; OM, outer mitochondrial membrane.
cardiolipin species homeostasis, caused by a deficiency in cardiolipin remodeling, thus leads to a polysymptomatic disease called Barth syndrome (Hauff and Hatch 2006; Schlame and Ren 2006).
RECENT AND PROSPECTIVE DEVELOPMENTS IN MITOCHONDRIAL RESEARCH Many of the topics that are currently fueling mitochondrial research have already been in the focus of attention in earlier times. Gathered knowledge and the continuous advancement of the experimental tools allow readdressing and extending these questions with confidence toward increasing our understanding of mitochondrial biology.
Mitochondrial Ultrastructure Organization of the IM: IBM, Cristae, and Crista Junctions A major breakthrough in our understanding of mitochondria was obtained by the pioneering work in electron microscopy of Palade and Sjöstrand in the 1950s (Palade 1952, 1953; Sjostrand 1953; Rasmussen 1995). Since then, mitochondria have been conceived as cellular compartments that are encircled by two membranes: the OM and the IM. The latter is further subdivided into two compartments: the IBM, which is apposed to the OM, and the CM, which represents membrane invaginations that protrude into the matrix compartment (Figs. 6.1 and 6.5A, B). Cristae exhibit a multitude of morphological appearances, depending on the physiological state of a cell, on the tissue, or the organism (Munn 1974; Fawcett 1981). Structural alterations, including electron-dense bodies within the matrix, are described in numerous human disorders, and dynamic changes in cristae morphology were reported to occur during apoptosis (for review see Perkins et al. 2009; Zick et al. 2009). Two major misconceptions are coined by the classical textbook presentation of mitochondria. First, mitochondria are usually represented as isolated organelles, although they rather form an interconnected, three-dimensional, tubular network in many tissues
c06.indd 95
5/6/2011 6:40:07 PM
96
CHAPTER 6
MITOCHONDRIA
(A) 1959
(C)
(B) 1997
(D)
(E)
(F)
(G)
Figure 6.5. Morphology of mitochondria. (A, B) Evolving view on the ultrastructure of mitochondria. (A) Three-dimensional reconstruction of a motor end plate mitochondrion made from electron micrographs of serial thin sections at a magnification of 185,000×. Reproduced from Andersson-Cedergren (1959) with permission from Elsevier. (B) Two views of a three-dimensional reconstruction of an electron tomography of a Purkinje cell dendritic mitochondrion imaged in situ. The outer membrane is shown in dark blue, the inner boundary membrane in light blue, and the cristae membranes in yellow. Reproduced from Perkins et al. (1997) with permission from Elsevier. (C–G) Morphology of the mitochondrial network. (C) Tubular mitochondrial network in the budding yeast Saccharomyces cerevisiae. A yeast strain expressing a green fluorescent protein targeted to mitochondria was grown under nonfermentable conditions to the logarithmic growth phase. The cell wall was separately stained with calcofluor white. A surface-rendered three-dimensional stack recorded with an MMM-4Pi confocal fluorescence microscope is shown. Reproduced from Egner et al. (2002) with permission. © 2002 National Academy of Sciences, USA. (D–G) Mitochondrial morphology in HEP-G2 cells transfected with a mitochondrially targeted fluorescent protein. All images were recorded by two-photon excitation with a confocal microscope. Adapted from Plecita-Hlavata et al. (2008) with permission from Elsevier. (D, E) Cells were cultivated in 25 mM glucose. The mitochondria form a tubular reticulum with highly interconnected branches. (F, G) Cells were cultivated in 5 mM glucose before treatment. Dissipation of the mitochondrial membrane potential by the addition of 10 μM rotenone induced the fragmentation of the originally highly interconnected mitochondrial reticulum.
c06.indd 96
5/6/2011 6:40:07 PM
RECENT AND PROSPECTIVE DEVELOPMENTS IN MITOCHONDRIAL RESEARCH
97
(Fig. 6.5C–G). Second, cristae are still often depicted as membrane folds harboring broad openings resembling the so-called baffle model. However, in the 1990s this view was challenged by electron tomographic studies, which demonstrated that the IBM and the CM are rather connected by small pore-like openings, termed crista junctions (CJs; Figs. 6.1 and 6.5A, B; Mannella et al. 1994, 1997; Frey and Mannella 2000). Interestingly, already careful analyses of thin serial sections, performed by Andersson-Cedergren in the 1950s and by Daems and Wisse in the 1960s, suggested the existence of such narrow entry pores, termed pediculi cristae (“cristae feet”) at that time (Andersson-Cedergren 1959; Daems and Wisse 1966). The appearance of CJs is rather uniform in size and shape, exhibiting narrow tubular, ring- or slot-like structures with diameters ranging from 12 to 40 nm and lengths ranging from 30 to 200 nm (Zick et al. 2009). Compartmentalization and Dynamic Protein Distribution Based on these structural properties and the location of CJs separating the IBM from the CM, CJs were suggested to represent diffusion barriers that regulate the distribution of proteins, lipids, and metabolites between the individual mitochondrial subcompartments (Mannella et al. 1997). A major implication imposed by such a degree of organization is that entry and exit of adenosine-5′-diphosphate (ADP) or protons might be regulated by CJs. As ADP is often the limiting metabolite in oxidative phosphorylation this would represent a novel way of regulating this fundamental bioenergetic process. And indeed, several lines of evidence support that the IM is composed of two distinct subcompartments. The CM mostly contains proteins involved in oxidative phosphorylation, iron–sulfur cluster biogenesis, protein synthesis, and transport of mtDNA-encoded proteins. The IBM, however, was rather enriched in proteins involved in mitochondrial fusion and protein transport of nuclear-encoded proteins (Vogel et al. 2006; Wurm and Jakobs 2006). This protein distribution is not static but rather appears to be dynamic, depending on the physiological state. How this is regulated and what components are required to form cristae and CJs are a matter of intensive research. Molecular Players Governing Cristae and CJ Formation Even though numerous proteins affect cristae morphology, convincing evidence for a direct role has been provided only in a few cases (Zick et al. 2009). The mitochondrial F1F0-ATP synthase was shown to assemble into dimers and higher oligomeric supercomplexes via its subunits e and g (Arnold et al. 1998). Disruption of this arrangement does not compromise the enzymatic activity of the F1F0-ATP synthase but results in a gross disorganization of the mitochondrial IM, which appears concentrically stacked, mimicking an onion-like structure (Velours et al. 2009). It appears that the F1F0-ATP synthase supercomplexes act as a structural backbone mediating normal cristae appearance (Paumard et al. 2002). Thereby, dimers and oligomers of the F1F0-ATP synthase are preferentially located at regions of the membrane that exhibit a positive membrane curvature, for example, at the outer rim of a flat crista sheet, or at the tip of a crista (Strauss et al. 2008; Rabl et al. 2009). In contrast, the yeast protein Fcj1, which was also shown to be required for CJ formation, is enriched at CJs, a membrane region exhibiting a negative membrane curvature. Fcj1 genetically interacts with subunits e and g and modulates the oligomeric state of the F1F0-ATP synthase in an antagonistic manner. By that interplay between Fcj1 and the subunits e and g, IM curvature might be regulated, thereby determining cristae morphology and CJ formation (Rabl et al. 2009). Mitofilin, the mammalian ortholog of Fcj1, was also proposed to be required for normal cristae morphology and CJ formation (John et al. 2005). Other factors, such as prohibitins, were also suggested to be involved
c06.indd 97
5/6/2011 6:40:17 PM
98
CHAPTER 6
MITOCHONDRIA
in CJ formation (Merkwirth and Langer 2009; Osman et al. 2009a, b), and certainly further still unknown, molecular players will have to be discovered. Apoptotic Cristae Remodeling Besides their potential role in regulation of oxidative phosphorylation, CJs gained major interest regarding their role during apoptosis. Induction of apoptosis was reported to cause opening of CJs, which in turn promoted the efficient release of cytochrome c (Scorrano et al. 2002). Thus, CJ remodeling was hypothesized as a necessary step in cytochrome c-dependent cell death pathways. Indeed, overexpression of OPA1, a large dynamin-like GTPase of the inner mitochondrial membrane, exerted an anti-apoptotic effect and prevented CJ opening during apoptosis (Cipolat et al. 2006; Frezza et al. 2006). Conversely, downregulation of OPA1 led to changes in cristae morphology and promoted cytochrome c release (Olichon et al. 2003). Due to the ability of OPA1 to form high-molecular-weight complexes, and to undergo self–self interactions, it was proposed to keep CJs in a tight or closed conformation, thereby preventing cytochrome c release. On the contrary, another study reported that upon addition of BH3-only proteins to isolated mitochondria, CJ diameters were even reduced while still cytochrome c release was promoted and OPA1 complexes were disassembled (Yamaguchi et al. 2008). This suggests that cytochrome c release can also be promoted in the absence of CJ opening. Nevertheless, OPA1 disassembly appeared to be correlated with cytochrome c release in all cases reported so far. The role of OPA1 in cristae remodeling in general is supported by the fact that Mgm1, the yeast ortholog of OPA1, was also suggested to be involved in stabilizing cristae morphology and that this also depends on its ability to form homotypic interactions (Meeusen et al. 2006). Future studies will have to address the controversial role of OPA1 in cristae remodeling during apoptosis, and to decipher how the large dynamin-like GTPases Mgm1 and OPA1 modulate cristae structure in general.
Mitochondrial Dynamics The highly dynamic behavior of mitochondria was already noticed almost a century ago (Lewis and Lewis 1914). These observations, however, fell into oblivion until the 1990s when the underlying events of fusion and fission, which constantly remodel the mitochondrial network (Fig. 6.5C–G), attracted considerable attention (Bereiter-Hahn and Voth 1994; Nunnari et al. 1997). This newly gained interest was sustained by the discovery that impairment of these processes is linked to the pathogenesis of several human neuropathies. Defects in fission or fusion of mitochondria lead to Charcot–Marie–Tooth neuropathy types 2A (Zuchner et al. 2004) and 4A (Baxter et al. 2002; Cuesta et al. 2002; Niemann et al. 2005), and autosomal dominant optic atrophy (Alexander et al. 2000; Delettre et al. 2000). Impaired mitochondrial dynamics were also associated with a pathophysiological role in neurodegenerative diseases, for example, Parkinson’s and Alzheimer ’s disease (Chen and Chan 2009; Su et al. 2010). Most of the molecular players that constitute the core machinery of mitochondrial dynamics were initially discovered and characterized in model organisms; while several key components are remarkably well conserved, the regulatory mechanisms seem to be more diverse (Westermann 2009). Fusion The fusion of mitochondria is particularly remarkable in two aspects. (1) Not only two but four lipid bilayers need to be fused in a coordinated manner. (2) In contrast to all other characterized cellular fusion events, mitochondrial fusion is not mediated by SNARE proteins. Instead, large dynamin-like GTPases that reside in the IM (Mgm1 in Saccharomyces
c06.indd 98
5/6/2011 6:40:17 PM
RECENT AND PROSPECTIVE DEVELOPMENTS IN MITOCHONDRIAL RESEARCH
99
cerevisiae/OPA1 in Homo sapiens) and OM (Fzo1 in S. cerevisiae/mitofusins Mfn1 and Mfn2 in H. sapiens), respectively, drive the sequential fusion of these membranes (Meeusen et al. 2004; Chan 2006; Hoppins et al. 2007; Song et al. 2009). This process is so far best characterized in yeast (Hoppins and Nunnari 2009): OM fusion requires the interaction of Fzo1 in trans, the hydrolysis of guanosine-5′-triphosphate (GTP) and a proton gradient across the IM (Meeusen et al. 2004). The in trans interaction of Mgm1 is similarly required for IM fusion, as well as an IM electrical potential is (Meeusen et al. 2004; Meeusen et al. 2006). A third protein that is essential for mitochondrial fusion in yeast is Ugo1, a modified member of the carrier protein family without any known homolog. It is distinctly required for both OM and IM fusion, and is proposed to operate at the lipid-mixing step (Hoppins et al. 2009). It is likely that further proteinaceous components of the mitochondrial fusion apparatus will be discovered. In addition, lipids play an important role in mitochondrial dynamics. Several yeast mutants defective in mitochondrial morphology were reported to exhibit altered levels of either cardiolipin, phosphatidylethanolamine, or both (Osman et al. 2009a). The mitochondrial phospholipase D (MitoPLD) was suggested to promote fusion by hydrolyzing cardiolipin after docking of two opposing outer membranes (Choi et al. 2006). Although initial concepts can be devised, we are still far from understanding the mechanistic details of how mitochondrial fusion is orchestrated. Fission Mitochondrial fission is also mediated by a large dynamin-like GTPase (Dnm1 in S. cerevisiae, DRP1 in H. sapiens), which is recruited from the cytosol to distinct patches on the outer surface of mitochondria, where it self-assembles into helical structures. This selfassembly facilitates the fission process and depends on auxiliary proteins (Fis1 and Mdv1 in S. cerevisiae), which were suggested to act as a platform on mitochondria (Lackner et al. 2009). Irrespective of the controversial discussions about the precise molecular mechanism underlying this process and its regulation, it appears that diverse modifications, such as ubiquitination, phosphorylation, sumoylation, and nitrosylation, of Dnm1/DRP1 are involved (Harder et al. 2004; Nakamura et al. 2006; Chang and Blackstone 2007; Taguchi et al. 2007; Zunino et al. 2007; Cho et al. 2009). In addition to generating individual organelles, mitochondrial fission was reported to be required for cytochrome c release during apoptosis (Frank et al. 2001; Karbowski et al. 2002; Lee et al. 2004). The proapoptotic Bcl-2 family members Bax and Bak, in turn, were suggested to promote mitochondrial fission (Autret and Martin 2009). Still, the necessity of mitochondrial fission in apoptosis remains controversial (Suen et al. 2008), as, for example, a knock-out mouse lacking the fission factor DRP1 showed no signs of impaired apoptosis (Ishihara et al. 2009). Quality Control of Mitochondria Mitochondria were shown to be strongly fragmented in numerous cases of mitochondrial dysfunction. This can be attributed mainly to the inactivation of the mitochondrial fusion machinery (Herlan et al. 2004; Duvezin-Caubet et al. 2006; Ishihara et al. 2006). Thereby dysfunctional mitochondria may become spatially separated from the intact mitochondrial network, preventing further harm, and the damaged, isolated organelles degraded in a directed manner (Herlan et al. 2004; Skulachev et al. 2004). Indeed, dysfunctional mitochondria were shown to be removed in toto by an organelle-specific autophagic process termed mitophagy (Lemasters 2005; Priault et al. 2005; Kim et al. 2007; Goldman et al. 2010). Moreover, mitophagy in mammalian cells was shown to depend on the fission factor DRP1, further supporting the role of mitochondrial dynamics in the selective removal of dysfunctional mitochondria (Twig et al. 2008). Mitophagy depends on the general
c06.indd 99
5/6/2011 6:40:17 PM
100
CHAPTER 6
MITOCHONDRIA
autophagic machinery but also requires several specific factors that direct the degradation of mitochondria (Kanki and Klionsky 2010), so far studied in baker ’s yeast: Uth1, Aup1, Atg11, Atg21, Atg24, Atg32, Atg33 (Kissova et al. 2004; Tal et al. 2007; Kanki and Klionsky 2008; Okamoto et al. 2009; Kanki et al. 2009a, b); and in mammalian cells: DRP1 (Twig et al. 2008), NIX (Schweers et al. 2007; Sandoval et al. 2008; Novak et al. 2010), Parkin (Narendra et al. 2008), and PINK1 (Dagda et al. 2009). The two latter proteins are involved in Parkinson’s disease, pointing to a role of defective mitophagy in this human neuropathy (Geisler et al. 2010; Narendra et al. 2010). Certainly, other control mechanisms apply as well. Misfolding and aggregation of proteins is minimized by chaperones and numerous proteases present in the different mitochondrial subcompartments (Voos 2009). Furthermore, severely and irreversibly damaged mitochondria may initiate programmed cell death and thus be eliminated at the cellular level. In general, ensuring functionality of mitochondria occurs at different levels, and we still only begin to understand the underlying mechanisms (Tatsuta and Langer 2008).
Crosstalk between Mitochondria and the ER Next to its previously mentioned role in lipid metabolism, the intimate physical relation of mitochondria with the ER (see also Chapters 7 and 11) governs critical functions in calcium homeostasis, signaling, and regulation of the apoptotic cell death (Pizzo and Pozzan 2007; Romagnoli et al. 2007; Pinton et al. 2008; Giorgi et al. 2009; Hayashi et al. 2009; Rizzuto et al. 2009). In contrast to the initially assumed role of mitochondria as mere buffers for cytosolic calcium excesses, the stream of calcium ions into the mitochondrial matrix appears to act as an important regulator of oxidative phosphorylation (Denton 2009; Griffiths and Rutter 2009). The massive and prolonged accumulation of Ca2+ within mitochondria, however, induces the opening of a large conductance channel, the so-called permeability transition pore, in the IM (Lemasters et al. 2009), swelling of the organelle that leads to the rupture of the outer membrane, and the concomitant release of several proapoptotic factors into the cytosol, ultimately resulting in cell death (Kroemer et al. 2007). While it is a known fact that up to 20% of the mitochondrial surface is in close contact with the ER (Rizzuto et al. 1998), the macromolecular complexes that tether the two membranes at a distance of 10–25 nm (Csordas et al. 2006) are scarcely characterized. Two recent studies indicated that several proteinaceous bridges redundantly link the mitochondrial with the ER (de Brito and Scorrano 2008; Kornmann et al. 2009). Future studies will have to elucidate the organization and dynamic regulation of this structural entity, and to decipher whether the various tethers fulfill different functions within the mitochondria– ER communication.
Mitochondrial Disease Based on the intricate role that mitochondria play in cellular physiology, dysfunction of literally any process involving mitochondria results in a pathologic condition (Duchen 2004; Schapira 2006; McFarland et al. 2007). The classical mitochondrial diseases are linked to primary defects within the process of oxidative phosphorylation (Fosslien 2001; Smeitink et al. 2001; Smeitink et al. 2006; Kucharczyk et al. 2009), which can result from either mtDNA mutations (Fig. 6.3; Leonard and Schapira 2000a) or nuclear gene defects (Leonard and Schapira 2000b). However, disruptions of any other mitochondrial function (Jacobs 2003; Fadeel and Orrenius 2005; Hauff and Hatch 2006; MacKenzie and Payne 2007; Copeland 2008; Rouault and Tong 2008; Scaglia and Wong 2008; Liesa et al. 2009;
c06.indd 100
5/6/2011 6:40:17 PM
REFERENCES
101
Moczulski et al. 2009; Zutz et al. 2009), which might entail a secondary impairment of the energy metabolism (McFarland and Turnbull 2009), result in a diverse set of disorders in multiple organ systems (Finsterer 2006). Thus, the consideration given to mitochondria in regard to disease pathogenesis has tremendously widened in recent years (Wallace 2005b; McFarland et al. 2007; DiMauro and Schon 2008; Wallace and Fan 2009). As the list of mitochondria-associated diseases includes diabetes (Friederich et al. 2009; Schiff et al. 2009), Alzheimer ’s disease (Moreira et al. 2007; Reddy 2009), Parkinson’s disease (Thomas and Beal 2007; Banerjee et al. 2009), and cancer (Wallace 2005a; Rustin and Kroemer 2007; Gogvadze et al. 2008), interest in mitochondria as therapeutic targets is constantly growing (Armstrong 2007; Henchcliffe and Beal 2008; Kroemer and Pouyssegur 2008; Koene and Smeitink 2009; Zorzano et al. 2009; Moreira et al. 2010; Wallace et al. 2010). In the long run, however, a necessary prerequisite to making these efforts a success will be a more thorough understanding of the complex entanglements of mitochondria with all aspects of the biology of eukaryotic cells. If this can be achieved, the modulation of mitochondrial functions holds promise to become an effective therapeutic strategy in the amelioration of symptoms in a broad range of diseases.
ACKNOWLEDGMENTS We are very grateful to Drs. L. Plecitá-Hlavatá, P. Ježek, S. Jakobs, S.W. Hell, and G.A. Perkins for providing high-quality images of their excellent work. This work was supported by the University of Munich FöFoLe program (MZ), the Deutsche Forschungsgemeinschaft SFB 594
project B8, and the Cluster of Excellence “Macromolecular Complexes” at the Goethe University Frankfurt DFG project EXC 115 (AR). We apologize to all colleagues whose excellent research could not be mentioned due to space constraints.
ABBREVIATIONS ADP ATP CJ CM
adenosine-5′-diphosphate adenosine-5′-triphosphate crista junction crista membrane
IBM inner boundary membrane IM inner membrane MitoPLD mitochondrial phospholipase D OM outer membrane
REFERENCES Aguilera P, Barry T, Tovar J. 2008. Entamoeba histolytica mitosomes: organelles in search of a function. Exp Parasitol 118:10–6. Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A, Deng CX, Finkel T. 2008. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci U S A 105:14447–52. Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A, Rodriguez M, Kellner U, Leo-Kottler B, Auburger G, Bhattacharya SS, Wissinger B. 2000. OPA1, encoding a dynaminrelated GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 26: 211–5.
c06.indd 101
Alfonzo JD, Soll D. 2009. Mitochondrial tRNA import— the challenge to understand has just begun. Biol Chem 390:717–22. Allison WS, Scheffler IE, Murphy AN. 2009. Mitochondrial function. Amsterdam, the Netherlands; London, UK: Academic Press. Altmann R. 1894. Die Elementarorganismen und Ihre Beziehung zu den Zellen. Leipzig, Germany: Verlag von Veit & Comp. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG. 1981. Sequence and organization of the human mitochondrial genome. Nature 290:457–65.
5/6/2011 6:40:17 PM
102
CHAPTER 6
MITOCHONDRIA
Andersson-Cedergren E. 1959. Ultrastructure of motor end plate and sarcoplasmic components of mouse skeletal muscle fiber as revealed by three-dimensional reconstructions from serial sections. J Ultrastructure Res 2:5–191. Armstrong JS. 2007. Mitochondrial medicine: pharmacological targeting of mitochondria in disease. Br J Pharmacol 151:1154–65. Arnold I, Pfeiffer K, Neupert W, Stuart RA, Schagger H. 1998. Yeast mitochondrial F1F0-ATP synthase exists as a dimer: identification of three dimer-specific subunits. EMBO J 17:7170–8. Autret A, Martin SJ. 2009. Emerging role for members of the Bcl-2 family in mitochondrial morphogenesis. Mol Cell 36:355–63. Ballard JWO, Rand DM. 2005. The population biology of mitochondrial DNA and its phylogenetic implications. Annu Rev Ecol Evol Syst 36:621–42. Banerjee R, Starkov AA, Beal MF, Thomas B. 2009. Mitochondrial dysfunction in the limelight of Parkinson’s disease pathogenesis. Biochim Biophys Acta 1792: 651–63. Baxter RV, Ben Othmane K, Rochelle JM, Stajich JE, Hulette C, Dew-Knight S, Hentati F, Ben Hamida M, Bel S, Stenger JE, Gilbert JR, Pericak-Vance MA, Vance JM. 2002. Ganglioside-induced differentiation-associated protein-1 is mutant in CharcotMarie-Tooth disease type 4A/8q21. Nat Genet 30:21–2. Bechtel W, Abrahamsen A. 2007. In search of mitochondrial mechanisms: interfield excursions between cell biology and biochemistry. J Hist Biol 40:1–33. Bellizzi D, Rose G, Cavalcante P, Covello G, Dato S, De Rango F, Greco V, Maggiolini M, Feraco E, Mari V, Franceschi C, Passarino G, De Benedictis G. 2005. A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 85:258–63. Benda C. 1898. Weitere Mitteilungen über die Mitochondria. Verh Physiol Ges Berlin Jahrg. 1898/99(4–7):376–83. Benda C. 1901. Die Mitochondriafärbung und andere Methoden zur Untersuchung der Zellsubstanzen. Verh. Anat. Ges. a. d. 15. Vers. Bonn, Ergänzungsh. z. 19. Bd. d. Anat. Anz.:155–74. Bereiter-Hahn J, Voth M. 1994. Die Mitochondriafärbung und andere Methoden zur Untersuchung der Zellsubstanzen. Microsc Res Tech 27:198–219. Bogdanov M, Mileykovskaya E, Dowhan W. 2008. Lipids in the assembly of membrane proteins and organization of protein supercomplexes: implications for lipidlinked disorders. Subcell Biochem 49:197–239. Bottema C, Parks L. 1980. Sterol analysis of the inner and outer mitochondrial membranes in yeast. Lipids 15: 987–92. Brandon M, Baldi P, Wallace DC. 2006. Mitochondrial mutations in cancer. Oncogene 25:4647–62. Budowle B, Allard MW, Wilson MR, Chakraborty R. 2003. Forensics and mitochondrial DNA: applications, debates, and foundations. Annu Rev Genomics Hum Genet 4:119–41. Burger G, Gray MW, Lang BF. 2003. Mitochondrial genomes: anything goes. Trends Genet 19:709–16.
c06.indd 102
Catalano D, Licciulli F, Turi A, Grillo G, Saccone C, D’Elia D. 2006. MitoRes: a resource of nuclear-encoded mitochondrial genes and their products in Metazoa. BMC Bioinformatics 7:36. Cavers F. 1914. Chondriosomes (mitochondria) and their significance. New Phytologist 13:96–106. Chacinska A, Koehler CM, Milenkovic D, Lithgow T, Pfanner N. 2009. Importing mitochondrial proteins: machineries and mechanisms. Cell 138:628–44. Chan DC. 2006. Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol 22:79–99. Chang CR, Blackstone C. 2007. Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J Biol Chem 282:21583–7. Chen XJ, Butow RA. 2005. The organization and inheritance of the mitochondrial genome. Nat Rev Genet 6:815–25. Chen H, Chan DC. 2009. Mitochondrial dynamics— fusion, fission, movement, and mitophagy—in neurodegenerative diseases. Hum Mol Genet 18:R169–76. Chicco AJ, Sparagna GC. 2007. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol 292:C33–44. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, Lipton SA. 2009. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324:102–5. Choi SY, Huang P, Jenkins GM, Chan DC, Schiller J, Frohman MA. 2006. A common lipid links Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis. Nat Cell Biol 8:1255–62. Cipolat S, Rudka T, Hartmann D, Costa V, Serneels L, Craessaerts K, Metzger K, Frezza C, Annaert W, D’Adamio L, Derks C, Dejaegere T, Pellegrini L, D’Hooge R, Scorrano L, De Strooper B. 2006. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 126:163–75. Claypool SM. 2009. Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function. Biochim Biophys Acta 1788:2059–68. Copeland WC. 2008. Inherited mitochondrial diseases of DNA replication. Annu Rev Med 59:131–46. Cotter D, Guda P, Fahy E, Subramaniam S. 2004. MitoProteome: mitochondrial protein sequence database and annotation system. Nucleic Acids Res 32: D463–7. Cowdry EV. 1953. Historical background of research on mitochondria. J Histochem Cytochem 1:183–7. Crane FL. 1961. Structure and function of mitochondria. Annu Rev Plant Physiol 12:13–34. Csordas G, Renken C, Varnai P, Walter L, Weaver D, Buttle KF, Balla T, Mannella CA, Hajnoczky G. 2006. Structural and functional features and significance of the physical linkage between ER and mitochondria. J Cell Biol 174:915–21. Cuesta A, Pedrola L, Sevilla T, Garcia-Planells J, Chumillas MJ, Mayordomo F, LeGuern E, Marin I, Vilchez JJ, Palau F. 2002. The gene encoding ganglioside-induced differentiation-associated protein 1
5/6/2011 6:40:17 PM
REFERENCES
is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 30:22–5. Da Cruz S, Parone PA, Martinou JC. 2005. Building the mitochondrial proteome. Expert Rev Proteomics 2: 541–51. Daems WT, Wisse E. 1966. Shape and attachment of the cristae mitochondriales in mouse hepatic cell mitochondria. J Ultrastruct Res 16:123–40. Dagda RK, Cherra SJ, 3rd, Kulich SM, Tandon A, Park D, Chu CT. 2009. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem 284:13843–55. Daum G. 1985. Lipids of mitochondria. Biochim Biophys Acta 822:1–42. Daum G, Vance JE. 1997. Import of lipids into mitochondria. Prog Lipid Res 36:103–30. de Brito OM, Scorrano L. 2008. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456: 605–10. de Kroon AI, Dolis D, Mayer A, Lill R, de Kruijff B. 1997. Phospholipid composition of highly purified mitochondrial outer membranes of rat liver and Neurospora crassa. Is cardiolipin present in the mitochondrial outer membrane? Biochim Biophys Acta 1325:108–16. Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, Astarie-Dequeker C, Lasquellec L, Arnaud B, Ducommun B, Kaplan J, Hamel CP. 2000. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26:207–10. Denton RM. 2009. Regulation of mitochondrial dehydrogenases by calcium ions. Biochim Biophys Acta 1787: 1309–16. Deponte M, Hell K. 2009. Disulphide bond formation in the intermembrane space of mitochondria. J Biochem 146:599–608. DiMauro S, Schon EA. 2008. Mitochondrial disorders in the nervous system. Annu Rev Neurosci 31:91–123. Distler AM, Kerner J, Hoppel CL. 2008. Proteomics of mitochondrial inner and outer membranes. Proteomics 8:4066–82. Duchen MR. 2004. Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med 25:365–451. Duchene AM, Pujol C, Marechal-Drouard L. 2009. Import of tRNAs and aminoacyl-tRNA synthetases into mitochondria. Curr Genet 55:1–18. Duvezin-Caubet S, Jagasia R, Wagener J, Hofmann S, Trifunovic A, Hansson A, Chomyn A, Bauer MF, Attardi G, Larsson NG, Neupert W, Reichert AS. 2006. Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J Biol Chem 281:37972–9. Edgar D, Shabalina I, Camara Y, Wredenberg A, Calvaruso MA, Nijtmans L, Nedergaard J, Cannon B, Larsson NG, Trifunovic A. 2009. Random point mutations with major effects on protein-coding genes are the driving force behind premature aging in mtDNA mutator mice. Cell Metab 10:131–8.
c06.indd 103
103
Egner A, Jakobs S, Hell SW. 2002. Fast 100-nm resolution three-dimensional microscope reveals structural plasticity of mitochondria in live yeast. Proc Natl Acad Sci U S A 99:3370–5. Elstner M, Andreoli C, Ahting U, Tetko I, Klopstock T, Meitinger T, Prokisch H. 2008. MitoP2: an integrative tool for the analysis of the mitochondrial proteome. Mol Biotechnol 40:306–15. Elstner M, Andreoli C, Klopstock T, Meitinger T, Prokisch H. 2009. The mitochondrial proteome database: MitoP2. Methods Enzymol 457:3–20. Emelyanov VV. 2001. Evolutionary relationship of Rickettsiae and mitochondria. FEBS Lett 501:11–8. Emelyanov VV. 2003. Mitochondrial connection to the origin of the eukaryotic cell. Eur J Biochem 270:1599–618. Ernster L, Schatz G. 1981. Mitochondria: a historical review. J Cell Biol 91:227s–55s. Fadeel B, Orrenius S. 2005. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med 258:479–517. Falkenberg M, Larsson NG, Gustafsson CM. 2007. DNA replication and transcription in mammalian mitochondria. Annu Rev Biochem 76:679–99. Fawcett DW. 1981. Mitochondria. In: Fawcett DW, editor. The Cell, 2nd edition. Philadelphia: WB Saunders, pp. 410–68. Finsterer J. 2006. Overview on visceral manifestations of mitochondrial disorders. Neth J Med 64:61–71. Fosslien E. 2001. Mitochondrial medicine—molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci 31:25–67. Foster LJ, de Hoog CL, Zhang Y, Xie X, Mootha VK, Mann M. 2006. A mammalian organelle map by protein correlation profiling. Cell 125:187–99. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, Smith CL, Youle RJ. 2001. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 1:515–25. Frey TG, Mannella CA. 2000. The internal structure of mitochondria. Trends Biochem Sci 25:319–24. Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, Bartoli D, Polishuck RS, Danial NN, De Strooper B, Scorrano L. 2006. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126:177–89. Friederich M, Hansell P, Palm F. 2009. Diabetes, oxidative stress, nitric oxide and mitochondria function. Curr Diabetes Rev 5:120–44. Gaigg B, Simbeni R, Hrastnik C, Paltauf F, Daum G. 1995. Characterization of a microsomal subfraction associated with mitochondria of the yeast, Saccharomyces cerevisiae. Involvement in synthesis and import of phospholipids into mitochondria. Biochim Biophys Acta 1234:214–20. Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, Springer W. 2010. PINK1/ Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12(2):119–31. Giorgi C, De Stefani D, Bononi A, Rizzuto R, Pinton P. 2009. Structural and functional link between the
5/6/2011 6:40:17 PM
104
CHAPTER 6
MITOCHONDRIA
mitochondrial network and the endoplasmic reticulum. Int J Biochem Cell Biol 41:1817–27. Gogvadze V, Orrenius S, Zhivotovsky B. 2008. Mitochondria in cancer cells: what is so special about them? Trends Cell Biol 18:165–73. Goldberg AV, Molik S, Tsaousis AD, Neumann K, Kuhnke G, Delbac F, Vivares CP, Hirt RP, Lill R, Embley TM. 2008. Localization and functionality of microsporidian iron-sulphur cluster assembly proteins. Nature 452:624–8. Goldman SJ, Taylor R, Zhang Y, Jin S. 2010. Autophagy and the degradation of mitochondria. Mitochondrion 10(4):309–15. Gray MW. 1992. The endosymbiont hypothesis revisited. Int Rev Cytol 141:233–357. Gray MW, Burger G, Lang BF. 1999. Mitochondrial evolution. Science 283:1476–81. Greaves LC, Turnbull DM. 2009. Mitochondrial DNA mutations and ageing. Biochim Biophys Acta 1790: 1015–20. Griffiths EJ, Rutter GA. 2009. Mitochondrial calcium as a key regulator of mitochondrial ATP production in mammalian cells. Biochim Biophys Acta 1787:1324–33. Guda P, Subramaniam S, Guda C. 2007. Mitoproteome: human heart mitochondrial protein sequence database. Methods Mol Biol 357:375–83. Hackenbrock CR. 1968. Chemical and physical fixation of isolated mitochondria in low-energy and high-energy states. Proc Natl Acad Sci U S A 61:598–605. Hackstein JH, Tjaden J, Huynen M. 2006. Mitochondria, hydrogenosomes and mitosomes: products of evolutionary tinkering! Curr Genet 50:225–45. Harder Z, Zunino R, McBride H. 2004. Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Curr Biol 14:340–5. Hauff KD, Hatch GM. 2006. Cardiolipin metabolism and Barth Syndrome. Prog Lipid Res 45:91–101. Hayashi T, Rizzuto R, Hajnoczky G, Su TP. 2009. MAM: more than just a housekeeper. Trends Cell Biol 19:81–8. Heazlewood JL, Millar AH. 2005. AMPDB: the arabidopsis mitochondrial protein database. Nucleic Acids Res 33:D605–10. Heazlewood JL, Tonti-Filippini JS, Gout AM, Day DA, Whelan J, Millar AH. 2004. Experimental analysis of the Arabidopsis mitochondrial proteome highlights signaling and regulatory components, provides assessment of targeting prediction programs, and indicates plantspecific mitochondrial proteins. Plant Cell 16:241–56. Henchcliffe C, Beal MF. 2008. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 4:600–9. Henle J. 1841. Vom Muskelgewebe. In: Henle J, editor. Allgemeine anatomie mischungs- und formbestandteile des menschlichen Körpers. Leipzig, Germany: Verlag Leopold Voss, pp. 573–613. Herlan M, Bornhovd C, Hell K, Neupert W, Reichert AS. 2004. Alternative topogenesis of Mgm1 and mitochondrial morphology depend on ATP and a functional import motor. J Cell Biol 165:167–73.
c06.indd 104
Hock MB, Kralli A. 2009. Transcriptional control of mitochondrial biogenesis and function. Annu Rev Physiol 71:177–203. Hogeboom GH, Schneider WC, Palade GE. 1947. The isolation of morphologically intact mitochondria from rat liver. Proc Soc Exp Biol Med 65:320–1. Hogeboom GH, Schneider WC, Pallade GE. 1948. Cytochemical studies of mammalian tissues; isolation of intact mitochondria from rat liver; some biochemical properties of mitochondria and submicroscopic particulate material. J Biol Chem 172:619–35. Hoppins S, Nunnari J. 2009. The molecular mechanism of mitochondrial fusion. Biochim Biophys Acta 1793: 20–6. Hoppins S, Lackner L, Nunnari J. 2007. The machines that divide and fuse mitochondria. Annu Rev Biochem 76:751–80. Hoppins S, Horner J, Song C, McCaffery JM, Nunnari J. 2009. Mitochondrial outer and inner membrane fusion requires a modified carrier protein. J Cell Biol 184: 569–81. Houtkooper RH, Vaz FM. 2008. Cardiolipin, the heart of mitochondrial metabolism. Cell Mol Life Sci 65: 2493–506. Hovius R, Lambrechts H, Nicolay K, de Kruijff B. 1990. Improved methods to isolate and subfractionate rat liver mitochondria. Lipid composition of the inner and outer membrane. Biochim Biophys Acta 1021:217–26. Huang JY, Hirschey MD, Shimazu T, Ho L, Verdin E. 2010. Mitochondrial sirtuins. Biochim Biophys Acta 1804(8):1645–51. Ingman M, Gyllensten U. 2006. mtDB: human mitochondrial genome database, a resource for population genetics and medical sciences. Nucleic Acids Res 34: D749–51. Ishihara N, Fujita Y, Oka T, Mihara K. 2006. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. Embo J 25:2966–77. Ishihara N, Nomura M, Jofuku A, Kato H, Suzuki SO, Masuda K, Otera H, Nakanishi Y, Nonaka I, Goto Y, Taguchi N, Morinaga H, Maeda M, Takayanagi R, Yokota S, Mihara K. 2009. Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat Cell Biol 11:958–66. Ito J, Taylor NL, Castleden I, Weckwerth W, Millar AH, Heazlewood JL. 2009. A survey of the Arabidopsis thaliana mitochondrial phosphoproteome. Proteomics 9:4229–40. Jacobs HT. 2003. Disorders of mitochondrial protein synthesis. Hum Mol Genet 12 Spec No 2:R293–301. John GB, Shang Y, Li L, Renken C, Mannella CA, Selker JM, Rangell L, Bennett MJ, Zha J. 2005. The mitochondrial inner membrane protein mitofilin controls cristae morphology. Mol Biol Cell 16:1543–54. Kagan VE, Bayir HA, Belikova NA, Kapralov O, Tyurina YY, Tyurin VA, Jiang J, Stoyanovsky DA, Wipf P, Kochanek PM, Greenberger JS, Pitt B, Shvedova AA, Borisenko G. 2009. Cytochrome c/ cardiolipin relations in mitochondria: a kiss of death. Free Radic Biol Med 46:1439–53.
5/6/2011 6:40:17 PM
REFERENCES
Kanki T, Klionsky DJ. 2008. Mitophagy in yeast occurs through a selective mechanism. J Biol Chem 283: 32386–93. Kanki T, Klionsky DJ. 2010. The molecular mechanism of mitochondria autophagy in yeast. Mol Microbiol 75(4):795–800. Kanki T, Wang K, Baba M, Bartholomew CR, LynchDay MA, Du Z, Geng J, Mao K, Yang Z, Yen WL, Klionsky DJ. 2009a. A genomic screen for yeast mutants defective in selective mitochondria autophagy. Mol Biol Cell 20:4730–8. Kanki T, Wang K, Cao Y, Baba M, Klionsky DJ. 2009b. Atg32 is a mitochondrial protein that confers selectivity during mitophagy. Dev Cell 17:98–109. Karbowski M, Lee YJ, Gaume B, Jeong SY, Frank S, Nechushtan A, Santel A, Fuller M, Smith CL, Youle RJ. 2002. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J Cell Biol 159:931–8. Keilin D. 1925. On cytochrome, a respiratory pigment, common to animals, yeast, and higher plants. Proc R Soc Lond B 98:312–39. Khrapko K, Vijg J. 2009. Mitochondrial DNA mutations and aging: devils in the details? Trends Genet 25:91–8. Kiebish MA, Han X, Cheng H, Chuang JH, Seyfried TN. 2008a. Brain mitochondrial lipid abnormalities in mice susceptible to spontaneous gliomas. Lipids 43:951–9. Kiebish MA, Han X, Cheng H, Chuang JH, Seyfried TN. 2008b. Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J Lipid Res 49:2545–56. Kiebish MA, Han X, Cheng H, Lunceford A, Clarke CF, Moon H, Chuang JH, Seyfried TN. 2008c. Lipidomic analysis and electron transport chain activities in C57BL/6J mouse brain mitochondria. J Neurochem 106:299–312. Kim I, Rodriguez-Enriquez S, Lemasters JJ. 2007. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 462:245–53. Kissova I, Deffieu M, Manon S, Camougrand N. 2004. Uth1p is involved in the autophagic degradation of mitochondria. J Biol Chem 279:39068–74. Klingenberg M. 2009. Cardiolipin and mitochondrial carriers. Biochim Biophys Acta 1788:2048–58. Knight RD, Freeland SJ, Landweber LF. 2001. Rewiring the keyboard: evolvability of the genetic code. Nat Rev Genet 2:49–58. Koene S, Smeitink J. 2009. Mitochondrial medicine: entering the era of treatment. J Intern Med 265:193–209. Kölliker A. 1856. Einige bemerkungen über die endigungen der hautnerven und den bau der muskeln. Z wissenschaftliche Zoologie 8:311–25. Kornmann B, Currie E, Collins SR, Schuldiner M, Nunnari J, Weissman JS, Walter P. 2009. An ERmitochondria tethering complex revealed by a synthetic biology screen. Science 325:477–81. Krebs HA, Henseleit K. 1932a. Untersuchungen über die harnstoffbildung im tierkörper. Hoppe-Seyler ’s Z Physiol Chem 210:33–66.
c06.indd 105
105
Krebs HA, Henseleit K. 1932b. Untersuchungen über die harnstoffbildung im tierkörper. Klin Wschr 11:757–9. Krebs HA, Henseleit K. 1932c. Untersuchungen über die Harnstoffbildung im Tierkörper. II. Klin Wschr 11: 1137–9. Krebs HA, Johnson WA. 1937. The role of citric acid in intermediate metabolism in animal tissues. Enzymologia 4:148–56. Kroemer G, Pouyssegur J. 2008. Tumor cell metabolism: cancer ’s Achilles’ heel. Cancer Cell 13:472–82. Kroemer G, Galluzzi L, Brenner C. 2007. Mitochondrial membrane permeabilization in cell death. Physiol Rev 87:99–163. Kucharczyk R, Zick M, Bietenhader M, Rak M, Couplan E, Blondel M, Caubet SD, di Rago JP. 2009. Mitochondrial ATP synthase disorders: molecular mechanisms and the quest for curative therapeutic approaches. Biochim Biophys Acta 1793:186–99. Kujoth GC, Bradshaw PC, Haroon S, Prolla TA. 2007. The role of mitochondrial DNA mutations in mammalian aging. PLoS Genet 3:e24. Lackner LL, Horner JS, Nunnari J. 2009. Mechanistic analysis of a dynamin effector. Science 325:874–7. Lee YJ, Jeong SY, Karbowski M, Smith CL, Youle RJ. 2004. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 15:5001–11. Lee J, Xu Y, Chen Y, Sprung R, Kim SC, Xie S, Zhao Y. 2007. Mitochondrial phosphoproteome revealed by an improved IMAC method and MS/MS/MS. Mol Cell Proteomics 6:669–76. Lemasters JJ. 2005. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res 8:3–5. Lemasters JJ, Theruvath TP, Zhong Z, Nieminen AL. 2009. Mitochondrial calcium and the permeability transition in cell death. Biochim Biophys Acta 1787: 1395–401. Leonard JV, Schapira AH. 2000a. Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 355:299–304. Leonard JV, Schapira AH. 2000b. Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects. Lancet 355:389–94. Lewis MR, Lewis WH. 1914. Mitochondria in tissue culture. Science 39:330–3. Lewis RN, McElhaney RN. 2009. The physicochemical properties of cardiolipin bilayers and cardiolipincontaining lipid membranes. Biochim Biophys Acta 1788:2069–79. Liesa M, Palacin M, Zorzano A. 2009. Mitochondrial dynamics in mammalian health and disease. Physiol Rev 89:799–845. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147–57. Liu B, Tewari AK, Zhang L, Green-Church KB, Zweier JL, Chen YR, He G. 2009. Proteomic analysis of protein
5/6/2011 6:40:17 PM
106
CHAPTER 6
MITOCHONDRIA
tyrosine nitration after ischemia reperfusion injury: mitochondria as the major target. Biochim Biophys Acta 1794:476–85. Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, Yang Y, Chen Y, Hirschey MD, Bronson RT, Haigis M, Guarente LP, Farese RV, Jr., Weissman S, Verdin E, Schwer B. 2007. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol 27:8807–14. MacKenzie JA, Payne RM. 2007. Mitochondrial protein import and human health and disease. Biochim Biophys Acta 1772:509–23. Malka F, Lombes A, Rojo M. 2006. Organization, dynamics and transmission of mitochondrial DNA: focus on vertebrate nucleoids. Biochim Biophys Acta 1763:463–72. Mannella CA, Marko M, Penczek P, Barnard D, Frank J. 1994. The internal compartmentation of rat-liver mitochondria: tomographic study using the high-voltage transmission electron microscope. Microsc Res Tech 27:278–83. Mannella CA, Marko M, Buttle K. 1997. Reconsidering mitochondrial structure: new views of an old organelle. Trends Biochem Sci 22:37–8. Maralikova B, Ali V, Nakada-Tsukui K, Nozaki T, van der Giezen M, Henze K, Tovar J. 2009. Bacterial-type oxygen detoxification and iron-sulfur cluster assembly in amoebal relict mitochondria. Cell Microbiol 12(3):331–42. Margulis L. 1981. Symbiosis in cell evolution. San Francisco, CA: W. H. Freeman. McFarland R, Turnbull DM. 2009. Batteries not included: diagnosis and management of mitochondrial disease. J Intern Med 265:210–28. McFarland R, Taylor RW, Turnbull DM. 2007. Mitochondrial disease—its impact, etiology, and pathology. Curr Top Dev Biol 77:113–55. Meeusen S, McCaffery JM, Nunnari J. 2004. Mitochondrial fusion intermediates revealed in vitro. Science 305:1747–52. Meeusen S, DeVay R, Block J, Cassidy-Stone A, Wayson S, McCaffery JM, Nunnari J. 2006. Mitochondrial inner-membrane fusion and crista maintenance requires the dynamin-related GTPase Mgm1. Cell 127: 383–95. Meisinger C, Sickmann A, Pfanner N. 2008. The mitochondrial proteome: from inventory to function. Cell 134:22–4. Mereschkowsky C. 1905. Über natur und ursprung der chromatophoren im pflanzenreiche. Biol Centralbl 25: 593–604. Merkwirth C, Langer T. 2009. Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim Biophys Acta 1793: 27–32. Michaelis L. 1900. Die vitale färbung, eine darstellungsmethode der zellgranula. Arch mikr Anat Entwick 55: 558–75. Mitchell P. 1961. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 191:144–8.
c06.indd 106
Moczulski D, Majak I, Mamczur D. 2009. An overview of beta-oxidation disorders. Postepy Hig Med Dosw (Online) 63:266–77. Moreira PI, Santos MS, Oliveira CR. 2007. Alzheimer ’s disease: a lesson from mitochondrial dysfunction. Antioxid Redox Signal 9:1621–30. Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, Smith MA. 2010. Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 1802:212–20. Munn EA. 1974. The structure of mitochondria. London, UK; New York: Academic Press. Nakamura N, Kimura Y, Tokuda M, Honda S, Hirose S. 2006. MARCH-V is a novel mitofusin 2- and Drp1binding protein able to change mitochondrial morphology. EMBO Rep 7:1019–22. Narendra D, Tanaka A, Suen DF, Youle RJ. 2008. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183:795–803. Narendra DP, Jin SM, Tanaka A, Suen D-F, Gautier CA, Shen J, Cookson MR, Youle RJ. 2010. PINK1 is selectively stabilized on impaired mitochondria to activate parkin. PLoS Biol 8:e1000298. Nass MM, Nass S. 1963a. Intramitochondrial fibers with DNA characteristics. I. Fixation and electron staining reactions. J Cell Biol 19:593–611. Nass S, Nass MM. 1963b. Intramitochondrial fibers with DNA characteristics. II. Enzymatic and other hydrolytic treatments. J Cell Biol 19:613–29. Neupert W, Herrmann JM. 2007. Translocation of proteins into mitochondria. Annu Rev Biochem 76:723–49. Niemann A, Ruegg M, La Padula V, Schenone A, Suter U. 2005. Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease. J Cell Biol 170:1067–78. Novak I, Kirkin V, McEwan DG, Zhang J, Wild P, Rozenknop A, Rogov V, Lohr F, Popovic D, Occhipinti A, Reichert AS, Terzic J, Dotsch V, Ney PA, Dikic I. 2010. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep 11:45–51. Nunnari J, Marshall WF, Straight A, Murray A, Sedat JW, Walter P. 1997. Mitochondrial transmission during mating in Saccharomyces cerevisiae is determined by mitochondrial fusion and fission and the intramitochondrial segregation of mitochondrial DNA. Mol Biol Cell 8:1233–42. O’Brien EA, Zhang Y, Wang E, Marie V, Badejoko W, Lang BF, Burger G. 2009. GOBASE: an organelle genome database. Nucleic Acids Res 37:D946–50. Ohlmeier S, Kastaniotis AJ, Hiltunen JK, Bergmann U. 2004. The yeast mitochondrial proteome, a study of fermentative and respiratory growth. J Biol Chem 279: 3956–79. Okamoto K, Kondo-Okamoto N, Ohsumi Y. 2009. Mitochondria-anchored receptor Atg32 mediates degradation of mitochondria via selective autophagy. Dev Cell 17:87–97. Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P, Lenaers G. 2003. Loss of OPA1 per-
5/6/2011 6:40:17 PM
REFERENCES
turbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 278:7743–6. Orrenius S, Gogvadze V, Zhivotovsky B. 2007. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47:143–83. Osman C, Haag M, Potting C, Rodenfels J, Dip PV, Wieland FT, Brugger B, Westermann B, Langer T. 2009a. The genetic interactome of prohibitins: coordinated control of cardiolipin and phosphatidylethanolamine by conserved regulators in mitochondria. J Cell Biol 184:583–96. Osman C, Merkwirth C, Langer T. 2009b. Prohibitins and the functional compartmentalization of mitochondrial membranes. J Cell Sci 122:3823–30. Ott M, Herrmann JM. 2009. Co-translational membrane insertion of mitochondrially encoded proteins. Biochim Biophys Acta 1803(6):767–75. Ott M, Zhivotovsky B, Orrenius S. 2007. Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Differ 14:1243–7. Pagliarini DJ, Dixon JE. 2006. Mitochondrial modulation: reversible phosphorylation takes center stage? Trends Biochem Sci 31:26–34. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, Walford GA, Sugiana C, Boneh A, Chen WK, Hill DE, Vidal M, Evans JG, Thorburn DR, Carr SA, Mootha VK. 2008. A mitochondrial protein compendium elucidates complex I disease biology. Cell 134:112–23. Pakendorf B, Stoneking M. 2005. Mitochondrial DNA and human evolution. Annu Rev Genomics Hum Genet 6:165–83. Palade GE. 1952. The fine structure of mitochondria. Anat Rec 114:427–51. Palade GE. 1953. An electron microscope study of the mitochondrial structure. J Histochem Cytochem 1: 188–211. Panigrahi AK, Ogata Y, Zikova A, Anupama A, Dalley RA, Acestor N, Myler PJ, Stuart KD. 2009. A comprehensive analysis of Trypanosoma brucei mitochondrial proteome. Proteomics 9:434–50. Paschen SA, Neupert W, Rapaport D. 2005. Biogenesis of beta-barrel membrane proteins of mitochondria. Trends Biochem Sci 30:575–82. Paumard P, Vaillier J, Coulary B, Schaeffer J, Soubannier V, Mueller DM, Brethes D, di Rago JP, Velours J. 2002. The ATP synthase is involved in generating mitochondrial cristae morphology. EMBO J 21:221–30. Perkins G, Renken C, Martone ME, Young SJ, Ellisman M, Frey T. 1997. Electron tomography of neuronal mitochondria: three-dimensional structure and organization of cristae and membrane contacts. J Struct Biol 119:260–72. Perkins G, Bossy-Wetzel E, Ellisman MH. 2009. New insights into mitochondrial structure during cell death. Exp Neurol 218:183–92. Pinton P, Giorgi C, Siviero R, Zecchini E, Rizzuto R. 2008. Calcium and apoptosis: ER-mitochondria Ca2+
c06.indd 107
107
transfer in the control of apoptosis. Oncogene 27: 6407–18. Pizzo P, Pozzan T. 2007. Mitochondria-endoplasmic reticulum choreography: structure and signaling dynamics. Trends Cell Biol 17:511–7. Plecita-Hlavata L, Lessard M, Santorova J, Bewersdorf J, Jezek P. 2008. Mitochondrial oxidative phosphorylation and energetic status are reflected by morphology of mitochondrial network in INS-1E and HEP-G2 cells viewed by 4Pi microscopy. Biochim Biophys Acta 1777:834–46. Popov-Celeketic D, Mapa K, Neupert W, Mokranjac D. 2008. Active remodelling of the TIM23 complex during translocation of preproteins into mitochondria. EMBO J 27:1469–80. Priault M, Salin B, Schaeffer J, Vallette FM, di Rago JP, Martinou JC. 2005. Impairing the bioenergetic status and the biogenesis of mitochondria triggers mitophagy in yeast. Cell Death Differ 12:1613–21. Prokisch H, Scharfe C, Camp DG, 2nd, Xiao W, David L, Andreoli C, Monroe ME, Moore RJ, Gritsenko MA, Kozany C, Hixson KK, Mottaz HM, Zischka H, Ueffing M, Herman ZS, Davis RW, Meitinger T, Oefner PJ, Smith RD, Steinmetz LM. 2004. Integrative analysis of the mitochondrial proteome in yeast. PLoS Biol 2:e160. Rabl R, Soubannier V, Scholz R, Vogel F, Mendl N, Vasiljev-Neumeyer A, Korner C, Jagasia R, Keil T, Baumeister W, Cyrklaff M, Neupert W, Reichert AS. 2009. Formation of cristae and crista junctions in mitochondria depends on antagonism between Fcj1 and Su e/g. J Cell Biol 185:1047–63. Rasmussen N. 1995. Mitochondrial structure and the practice of cell biology in the 1950s. J Hist Biol 28:381–429. Reddy PH. 2009. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer ’s disease. Exp Neurol 218:286–92. Regev-Rudzki N, Pines O. 2007. Eclipsed distribution: a phenomenon of dual targeting of protein and its significance. Bioessays 29:772–82. Rehling P, Brandner K, Pfanner N. 2004. Mitochondrial import and the twin-pore translocase. Nat Rev Mol Cell Biol 5:519–30. Reinders J, Wagner K, Zahedi RP, Stojanovski D, Eyrich B, van der Laan M, Rehling P, Sickmann A, Pfanner N, Meisinger C. 2007. Profiling phosphoproteins of yeast mitochondria reveals a role of phosphorylation in assembly of the ATP synthase. Mol Cell Proteomics 6:1896–906. Reja R, Venkatakrishnan A, Lee J, Kim B-C, Ryu J-W, Gong S, Bhak J, Park D. 2009. MitoInteractome: mitochondrial protein interactome database, and its application in “aging network” analysis. BMC Genomics 10:S20. Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM, Tuft RA, Pozzan T. 1998. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science 280:1763–6. Rizzuto R, Marchi S, Bonora M, Aguiari P, Bononi A, De Stefani D, Giorgi C, Leo S, Rimessi A, Siviero R,
5/6/2011 6:40:17 PM
108
CHAPTER 6
MITOCHONDRIA
Zecchini E, Pinton P. 2009. Ca(2+) transfer from the ER to mitochondria: when, how and why. Biochim Biophys Acta 1787:1342–51. Romagnoli A, Aguiari P, De Stefani D, Leo S, Marchi S, Rimessi A, Zecchini E, Pinton P, Rizzuto R. 2007. Endoplasmic reticulum/mitochondria calcium cross-talk. Novartis Found Symp 287:122–31; discussion 131–9. Rouault TA, Tong WH. 2008. Iron-sulfur cluster biogenesis and human disease. Trends Genet 24:398–407. Ruiz-Pesini E, Lott MT, Procaccio V, Poole JC, Brandon MC, Mishmar D, Yi C, Kreuziger J, Baldi P, Wallace DC. 2007. An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res 35:D823–8. Rustin P, Kroemer G. 2007. Mitochondria and cancer. Ernst Schering Found Symp Proc (4):1–21. Sagan L. 1967. On the origin of mitosing cells. J Theor Biol 14:255–74. Sandoval H, Thiagarajan P, Dasgupta SK, Schumacher A, Prchal JT, Chen M, Wang J. 2008. Essential role for Nix in autophagic maturation of erythroid cells. Nature 454:232–5. Scaglia F, Wong LJ. 2008. Human mitochondrial transfer RNAs: role of pathogenic mutation in disease. Muscle Nerve 37:150–71. Schaefer AM, McFarland R, Blakely EL, He L, Whittaker RG, Taylor RW, Chinnery PF, Turnbull DM. 2008. Prevalence of mitochondrial DNA disease in adults. Ann Neurol 63:35–9. Schapira AH. 2006. Mitochondrial disease. Lancet 368:70–82. Schatz G, Haslbrunner E, Tuppy H. 1964. Deoxyribonucleic acid associated with yeast mitochondria. Biochemical Biophysical Res Comms 15:127–32. Scheffler IE. 2001. A century of mitochondrial research: achievements and perspectives. Mitochondrion 1:3–31. Schiff M, Loublier S, Coulibaly A, Benit P, Ogier de Baulny H, Rustin P. 2009. Mitochondria and diabetes mellitus: untangling a conflictive relationship? J Inherit Metab Dis 32(6):684–98. Schimper AFW. 1883. Über die entwicklung der chlorophyllkörner und farbkörper. Bot Ztg 41:105–12. Schlame M. 2008. Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes. J Lipid Res 49:1607–20. Schlame M, Ren M. 2006. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett 580: 5450–5. Schlame M, Ren M. 2009. The role of cardiolipin in the structural organization of mitochondrial membranes. Biochim Biophys Acta 1788:2080–3. Schlame M, Rua D, Greenberg ML. 2000. The biosynthesis and functional role of cardiolipin. Prog Lipid Res 39:257–88. Schug ZT, Gottlieb E. 2009. Cardiolipin acts as a mitochondrial signalling platform to launch apoptosis. Biochim Biophys Acta 1788:2022–31. Schweers RL, Zhang J, Randall MS, Loyd MR, Li W, Dorsey FC, Kundu M, Opferman JT, Cleveland JL, Miller JL, Ney PA. 2007. NIX is required for pro-
c06.indd 108
grammed mitochondrial clearance during reticulocyte maturation. Proc Natl Acad Sci U S A 104:19500–5. Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Mannella CA, Korsmeyer SJ. 2002. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2:55–67. Shutt TE, Shadel GS. 2007. Expanding the mitochondrial interactome. Genome Biol 8:203. Sickmann A, Reinders J, Wagner Y, Joppich C, Zahedi R, Meyer HE, Schonfisch B, Perschil I, Chacinska A, Guiard B, Rehling P, Pfanner N, Meisinger C. 2003. The proteome of Saccharomyces cerevisiae mitochondria. Proc Natl Acad Sci U S A 100:13207–12. Sjostrand FS. 1953. Electron microscopy of mitochondria and cytoplasmic double membranes. Nature 171:30–2. Skulachev VP, Bakeeva LE, Chernyak BV, Domnina LV, Minin AA, Pletjushkina OY, Saprunova VB, Skulachev IV, Tsyplenkova VG, Vasiliev JM, Yaguzhinsky LS, Zorov DB. 2004. Thread-grain transition of mitochondrial reticulum as a step of mitoptosis and apoptosis. Mol Cell Biochem 256–257:341–58. Smeitink J, van den Heuvel L, DiMauro S. 2001. The genetics and pathology of oxidative phosphorylation. Nat Rev Genet 2:342–52. Smeitink JA, Zeviani M, Turnbull DM, Jacobs HT. 2006. Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab 3:9–13. Smith AC, Robinson AJ. 2009. MitoMiner, an integrated database for the storage and analysis of mitochondrial proteomics data. Mol Cell Proteomics 8:1324–37. Song Z, Ghochani M, McCaffery JM, Frey TG, Chan DC. 2009. Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol Biol Cell 20:3525–32. Spelbrink JN. 2009. Functional organization of mammalian mitochondrial DNA in nucleoids: history, recent developments, and future challenges. IUBMB Life 62: 19–32. Sperka-Gottlieb CD, Hermetter A, Paltauf F, Daum G. 1988. Lipid topology and physical properties of the outer mitochondrial membrane of the yeast, Saccharomyces cerevisiae. Biochim Biophys Acta 946:227–34. Steinmetz LM, Scharfe C, Deutschbauer AM, Mokranjac D, Herman ZS, Jones T, Chu AM, Giaever G, Prokisch H, Oefner PJ, Davis RW. 2002. Systematic screen for human disease genes in yeast. Nat Genet 31:400–4. Strauss M, Hofhaus G, Schroder RR, Kuhlbrandt W. 2008. Dimer ribbons of ATP synthase shape the inner mitochondrial membrane. EMBO J 27:1154–60. Su B, Wang X, Zheng L, Perry G, Smith MA, Zhu X. 2010. Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim Biophys Acta 1802:135–42. Suen DF, Norris KL, Youle RJ. 2008. Mitochondrial dynamics and apoptosis. Genes Dev 22:1577–90. Taguchi N, Ishihara N, Jofuku A, Oka T, Mihara K. 2007. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem 282:11521–9.
5/6/2011 6:40:17 PM
REFERENCES
Tal R, Winter G, Ecker N, Klionsky DJ, Abeliovich H. 2007. Aup1p, a yeast mitochondrial protein phosphatase homolog, is required for efficient stationary phase mitophagy and cell survival. J Biol Chem 282:5617–24. Tarassov I, Kamenski P, Kolesnikova O, Karicheva O, Martin RP, Krasheninnikov IA, Entelis N. 2007. Import of nuclear DNA-encoded RNAs into mitochondria and mitochondrial translation. Cell Cycle 6:2473–7. Tatsuta T, Langer T. 2008. Quality control of mitochondria: protection against neurodegeneration and ageing. EMBO J 27:306–14. Taylor RW, Turnbull DM. 2005. Mitochondrial DNA mutations in human disease. Nat Rev Genet 6:389–402. Thomas B, Beal MF. 2007. Parkinson’s disease. Hum Mol Genet 16 Spec No. 2:R183–94. Tielens AG, Rotte C, van Hellemond JJ, Martin W. 2002. Mitochondria as we don’t know them. Trends Biochem Sci 27:564–72. Tovar J, Fischer A, Clark CG. 1999. The mitosome, a novel organelle related to mitochondria in the amitochondrial parasite Entamoeba histolytica. Mol Microbiol 32:1013–21. Tovar J, Leon-Avila G, Sanchez LB, Sutak R, Tachezy J, van der Giezen M, Hernandez M, Muller M, Lucocq JM. 2003. Mitochondrial remnant organelles of Giardia function in iron-sulphur protein maturation. Nature 426:172–6. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly YM, Gidlof S, Oldfors A, Wibom R, Tornell J, Jacobs HT, Larsson NG. 2004. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429: 417–23. Trifunovic A, Hansson A, Wredenberg A, Rovio AT, Dufour E, Khvorostov I, Spelbrink JN, Wibom R, Jacobs HT, Larsson NG. 2005. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci U S A 102:17993–8. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, Shirihai OS. 2008. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27:433–46. Underhill PA, Kivisild T. 2007. Use of y chromosome and mitochondrial DNA population structure in tracing human migrations. Annu Rev Genet 41:539–64. van der Giezen M. 2009. Hydrogenosomes and mitosomes: conservation and evolution of functions. J Eukaryot Microbiol 56:221–31. van der Giezen M, Tovar J. 2005. Degenerate mitochondria. EMBO Rep 6:525–30. Velours J, Dautant A, Salin B, Sagot I, Brethes D. 2009. Mitochondrial F1F0-ATP synthase and organellar internal architecture. Int J Biochem Cell Biol 41: 1783–9. Vogel F, Bornhovd C, Neupert W, Reichert AS. 2006. Dynamic subcompartmentalization of the mitochondrial inner membrane. J Cell Biol 175:237–47.
c06.indd 109
109
Voos W. 2009. Mitochondrial protein homeostasis: the cooperative roles of chaperones and proteases. Res Microbiol 160:718–25. Wallace DC. 2005a. Mitochondria and cancer: warburg addressed. Cold Spring Harb Symp Quant Biol 70: 363–74. Wallace DC. 2005b. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39: 359–407. Wallace DC, Fan W. 2009. The pathophysiology of mitochondrial disease as modeled in the mouse. Genes Dev 23:1714–36. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Elsas LJ, 2nd, Nikoskelainen EK. 1988a. Mitochondrial DNA mutation associated with Leber ’s hereditary optic neuropathy. Science 242:1427–30. Wallace DC, Zheng XX, Lott MT, Shoffner JM, Hodge JA, Kelley RI, Epstein CM, Hopkins LC. 1988b. Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 55:601–10. Wallace DC, Fan W, Procaccio V. 2010. Mitochondrial energetics and therapeutics. Annu Rev Pathol Mech Dis 5(1):297–348. Wallin IE. 1923. The mitochondria problem. Am Nat 57:255–61. Walther DM, Rapaport D. 2009. Biogenesis of mitochondrial outer membrane proteins. Biochim Biophys Acta 1793:42–51. Warburg OH. 1913. Über sauerstoffatmende körnchen aus leberzellen und über sauerstiffatmung in berkefeldfiltraten wässriger leberextrakte. Pflüger ’s Arch ges Physiol 154:599–617. Westermann B. 2009. Mitochondrial dynamics in model organisms: what yeasts, worms and flies have taught us about fusion and fission of mitochondria. Semin Cell Dev Biol 21(6):542–9. Wieckowski MR, Giorgi C, Lebiedzinska M, Duszynski J, Pinton P. 2009. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat Protoc 4:1582–90. Williams BA, Hirt RP, Lucocq JM, Embley TM. 2002. A mitochondrial remnant in the microsporidian Trachipleistophora hominis. Nature 418:865–9. Wittig I, Schagger H. 2009. Supramolecular organization of ATP synthase and respiratory chain in mitochondrial membranes. Biochim Biophys Acta 1787: 672–80. Wriessnegger T, Leitner E, Belegratis MR, Ingolic E, Daum G. 2009. Lipid analysis of mitochondrial membranes from the yeast Pichia pastoris. Biochim Biophys Acta 1791:166–72. Wurm CA, Jakobs S. 2006. Differential protein distributions define two sub-compartments of the mitochondrial inner membrane in yeast. FEBS Lett 580: 5628–34. Yamaguchi R, Lartigue L, Perkins G, Scott RT, Dixit A, Kushnareva Y, Kuwana T, Ellisman MH,
5/6/2011 6:40:17 PM
110
CHAPTER 6
MITOCHONDRIA
Newmeyer DD. 2008. Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization. Mol Cell 31: 557–69. Yamano K, Kuroyanagi-Hasegawa M, Esaki M, Yokota M, Endo T. 2008. Step-size analyses of the mitochondrial Hsp70 import motor reveal the Brownian ratchet in operation. J Biol Chem 283:27325–32. Zick M, Rabl R, Reichert AS. 2009. Cristae formationlinking ultrastructure and function of mitochondria. Biochim Biophys Acta 1793:5–19. Zinser E, Sperka-Gottlieb CD, Fasch EV, Kohlwein SD, Paltauf F, Daum G. 1991. Phospholipid synthesis and lipid composition of subcellular membranes in the unicellular eukaryote Saccharomyces cerevisiae. J Bacteriol 173:2026–34. Zorzano A, Sebastian D, Segales J, Palacin M. 2009. The molecular machinery of mitochondrial fusion and
fission: an opportunity for drug discovery? Curr Opin Drug Discov Devel 12:597–606. Zuchner S, Mersiyanova IV, Muglia M, BissarTadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E, Patitucci A, Senderek J, Parman Y, Evgrafov O, Jonghe PD, Takahashi Y, Tsuji S, Pericak-Vance MA, Quattrone A, Battaloglu E, Polyakov AV, Timmerman V, Schroder JM, Vance JM. 2004. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 36:449–51. Zunino R, Schauss A, Rippstein P, Andrade-Navarro M, McBride HM. 2007. The SUMO protease SENP5 is required to maintain mitochondrial morphology and function. J Cell Sci 120:1178–88. Zutz A, Gompf S, Schagger H, Tampe R. 2009. Mitochondrial ABC proteins in health and disease. Biochim Biophys Acta 1787:681–90.
FURTHER READING A valuable number of excellent monographs covering the diverse facets of mitochondrial biology in greater detail are available. We would like to suggest a few of them to the readers that became captivated by
mitochondria and intend to widen and deepen their knowledge about this versatile and fascinating organelle.
General Lane N. 2006. Power, sex, suicide: mitochondria and the meaning of life. Oxford, UK: Oxford University Press. Sczheffler IE. 2008. Mitochondria, 2nd ed. Hoboken, NJ: Wiley-Liss. Nicholls DG, Ferguson SJ. 2002. Bioenergetics 3, Amsterdam, the Netherlands; London, UK: Academic Press.
Schaffer SW, Suleiman MS. 2007. Mitochondria: the dynamic organelle. Advances in biochemistry in health and disease 2. New York: Springer. Chadwick D, Goode J. 2007. Mitochondrial biology: new perspectives. London, UK: John Wiley.
Origin of Mitochondria and Related Organelles Martin WF, Müller M. 2007. Origin of mitochondria and hydrogenosomes. Berlin, Germany; New York: Springer.
Tachezy J. 2008. Hydrogenosomes and mitosomes: mitochondria of anaerobic eukaryotes. Microbiology Monographs 9. Berlin, Germany: Springer.
Mitochondria and Disease Holt IJ. 2003. Genetics of mitochondrial diseases. Oxford, UK: Oxford University Press. Berdanier CD. 2005. Mitochondria in health and disease. Oxidative stress and disease 16. Boca Raton, FL: CRC Press. Gibson GE, Ratan RR, Beal MF; New York Academy of Sciences. 2008. Mitochondria and oxidative stress
c06.indd 110
in neurodegenerative disorders. Boston; Oxford, UK: Blackwell. Lemasters JJ, Nieminen A-L. 2001. Mitochondria in pathogenesis. New York; London, UK: Kluwer Academic Publishers. Singh KK, Costello L. 2008. Mitochondria and cancer. New York: Springer.
5/6/2011 6:40:17 PM
FURTHER READING
111
Experimental Approach to Mitochondria Pon LA, Schon EA; American Society for Cell Biology. 2007. Mitochondria, 2nd ed. Methods in Cell Biology 80. San Diego, CA: Academic Press. Leister D, Herrmann J. 2007. Mitochondria: practical protocols. Methods in Molecular Biology 372, Totowa, NJ: Humana Press.
c06.indd 111
Stuart JA. 2009. Mitochondrial DNA: methods and protocols, 2nd ed. Methods in Molecular Biology 554. Totowa, NJ: Humana Press.
5/6/2011 6:40:17 PM
.
CH A P T E R
7
THE ENDOPLASMIC RETICULUM Jody Groenendyk Marek Michalak
DEFINITION OF THE DOMAIN The endoplasmic reticulum (ER) is an intracellular membrane organelle that forms a network of tubules, vesicles, and cisternae within the cell, and is interconnected with the nuclear envelope that surrounds the nucleus. The ER is a multifunctional organelle responsible for the synthesis and facilitation of intracellular transport of membrane-associated and secreted proteins, lipid and steroid synthesis and transport, Ca2+ signaling, communication with other intracellular organelles including mitochondria and plasma membrane, and stress responses. The ER contains a number of multifunctional integral and resident molecular chaperones and folding enzymes responsible for quality control of proteins, posttranslational modifications, regulation of Ca2+ signaling, and homeostasis and control of ER stress. For example, calreticulin, calnexin, and ERp57 play a role in the quality control of newly synthesized glycoproteins. Other enzymes, including oxidoreductases, oligosaccharide transferases, glucosidases, and mannosidases, are responsible for protein modifications such as disulfide bond formation and N-linked glycosylation. ER luminal chaperones are also responsible for the regulation of the ER stress response and ERassociated degradation (ERAD). ER resident chaperones are major ER luminal Ca2+ buffers, which, together with the inositol-1,4,5-trisphosphate (InsP3) receptor/Ca2+ channel, the sarcoplasmic/ER Ca2+ ATPase (SERCA), and the stromal-interacting molecule 1 (STIM1), a sensor of ER luminal Ca2+, are critical for the regulation of Ca2+ signaling in cells. The ER is also one of the most sophisticated sensors of cellular stresses evoked by environmental or intracellular signals. The membrane has developed a network of integral membrane kinases and resident proteins to regulate ER stress responses. Therefore, the ER is able to contribute during cellular adaptation to many different challenges, which include environmental, metabolic, and intrinsic demands as well as developmental pathways.
INTRODUCTION AND HISTORICAL PERSPECTIVES The ER was first visualized using electron microscopy, by staining Purkinje cells and muscle using heavy metals or basic dyes in the late nineteenth century and has since been found to be present in nearly all cells of higher plants and animals. In 1945, using electron microscopy techniques, Keith Porter and collaborators noted the presence of a “lacelike” structure in cells grown in culture and termed this structure the ER (Porter et al. 1945;
Cellular Domains, First Edition. Edited by Ivan R. Nabi. © 2011 John Wiley & Sons, Inc. Published 2011 by John Wiley & Sons, Inc.
113
c07.indd 113
5/6/2011 6:45:47 PM
114
CHAPTER 7
THE ENDOPLASMIC RETICULUM
Palade 1956). Further examination recognized the ER as the organelle responsible for protein production by the discovery of ribosome-studded portions that corresponded to areas of high biosynthetic activity (Palade and Porter 1954; Palade 1955). Electron microscopy studies have identified the ER as a continuous, dynamic, interconnected membrane system containing microenvironments associated with specific functions and that interacts with other organelles within the cell (Sabatini et al. 1963; Song et al. 1991). The concept of the ER as an important intracellular Ca2+ store was proposed by Heilbrunn over 60 years ago (Heilbrunn and Wiercinsky 1947). Later, the concept of Ca2+ transporters (SERCA) and Ca2+-induced Ca2+ release was developed (Franzini-Armstrong 1998), followed by the discovery of the receptor-activated, second-messenger-induced intracellular Ca2+ release (Nielsen and Petersen 1972; Case and Clausen 1973). Seminal experiments a decade later by Berridge and his colleagues showed that this alternative pathway for intracellular Ca2+ release is mediated by the second messenger InsP3 (Streb et al. 1983). The ER Ca2+ release channels were molecularly characterized revealing two main families: the Ca2+-gated and InsP3-gated channels. Discoveries of ER signaling (Horton et al. 2002; BengoecheaAlonso and Ericsson 2007) and ER stress (Malhotra and Kaufman 2007) pathways further reinforced the distinctive nature of this fascinating intracellular organelle. The focus of this chapter is on the structure and function of the ER, with a major emphasis on its role as the entry site for the secretory pathway and a modulator of Ca2+ homeostasis. Sarcoplasmic reticulum (SR), a muscle-specific ER, is discussed here in context of ERdependent regulation of Ca2+ homeostasis. Many excellent reviews on the structure and function of the SR have been published (Mazzarello et al. 2003; Treves et al. 2009) including the latest commentary on the ER and SR in cardiac muscle (Michalak and Opas 2009).
STRUCTURE AND DYNAMICS OF THE ER Today, the ER is recognized as a heterogeneous and dynamic membrane system containing specific microdomains involved in protein folding, transport, and Ca2+ signaling (Papp et al. 2003). There are three main areas of the ER: the rough ER, the smooth ER, and the nuclear envelope. The rough ER is characterized by association with ribosomes, which are responsible for supporting translation of mRNA into protein and targeting the mRNA to a translocon located in the ER membrane. The smooth ER is where the ER cargo is exported and is characterized by the presence of coat protein complex (COP) II coatomer and cargo receptors such as the ER–Golgi intermediate compartment 53 (ERGIC-53) (Hobman et al. 1998). Smooth ER might also play an important role in the control of cellular Ca2+ homeostasis. The third subdomain, the nuclear envelope, is responsible for transit to the nucleus of Ca2+ and proteins involved in gene expression and will not be discussed here (see also Chapter 24 on the nuclear pore). One critical part of the ER structure is its dynamic capacity, continually moving and shaping via the action of motor proteins attached to the microtubule network (WatermanStorer and Salmon 1998; Wozniak et al. 2009) (see also Chapter 14 on microtubules). In cells that are treated with a microtubule inhibitor such as nocodazole, or by downregulation of kinesin, a motor protein, motility of the ER structures is blocked (Wozniak et al. 2009). As well, a direct interaction between ER tubules and growing microtubule plus ends via tip attachment complexes has recently been identified, with these contacts generated by the interaction of the microtubule plus-end-binding protein, EB1 with an ER resident membrane protein, STIM1 (Grigoriev et al. 2008). Another motor protein, dynein, is involved in the movement of ER tubules in the reverse direction (Lane and Allan 1999). Blockage of kinesin slows cargo exit from the ER, while loss of microtubules results in
c07.indd 114
5/6/2011 6:45:47 PM
ER: A MULTIFUNCTIONAL ORGANELLE
115
lateral mobility of translocon machinery (Nikonov et al. 2007; Gupta et al. 2008). Cytoskeleton-linking membrane proteins (CLIMPs) and cytoplasmic linker proteins (CLIPs) link the ER membrane to the microtubule network via tubulin-binding domains (Rickard and Kreis 1996; Klopfenstein et al. 1998). Ankyrins are directly involved in restricting specific proteins (including the ryanodine receptor [RyR], InsP3 receptor, and SERCA) to specialized regions of the ER (Tuvia et al. 1999). These discrete subdomains may be critical for coordination and optimization of global ER function and interaction with other organelles or membranes (Baumann and Walz 2001).
ER PROTEOME Following the recent wave of total genome sequencing analysis, research has turned to understanding the functions, modifications, and regulation of all proteins encoded by a genome (Au et al. 2007). Large-scale proteomics technologies and tools have made organelle-scale studies feasible and have become powerful methods for studying organelles, including the ER and their components and dynamics (Yates et al. 2005). Proteomics is the identification of the total protein complement or proteome of various organelles and cells. The basic rationale of proteomics research is to integrate the information obtained from analysis into a comprehensive proteome database that contains protein identities and functional characteristics. Subcellular fractionation followed by two-dimensional gel electrophoresis combined with peptide analyses using matrix-assisted laser desorption/ ionization mass spectroscopy and tandem mass spectrometry provides a sensitive analytical tool that identifies proteins. These techniques have been used successfully to determine the protein composition of subcellular structures including the luminal ER (Knoblach et al. 2003; Gilchrist et al. 2006), trafficking vesicles (Takamori et al. 2006), and specialized cell types such as platelets (O’Neill et al. 2002). Proteomic analysis of the ER has identified over 400 proteins associated with the ER, the majority belonging to functional categories including ribosomal proteins, translocon subunits, chaperones, secretory proteins, and glycolipid processing enzymes (Knoblach et al. 2003; Gilchrist et al. 2006; Chen et al. 2010). The ER cargo proteins are another important class of proteins identified, which move through the ER via the secretory pathway, an example being transferrin, an ironbinding protein; a number of secreted pheromone-binding proteins termed major urinary proteins (MUPs); and apolipoprotein A, which transports cholesterol from tissues to the liver (Knoblach et al. 2003). Additional classes of identified proteins are involved in other vital functions of the ER, including membrane trafficking, Ca2+ storage, and oligosaccharide biosynthesis. Table 7.1 shows a list of selected ER-associated proteins identified by proteomic techniques. An important benefit of doing organellar proteomics is the identification of novel proteins, such as two protein disulfide isomerase (PDI)-like proteins, ERp19 and ERp46 (Knoblach et al. 2003), as well as sapreticulin involved in sphingolipid degradation (Gilchrist et al. 2006). The real power of proteomics analysis of the ER will be realized when comprehensive and comparative analyses of the ER proteome are carried out in different cell types, under different physiological states, and in normal and diseased cells.
ER: A MULTIFUNCTIONAL ORGANELLE The ER is a multifunctional intracellular organelle influencing virtually every aspect of cellular function (Baumann and Walz 2001; Sitia and Braakman 2003). The ER is the entry
c07.indd 115
5/6/2011 6:45:47 PM
116
CHAPTER 7
THE ENDOPLASMIC RETICULUM
TABLE 7.1. Selected Proteins Identified from Endoplasmic Reticulum Proteomic Analysis (Knoblach et al. 2003; Gilchrist et al. 2006; Chen et al. 2010)
Protein Name Spectrin alpha chain Clathrin heavy chain Protein disulfide isomerase (PDI) precursor 78-kDa glucose-regulated protein precursor glucose-regulated protein (GRP) 78 Transferrin Glutamate dehydrogenase, mitochondrial precursor Eukaryotic translation elongation factor 2 Cytochrome P450 2D2 Myosin heavy chain myr 4 ERp46 Calreticulin precursor Calnexin precursor 60S ribosomal protein L4 Endoplasmic reticulum–Golgi intermediate compartment 53 (ERGIC-53) protein precursor Carboxylesterase 3 precursor Pyruvate carboxylase, mitochondrial precursor Tubulin β2 Polymeric immunoglobulin receptor precursor Annexin A5 Endoplasmic reticulum protein 29 Golgi synaptosomal associated protein (SNAP) receptor complex member 1 Major urinary protein (MUP) precursor Low-density lipoprotein receptor-related protein-associated protein 1 Apolipoprotein A Chloride intracellular channel protein 4 N-cadherin Ras-related protein Rab-18 Signal recognition particle receptor subunit beta Endoplasmic reticulum α-1,2-mannosidase ERp19
Function Cytoskeleton Coatomer PDI family Chaperone Secretion Mitochondria Translation Mitochondria Cytoskeleton PDI family Chaperone Chaperone Translation Secretion Lipid metabolism Mitochondria Cytoskeleton Cargo Cytoskeleton PDI family Secretion Secretion Cargo Cargo Cargo Cytoskeleton Signaling Transcription Oligosaccharide PDI family
point of the secretory pathway, with the ER environment containing a high concentration of protein (∼300 mg/mL), having an oxidizing environment and high in Ca2+ concentration, similar to the outside of the cell. As one-third of newly synthesized proteins traverse the ER, homeostasis of the ER secretory pathway is mandatory and is maintained by entrance of nascent polypeptides balanced by exit of either correctly folded proteins or degradation of misfolded proteins. The ER is the site for specific protein modifications such as addition of N-linked glycosylation, disulfide bond formation, and attachment of glycosylphosphatidylinositol (GPI) anchors. If this secretory pathway is disrupted in any manner, ER stress results due to a buildup of misfolded protein, triggering a cellular response termed the unfolded protein response (UPR). In conjunction, ERAD is initiated in an attempt to recover homeostasis, and subsequently, the apoptotic pathway is activated. Not surprisingly, there are a variety of pathological conditions linked to a breakdown in ERassociated processes, including vascular diseases such as myocardial infarction and atherosclerosis (Brooks 1997, 1999; Jakob et al. 2001; Sherman and Goldberg 2001; Graf
c07.indd 116
5/6/2011 6:45:47 PM
ER: A MULTIFUNCTIONAL ORGANELLE
TABLE 7.2.
Protein
Knockout Mouse Models and Associated Diseases
Knockout Mouse Model
BiP/GRP78
GRP94 ERp57
Embryonic lethal at E3.5 • Failure of embryo to periimplant Embryonic lethal Embryonic lethal at E13.5 • Disruption in Stat3 signaling • Disruption in major histocompatability complex (MHC) Class I loading (ERp57 conditional knockout) Not done
PDI
117
Calnexin
Not embryonic lethal • Postnatal motor disorders
Calreticulin
Embryonic lethal at E14.5 • Defective cardiac development
UGGT
Embryonic lethal at E13
Diseases
References
Cancer, Alzheimer ’s disease, Parkinson’s disease, prion diseases, atherosclerosis
Luo et al. (2006); Hoshino et al. (2007)
Cancer, prion diseases, autoimmune diseases Prion diseases, Alzheimer ’s disease, autoimmune diseases
Wanderling et al. (2007) Coe et al. (pers. comm.); Garbi et al. (2006); Solda et al. (2006)
Alzheimer ’s disease, Parkinson’s disease Alzheimer ’s disease, cystic Denzel et al. (2002); fibrosis, Charcot–Marie– Kraus et al. (pers. comm.) Tooth disease Cardiac hypertrophy, Mesaeli et al. (1999) Alzheimer ’s disease, autoimmune diseases None associated Molinari et al. (2005)
et al. 2004); neurodegenerative diseases, such as Alzheimer ’s disease, Creutzfeldt–Jakob disease and Charcot–Marie–Tooth disease (Jeffery et al. 2000; Soti and Csermely 2002; Shames et al. 2003; Rutkowski and Kaufman 2004); systemic diseases, such as cystic fibrosis and familial hypercholesterolemia (Chevet et al. 1999; Sorensen et al. 2006); as well as a number of cancer conditions, including malignant melanoma and breast cancer (Li et al. 2001; Dissemond et al. 2004) (Table 7.2).
Protein Synthesis, Folding, and Quality Control Folding within the ER involves three classes of proteins termed molecular chaperones, folding enzymes, and folding sensors. Molecular chaperones reduce the rate of protein folding by transiently interacting with substrates and increasing the efficiency of folding. Folding enzymes accelerate the rate-limiting steps of the folding process, such as disulfide bond formation, while folding sensors detect misfolded protein and interact with exposed hydrophobic domains and send the unfolded protein back into the folding cycle. For example, the molecular chaperones BiP/GRP78 and GRP94 recognize exposed hydrophobic regions assisting in the folding and assembly of the nascent protein (Argon and Simen 1999; Gething 1999), while calreticulin and calnexin interact with glycoproteins via their lectin-binding ability (Helenius et al. 1997). The folding enzymes PDI and ERp57, both thiol oxidoreductases, utilize the oxidizing environment of the ER to generate disulfide linkages (Oliver et al. 1997; Molinari and Helenius 1999; Noiva 1999), with the formation of these intra- and interchain disulfide bonds, an integral part of the maturation of most secretory and membrane-bound proteins in the ER. The folding sensor, uridine diphosphate (UDP)-glucose : glycoprotein glucosyltransferase (UGGT), recognizes unfolded proteins that are glycosylated and sends them back into the quality control cycle (Taylor et al. 2003). These chaperones and folding enzymes share a specific retention and
c07.indd 117
5/6/2011 6:45:47 PM
118
CHAPTER 7
THE ENDOPLASMIC RETICULUM
retrieval signals responsible for their retention in the ER. ER luminal resident proteins contain a C-terminal amino acid sequence of KDEL (Lys-Asp-Glu-Leu) or its variant (Nilsson and Warren 1994) and are retrieved by a receptor-mediated process (Michelsen et al. 2005). ER integral membrane proteins contain a KKXX (Lys-Lys-X-X) C-terminal amino acid sequence (Griffiths et al. 1994; Nilsson and Warren 1994) and utilize a COPdependent pathway for retention (Nilsson and Warren 1994). Carbohydrate modification of newly synthesized proteins plays an important role in protein folding and posttranslational modification (Helenius and Aebi 2004) (see Chapter 8 for discussion of glycosylation in the Golgi apparatus). As nascent glycoproteins are translocated into the lumen of the ER, they associate with Ca2+-dependent molecular chaperones (Helenius and Aebi 2004) responsible for appropriate folding (Molinari and Helenius 2000). The proteins utilize the quality control machinery, which includes the lectin chaperones calreticulin and calnexin, oxidoreductase ERp57, glucosidases, mannosidases, and UGGT (Helenius and Aebi 2004; Hebert and Molinari 2007) (Fig. 7.1).
Ribosome Oligosaccharide-DP
Flippase
OST
CNX
ERp57
ERp57
CRT
Glucosidase II
UGGT
α-Mann I
BiP α-Mann I PDI
ER lumen
GRP94
ERAD Transit of correctly folded protein
UPR
Figure 7.1. Endoplasmic reticulum quality control. The oligosaccharide is generated in the cytoplasm and is linked to a membrane-bound anchor, dolicholphosphate (DP), followed by flipping to the lumen of the ER, where it is linked to the N in the specific sequence, NXS/T of a nascent protein by the enzyme oligosaccharyltransferase (OST). This nascent protein then associates with the quality control apparatus, including calnexin (CNX), calreticulin (CRT), ERp57, and UDP-glucose : glycoprotein glucosyltransferase (UGGT). These enzymes and chaperones cooperate to fold nascent glycoproteins. If this protein is not able to fold after repeated cycles of quality control, it undergoes cleavage of mannose residues by the α-mannosidase I (α-mann I) and is targeted for ERAD. As well, the accumulation of misfolded protein triggers the UPR upon the interaction of BiP/GRP78 with the misfolded protein. Once the protein is folded properly, it exits the ER and transits to other locations within the cell. PDI, protein disulfide isomerase.
c07.indd 118
5/6/2011 6:45:47 PM
ER: A MULTIFUNCTIONAL ORGANELLE
119
Nonglycosylated proteins associate with BiP/GRP78 and GRP94 molecular chaperones and PDI folding enzyme (Ni and Lee 2007) (Fig. 7.1). BiP/GRP78 utilizes the energy of ATP to assist in folding the nascent protein and plays a role as a central protein in the lumen of the ER by performing numerous functions including buffering Ca2+, functioning as a permeability barrier via physically blocking of the translocon pore, ratcheting the nascent protein through the pore, binding hydrophobic domains and folding nascent proteins, sensing and binding misfolded proteins that are exposing hydrophobic regions, and regulating the UPR and ERAD (Ni and Lee 2007). The molecular chaperone GRP94 interacts with partially folded polypeptides after BiP/GRP78, in an ATP-dependent manner with the hydrolysis of ATP a necessary part of the folding process (Ostrovsky et al. 2009). Calnexin and calreticulin, two members of the quality control cycle, interact with partially folded polypeptides by binding immature N-linked oligosaccharides. A core carbohydrate containing two N-acetylglucosamine residues, nine mannose residues with three terminal glucose residues is assembled and transferred onto an asparagine amino acid of the nascent polypeptide chain. As soon as the oligosaccharide is added, trimming begins. Three terminal glucoses are trimmed by glucosidase I and II, and a terminal mannose is trimmed by one or more ER mannosidases. The binding of calreticulin and calnexin to their substrates is mediated, at least in part, by a lectin site that recognizes the N-linked oligosaccharide processing intermediate Glc1Man9GlcNAc2 (Leach et al. 2002). This serves to prevent aggregation, protect proteins from premature degradation, and assure the correct folding status of proteins before continuing in the intracellular trafficking pathway. There is evidence that calnexin and calreticulin also recognize the polypeptide segments of the glycoproteins as well (Swanton et al. 2003; Williams 2006). Binding of substrates to calreticulin or calnexin is terminated by removal of the terminal glucose by glucosidase II. If the protein is not correctly folded, it can be reglucosylated by UGGT, allowing reassociation with calreticulin and calnexin. Finally, a terminal mannose is trimmed via an ER-localized α-1,2-mannosidase in a time-dependent manner (Fig. 7.1). Mannose trimming allows discrimination between unfolded and terminally misfolded glycoproteins. Misfolded proteins are recognized by part of the degradation machinery, the ER degradation-enhancing 1,2-mannosidase-like protein (EDEM), a membrane protein that selectively trims mannose glycans on misfolded proteins for recognition by the ERAD lectin, osteosarcoma-9 (OS-9), which targets the misfolded protein for retrotranslocation and degradation (Lederkremer 2009; Aebi et al. 2010). This quality control cycle serves as an efficient retention method, as unfolded glycoproteins can be reglucosylated by the unfolding sensor UGGT and interact with calreticulin or calnexin again until proper folding occurs. This cycle may occur numerous times until the protein is folded correctly or, if the quality control is unable to fold the protein, these misfolded and unfolded proteins accumulate and result in a variety of signaling pathways being activated to control the ensuing ER stress, including ERAD and UPR (Fig. 7.1). An important component of protein folding is the generation and isomerization of disulfide bonds, which assist in protein folding by lowering the number of available conformations that the protein can assume, as disulfide linkages physically limit the protein. Calnexin and calreticulin also present polypeptides for disulfide bond formation to a member of the PDI family, ERp57, a folding enzyme that directly binds to calnexin and calreticulin (Oliver et al. 1999) (Fig. 7.1). ERp57 is one of many PDI-like oxidoreductases associated with the ER (Elliott et al. 1997). PDI is an abundant and versatile oxidoreductase that has oxidase, reductase, and isomerase activity, and interacts with a variety of substrates (Edman et al. 1985). PDI contains a thioredoxin active site, composed of two cysteines separated by two other amino acid residues (the CXXC motif), as well as the typical fold of thioredoxin (Ferrari and Söling 1999). The protein also works as a molecular
c07.indd 119
5/6/2011 6:45:47 PM
120
CHAPTER 7
THE ENDOPLASMIC RETICULUM
chaperone by binding polypeptides and preventing protein aggregation (Freedman et al. 1994). The combination of redox and chaperone activities is what makes PDI an effective and important enzyme in oxidative protein folding (Sitia and Molteni 2004). ERp57 differs from PDI by catalyzing disulfide bond formation almost exclusively in glycoproteins in conjunction with calreticulin and calnexin (Oliver et al. 1997, 1999). Since disulfide bonds increase the stability of the native conformation, their absence or mispairing produces severely misfolded species, resulting in protein aggregation.
ERAD ERAD is a process by which misfolded ER proteins are detected and removed from the secretory pathway by ER-resident factors and directed to translocation machinery for retrotranslocation into the cytoplasm, where they undergo ubiquitin- and proteasomedependent degradation. ERAD is triggered when these misfolded proteins are targeted by the ER α-1,2-mannosidase I, which cleaves one or more mannose residues from the middle branch of the oligosaccharide (Frenkel et al. 2003). Trimming of these mannose residues effectively prevents reglucosylation by UGGT, thereby disrupting any interaction with calnexin in an attempt to refold the protein (Eriksson et al. 2004). Mannose-trimmed oligosaccharides are specifically recognized by EDEM (Spiro 2004), which accepts the protein from calnexin (Oda et al. 2003) and selectively trims further mannose glycans on the misfolded protein for recognition by the ERAD lectin, OS-9, which targets the misfolded protein for retrotranslocation and degradation (Hosokawa et al. 2001; Jakob et al. 2001; Oda et al. 2006; Aebi et al. 2009; Lederkremer 2009). The misfolded protein is unfolded and retrotranslocated into the cytoplasm, poly-ubiquitinated, and subsequently targeted to the 26S proteasome for degradation (Tsai et al. 2002). The retrotranslocation machinery, named Derlin1, in complex with cytoplasmic valosin-containing protein (VCP) also termed AAA ATPase p97 (Ye et al. 2005), and N-glycanase, which removes the oligosaccharide (Katiyar et al. 2005), appears to be distinct from the Sec61 translocon (Lilley and Ploegh 2004, 2005; Ye et al. 2004). Derlin1 transfers the misfolded polypeptide from the lumen of the ER to the cytoplasm for degradation by the proteasome, with this machinery an essential constituent of ERAD (Oda et al. 2006).
ER Ca2+ Homeostasis: Ca2+ Buffers As the ER is the major physiological source of Ca2+ within the cell, it plays an instrumental role as a signal-transducing organelle that responds to environmental cues that trigger intracellular Ca2+ signaling, as well as maintaining Ca2+ homeostasis (Berridge 2002; Michalak et al. 2002). Changes in Ca2+ homeostasis within the ER as well as Ca2+ released from the ER activates transcriptional and translational cascades that ultimately regulate chaperones responsible for protein folding, ER stress, UPR, and ERAD, as well as proteins involved in the apoptotic pathway (Berridge 2002; Breckenridge et al. 2003). Ca2+ homeostasis and signaling are maintained by controlling Ca2+ release from the ER by the InsP3 receptor (Patel et al. 1999) and RyR (Franzini-Armstrong and Protasi 1997), with the stores being refilled by SERCA (Ashby and Tepikin 2001) (Fig. 7.2). The ER Ca2+ stores not only serve as a source of easily accessible Ca2+ but are also important as a regulator of a number of ER enzymes and proteins including feedback regulation of the InsP3 receptor, the RyR, and SERCA. Localized to the lumen of the ER are proteins involved in Ca2+ signaling and buffering, affecting numerous aspects of ER function (Bergeron et al. 1994; Williams and Watts 1995; Meldolesi and Pozzan 1998; Nauseef 1999; Corbett and
c07.indd 120
5/6/2011 6:45:47 PM
121
ER: A MULTIFUNCTIONAL ORGANELLE
Ca
InsP3R
CSQ
CRT
PM
ERp57
BiP PDI
SERCA ERp57
GRP94
CRT
ORAI1 Stim1
ERp72 ERcalcistorin ER lumen
Figure 7.2. Endoplasmic reticulum Ca2+ homeostasis. The ER contains the greatest concentration of Ca2+ within the cell and maintains this concentration through the efforts of SERCA, an ATPase pump, and InsP3R, a Ca2+ transporter. Ca2+ is buffered in the lumen of the ER through the actions of calreticulin, PDI, BiP/GRP78, GRP94, calsequestrin (CSQ), ERp72, and ERcalcistorin. ER Ca2+ stores once released are refilled with STIM1 sensing Ca2+ concentration and triggering opening of the plasma membrane (PM) transporter, termed ORAI1, which increases cytoplasmic Ca2+ and allows refilling of ER Ca2+ stores. CRT, calreticulin; PDI, protein disulfide isomerise.
Michalak 2000; High et al. 2000; Molinari and Helenius 2000; Baumann and Walz 2001; Jakob et al. 2001). Ca2+-buffering proteins are necessary as the total Ca2+ concentration of the ER is in the micromolar to millimolar range. Stringent maintenance of low ER luminal free Ca2+ concentrations (below 300 μM) via Ca2+-buffering proteins is important for the preservation of cellular integrity. Many of the ER Ca2+-buffering proteins have a high Ca2+-binding capacity (>10 mol 2+ of Ca per mole of protein) coupled with low affinity (Kd = 1 mM or higher), while others have low capacity (1–2 mol of Ca2+ per mole of protein) but high affinity (Kd = 1 μM). Calreticulin utilizes an acidic region at its C-terminus as a high-capacity Ca2+ binding site, with 43 acidic residues in the last 82 amino acids of the protein, to bind 25 mol of Ca2+ per mole of protein with low affinity (Kd = 2 mM) (Baksh and Michalak 1991). Calreticulin is responsible for buffering approximately 50% of ER luminal Ca2+ (Nakamura et al. 2001). GRP94, like calreticulin, contains an acidic C-terminal region, which comprises its
c07.indd 121
5/6/2011 6:45:47 PM
122
CHAPTER 7
THE ENDOPLASMIC RETICULUM
low-affinity Ca2+ binding site. It contains approximately 19 Ca2+ binding sites, 4 of which have high affinity (Kd = 2 μM) and low capacity (1 mol of Ca2+ per mole of protein) and 15 of which have low affinity (Kd = 600 μM) but high capacity (10 mol of Ca2+ per mole of protein) and are composed of negatively charged amino acids (Van et al. 1989). While BiP/GRP78 has a relatively low capacity for binding Ca2+ (1–2 mol of Ca2+ per mole of protein), it contributes possibly as much as 25% of the total Ca2+ buffering capacity of the ER, and elevated expression causes an appreciable increase in ER Ca2+ storage capacity (Lievremont et al. 1997) (Fig. 7.2). ER resident oxidoreductases, a PDI-like family of proteins, also contribute to Ca2+ buffering in the lumen of ER. PDI utilizes